Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151211484-151227205	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol		NA	NA		51000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	19.0	18.8	16.1	11.1	16.2	7.6	14.8	15.1	19.5	13.8	14.2	18.8	6.0	16.6	12.1	19.2	14.4	8.9	27.9	16.0	16.7	20.2	12.3	14.6	11.6	18.0	16.5	15.0	15.0	14.3	17.0	10.3	17.3	16.1	10.8	10.8	14.2	10.2	61.2	16.3	13.4	14.1	16.2	15.6	16.6	18.7	16.5	11.5	13.8	20.2	15.2	19.5	13.9	16.9	33.0	50.3	18.8	66.0	36.6	31.1	25.1	40.6	33.0	49.9	42.1	47.9	22.1	57.4	34.3	42.8	40.9	25.2	58.9	47.8	49.5	28.1	48.8	23.1	26.3	27.4	43.3	58.0	35.7	42.3	39.6	54.6	34.4	21.2	40.7	32.5	68.4	22.9	43.2	80.1	60.4	70.3	46.8	37.6	54.5	40.3	30.1	50.5	35.4	24.0	32.9	31.0	39.5	37.5	26.8	19.5	16.2	29.0	40.7	31.7	12.8	39.6	61.7	46.9	54.5	42.7	43.5	56.4	60.3	7.9	11.3	3.8	13.8	13.3	19.5	11.9	14.2	13.7	13.1	13.1	13.3	13.8	1.6	14.5	15.1	9.8	15.8	14.7	16.1	16.2	15.1	19.5	16.0	16.7	18.0	16.5	17.3	16.2	16.5	16.9	4.7	0.0	0.5	10.1	15.9	27.1	25.9	22.5	14.2	17.4	0.3	0.6	23.5	7.2	9.5	0.0	8.4	29.5	10.0	28.4	0.0	0.0	47.0	0.1	0.1	12.8	6.7	18.3	12.6	0.0	28.8	13.8	16.3	0.0	10.2	0.0	12.5	12.9	20.7	10.1	12.6	9.1	12.2	10.4	11.5	55.9	10.5	6.7	19.6	7.5	6.2	14.1	14.4	7.1	10.4	0.0	18.9	14.7	14.0	29.8	15.7	0.0	6.6	16.9	13.1	25.7	15.1	31.0	12.4	21.5	25.1	32.3	10.9	0.1	15.1	19.6
AC008878.1		ENSG00000267952	"Novel transcript"		19	7507052-7519622	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 12.9;skeletal muscle: 12.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 12.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.0;ASC diff: 12.2;fHDF/TERT166: 13.7;hTERT-RPE1: 15.6;SuSa: 11.7"															NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"														"unprognostic (4.56e-1)"							"unprognostic (8.56e-2)"	0.6	0.9	2.5	0.4	3.0	0.8	1.8	2.5	12.9	4.5	2.6	0.9	0.0	0.9	0.0	0.3	2.0	0.0	0.5	2.7	2.8	2.6	0.6	0.8	0.1	2.8	3.0	0.6	0.1	0.0	0.2	0.2	2.9	0.3	0.7	5.1	0.3	0.0	12.2	0.4	0.6	0.0	2.6	1.1	0.4	0.4	3.0	0.9	0.8	1.1	0.0	0.5	0.3	2.7	0.0	0.0	11.0	1.2	12.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.6	0.0	1.1	2.6	7.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.3	15.6	4.5	0.0	0.0	0.0	3.0	0.7	0.2	0.0	0.2	3.1	0.0	2.7	3.9	2.0	4.0	0.0	0.0	3.2	1.2	1.1	0.0	11.7	0.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	2.5	12.9	2.7	2.8	2.8	3.0	2.9	2.6	3.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 98.2;skeletal muscle: 163.2;tongue: 48.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 86.2;Erythroid cells: 37.7;Exocrine glandular cells: 39.7;Horizontal cells: 55.5;Paneth cells: 118.3;Proximal enterocytes: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 13.0;K-562: 13.9;Karpas-707: 19.7;U-2 OS: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		990000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.7	20.9	2.2	16.8	7.9	2.0	37.1	32.5	5.0	0.0	7.6	4.9	2.6	0.2	2.3	3.2	1.3	12.5	8.0	98.2	8.8	4.1	4.4	3.5	66.1	54.2	4.6	4.3	4.7	8.3	0.7	72.7	8.1	1.8	5.7	7.1	1.6	163.2	1.3	9.1	0.5	26.2	3.5	2.4	3.9	58.1	3.6	2.3	48.0	1.5	1.4	3.7	10.5	0.0	0.2	0.2	0.2	0.3	0.0	7.9	0.3	0.0	0.1	0.2	13.0	0.1	0.0	0.6	0.0	1.2	0.6	2.0	0.1	0.0	4.6	0.5	0.2	0.1	0.2	0.1	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.1	13.9	19.7	0.1	4.3	0.0	0.2	1.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.8	1.5	0.1	0.8	0.0	2.9	0.0	0.0	0.2	0.5	6.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	16.8	37.1	32.5	8.0	98.2	66.1	54.2	72.7	26.2	58.1	10.5	0.5	0.0	0.0	3.3	0.5	0.8	20.9	0.9	6.2	13.5	2.9	1.1	6.4	5.7	0.4	0.0	0.0	8.2	0.9	86.2	0.0	10.5	0.0	0.5	1.5	2.1	3.5	37.7	4.7	39.7	2.6	3.0	1.5	2.4	0.0	7.4	2.2	0.4	0.8	55.5	9.7	12.0	0.0	0.3	6.6	0.4	0.6	1.7	1.8	1.0	4.6	11.4	0.0	8.5	0.8	20.1	118.3	0.7	1.8	20.4	45.6	1.1	0.1	6.8	0.0	13.5	4.9	4.1	8.0	1.7	1.0	7.1	0.6	1.4	4.6	15.2
ACTR1A	"ARP1, Arp1A"	ENSG00000138107	"Actin related protein 1A"	P61163	10	102461881-102502712	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037193, HPA047443"	Approved		Approved	Microtubules		NA	NA		560000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules		"CAB037193: AB_258253, HPA047443: AB_2680049"	"unprognostic (9.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.13e-1)"	59.4	58.8	98.3	39.4	100.6	36.8	51.5	101.9	108.4	50.9	78.4	90.0	37.8	61.8	37.5	61.6	47.4	36.1	93.0	101.9	108.0	49.0	40.4	58.5	33.7	116.3	105.9	36.9	41.9	56.5	54.7	45.3	116.9	53.0	41.7	41.9	46.4	51.9	174.3	65.1	49.1	69.0	97.4	48.7	56.2	40.4	104.0	56.8	41.2	127.0	42.2	74.8	51.2	104.4	80.5	95.8	113.5	117.1	138.0	109.2	45.5	100.3	177.3	154.4	142.4	52.7	63.3	54.4	75.2	149.5	76.2	78.3	109.9	123.7	106.5	70.7	75.8	72.9	53.4	77.9	99.6	56.9	65.0	112.4	89.6	141.2	100.7	155.7	201.6	88.7	60.5	53.5	154.6	67.1	103.5	97.9	45.4	62.5	86.2	78.5	146.0	35.0	125.2	43.9	40.5	88.8	60.1	35.4	75.1	98.3	130.0	38.9	147.0	74.7	71.5	83.6	102.1	54.0	58.8	63.3	78.7	98.3	45.9	32.2	40.7	44.3	31.1	51.8	25.5	18.8	22.0	30.4	40.6	17.6	18.0	20.7	31.2	23.9	57.0	20.8	33.6	39.2	98.3	100.6	101.9	108.4	101.9	108.0	116.3	105.9	116.9	97.4	104.0	104.4	40.0	57.7	41.0	10.1	23.4	33.8	24.0	42.3	13.1	26.6	22.1	17.1	51.6	14.3	34.8	27.6	16.7	54.9	23.8	52.4	54.8	75.5	53.0	15.3	21.0	45.2	39.6	45.9	14.9	77.5	63.3	36.9	23.4	19.3	32.3	27.3	34.6	24.1	73.9	26.9	15.5	24.4	46.8	37.6	38.2	53.9	33.2	44.5	51.6	5.6	70.3	31.5	38.1	10.1	15.3	92.0	36.8	36.1	30.0	26.7	40.9	45.6	26.5	24.5	46.0	17.1	48.5	61.9	14.0	27.3	32.4	104.7	28.2	32.9	24.2	26.6
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.4;tongue: 163.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 162.6;Excitatory neurons: 158.8;Oligodendrocytes: 180.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	19.5	42.8	64.9	5.4	72.9	7.1	15.7	74.8	85.4	10.6	61.5	14.3	7.4	11.5	12.8	10.4	11.6	8.5	63.4	63.9	72.8	14.5	28.0	10.6	10.9	69.5	68.8	9.3	12.7	13.6	26.2	6.5	70.3	14.4	5.3	24.1	15.2	9.2	207.4	9.9	9.0	7.9	70.4	12.7	12.9	10.2	70.4	10.7	12.6	163.2	8.4	14.0	10.7	76.9	11.7	5.9	6.0	4.4	23.7	17.3	3.7	11.5	9.7	8.3	7.3	1.5	7.1	21.5	33.0	12.6	7.8	8.5	3.3	10.8	7.4	14.4	13.1	13.4	6.3	16.3	8.5	12.7	6.3	13.6	19.3	5.6	9.5	15.2	3.9	9.8	5.5	11.5	17.9	7.6	7.5	17.0	5.9	8.4	6.7	5.4	4.7	12.2	18.8	10.6	17.6	10.0	17.4	10.0	5.7	1.9	3.4	13.2	10.9	11.5	10.6	3.5	11.1	21.4	12.5	10.2	16.3	24.3	12.4	41.2	14.0	26.1	16.9	13.0	15.4	29.0	16.6	16.1	20.3	26.9	20.1	16.4	11.5	18.6	13.5	33.4	16.3	11.3	64.9	72.9	74.8	85.4	63.9	72.8	69.5	68.8	70.3	70.4	70.4	76.9	21.7	16.0	17.9	84.9	30.6	20.5	41.9	52.8	18.8	15.5	49.7	65.7	162.6	34.3	32.0	18.4	10.4	13.6	27.9	24.5	62.6	24.3	86.8	29.5	23.6	23.1	30.6	14.5	158.8	38.1	6.1	21.0	26.0	19.5	19.7	17.6	30.7	74.2	31.9	28.6	134.1	21.9	36.7	40.0	28.5	64.7	13.4	25.4	23.2	59.0	26.1	90.1	24.7	67.8	180.1	29.9	18.8	30.9	36.4	27.4	29.1	55.6	32.2	31.6	52.6	30.8	30.0	22.9	9.8	28.9	21.3	10.3	22.7	29.7	18.6	45.0
ADCY2	"AC2, HBAC2, KIAA1060"	ENSG00000078295	"Adenylate cyclase 2"	Q08462	5	7396138-7830081	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 50.8;skeletal muscle: 68.3;tongue: 30.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 647.1;Excitatory neurons: 406.6;Horizontal cells: 201.9;Inhibitory neurons: 423.9;Oligodendrocyte precursor cells: 181.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 5.6;NTERA-2: 4.3;SK-MEL-30: 4.6;SuSa: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031482, HPA038015, HPA038483"	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799"	"unprognostic (6.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.03e-4)"	"unprognostic (1.94e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.09e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.92e-3)"	1.4	2.2	32.3	0.3	39.1	0.1	1.8	25.9	39.9	4.5	8.0	3.2	0.9	3.2	0.6	3.0	3.0	1.1	0.4	38.2	37.6	0.2	0.0	0.3	0.0	43.4	44.1	3.9	0.8	0.4	6.3	0.8	34.1	5.2	0.5	7.0	1.8	3.9	68.3	5.4	1.1	3.3	50.8	0.2	1.6	2.7	33.8	0.2	0.4	30.8	0.1	1.9	3.1	37.8	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	3.8	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.3	39.1	25.9	39.9	38.2	37.6	43.4	44.1	34.1	50.8	33.8	37.8	0.3	3.2	2.7	647.1	0.1	5.9	0.7	0.1	0.0	26.8	1.5	1.5	2.2	1.5	2.6	0.0	68.8	0.6	0.2	0.2	0.0	0.6	3.2	0.2	1.6	1.3	12.6	0.0	406.6	0.5	0.3	3.5	0.0	0.2	1.3	3.2	0.4	0.2	0.2	201.9	423.9	1.2	0.0	0.0	5.0	4.9	4.4	0.9	40.9	20.6	0.0	2.0	0.0	181.5	10.6	3.6	7.6	1.9	0.0	8.0	0.2	0.2	5.3	4.9	0.0	11.9	0.9	1.2	1.7	0.0	4.7	0.8	0.7	0.3	0.4	1.4
AF241726.1		ENSG00000250349	"Novel proline rich Gla (G-carboxyglutamic acid) 1 (PRRG1) and tetraspanin 7 (TSPAN7) protein"		X	37349330-38687674	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	5	"brain: 3.1;skeletal muscle: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;JURKAT: 1.4;RPTEC TERT1: 2.1"									HPA003140	Uncertain					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA003140: AB_1078454"																		0.6	0.2	0.7	0.0	1.4	0.0	0.0	2.1	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.1	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.1	0.1	0.0	4.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.1	0.0	3.1	1.1	0.2	0.2	0.1	0.4	0.2	0.0	0.2	0.6	0.1	0.3	1.4	0.2	0.0	0.9	0.2	0.1	0.1	1.2	0.7	0.1	0.3	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.7	0.4	0.2	0.2	0.1	0.4	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.1	0.0	0.2	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	2.1	0.9	0.8	0.8	1.9	1.2	1.9	1.9	1.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866486-127877675	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1346.2;tongue: 783.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.3;Late spermatids: 1031.8;Muller glia cells: 287.6;Peritubular cells: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		NA	NA		24000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	28.5	34.5	81.3	11.5	79.2	28.4	17.0	87.9	95.1	37.5	145.8	33.8	17.9	14.3	28.5	32.0	342.2	22.5	270.0	79.5	88.5	31.4	26.5	74.6	5.0	97.4	99.8	45.0	14.9	47.0	33.8	7.6	99.0	17.1	39.5	29.0	33.1	35.9	1346.2	14.2	12.1	21.9	105.0	20.8	23.9	63.1	89.4	3.9	34.8	783.3	12.6	19.7	19.4	97.2	56.7	23.6	30.1	40.4	71.2	142.9	27.4	38.3	38.2	66.7	40.4	18.0	34.9	1.5	40.8	79.4	44.1	79.2	0.3	43.1	26.6	9.0	26.1	8.3	65.2	31.6	40.1	0.0	1.0	110.9	81.8	49.9	35.5	36.8	90.3	0.8	33.7	2.3	76.7	53.5	0.1	1.1	10.6	139.7	74.2	1.3	30.0	12.6	44.8	4.1	48.3	30.4	101.0	57.4	29.8	15.3	45.8	33.3	75.9	45.9	18.8	163.8	37.3	3.5	0.6	0.2	57.7	0.3	32.4	0.2	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.2	0.1	0.9	0.0	0.3	81.3	79.2	87.9	95.1	79.5	88.5	97.4	99.8	99.0	105.0	89.4	97.2	12.8	41.7	148.1	25.8	2.6	26.4	17.2	84.5	6.2	54.6	11.5	7.9	49.7	28.6	79.4	7.3	16.7	7.5	5.7	210.1	17.6	116.7	281.3	7.3	8.0	39.8	106.3	97.0	11.1	60.9	46.8	37.3	46.4	4.8	1.3	2.7	49.2	77.3	59.3	48.8	12.0	62.7	120.1	3.7	22.3	1031.8	226.5	7.9	83.6	2.8	2.3	287.6	10.3	4.5	9.7	57.2	132.7	386.3	4.2	14.4	22.8	8.2	186.5	69.5	26.3	107.2	56.4	20.2	16.7	33.6	28.4	13.5	7.1	83.4	65.5	25.3
AKAP6	"ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6"	ENSG00000151320	"A-kinase anchoring protein 6"	Q13023	14	32329298-32837684	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.8;heart muscle: 54.6;skeletal muscle: 47.5;tongue: 50.7"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 601.6;Inhibitory neurons: 663.1;Oligodendrocyte precursor cells: 412.7;Oligodendrocytes: 1162.5"	"Cancer enhanced"	"Detected in many"		"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"naive B-cell: 3.5"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001983, HPA048741"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB001983: , HPA048741: AB_2680506"	"unprognostic (1.99e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.81e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.54e-1)"	"unprognostic (3.33e-16)"	"unprognostic (8.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.79e-3)"	1.6	5.6	21.0	2.5	31.4	0.5	4.6	20.3	24.6	1.6	0.0	5.5	1.8	3.9	5.6	5.4	2.9	3.7	54.6	16.9	36.7	2.9	2.1	2.3	0.8	52.0	34.9	2.5	0.8	3.5	3.6	4.5	51.9	2.0	2.2	13.6	2.6	1.2	47.5	1.2	2.4	7.7	22.4	0.8	2.0	5.9	34.8	0.9	4.8	50.7	0.7	4.2	1.5	59.8	0.3	0.8	1.0	0.9	0.2	1.7	0.2	1.3	3.6	0.2	0.4	1.1	1.0	1.4	0.9	15.8	0.6	0.8	1.2	1.4	0.5	1.3	1.0	1.3	1.5	1.1	0.5	0.1	0.3	1.8	1.3	0.0	0.4	0.6	0.1	2.1	0.3	4.1	1.1	0.8	0.7	0.2	0.2	1.1	1.1	0.7	4.9	0.6	0.4	1.2	5.2	4.2	1.1	0.7	3.2	0.7	2.9	0.1	0.3	0.2	0.8	0.8	0.5	2.5	2.4	0.6	1.5	0.1	5.4	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	3.5	0.4	0.6	0.5	0.1	0.1	0.4	0.0	0.3	21.0	31.4	20.3	24.6	16.9	36.7	52.0	34.9	51.9	22.4	34.8	59.8	0.6	6.4	2.7	111.3	2.2	2.3	2.9	1.0	5.2	49.2	8.7	3.0	108.0	0.0	4.9	1.8	50.1	0.8	0.1	1.1	0.0	0.8	32.4	6.7	0.4	1.7	1.2	0.0	601.6	0.5	0.3	6.3	0.0	1.4	1.3	0.6	1.1	2.7	1.2	26.9	663.1	0.6	4.1	0.6	1.6	13.7	14.6	1.1	7.2	23.4	0.7	2.5	0.0	412.7	1162.5	0.3	0.1	33.1	2.0	1.1	1.9	1.5	23.6	21.5	19.7	25.8	14.3	25.9	1.3	1.1	1.6	0.4	0.6	3.4	0.9	0.9
AKT1S1	"Lobe, MGC2865, PRAS40"	ENSG00000204673	"AKT1 substrate 1"	Q96B36	19	49869033-49878459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021903, HPA043590, HPA064427"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB021903: , HPA043590: AB_2678569, HPA064427: AB_2685261"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.60e-4)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.65e-1)"	39.0	54.0	35.6	14.2	37.9	14.3	34.9	37.2	41.0	33.1	28.6	40.3	21.8	39.1	14.3	53.2	32.6	12.4	47.1	34.7	36.6	36.2	65.9	25.6	8.7	40.5	41.4	33.1	39.2	24.4	34.2	16.7	40.5	35.0	14.1	6.6	32.8	20.0	118.3	54.0	29.3	17.6	33.9	24.6	40.5	24.0	39.5	8.2	31.4	45.4	9.7	38.5	33.2	39.4	70.9	83.8	24.1	56.0	50.2	53.4	42.5	62.2	69.4	57.4	49.4	45.7	46.0	14.1	31.1	70.6	43.5	47.9	41.9	70.5	33.5	32.2	116.6	17.0	48.2	43.5	44.6	14.9	26.8	65.9	64.0	62.3	70.2	43.0	53.9	16.8	57.0	18.2	52.5	49.5	14.0	36.7	63.0	85.7	120.9	17.1	33.8	43.2	57.9	49.3	56.2	65.4	53.2	93.7	39.9	28.1	49.1	28.9	52.5	118.1	61.7	34.2	62.1	26.4	69.8	15.2	68.4	27.2	57.5	0.1	1.1	0.9	0.7	1.4	0.4	0.4	0.5	0.7	0.8	0.7	0.4	0.7	1.7	0.7	1.6	1.2	1.0	0.6	35.6	37.9	37.2	41.0	34.7	36.6	40.5	41.4	40.5	33.9	39.5	39.4	20.7	0.0	3.3	7.2	15.1	14.7	22.9	33.8	18.8	12.6	31.2	22.6	6.2	27.1	15.5	11.0	2.1	64.0	10.7	56.1	45.0	36.8	24.8	18.2	22.9	20.6	30.0	42.5	4.1	40.2	52.3	23.5	32.1	25.3	4.5	18.6	17.9	42.8	31.1	10.1	4.9	38.8	30.5	20.7	22.8	10.8	23.9	16.6	12.4	4.7	26.9	32.9	15.5	2.5	8.1	34.5	32.9	28.6	17.1	43.3	57.1	55.8	7.2	11.7	26.3	23.7	25.3	12.3	19.3	32.1	20.0	130.0	9.4	26.5	38.1	31.3
AL139353.1		ENSG00000203546	"Novel protein"		14	31334312-31457441	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.1;skeletal muscle: 1.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Breast glandular cells: 3.2;Breast myoepithelial cells: 5.8;Cytotrophoblasts: 4.6;Distal tubular cells: 3.9;Proximal tubular cells: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"		"Cluster 7: Non-specific - Mitochondria"				"unprognostic (2.86e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.63e-3)"	"unprognostic (8.26e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.10e-2)"	1.1	0.1	0.2	0.0	0.3	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.1	0.7	0.2	0.1	0.0	1.3	0.0	0.6	0.5	0.0	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.2	3.2	2.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.2	5.8	0.0	0.0	0.6	1.8	0.0	4.6	0.4	0.0	3.9	1.5	0.0	2.5	1.6	0.6	0.0	0.0	0.0	1.3	1.6	1.1	0.0	0.7	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	6.5	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.5	0.3	1.1	0.0	0.0
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutarate dependent dioxygenase"	Q96Q83	11	43880811-43920274	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 90.9;Late spermatids: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	20.6	15.7	14.6	9.1	16.0	7.9	20.6	18.3	20.9	21.3	15.7	18.3	10.9	20.5	24.7	18.5	19.5	9.2	15.3	15.3	15.4	16.7	18.5	13.2	13.8	15.5	15.2	22.9	23.6	16.9	18.2	7.3	15.3	21.9	12.8	17.0	19.3	13.5	35.2	23.4	15.9	13.6	15.3	19.6	20.0	20.4	15.2	15.9	15.3	25.8	14.6	19.2	19.9	17.6	15.8	26.0	10.7	0.0	20.3	26.1	0.0	19.5	42.0	36.9	34.7	10.7	12.0	2.6	12.2	28.7	20.5	21.3	14.6	32.3	33.1	0.0	49.6	23.7	17.1	27.4	51.9	44.5	30.5	27.8	55.7	17.0	81.4	15.2	26.5	44.7	33.9	25.9	18.3	18.4	38.6	21.9	20.6	16.2	38.5	11.6	23.8	30.3	21.3	23.2	20.3	16.1	15.7	22.6	37.1	9.7	32.9	26.3	20.6	21.6	12.5	35.7	28.0	23.1	25.1	26.3	31.3	18.3	17.6	34.4	16.4	9.4	19.8	18.4	19.3	18.6	20.9	18.2	23.5	21.8	24.8	22.9	2.9	24.6	29.4	20.9	21.3	17.4	14.6	16.0	18.3	20.9	15.3	15.4	15.5	15.2	15.3	15.3	15.2	17.6	12.0	16.0	10.9	15.0	12.6	10.3	8.8	16.5	10.8	11.5	10.9	12.8	6.8	14.3	13.3	16.5	4.2	3.4	13.7	9.8	31.3	24.6	90.9	6.3	7.3	14.6	9.5	9.9	15.8	32.6	4.6	14.0	10.2	4.8	7.6	12.5	13.2	12.9	19.0	10.1	15.8	11.3	6.1	11.2	7.0	103.3	16.1	13.1	17.8	3.7	14.1	20.4	22.6	13.0	16.1	27.7	8.6	10.5	12.4	9.3	15.5	17.1	14.0	13.0	6.6	9.9	15.3	29.3	12.6	20.6	7.1	2.2	12.7	15.7	12.5	8.3
AOPEP	"AP-O, APO, C90RF3, C9orf3, FLJ14675"	ENSG00000148120	"Aminopeptidase O (putative)"	Q8N6M6	9	94726604-95087159	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 148.2;Cytotrophoblasts: 65.9;Extravillous trophoblasts: 43.7;Syncytiotrophoblasts: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	5.6	6.6	11.8	4.9	20.4	2.2	7.0	16.9	16.3	8.1	23.8	6.9	4.3	18.5	8.3	16.9	10.3	12.1	29.4	15.9	15.5	7.2	7.6	10.4	2.2	23.0	15.7	8.1	11.2	16.3	5.7	24.3	20.7	14.3	5.8	4.7	12.2	15.2	30.5	38.6	5.0	15.8	11.1	5.0	5.7	6.0	15.4	2.6	11.2	15.3	5.6	7.7	6.8	40.5	6.8	27.6	3.3	5.3	3.4	3.8	12.4	6.4	3.0	6.3	4.1	6.3	8.7	2.1	5.3	9.8	8.7	24.8	5.7	6.1	3.4	13.2	4.9	2.0	30.1	5.8	6.1	1.8	1.4	4.4	23.7	5.5	4.1	17.7	3.5	3.3	3.4	3.0	11.4	10.1	2.8	2.3	4.4	7.8	10.7	4.2	9.4	2.7	11.0	6.4	6.6	9.7	11.2	9.4	2.5	8.5	10.8	1.5	2.7	2.9	2.8	10.8	3.4	2.5	3.6	1.0	9.8	1.7	4.8	0.0	1.4	0.9	1.4	1.0	0.8	0.9	1.1	1.2	2.2	2.2	0.8	1.0	0.5	1.4	0.7	2.1	0.8	0.7	11.8	20.4	16.9	16.3	15.9	15.5	23.0	15.7	20.7	11.1	15.4	40.5	20.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.2	0.0	0.0	0.0	0.0	65.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	43.7	13.8	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	88.2	0.2	0.0	0.0	0.0
ARFGAP2	"FLJ14576, IRZ, Zfp289, ZNF289"	ENSG00000149182	"ADP ribosylation factor GTPase activating protein 2"	Q8N6H7	11	47164299-47177125	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016649, HPA018152"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA016649: AB_1844980, HPA018152: AB_1844979"	"unprognostic (1.69e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.00e-2)"	"prognostic favorable (7.65e-7)"	"unprognostic (2.05e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.20e-2)"	38.0	51.4	62.1	36.3	63.9	82.2	41.7	63.2	68.3	42.3	57.2	49.4	40.0	43.3	35.5	60.8	49.3	32.1	58.7	62.5	60.1	47.6	76.8	40.7	51.9	65.1	61.8	44.6	69.7	48.2	38.7	39.9	61.8	51.4	39.4	38.9	56.1	41.7	115.9	78.7	43.8	38.8	60.6	51.2	55.7	30.7	63.1	49.8	47.4	81.4	50.5	44.7	43.3	70.3	55.7	36.4	54.9	43.3	45.9	37.3	51.6	51.2	48.1	64.1	48.4	41.3	45.3	91.3	32.4	58.7	40.8	82.3	47.2	74.6	40.3	45.0	46.1	77.6	85.5	50.8	53.7	107.0	84.4	56.7	82.3	33.3	71.1	46.1	60.4	65.6	111.8	67.8	58.5	102.5	50.8	87.8	43.6	98.3	48.4	78.8	94.8	116.8	60.3	79.3	53.0	47.0	58.7	81.7	38.8	26.1	126.8	78.8	48.7	55.2	43.3	50.5	68.6	58.6	60.7	78.3	38.6	81.2	56.4	108.5	69.1	92.8	74.0	77.3	66.6	59.0	57.1	66.2	65.9	63.1	63.0	63.4	41.8	69.2	98.4	35.4	71.8	108.1	62.1	63.9	63.2	68.3	62.5	60.1	65.1	61.8	61.8	60.6	63.1	70.3	23.8	35.3	45.9	25.1	46.5	22.2	31.4	22.1	29.6	73.6	30.9	25.8	13.0	20.0	41.2	31.3	114.7	64.3	40.7	38.6	25.4	38.7	2.7	20.3	26.4	29.8	45.4	47.1	16.2	36.6	47.1	29.7	34.1	27.0	60.8	44.9	31.1	44.0	36.8	74.0	15.1	35.0	38.7	33.6	25.4	6.6	34.2	28.6	28.4	15.9	58.1	51.1	71.1	13.0	23.7	39.2	45.0	26.4	31.7	26.4	41.0	26.3	34.1	115.4	39.5	33.0	28.0	24.7	35.9	30.3	26.7	91.8	43.7	40.3	36.3	34.0
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014160-65022184	"FDA approved drug targets, Predicted intracellular proteins"	"Cell cycle"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	124.8	93.7	161.5	40.6	190.2	51.3	112.0	172.4	200.2	106.3	132.3	123.1	52.7	121.2	28.2	67.2	94.6	48.0	169.1	157.0	168.7	138.5	22.5	90.4	37.7	171.5	167.9	95.7	75.3	65.3	68.5	56.1	167.2	84.7	32.9	43.5	67.9	66.6	214.2	95.8	73.4	60.9	171.4	63.4	85.2	116.1	167.4	33.5	85.7	158.1	29.0	112.2	93.5	184.4	162.0	257.0	76.5	115.8	207.4	156.5	70.5	82.5	181.7	111.2	109.1	72.8	110.0	62.1	144.5	112.7	168.1	101.4	82.9	140.0	53.1	65.5	130.6	61.9	109.2	111.9	157.8	77.9	54.9	123.7	114.6	92.6	204.4	160.5	150.4	74.0	152.8	110.1	76.4	194.1	63.1	174.5	120.3	77.7	208.6	33.4	81.6	152.9	120.9	70.6	143.3	79.3	66.4	67.6	225.8	74.4	72.3	94.3	109.2	205.9	68.6	164.7	82.1	37.9	57.6	38.5	97.2	112.5	171.3	46.5	78.2	72.5	120.4	80.2	130.9	163.1	110.0	116.9	101.7	149.0	123.5	137.2	10.2	83.3	48.2	140.1	79.0	136.9	161.5	190.2	172.4	200.2	157.0	168.7	171.5	167.9	167.2	171.4	167.4	184.4	179.1	22.4	43.6	0.0	42.7	81.4	94.4	118.4	63.7	70.2	66.8	83.9	103.2	51.5	66.4	82.8	29.2	179.7	40.0	110.0	268.0	142.0	430.8	42.2	59.0	148.0	83.3	69.4	0.0	76.0	193.5	107.0	29.6	50.7	95.7	71.5	137.4	19.7	98.3	69.0	0.0	68.4	83.4	49.7	73.5	1125.1	71.7	49.5	177.9	0.0	100.6	208.4	55.6	0.0	0.0	68.3	115.7	71.1	16.5	79.9	162.4	505.5	47.0	48.9	65.7	74.2	109.7	126.5	79.4	56.3	82.8	107.3	40.0	65.7	98.0	75.9
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 114.2;B-cells: 80.3;Cholangiocytes: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 57.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"	65.8	10.7	50.9	23.7	61.3	80.0	49.8	52.9	67.2	31.7	34.2	30.8	12.2	22.8	7.7	22.1	27.7	22.8	34.4	43.2	48.4	32.9	20.4	75.0	38.7	64.7	61.1	13.7	16.5	71.6	17.2	14.4	58.0	33.6	12.1	1.3	44.2	18.8	204.8	30.7	43.4	11.1	50.4	58.4	27.7	5.2	53.1	24.8	44.0	49.3	35.0	32.6	32.0	81.3	12.1	21.2	0.4	10.6	8.5	7.8	8.4	6.8	19.3	5.6	5.5	4.8	22.9	22.1	18.9	5.8	9.1	7.9	8.4	6.2	4.4	14.5	12.3	16.8	18.0	6.8	7.8	12.9	24.0	8.4	9.6	6.5	9.9	10.5	9.6	13.9	19.7	0.6	5.4	18.4	9.8	35.6	2.7	26.4	34.9	57.7	0.2	16.8	8.1	11.0	5.0	5.2	11.1	11.0	11.5	1.7	6.7	32.5	21.1	9.7	7.5	32.9	8.6	1.6	0.1	24.8	15.5	48.6	7.7	3.7	5.8	3.6	3.6	4.8	2.5	3.4	6.1	4.6	3.0	5.3	14.1	7.5	2.3	6.6	5.7	1.8	5.1	4.4	50.9	61.3	52.9	67.2	43.2	48.4	64.7	61.1	58.0	50.4	53.1	81.3	114.2	16.0	15.5	1.6	80.3	6.4	19.8	14.0	13.1	0.4	16.7	11.0	7.3	64.3	15.8	9.2	0.0	0.7	47.7	12.7	1.9	10.8	0.8	10.7	13.0	29.9	18.5	44.6	3.8	6.2	7.8	9.2	23.4	29.8	26.6	3.3	17.2	7.0	17.9	0.0	0.5	12.3	16.2	31.0	58.7	1.2	4.7	50.3	5.4	9.4	14.5	1.1	13.4	0.5	20.0	15.4	9.4	7.5	13.6	24.9	3.5	0.5	15.9	0.4	13.1	14.0	15.9	0.5	3.9	7.6	7.1	1.2	38.6	5.0	5.6	26.7
ART3	ARTC3	ENSG00000156219	"ADP-ribosyltransferase 3 (inactive)"	Q13508	4	76011184-76112802	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 67.3;skeletal muscle: 220.2;testis: 96.4;tongue: 101.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 76.2;Spermatocytes: 262.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"NB-4: 5.5;NTERA-2: 14.1;SK-MEL-30: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		48000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	1.0	0.4	3.4	1.1	4.2	0.0	0.9	6.9	9.4	2.2	4.0	3.7	0.3	0.3	0.5	4.7	0.9	0.2	67.3	4.7	4.6	0.2	0.2	0.4	0.3	3.3	3.3	0.4	7.9	0.1	2.5	0.1	2.8	2.0	2.2	0.2	3.1	1.3	220.2	0.9	2.3	0.4	3.5	2.7	1.9	96.4	2.7	0.6	0.3	101.6	0.1	0.7	1.7	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	14.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	6.9	9.4	4.7	4.6	3.3	3.3	2.8	3.5	2.7	9.9	0.4	0.0	0.0	0.7	0.1	0.5	0.5	1.1	0.0	0.5	0.2	0.3	76.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.3	2.1	0.4	0.8	0.0	0.0	37.9	0.0	0.1	2.6	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.4	13.5	1.8	0.2	1.8	0.0	0.0	0.3	0.0	5.0	7.3	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.3	0.0	21.7	2.7	262.8	24.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.4;ovary: 78.7;skeletal muscle: 26.7"	"Group enriched"	"Detected in some"	5	"Enteroendocrine cells: 83.7;Inhibitory neurons: 53.2;Leydig cells: 131.7;Peritubular cells: 70.0;Theca cells: 66.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.9;PC-3: 3.9;THP-1: 1.7;U-266/70: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"				"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.0	0.1	7.6	0.0	10.1	0.0	0.3	0.0	17.4	0.0	0.0	0.9	3.5	0.0	0.1	0.1	1.1	0.0	0.0	10.1	6.0	0.1	0.0	0.4	0.0	0.0	0.0	78.7	1.4	1.8	0.3	0.0	0.1	0.7	0.9	0.0	0.2	0.0	26.7	0.0	0.7	0.0	0.0	0.2	5.5	7.2	0.4	0.0	0.2	1.9	0.4	0.0	0.2	8.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	3.9	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.1	0.0	0.0	8.3	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	10.1	0.0	17.4	10.1	6.0	0.0	0.0	0.1	0.0	0.4	8.0	0.0	0.0	0.0	14.0	0.3	0.0	2.5	0.5	0.0	0.0	0.3	0.0	0.5	0.0	2.2	0.0	0.0	0.2	0.1	1.9	0.0	0.0	1.2	0.0	0.0	0.1	83.7	0.0	0.2	0.0	2.4	4.7	4.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	53.2	3.6	4.1	0.0	0.0	3.6	131.7	0.2	0.0	3.7	0.0	0.0	0.0	3.5	0.6	0.3	0.8	70.0	0.9	1.3	0.1	0.1	11.3	0.0	0.0	1.5	0.3	0.5	0.3	0.0	0.0	0.1	0.3	66.8	1.9	1.6
ASB1	ASB-1	ENSG00000065802	"Ankyrin repeat and SOCS box containing 1"	Q9Y576	2	238426742-238452250	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003508	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA003508: AB_1845065"	"unprognostic (1.02e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (4.04e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-1)"	6.6	5.5	19.1	7.3	18.8	2.9	5.3	14.6	18.1	8.9	9.7	10.1	3.9	10.7	3.7	5.0	8.6	5.3	16.2	17.0	18.6	6.2	6.4	6.4	8.0	18.1	20.0	10.2	5.9	8.4	7.6	3.2	19.5	7.5	4.7	5.5	5.4	7.9	21.1	5.7	8.3	8.1	18.9	7.8	8.0	10.7	19.3	6.7	5.8	23.3	8.5	8.1	6.5	17.1	11.1	15.7	21.2	17.0	13.3	14.0	17.1	29.9	19.8	17.7	19.8	7.7	7.7	9.6	4.0	28.2	39.3	12.0	21.1	47.7	27.7	24.3	17.2	12.1	15.2	19.3	31.1	16.8	15.5	15.0	21.7	51.7	69.7	27.8	7.7	16.7	25.9	6.3	32.9	7.6	9.2	17.8	22.6	9.7	13.2	13.3	43.1	6.4	12.9	15.1	17.1	23.2	9.4	6.9	15.7	12.7	5.2	17.9	16.6	31.8	20.6	25.1	59.9	22.8	15.2	16.5	50.2	5.3	16.2	0.0	0.5	1.0	4.2	0.7	2.2	4.3	3.0	4.1	0.6	2.1	2.5	3.0	0.2	2.1	0.4	2.8	4.1	1.3	19.1	18.8	14.6	18.1	17.0	18.6	18.1	20.0	19.5	18.9	19.3	17.1	2.3	9.6	3.7	7.8	12.2	7.9	27.5	16.4	7.4	10.0	7.4	7.1	45.3	15.7	11.3	9.2	4.2	12.3	12.8	5.2	1.9	15.8	35.2	9.8	8.1	4.0	12.7	19.1	6.1	21.0	28.6	15.0	14.8	4.6	15.9	7.6	5.0	12.5	23.7	10.1	6.1	6.6	10.2	9.5	4.3	19.5	7.8	10.4	7.2	3.7	12.3	9.8	11.3	6.6	8.5	30.4	16.3	14.7	18.5	20.1	8.4	11.3	18.4	6.5	26.3	10.6	16.0	52.1	37.4	7.2	6.8	5.7	13.9	9.9	7.1	15.4
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155563162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	14.1	12.8	21.3	8.5	23.4	11.9	16.8	27.0	25.7	14.4	14.8	13.0	9.7	14.4	20.8	9.2	11.4	9.0	12.6	23.8	19.2	13.9	10.0	10.3	10.9	18.7	19.8	21.3	9.9	18.2	8.4	10.3	18.9	15.7	11.5	26.2	14.8	15.4	30.3	20.4	10.2	12.7	19.3	10.5	11.9	6.8	20.7	12.1	15.8	24.3	9.7	11.7	10.0	23.4	17.2	12.3	9.5	9.4	28.0	22.8	9.6	14.7	13.5	8.3	6.5	10.5	12.3	5.4	14.2	17.0	5.4	19.2	13.6	12.6	13.6	7.6	8.9	8.0	13.2	9.8	14.5	8.8	6.6	16.2	18.0	13.6	15.0	17.1	11.0	6.0	12.3	8.3	18.8	19.0	6.4	8.8	8.3	28.8	13.1	6.1	18.5	10.4	18.6	16.0	9.1	14.3	20.1	25.9	12.9	9.3	16.6	26.6	17.4	13.6	15.8	13.4	17.9	8.0	5.3	8.9	10.7	9.1	13.1	1.0	0.4	0.8	0.7	0.2	0.5	0.9	0.5	0.5	0.2	0.8	0.8	0.5	1.0	0.6	0.1	0.7	0.9	0.2	21.3	23.4	27.0	25.7	23.8	19.2	18.7	19.8	18.9	19.3	20.7	23.4	96.5	60.9	103.2	171.7	108.3	103.9	97.4	52.9	109.3	147.6	75.9	58.3	107.8	50.1	82.7	51.5	202.3	53.6	83.3	76.2	17.6	41.5	25.9	72.0	107.4	77.6	67.5	46.7	220.6	39.8	25.2	93.7	101.4	87.9	81.1	72.3	63.1	39.0	24.6	114.4	211.8	59.0	26.4	42.1	106.9	22.8	102.2	69.1	53.4	203.3	85.2	68.4	89.6	190.5	265.0	37.5	64.8	118.8	110.1	112.0	68.9	31.0	47.1	116.7	98.6	134.4	104.6	85.6	56.1	80.9	112.0	76.2	98.7	87.3	60.2	111.6
ATF7	ATFA	ENSG00000170653	"Activating transcription factor 7"	P17544	12	53507856-53626410	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003384	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.59e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.28e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.17e-1)"	26.4	13.2	12.4	18.1	19.6	15.4	23.9	26.1	16.7	21.1	11.5	21.9	12.6	24.4	14.5	22.4	17.8	18.1	20.6	15.1	15.5	17.4	14.6	20.2	13.2	20.8	16.9	24.6	18.4	14.2	11.5	18.3	21.8	19.0	21.1	15.3	24.2	14.6	30.5	24.6	14.0	25.9	14.8	14.3	18.0	12.6	18.2	16.4	16.4	22.2	15.7	19.9	20.9	29.1	16.6	32.1	16.6	18.2	30.8	39.1	10.8	19.6	20.1	21.3	14.2	23.0	25.2	25.8	25.4	24.2	8.7	20.2	13.0	21.7	19.2	25.2	16.7	22.6	37.4	24.8	20.7	29.0	16.1	30.7	28.1	26.5	29.9	35.3	42.6	14.0	26.0	23.2	32.1	30.9	17.6	20.2	16.3	18.7	17.4	22.9	19.7	24.9	32.3	21.2	13.8	14.6	29.9	21.7	30.8	16.0	29.2	17.6	31.4	25.2	17.7	20.2	17.9	11.4	14.6	16.2	20.6	27.1	23.6	15.3	13.8	13.8	7.4	19.1	7.6	10.5	10.1	7.5	10.8	11.5	7.2	8.6	8.6	14.2	14.1	7.5	10.4	8.8	12.4	19.6	26.1	16.7	15.1	15.5	20.8	16.9	21.8	14.8	18.2	29.1	30.5	12.8	17.3	83.2	16.3	22.2	24.0	35.9	25.6	9.4	33.3	31.1	18.2	22.8	23.4	14.7	25.0	22.2	14.0	21.4	37.2	30.3	32.2	16.5	23.1	25.4	18.6	13.2	29.0	31.6	25.0	23.8	17.3	22.5	28.6	25.0	28.9	14.7	25.3	10.1	29.7	20.3	24.4	24.1	23.1	35.8	27.1	24.9	24.9	55.3	24.0	23.9	17.5	40.7	141.9	27.5	13.8	24.5	12.5	25.0	17.9	46.0	17.0	10.9	26.3	25.6	27.5	9.9	17.9	34.1	28.8	27.9	17.3	20.2	18.4	28.9
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.8;Late spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059551	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA059551: AB_2684060"	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	25.6	23.6	27.2	17.3	29.0	44.7	19.2	27.8	36.6	19.5	10.0	25.6	31.4	24.1	14.2	31.4	18.8	21.8	42.1	30.0	24.3	20.0	25.9	23.7	19.4	29.0	26.7	20.4	28.1	31.2	17.6	30.7	26.2	21.6	21.8	24.6	23.9	22.8	116.8	32.1	29.7	28.1	24.3	21.7	22.8	62.2	27.6	15.7	18.4	62.7	21.2	22.7	22.7	28.6	29.4	35.7	26.9	64.0	50.3	55.1	35.9	52.1	56.1	67.3	60.2	52.9	38.8	7.7	43.7	79.8	54.7	58.0	43.2	56.9	49.6	22.6	70.7	55.7	90.1	63.9	54.9	14.1	40.6	56.7	91.4	68.7	63.0	60.9	68.2	18.6	75.6	27.0	46.2	38.3	12.2	33.4	19.5	28.5	26.9	16.9	36.7	30.2	40.0	38.6	42.6	25.7	52.0	46.7	46.5	52.0	17.3	39.3	52.5	67.0	32.3	28.7	47.1	15.5	14.7	11.2	55.7	33.9	37.2	6.5	12.4	6.3	7.2	18.0	7.2	5.6	5.6	9.1	8.5	3.6	5.4	6.1	11.2	9.7	22.6	4.1	7.1	11.6	27.2	29.0	27.8	36.6	30.0	24.3	29.0	26.7	26.2	24.3	27.6	28.6	0.3	0.0	4.5	12.7	8.2	7.8	7.6	10.6	8.6	18.9	0.3	0.3	33.2	17.2	7.1	0.0	14.6	26.8	4.1	44.0	0.0	0.2	83.8	0.6	1.5	10.0	13.8	34.7	15.2	0.5	24.4	9.1	11.7	0.8	10.2	0.3	16.8	37.1	11.5	21.9	14.1	17.6	6.1	13.3	7.0	105.9	14.0	4.8	10.6	5.6	7.0	20.5	9.2	9.5	12.5	0.3	27.6	8.6	6.7	13.4	39.3	0.3	4.7	15.7	13.1	7.1	5.5	54.9	13.8	14.2	11.1	34.8	7.5	0.8	18.5	10.5
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 515.9;skeletal muscle: 882.2;tongue: 478.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 515.8;Cardiomyocytes: 158.7;Microglial cells: 141.5;Muller glia cells: 73.0;Oligodendrocyte precursor cells: 94.0;Sertoli cells: 85.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 51.9;HHSteC: 14.6;RH-30: 16.8;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"							CAB022230	Enhanced					NA	NA		170000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	37.4	4.1	401.5	1.5	480.5	0.0	27.4	419.8	412.8	9.3	164.9	55.8	3.6	5.6	12.5	33.5	14.5	8.0	144.6	337.4	398.5	3.9	1.2	6.4	0.3	429.5	478.8	18.9	1.4	0.3	32.3	3.3	375.3	28.5	8.1	58.5	18.2	28.5	882.2	4.7	15.9	7.8	365.0	1.8	15.7	5.8	515.9	0.6	3.5	478.0	0.5	29.9	9.8	327.7	0.0	0.0	51.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	4.6	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	401.5	480.5	419.8	412.8	337.4	398.5	429.5	478.8	375.3	365.0	515.9	327.7	1.4	0.0	0.0	515.8	0.1	0.5	1.6	0.0	0.6	1.3	2.5	0.9	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	1.2	11.1	0.0	0.0	5.5	0.0	0.0	4.8	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.3	1.4	28.9	0.5	0.0	141.5	0.5	73.0	0.0	94.0	2.5	0.0	0.0	39.5	0.0	0.8	0.0	0.1	0.1	3.9	85.5	54.9	45.8	0.3	0.2	0.2	0.6	0.1	0.1	5.8	0.0	0.6
ATP5MC2	ATP5G2	ENSG00000135390	"ATP synthase membrane subunit c locus 2"	Q06055	12	53632726-53677408	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1335.2;Breast myoepithelial cells: 1873.6;Distal tubular cells: 1762.9;Hofbauer cells: 1076.1;Proximal tubular cells: 2061.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA051469	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA051469: AB_2681496"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (3.78e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.09e-2)"	250.6	297.8	487.0	240.0	510.5	445.5	485.5	498.2	574.6	338.4	492.0	444.0	383.6	279.1	463.7	340.5	533.7	296.1	759.6	475.9	499.0	437.4	469.4	243.6	406.4	509.5	488.1	487.2	499.1	503.0	18.9	265.3	507.8	322.2	551.7	275.9	483.0	284.9	1405.5	345.5	322.5	361.1	504.7	295.8	312.1	126.9	500.7	453.9	314.0	1447.2	540.2	365.6	15.2	519.7	325.4	684.8	701.3	640.3	478.0	1162.4	330.7	278.3	630.3	824.5	561.2	236.2	745.1	392.9	668.3	554.8	263.9	304.7	914.6	652.8	729.3	660.9	1096.7	1068.7	515.2	495.7	1034.1	819.7	508.5	1297.4	956.8	797.0	1315.9	1313.7	1078.7	468.0	776.8	1116.6	852.6	857.0	842.8	1996.5	603.6	681.5	756.7	838.3	665.2	981.9	1019.4	407.0	365.8	669.0	376.5	431.6	974.2	610.1	1403.7	1473.7	512.5	396.4	542.2	307.5	441.4	577.6	537.6	288.1	589.9	863.0	620.2	367.7	977.3	281.8	645.6	924.4	710.5	1119.6	826.1	693.6	1324.3	974.6	896.6	755.0	214.2	769.1	849.6	1023.6	955.8	1565.2	487.0	510.5	498.2	574.6	475.9	499.0	509.5	488.1	507.8	504.7	500.7	519.7	412.1	182.7	266.7	0.0	167.8	0.0	0.0	0.0	0.0	0.0	1335.2	1873.6	0.0	0.0	177.0	527.8	0.0	732.4	297.0	0.0	1762.9	470.7	0.0	529.1	446.9	190.2	0.0	0.0	0.0	676.5	777.5	222.2	0.0	454.1	224.5	715.4	0.0	0.0	1076.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	358.0	0.0	0.0	380.9	0.0	0.0	0.0	0.0	392.7	0.0	0.0	52.8	0.0	0.0	2061.3	215.7	0.0	0.0	0.0	248.9	0.0	0.0	0.0	0.0	507.7	182.6	802.8	0.0	0.0
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		3100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	29.0	19.0	61.4	13.0	55.0	6.6	24.6	48.0	70.1	28.4	44.0	43.7	12.5	31.0	9.6	32.4	20.0	14.9	40.8	58.4	51.6	24.6	38.8	19.6	5.9	53.6	53.6	19.6	51.5	14.2	24.7	10.1	53.0	31.2	10.2	8.9	27.3	23.8	61.0	32.8	15.2	26.3	52.6	12.0	22.4	22.6	55.2	3.1	14.3	33.2	6.8	37.0	26.8	52.6	61.6	38.4	45.3	76.0	51.3	54.5	37.8	54.2	55.9	54.8	50.9	30.4	51.4	38.4	31.6	112.3	52.5	39.9	36.8	72.8	14.0	39.6	80.2	23.2	37.8	66.9	43.2	20.6	0.8	47.0	79.1	39.3	71.4	55.3	65.5	15.9	51.7	25.3	46.7	45.3	15.3	18.6	65.6	35.7	56.7	44.3	48.2	62.7	33.9	29.3	72.7	58.5	31.1	89.4	38.5	16.9	38.6	17.5	39.3	90.8	102.4	63.8	78.5	7.6	17.8	15.9	40.4	16.9	64.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	61.4	55.0	48.0	70.1	58.4	51.6	53.6	53.6	53.0	52.6	55.2	52.6	9.7	0.0	8.8	7.5	2.2	7.8	10.3	10.8	1.8	13.3	15.0	18.9	14.0	7.2	7.4	14.7	4.2	2.0	1.2	10.2	1.9	13.3	16.4	6.2	16.2	10.4	16.3	1.3	8.0	20.6	8.0	15.2	13.7	8.7	0.0	23.8	6.1	18.7	2.3	18.5	5.6	22.6	2.0	1.0	3.3	6.7	16.4	1.5	3.6	1.0	1.6	15.0	0.0	5.0	9.8	27.3	6.1	12.4	5.0	25.9	6.4	8.8	4.4	12.2	6.6	9.8	14.3	6.2	15.6	7.6	12.6	0.5	1.7	21.1	15.3	16.1
BANF1	BAF	ENSG00000175334	"BAF nuclear assembly factor 1"	O75531	11	66002228-66004149	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: AB_2676409"	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	116.4	149.0	252.8	144.8	256.8	127.2	151.4	261.0	312.9	135.4	248.4	153.7	107.2	168.0	248.5	136.0	279.6	100.9	272.2	249.9	259.6	115.6	174.0	111.3	178.5	258.4	254.4	207.6	132.5	148.8	69.0	120.8	261.1	139.2	155.9	98.7	148.2	169.7	582.1	121.0	105.0	190.0	258.5	116.0	92.7	111.1	254.8	220.7	164.6	394.8	211.9	140.6	82.4	274.5	665.5	712.0	452.8	427.9	237.7	306.5	220.5	364.7	349.4	715.9	447.0	415.3	496.1	606.5	651.8	503.3	544.0	433.5	641.7	600.1	559.1	476.4	411.5	699.5	431.3	537.0	296.0	503.4	480.4	292.5	404.6	453.8	418.1	404.6	494.6	526.5	552.5	459.6	687.5	1196.3	607.7	1023.8	494.7	410.4	525.6	507.0	447.1	1297.4	647.9	361.7	362.9	458.0	399.1	636.4	469.4	352.9	698.8	378.6	350.4	535.8	574.2	601.8	515.8	313.6	680.4	771.1	442.7	420.2	485.5	112.7	231.7	82.2	165.2	239.1	159.1	243.7	139.0	160.5	252.9	234.6	166.0	174.4	28.7	219.7	266.2	238.2	125.5	324.0	252.8	256.8	261.0	312.9	249.9	259.6	258.4	254.4	261.1	258.5	254.8	274.5	135.8	54.5	41.9	11.4	112.7	126.8	154.6	301.2	142.9	52.8	164.8	230.0	32.1	102.9	153.6	196.8	25.0	296.5	101.4	70.7	326.8	196.8	17.1	164.8	147.2	126.5	142.8	144.5	12.3	177.3	346.6	126.6	86.6	116.2	140.2	199.7	79.9	130.8	324.5	50.5	13.4	171.4	223.8	80.6	169.8	41.9	142.0	124.7	186.7	8.4	155.9	123.8	186.4	9.0	22.2	170.3	107.1	123.8	110.8	126.8	77.4	251.5	187.7	57.8	72.3	123.9	145.5	250.2	325.1	227.0	118.1	174.7	104.9	172.6	196.2	148.9
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836043-49843106	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 22.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favorable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.06e-4)"	2.0	2.9	5.4	2.8	5.5	1.1	4.0	6.0	6.8	2.9	5.3	2.3	2.4	2.5	3.7	2.7	3.9	2.4	2.6	5.4	5.2	3.3	3.7	2.1	4.8	5.5	5.2	3.8	3.5	4.3	2.2	2.3	5.5	3.8	2.8	2.6	4.2	2.7	22.1	3.8	2.8	2.6	5.3	3.2	3.1	2.5	5.3	4.2	3.9	3.0	4.2	2.4	1.9	6.4	2.8	4.0	3.8	5.8	8.0	4.7	3.8	3.9	5.1	4.1	4.2	2.1	7.0	2.5	4.2	1.8	3.0	3.4	3.9	2.3	2.2	8.7	5.1	3.3	3.1	1.3	6.3	4.0	3.3	2.5	9.2	2.9	4.1	5.1	1.9	5.3	6.4	6.7	2.6	7.2	4.5	6.4	3.8	6.3	7.1	4.7	3.6	5.0	4.0	2.6	5.2	7.2	4.6	7.4	5.7	3.0	8.9	4.4	2.1	3.2	2.4	5.0	2.1	6.3	5.7	4.8	3.5	2.9	2.2	4.0	3.0	1.6	4.5	4.0	6.0	6.7	5.7	4.4	3.2	5.7	6.4	5.9	2.4	4.4	4.2	1.7	5.3	3.0	5.4	5.5	6.0	6.8	5.4	5.2	5.5	5.2	5.5	5.3	5.3	6.4	4.0	32.1	25.0	2.9	9.4	2.2	7.3	7.6	5.2	6.8	7.4	6.7	2.4	5.7	10.2	1.8	0.0	12.6	4.8	3.6	13.7	10.1	1.7	5.9	6.0	4.6	1.8	9.5	3.3	9.8	7.4	6.8	5.1	5.0	10.8	4.6	3.9	7.7	5.8	5.0	5.2	5.6	6.1	4.1	1.2	0.9	8.4	4.3	0.0	2.8	3.1	7.2	13.4	4.0	11.0	6.4	4.8	6.4	4.9	5.7	6.9	8.7	14.2	6.2	0.0	4.7	4.5	11.8	8.7	5.1	3.1	7.7	9.1	6.8	5.1	2.8
BEST3	"MGC13168, MGC40411, VMD2L3"	ENSG00000127325	"Bestrophin 3"	Q8N1M1	12	69643360-69699476	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 69.1;tongue: 55.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 10.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 70.4;Skeletal myocytes: 28.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"REH: 36.1;RPMI-8226: 38.4;U-698: 63.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054582	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA054582: AB_2682530"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.26e-3)"		"unprognostic (7.30e-7)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.47e-2)"		"unprognostic (3.03e-1)"	0.0	0.6	3.9	0.1	3.7	2.8	0.6	15.4	5.8	0.1	0.7	0.2	0.2	0.1	0.6	1.9	0.1	0.2	0.4	4.2	1.4	0.4	0.3	0.1	0.2	5.2	3.8	0.2	1.1	0.1	1.1	0.3	5.3	1.9	0.2	2.6	3.1	0.1	69.1	0.9	0.1	0.0	2.7	0.1	0.1	3.1	3.2	1.4	0.1	55.8	0.2	0.0	0.0	7.8	0.2	0.5	1.3	0.1	0.0	0.0	0.3	0.3	0.3	0.7	0.8	0.3	0.4	2.4	0.6	0.0	2.0	0.2	0.0	0.1	0.8	0.5	0.1	1.0	0.8	0.3	0.0	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.4	0.1	0.5	0.0	1.5	0.2	0.0	0.1	1.4	0.7	0.5	36.1	1.1	38.4	1.8	0.1	0.7	0.0	0.2	0.2	0.0	2.3	0.3	0.0	0.2	0.3	0.9	0.2	1.3	0.2	0.4	63.7	2.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.9	3.7	15.4	5.8	4.2	1.4	5.2	3.8	5.3	2.7	3.2	7.8	0.0	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	10.3	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	17.9	0.0	0.2	1.8	0.0	0.0	7.6	0.0	70.4	0.1	0.8	0.0	0.0	0.0	0.6	0.0	7.0	0.0	0.3	0.0	28.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107288	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 2105.3;tongue: 803.2"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 164.9;NK-cells: 176.1;Oligodendrocytes: 186.4;Proximal tubular cells: 255.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 186.6;MAIT T-cell: 163.9;memory B-cell: 165.9;memory CD4 T-cell: 192.1;memory CD8 T-cell: 187.4;naive B-cell: 181.2;naive CD4 T-cell: 177.1;naive CD8 T-cell: 171.1;NK-cell: 178.9;T-reg: 249.8"	"Group enriched"	"Detected in all"	9	"B-cells: 181.2;NK-cells: 178.9;T-cells: 249.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol		NA	NA		430000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	43.7	93.2	178.8	25.7	232.8	12.0	37.3	162.6	209.6	53.8	85.9	35.2	17.4	38.7	16.8	33.5	53.5	22.6	16.5	174.2	160.6	83.4	34.7	22.7	41.0	204.2	194.8	34.4	21.5	19.6	41.0	23.5	189.8	58.1	13.1	53.7	42.6	24.0	2105.3	14.8	31.5	19.6	155.4	54.7	45.0	10.4	199.2	18.4	28.5	803.2	27.5	89.0	36.6	310.5	52.0	27.9	32.8	39.3	95.9	76.5	11.4	15.3	33.1	35.8	23.4	107.6	31.3	0.0	46.0	28.9	20.8	6.8	14.6	25.0	9.5	5.9	4.1	15.1	46.9	7.1	86.2	0.2	2.8	70.2	6.1	77.3	14.0	46.4	49.1	5.1	3.2	1.6	44.8	1.1	4.9	43.3	24.8	114.2	31.4	11.8	36.3	4.8	126.7	0.1	22.4	61.9	55.5	21.2	17.7	34.7	1.3	9.7	59.3	40.9	39.9	52.8	52.1	1.3	1.4	0.3	60.3	2.6	19.2	1.2	3.1	0.6	186.6	2.0	163.9	165.9	192.1	187.4	15.1	181.2	177.1	171.1	6.0	178.9	3.2	21.5	249.8	133.5	178.8	232.8	162.6	209.6	174.2	160.6	204.2	194.8	189.8	155.4	199.2	310.5	15.6	9.6	10.0	10.7	80.1	18.6	10.0	3.3	1.2	144.1	10.7	9.1	5.6	44.3	5.5	14.7	125.1	1.8	98.3	18.6	37.2	15.2	16.1	11.7	46.2	21.9	46.0	11.6	36.9	29.4	4.2	68.7	29.0	19.0	2.5	28.7	15.0	18.3	164.9	30.3	47.2	28.0	10.2	27.0	62.3	55.8	78.6	50.1	23.2	58.1	10.4	25.3	176.1	11.6	186.4	16.7	18.1	30.5	14.6	26.2	14.3	255.7	1.4	133.4	13.1	75.7	28.8	2.6	10.9	1.6	8.9	2.9	98.2	40.0	50.1	9.8
BLCAP	BC10	ENSG00000166619	"BLCAP apoptosis inducing factor"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 466.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 358.9"	"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli		"HPA047390: AB_2680025"	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.28e-5)"	65.3	56.2	161.7	27.2	189.7	35.9	59.5	106.0	147.2	49.3	159.6	54.9	51.1	34.5	52.5	86.3	141.0	29.0	75.7	147.4	163.5	60.5	101.0	37.3	40.0	123.5	137.6	40.8	27.3	50.8	149.1	76.0	145.4	59.5	52.2	70.9	57.2	56.3	466.4	88.3	48.0	34.0	108.3	46.8	39.2	30.6	197.8	41.6	45.5	120.2	53.1	72.5	60.0	117.3	138.0	38.8	45.8	48.6	86.2	66.0	63.8	64.3	62.2	56.4	45.5	137.9	109.3	70.7	62.1	90.1	53.7	259.1	34.4	268.1	57.5	14.7	31.5	23.2	94.0	130.5	55.8	46.5	29.9	84.8	283.9	54.3	101.0	46.1	79.6	51.3	22.7	51.9	114.1	77.0	39.0	37.1	36.9	77.6	109.6	36.6	171.0	47.2	64.6	358.9	41.8	50.2	77.3	221.2	54.7	46.5	73.6	44.4	75.2	144.6	37.2	51.3	28.2	28.1	37.5	34.2	60.4	42.4	26.5	74.9	56.6	69.9	45.2	56.0	49.6	93.9	51.3	48.4	52.8	113.6	67.1	52.6	59.3	48.2	53.8	22.6	55.4	52.8	161.7	189.7	106.0	147.2	147.4	163.5	123.5	137.6	145.4	108.3	197.8	117.3	24.4	80.1	31.0	14.0	38.4	147.0	97.3	135.9	137.1	43.0	29.0	60.8	56.8	30.0	68.7	40.5	22.9	115.1	25.5	72.4	82.2	35.7	73.7	58.8	26.3	54.0	40.9	15.6	26.8	33.9	84.8	29.5	17.9	18.1	29.2	32.1	89.6	81.0	55.8	42.1	29.8	58.8	52.9	41.9	36.2	161.7	29.8	29.1	35.6	13.1	30.1	64.0	24.7	16.6	11.4	54.0	31.4	59.5	16.5	88.6	69.9	55.7	63.2	36.2	32.9	28.6	27.0	30.8	27.1	66.8	122.9	65.0	26.1	54.0	33.3	133.4
BMERB1	"C16orf45, FLJ32618"	ENSG00000166780	"BMERB domain containing 1"	Q96MC5	16	15434475-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 57.0"	"Cancer enhanced"	"Detected in all"		"glioma: 30.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 101.8;U-2197: 81.3;U-87 MG: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	30.9	15.4	90.3	10.5	111.6	1.1	21.6	67.4	112.7	46.0	48.2	46.1	8.3	40.5	19.7	21.4	38.4	23.9	47.3	107.0	87.2	23.1	21.8	13.4	6.4	123.0	74.0	40.9	18.6	3.9	40.8	1.3	118.5	32.4	9.3	40.6	12.6	27.6	86.9	13.0	19.1	35.6	69.6	9.2	21.6	40.3	80.5	4.0	13.5	41.3	4.0	44.4	25.3	96.2	1.4	31.5	12.8	1.5	56.7	50.7	0.3	18.1	62.6	15.5	8.4	0.0	0.9	0.1	4.0	101.8	37.5	0.2	4.1	5.3	7.9	0.4	0.7	6.7	11.9	1.5	19.4	0.1	13.6	24.5	5.2	33.8	0.5	25.8	25.2	14.5	0.4	0.5	24.2	21.6	5.1	0.9	17.2	0.4	10.7	1.0	16.3	0.1	8.8	4.6	26.2	27.6	0.9	8.3	5.5	2.1	0.4	0.4	8.9	34.2	17.6	81.3	9.4	5.7	12.5	0.2	124.3	0.2	7.1	0.1	0.1	0.1	8.7	0.0	1.7	2.1	2.0	5.2	0.5	1.3	1.5	2.8	0.6	0.2	0.1	0.2	2.6	1.1	90.3	111.6	67.4	112.7	107.0	87.2	123.0	74.0	118.5	69.6	80.5	96.2	7.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0
BOD1	FAM44B	ENSG00000145919	"Biorientation of chromosomes in cell division 1"	Q96IK1	5	173607145-173616659	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036293	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"HPA036293: AB_10673127"	"unprognostic (2.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.21e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-1)"	42.2	41.8	34.1	19.2	36.2	7.6	44.0	33.9	42.6	43.6	35.2	40.4	22.6	37.9	37.9	25.3	35.4	22.8	45.4	33.8	35.7	33.9	29.6	29.2	22.2	35.0	35.0	53.8	48.9	34.8	34.6	34.5	34.4	34.7	24.6	45.5	27.4	29.4	111.7	38.0	24.1	27.9	34.8	25.9	34.5	40.3	36.8	18.8	50.0	78.0	17.7	39.9	35.3	39.6	57.9	60.8	113.5	117.8	98.1	74.8	88.1	50.7	102.1	82.1	132.3	116.0	61.7	39.3	123.4	77.0	201.5	45.8	91.1	124.6	108.6	34.7	72.2	11.5	51.0	106.5	115.8	25.7	15.6	73.9	101.7	54.3	208.6	60.5	69.2	24.6	24.3	25.7	70.2	120.4	38.7	31.1	94.7	64.4	107.0	35.4	58.5	34.5	34.1	55.9	142.2	59.0	38.7	42.8	163.6	95.5	125.7	29.6	53.0	92.1	56.7	73.1	78.5	29.7	34.9	47.6	49.0	37.8	71.5	0.0	2.0	5.6	2.7	2.4	2.1	2.3	2.0	2.4	2.8	2.4	3.8	2.9	0.4	3.5	1.1	3.5	2.3	1.1	34.1	36.2	33.9	42.6	33.8	35.7	35.0	35.0	34.4	34.8	36.8	39.6	56.6	32.1	20.3	7.5	24.2	72.8	50.2	15.0	27.9	41.0	47.7	46.0	41.8	28.6	22.0	9.2	12.5	67.1	20.8	10.2	60.7	38.3	116.0	24.6	52.6	47.1	23.4	7.2	7.0	26.9	83.5	58.5	23.9	28.5	8.8	93.9	28.2	16.6	27.8	53.8	7.9	26.2	20.3	12.0	33.1	141.1	73.0	16.8	33.8	4.7	23.9	61.9	25.7	8.5	10.1	21.9	13.4	59.8	17.4	84.1	19.1	50.4	14.8	39.7	13.1	50.7	46.2	89.7	69.5	30.9	83.5	59.4	19.0	165.5	37.5	47.9
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188345-8190180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		11000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA045415: AB_10964575, HPA060791: AB_2684367"	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	6.4	8.4	9.8	5.0	9.9	4.2	5.7	10.1	10.4	5.7	7.9	8.3	7.2	6.6	3.7	10.9	5.2	2.3	10.1	9.1	8.9	7.7	8.0	5.4	6.7	11.8	10.0	4.1	14.4	6.1	4.7	4.0	10.7	6.2	2.7	3.1	6.2	4.9	15.0	12.5	8.6	2.8	9.8	11.6	8.2	5.5	9.9	5.3	5.7	6.0	4.9	7.1	6.5	10.8	6.3	7.5	2.5	5.1	5.3	3.9	10.0	4.6	5.1	4.4	4.7	4.2	4.2	5.9	9.9	3.7	4.2	9.2	3.9	5.4	1.5	17.8	16.3	4.5	7.0	6.5	6.0	2.7	9.5	4.0	5.7	4.0	4.6	3.9	7.2	8.6	5.1	12.0	2.7	6.7	9.0	7.7	1.8	4.0	8.3	10.6	3.2	8.9	6.1	3.5	3.0	6.9	4.7	3.5	4.2	2.5	5.1	4.2	5.8	2.7	2.4	4.2	5.0	18.0	8.8	2.7	3.9	9.5	3.3	46.4	18.6	50.7	27.8	18.7	22.7	23.5	23.4	29.6	20.9	23.3	22.0	24.9	17.0	28.5	23.1	18.3	23.5	21.4	9.8	9.9	10.1	10.4	9.1	8.9	11.8	10.0	10.7	9.8	9.9	10.8	13.5	9.6	6.4	0.0	21.6	0.0	2.6	0.0	14.2	23.1	9.0	9.5	0.0	11.5	0.6	5.5	6.2	20.4	22.3	12.2	7.9	9.7	2.4	5.6	3.8	10.9	1.2	11.4	0.0	17.7	12.0	4.4	4.1	5.7	3.8	5.2	12.5	9.4	20.9	18.5	0.0	8.6	0.0	21.1	0.0	3.2	5.9	21.5	0.0	0.0	25.6	23.8	45.3	0.0	0.0	11.3	18.3	6.8	18.5	3.5	29.8	10.3	0.0	19.7	32.9	4.3	6.7	9.0	1.3	17.3	0.0	6.2	18.7	9.4	7.5	1.5
BRD3	"KIAA0043, ORFX, RING3L"	ENSG00000169925	"Bromodomain containing 3"	Q15059	9	134030305-134068535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051830	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA051830: AB_2681627"	"unprognostic (3.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.00e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.42e-1)"	10.6	10.3	14.2	7.3	14.7	8.2	10.2	13.0	13.6	12.9	6.4	16.1	7.9	14.6	9.4	8.6	12.5	6.9	9.5	11.6	14.6	7.8	11.0	9.2	7.5	13.9	12.6	11.6	10.7	10.1	9.2	9.0	11.7	11.8	5.6	10.6	9.6	11.6	19.3	12.6	9.6	9.0	10.4	12.4	9.9	13.0	13.5	13.4	11.8	11.5	5.8	11.8	10.3	15.9	8.5	25.3	31.4	24.6	17.1	13.8	28.7	8.4	9.5	9.2	9.3	21.2	13.7	3.2	8.7	7.7	10.4	28.7	29.4	11.7	7.2	20.1	16.5	18.2	29.1	24.1	15.3	24.1	15.7	14.8	14.1	10.6	12.0	14.9	15.2	30.0	16.7	9.3	9.5	28.4	44.9	32.2	42.0	21.9	19.2	32.8	45.3	16.1	13.1	8.9	45.8	42.3	37.7	14.1	10.1	18.7	20.3	39.6	19.5	22.3	12.3	14.6	7.6	5.0	5.6	3.0	11.2	16.4	15.1	6.6	12.9	15.8	11.4	10.1	9.6	6.9	9.1	10.2	12.9	6.7	8.6	9.1	15.0	16.3	8.6	17.1	4.6	9.4	14.2	14.7	13.0	13.6	11.6	14.6	13.9	12.6	11.7	10.4	13.5	15.9	27.6	32.1	21.9	13.1	18.3	32.4	21.2	19.8	42.1	60.9	32.8	24.3	24.3	28.6	25.7	23.9	37.5	26.0	31.8	22.6	19.6	42.7	49.2	22.9	37.9	32.1	54.0	70.1	13.4	24.4	20.5	32.4	21.9	25.3	15.9	53.2	35.7	34.0	18.7	57.2	16.8	26.6	14.2	27.9	22.8	20.7	57.2	33.6	23.2	10.3	33.6	45.6	30.9	12.5	19.3	27.7	21.4	67.4	9.1	51.0	19.2	15.7	20.1	58.0	59.2	55.8	40.0	20.7	53.1	31.9	35.7	32.7	26.4	178.7	30.8	22.3
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016423-83067252	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 325.0;tongue: 230.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	36.8	26.7	39.8	24.9	41.0	36.3	28.8	40.4	48.1	24.8	26.2	33.4	32.5	24.2	25.7	30.4	31.5	28.7	107.2	41.3	43.8	37.8	34.3	23.9	36.7	40.7	41.4	23.6	17.2	46.4	22.1	24.1	38.5	30.1	35.5	28.4	21.0	24.0	325.0	16.5	29.9	26.5	44.4	25.9	23.9	58.4	46.8	35.5	37.1	230.8	34.2	36.2	18.2	46.0	45.8	43.1	37.3	37.0	57.5	98.2	19.5	64.9	88.0	54.8	60.6	27.4	46.4	91.0	78.4	73.2	45.6	56.4	82.7	52.0	64.4	73.4	67.1	77.7	62.6	39.6	67.6	74.2	82.9	80.6	45.8	37.2	55.4	71.0	82.0	35.2	70.2	49.9	117.2	24.1	55.8	38.5	52.2	39.9	47.0	57.1	94.4	45.5	55.0	106.7	64.9	46.6	75.1	61.6	111.2	50.7	46.5	61.6	82.9	61.9	46.1	86.0	91.2	50.6	84.0	88.4	66.7	123.6	43.8	1.3	2.9	5.7	3.1	3.2	2.7	2.7	2.9	4.0	5.2	3.4	3.2	3.2	1.6	2.4	4.2	2.2	3.0	1.3	39.8	41.0	40.4	48.1	41.3	43.8	40.7	41.4	38.5	44.4	46.8	46.0	24.2	16.0	5.8	30.7	22.0	15.2	13.7	9.6	13.6	9.4	11.4	6.9	84.9	8.6	18.1	11.0	6.2	8.4	23.6	20.8	17.6	14.2	35.8	19.9	16.6	16.8	23.3	18.7	36.0	10.5	13.5	15.8	18.8	14.5	17.7	11.0	17.2	11.0	18.0	11.8	38.4	10.8	14.2	23.6	24.6	24.5	8.7	21.2	12.4	37.5	22.8	11.1	9.2	32.2	28.6	15.1	19.8	11.3	22.6	11.8	15.8	15.7	24.7	8.6	6.6	21.0	15.3	46.2	14.9	16.0	12.1	8.1	18.8	22.0	18.4	18.7
BTBD6	BDPL	ENSG00000184887	"BTB domain containing 6"	Q96KE9	14	105248490-105251093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031355	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031355: AB_10611812"	"prognostic favorable (1.11e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.25e-4)"	"unprognostic (8.48e-3)"	"prognostic favorable (6.51e-5)"	"unprognostic (6.55e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.86e-2)"	"unprognostic (9.85e-2)"	69.4	26.3	52.1	20.4	52.6	28.2	56.6	48.3	60.3	32.6	48.1	43.8	28.8	31.4	28.1	50.9	30.8	20.5	52.1	54.2	51.7	34.5	44.2	34.7	22.0	49.7	51.0	36.7	13.2	12.6	39.9	15.6	49.9	43.6	23.1	14.6	42.8	23.5	169.4	48.5	39.5	18.8	48.4	31.4	46.9	79.3	52.1	18.4	30.4	144.6	19.0	38.9	37.7	51.3	50.8	39.8	21.4	56.8	66.8	46.2	0.1	45.6	41.1	69.2	46.9	31.3	45.2	15.9	27.4	67.0	14.5	66.2	41.3	43.9	34.0	41.2	33.5	11.7	58.6	0.0	45.6	35.8	21.7	48.3	59.6	31.9	25.7	26.9	55.9	52.2	0.0	0.3	37.3	71.8	37.8	14.5	9.1	47.6	67.6	40.3	0.1	14.9	26.5	55.0	34.8	14.8	42.9	34.3	35.0	14.7	69.9	45.3	37.9	55.5	1.5	82.1	57.8	10.2	14.7	7.8	57.2	16.4	44.1	0.5	0.6	2.9	2.3	1.0	2.2	1.3	2.4	2.3	0.7	0.7	1.8	1.2	0.3	0.4	0.8	1.5	5.3	0.6	52.1	52.6	48.3	60.3	54.2	51.7	49.7	51.0	49.9	48.4	52.1	51.3	31.5	25.6	24.3	3.9	5.4	11.7	25.7	6.5	6.2	23.1	24.0	23.4	22.0	14.3	15.3	11.0	6.2	2.8	25.3	31.0	21.5	5.7	15.0	25.6	19.5	17.8	20.4	5.2	12.4	0.0	3.8	17.3	10.2	34.9	24.7	22.2	17.9	15.4	7.8	20.2	12.5	31.2	10.2	9.8	10.0	35.2	9.3	10.3	12.4	8.4	3.6	19.1	5.2	5.0	3.7	1.0	11.6	7.5	7.6	16.3	20.5	11.6	15.5	18.8	13.1	15.7	13.0	7.8	8.3	9.6	12.6	2.2	16.4	15.2	21.9	19.5
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
C11orf68	"BLES03, P5326"	ENSG00000175573	"Chromosome 11 open reading frame 68"	Q9H3H3	11	65916810-65919062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045938	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA045938: AB_10961633"	"unprognostic (3.18e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-3)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.18e-1)"	36.0	29.3	68.1	14.9	70.3	10.1	33.5	74.7	82.3	50.4	59.4	50.1	17.2	56.1	39.0	29.7	40.5	20.7	50.7	71.0	65.1	31.2	28.0	31.9	24.8	69.0	67.0	43.4	27.2	25.6	24.0	23.4	67.6	42.6	15.7	12.5	30.9	31.7	81.1	32.8	31.0	27.0	66.3	41.6	32.8	53.9	67.9	29.1	32.6	51.4	21.3	45.9	39.5	71.4	76.4	33.6	20.4	22.2	70.0	67.3	17.6	59.7	90.2	74.3	45.2	12.6	83.9	15.6	40.6	89.5	118.6	24.0	15.9	36.6	39.8	24.2	16.1	18.5	23.4	33.2	55.7	14.9	23.7	62.9	53.8	53.9	58.9	76.6	56.1	26.1	25.1	37.7	136.2	34.5	19.7	35.9	20.5	16.5	165.8	28.8	23.1	44.4	39.6	14.5	13.9	21.6	23.1	30.1	59.8	21.0	39.0	14.0	61.4	118.0	57.9	162.1	30.9	25.3	11.9	13.1	69.8	11.1	94.1	6.8	2.5	3.7	5.3	3.9	3.8	3.0	3.4	4.4	2.0	5.3	5.2	5.2	9.1	3.8	2.1	2.7	4.2	2.2	68.1	70.3	74.7	82.3	71.0	65.1	69.0	67.0	67.6	66.3	67.9	71.4	17.8	16.0	5.1	6.5	7.3	15.3	32.9	4.2	6.8	11.4	14.7	22.5	16.6	14.3	2.3	16.5	10.4	16.4	14.5	10.8	7.9	14.5	7.9	8.1	17.8	13.8	4.8	2.1	7.9	11.7	16.5	18.5	7.1	11.8	3.8	12.9	18.2	10.5	14.2	16.8	7.5	13.1	4.1	13.9	7.5	24.5	21.5	8.7	10.6	7.5	14.1	26.7	22.6	4.5	8.6	19.3	3.4	35.3	3.6	23.2	11.8	5.4	1.9	9.9	19.7	13.5	16.4	15.0	17.1	6.2	12.8	21.9	8.3	23.3	9.2	31.3
C12orf73	"BRAWNIN, DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103940763-103965708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favorable (1.61e-4)"	6.0	11.4	15.6	7.7	15.4	4.4	7.9	17.1	16.1	8.5	13.3	7.2	7.0	8.2	10.3	6.4	7.3	4.6	12.3	15.5	16.7	10.3	8.3	5.8	9.2	14.7	15.0	10.1	7.7	10.0	10.8	6.1	15.2	8.7	7.6	13.2	7.2	7.3	42.5	8.3	6.8	6.5	14.4	6.9	8.9	10.9	15.3	8.3	12.9	27.6	8.9	7.3	6.9	17.3	11.8	21.2	31.8	19.4	8.9	11.6	20.7	12.6	7.4	13.4	10.8	23.2	9.9	13.7	15.9	7.5	11.7	18.3	19.1	15.6	10.1	19.7	38.4	20.9	32.9	29.1	13.1	30.8	18.2	10.3	17.6	6.9	11.9	32.5	12.5	39.5	27.0	9.2	12.5	13.2	34.5	46.1	15.6	11.0	35.9	19.7	11.9	13.7	17.8	16.6	51.8	18.5	13.0	21.9	29.7	14.1	36.4	16.7	6.5	16.4	9.3	12.4	12.8	24.5	40.6	28.8	22.4	17.4	14.5	10.1	5.6	10.6	11.7	5.0	11.4	14.6	10.6	11.1	8.6	11.3	15.7	14.8	1.7	14.5	4.5	13.3	17.0	4.2	15.6	15.4	17.1	16.1	15.5	16.7	14.7	15.0	15.2	14.4	15.3	17.3	6.8	6.4	6.8	7.5	7.8	6.0	9.4	16.3	18.8	16.3	9.0	11.0	16.5	7.2	10.0	9.2	0.0	11.6	8.6	7.1	27.4	20.3	87.1	8.7	10.3	8.3	11.4	18.5	5.0	12.1	11.7	7.9	15.3	9.1	9.5	13.8	8.9	15.5	17.5	8.4	6.0	13.2	20.3	7.9	5.1	36.6	8.7	8.7	1.8	2.8	12.4	17.1	22.6	7.5	9.0	19.9	5.6	8.6	13.7	13.7	16.0	25.9	10.9	15.2	6.6	5.6	11.7	31.1	25.6	16.0	5.3	8.9	8.8	6.4	12.3	8.6
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 90.0;skeletal muscle: 259.4;tongue: 139.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 45.2;Late spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favorable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	6.7	5.9	16.0	6.6	16.1	8.3	8.3	11.6	14.7	8.6	1.8	7.6	5.6	7.7	4.0	12.6	6.0	3.5	90.0	12.2	10.0	5.8	7.7	6.4	7.6	15.4	15.0	6.7	5.2	6.6	7.5	6.5	14.0	8.8	2.9	2.5	10.5	6.4	259.4	12.3	6.0	3.9	13.1	7.4	6.2	26.5	13.9	7.3	6.9	139.1	4.4	8.5	8.7	17.1	20.3	30.5	12.7	13.8	7.4	6.6	17.4	20.6	9.3	19.1	22.9	25.5	8.3	23.5	11.1	9.7	10.0	9.9	15.5	18.9	7.9	29.1	19.1	19.3	18.2	19.6	5.5	19.5	11.9	6.6	11.0	25.6	9.0	5.1	11.7	21.5	24.0	13.4	15.9	19.9	29.4	11.0	8.2	16.2	11.5	28.8	20.7	11.8	6.1	17.6	16.2	13.2	22.1	20.5	8.1	7.4	12.2	15.9	15.7	23.7	16.6	16.2	28.4	16.0	24.2	24.1	10.1	18.6	16.7	29.0	2.2	6.6	1.6	2.0	2.0	2.0	3.0	2.7	2.1	2.5	2.0	1.4	7.3	2.5	2.3	2.1	2.3	2.1	16.0	16.1	11.6	14.7	12.2	10.0	15.4	15.0	14.0	13.1	13.9	17.1	2.6	3.2	2.8	9.1	2.6	4.8	3.2	2.6	4.0	3.1	4.9	5.0	45.2	2.8	2.3	0.0	2.1	11.0	1.5	3.6	0.0	3.5	12.5	2.5	2.3	4.3	3.6	1.7	19.2	4.7	13.8	6.2	2.6	2.7	4.5	3.6	5.7	5.0	6.6	3.3	15.4	3.4	0.0	6.2	4.1	27.4	1.8	2.8	5.4	8.4	3.3	2.9	3.1	9.5	11.2	4.4	1.4	6.8	6.5	2.0	2.8	2.8	1.3	2.0	6.6	7.1	3.8	18.2	6.3	4.1	7.0	15.9	3.3	1.4	2.4	1.8
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387029-184629019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 52.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 305.1;Syncytiotrophoblasts: 284.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 3.9;memory CD8 T-cell: 2.0;naive CD8 T-cell: 1.8;NK-cell: 2.6"	"Group enriched"	"Detected in many"	13	"NK-cells: 2.6;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.3;HSkMC: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	9.8	13.2	7.4	1.3	11.8	0.5	13.4	8.3	12.4	15.5	0.0	14.6	3.0	13.0	6.8	8.2	12.8	2.8	12.7	10.6	3.8	3.3	5.6	7.9	0.8	7.4	2.7	11.3	3.4	2.5	4.7	1.9	7.7	14.1	5.0	7.4	4.6	6.8	52.6	16.5	11.9	3.8	3.2	5.5	9.7	1.6	6.1	1.5	3.4	20.6	1.0	15.7	15.0	5.5	0.2	0.1	3.8	0.2	5.9	6.0	5.0	1.7	1.7	1.0	0.6	0.0	0.0	0.0	0.0	2.5	0.3	1.1	1.6	1.7	0.9	12.3	3.9	0.0	0.8	0.0	2.3	1.2	0.6	8.7	4.0	1.2	0.9	4.4	1.4	2.8	0.0	3.5	1.4	1.3	1.4	0.3	4.4	2.0	0.3	1.9	2.5	2.1	0.0	0.8	1.6	6.0	1.0	0.7	3.5	2.2	0.1	0.1	1.7	2.2	0.8	4.2	2.3	7.2	4.1	0.0	3.7	1.8	2.4	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.5	2.0	0.2	0.0	0.2	1.8	0.0	2.6	0.0	0.1	0.0	0.9	7.4	11.8	8.3	12.4	10.6	3.8	7.4	2.7	7.7	3.2	6.1	5.5	107.5	38.5	113.0	201.4	1.2	152.6	234.9	29.6	82.6	23.4	87.9	63.6	90.7	25.8	38.1	1.8	0.0	119.3	99.8	149.9	7.9	6.7	47.0	11.0	89.3	98.4	19.2	14.5	144.2	19.6	99.3	91.8	7.1	21.7	10.1	11.2	101.4	83.7	40.9	26.9	165.9	66.3	24.4	8.8	31.5	37.8	76.4	9.5	64.0	16.9	19.7	42.9	141.1	305.1	3.6	14.1	203.3	19.2	20.2	105.7	193.6	12.3	17.5	9.5	19.7	108.8	48.2	3.4	17.3	76.3	145.6	284.6	32.2	32.8	76.4	181.7
C1orf43	"DKFZp586G1722, NICE-3"	ENSG00000143612	"Chromosome 1 open reading frame 43"	Q9BWL3	1	154206696-154220637	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010725	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA010725: AB_1078341"	"unprognostic (3.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.23e-1)"	126.7	131.9	148.0	72.6	160.4	77.3	119.7	158.9	168.6	90.5	145.1	109.3	118.4	80.7	115.3	107.7	100.5	86.7	179.7	141.7	158.3	187.7	222.0	106.3	82.0	153.0	152.6	77.1	149.7	149.6	85.7	67.6	151.6	94.9	121.2	135.7	99.1	90.2	477.6	105.8	106.1	90.6	152.4	81.6	117.2	62.0	154.2	92.0	108.7	368.2	99.0	113.9	85.7	169.3	183.5	188.4	156.5	185.1	231.1	230.7	96.2	180.2	309.4	205.0	188.4	127.7	249.8	237.9	268.1	162.9	177.5	182.4	218.5	163.3	147.2	191.1	232.1	184.9	182.6	168.1	357.9	235.4	209.6	187.1	376.6	219.8	449.7	278.6	239.9	262.6	199.1	220.1	268.4	287.5	177.4	212.1	302.3	414.8	282.3	159.8	145.8	435.9	256.0	180.6	254.8	333.5	161.1	420.8	624.9	180.8	416.6	513.5	164.4	157.9	133.6	193.3	229.7	403.5	424.1	227.6	263.4	234.4	430.9	189.9	204.8	134.3	85.9	185.4	102.4	100.3	98.7	93.3	211.5	90.0	102.8	86.8	114.9	83.3	174.6	156.2	154.3	242.7	148.0	160.4	158.9	168.6	141.7	158.3	153.0	152.6	151.6	152.4	154.2	169.3	107.2	115.4	100.8	27.1	92.1	94.2	128.4	155.3	81.4	112.6	132.9	114.4	135.8	128.7	115.4	71.7	29.2	87.2	86.8	106.1	252.4	171.5	247.1	69.6	62.1	105.4	122.0	110.0	27.3	202.0	125.1	80.2	77.5	58.1	62.1	79.5	100.6	146.9	178.9	58.9	30.8	133.9	116.0	162.5	116.1	171.8	65.0	131.5	124.5	16.9	155.4	107.0	64.9	26.2	50.5	162.8	131.6	74.9	104.1	186.1	218.3	262.1	85.7	89.5	72.3	75.8	86.6	70.7	59.2	113.9	100.6	126.1	76.7	117.4	133.6	167.5
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249306-3407669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 226.9;Cone photoreceptor cells: 202.3;Excitatory neurons: 205.6;Inhibitory neurons: 163.1;Oligodendrocyte precursor cells: 135.7;Oligodendrocytes: 191.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Cytosol"		"HPA052103: AB_2681727, HPA067418: AB_2685835"	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	11.8	9.5	19.7	5.2	22.4	3.6	8.7	18.5	20.1	10.1	6.8	14.4	4.1	10.4	5.4	8.4	9.8	8.3	15.3	19.5	21.4	11.2	2.6	10.0	4.5	21.5	22.9	12.3	6.3	4.2	8.8	9.1	21.1	8.6	4.3	16.4	5.8	11.6	32.3	5.6	6.6	12.9	19.6	7.3	9.7	10.4	21.8	3.8	9.6	11.6	2.9	12.6	8.9	26.0	4.0	3.6	9.7	4.7	19.7	21.6	1.1	9.2	10.3	6.0	7.5	0.0	4.3	0.0	2.5	12.3	7.7	4.7	3.7	9.1	8.2	0.9	1.8	1.1	1.4	10.0	9.2	1.2	0.5	17.7	6.9	7.9	6.8	8.6	12.2	3.5	2.0	0.0	8.9	1.8	2.5	6.5	2.9	2.2	2.3	2.9	8.8	0.1	7.8	8.1	1.9	5.7	4.1	7.2	12.0	8.3	6.8	11.3	13.7	7.5	3.2	4.7	4.5	0.1	0.0	0.0	2.4	1.2	5.8	0.4	0.8	0.0	0.5	0.4	0.2	0.2	0.3	0.4	0.9	0.4	0.1	0.3	0.0	0.0	0.4	1.0	0.4	0.2	19.7	22.4	18.5	20.1	19.5	21.4	21.5	22.9	21.1	19.6	21.8	26.0	23.6	28.9	9.2	226.9	3.7	6.9	6.7	10.8	8.6	35.1	10.1	10.8	28.5	15.7	10.3	12.9	202.3	1.8	8.9	0.1	1.9	9.1	31.8	10.6	15.9	20.1	0.0	4.0	205.6	4.7	5.4	13.4	19.4	12.1	14.0	53.3	25.7	2.3	19.6	30.3	163.1	0.5	4.1	34.0	25.5	8.9	19.9	22.4	8.8	89.9	14.1	10.0	3.1	135.7	191.2	9.4	14.8	13.5	1.5	5.4	7.4	8.4	21.8	13.9	13.1	18.4	22.2	28.5	25.0	7.2	5.7	1.8	7.8	16.4	1.4	5.2
C22orf39	MGC74441	ENSG00000242259	"Chromosome 22 open reading frame 39"	Q6P5X5	22	19351368-19447711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 118.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA073701			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA073701: AB_2686627"	"unprognostic (4.97e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.45e-3)"	"unprognostic (5.34e-3)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.51e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.32e-2)"	25.2	22.9	35.2	8.9	34.3	13.7	22.0	34.7	49.6	22.0	33.8	38.1	10.5	22.2	11.2	15.4	22.3	7.7	47.2	34.2	33.2	26.5	18.0	17.8	12.8	35.6	34.8	19.8	26.3	22.6	24.3	10.4	36.3	26.2	11.8	23.9	16.4	13.6	118.6	19.3	19.7	11.3	35.0	21.0	23.5	16.7	35.9	16.2	27.9	44.8	12.4	26.9	17.8	34.4	20.7	7.1	16.3	11.5	17.5	15.4	12.1	5.9	5.7	13.7	15.8	11.3	4.8	15.8	6.8	6.4	8.2	17.3	16.3	10.9	14.7	17.3	66.7	20.1	19.2	26.5	17.1	30.8	19.5	12.9	17.6	7.3	19.9	14.7	14.0	33.6	60.6	21.5	9.0	10.1	24.0	27.3	7.2	42.4	18.2	25.8	23.9	11.5	18.4	12.1	24.8	12.4	11.8	8.3	23.9	14.9	11.4	18.4	13.4	9.9	18.6	7.0	9.1	29.4	12.6	22.8	11.6	14.7	9.4	36.4	29.6	72.0	23.0	33.8	21.9	27.8	25.7	19.7	26.1	27.9	25.9	21.4	43.0	31.1	30.3	38.8	35.3	26.7	35.2	34.3	34.7	49.6	34.2	33.2	35.6	34.8	36.3	35.0	35.9	34.4	41.6	22.4	40.4	10.1	39.5	24.3	28.4	58.8	23.3	28.7	42.8	44.3	94.1	27.1	50.8	36.8	16.7	54.6	50.8	44.3	107.6	40.4	21.5	36.0	20.8	29.7	45.1	41.2	13.9	77.9	47.9	31.2	35.7	26.4	26.6	25.9	36.0	35.3	65.4	18.5	17.3	44.4	52.9	38.0	33.5	12.7	35.1	32.8	39.2	5.6	59.6	52.3	60.8	10.1	14.5	58.7	42.0	33.8	37.6	34.6	69.0	67.2	46.1	20.4	46.0	31.9	36.9	54.8	57.6	37.8	32.5	50.3	34.9	33.1	55.9	31.2
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443777	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.7;tongue: 98.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 543.1;Inhibitory neurons: 383.3;Oligodendrocyte precursor cells: 357.9;Oligodendrocytes: 662.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 127.4;HUVEC TERT2: 54.9;SH-SY5Y: 62.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		390000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	11.6	14.5	9.8	4.3	11.9	0.0	4.1	1.2	15.4	5.3	0.0	13.0	5.1	7.4	2.4	5.3	3.9	6.4	31.3	18.8	13.3	8.4	1.3	3.4	1.9	4.6	26.0	7.9	1.5	1.2	6.3	4.2	9.5	13.7	5.1	8.3	2.6	6.4	78.7	4.7	3.4	12.2	8.1	4.4	5.6	3.7	34.2	3.9	18.9	98.5	3.1	7.1	3.4	12.8	0.0	12.7	10.6	0.0	18.2	22.9	0.0	23.4	15.0	11.4	11.1	0.0	3.5	0.0	0.0	20.4	14.1	0.0	11.2	0.0	14.8	0.0	15.0	0.7	14.4	0.0	11.9	5.3	0.0	13.6	0.1	39.6	0.1	127.4	54.9	0.0	0.0	0.2	25.7	0.1	0.0	0.0	12.6	0.0	5.0	2.3	2.1	0.0	0.9	0.9	21.1	62.3	4.6	0.1	0.0	11.1	0.1	0.0	39.6	20.1	15.0	20.1	0.0	0.1	0.0	0.0	16.9	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	11.9	1.2	15.4	18.8	13.3	4.6	26.0	9.5	8.1	34.2	12.8	6.3	0.0	1.7	137.1	0.0	5.7	4.5	0.1	8.0	47.7	6.6	3.9	88.0	0.0	1.3	7.3	18.8	0.1	0.1	0.0	0.0	0.0	64.2	0.5	20.7	6.8	38.8	0.0	543.1	0.0	0.0	20.6	14.3	0.4	25.3	29.9	1.4	0.4	0.2	25.2	383.3	2.6	16.2	0.0	2.9	42.4	10.2	0.4	1.8	87.1	0.6	5.6	0.0	357.9	662.8	0.8	0.0	6.0	0.2	11.2	0.0	9.5	0.7	6.1	6.6	17.6	21.5	1.5	1.9	1.9	6.5	0.1	0.4	32.7	0.2	1.4
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 135.0"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.4;REH: 12.4;U-266/84: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	Cytosol	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	3.0	3.2	7.9	0.5	7.9	1.0	1.9	6.4	8.7	4.8	7.6	6.5	0.9	6.4	2.2	2.4	6.2	1.7	25.3	8.0	9.6	2.4	1.6	2.4	0.8	8.0	7.4	5.0	2.4	5.4	8.3	0.8	8.3	3.6	0.7	2.2	3.3	3.0	135.0	1.4	2.3	3.4	6.6	2.2	3.3	15.7	8.8	0.8	3.1	36.2	0.6	4.4	2.7	8.6	0.8	1.6	5.6	0.2	0.2	0.1	0.3	1.4	0.6	3.4	4.1	0.9	0.3	1.0	1.9	0.9	0.9	0.2	6.4	0.1	2.6	1.8	19.4	1.5	2.9	1.4	5.2	0.2	0.1	1.2	0.3	3.1	0.1	3.3	0.7	7.2	5.3	1.0	1.0	3.3	2.6	0.8	3.8	0.4	2.0	12.4	1.2	1.0	0.2	1.5	3.9	4.6	0.1	0.9	1.2	1.1	1.6	6.3	0.4	1.0	0.9	1.0	1.4	1.3	9.9	8.4	0.6	1.2	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	7.9	7.9	6.4	8.7	8.0	9.6	8.0	7.4	8.3	6.6	8.8	8.6	0.9	3.2	1.1	5.9	0.2	0.4	0.8	0.6	1.8	16.0	0.4	0.5	4.8	1.5	0.7	1.8	10.4	0.2	0.2	0.1	0.0	0.9	120.6	0.4	1.4	1.8	0.0	0.4	19.3	0.0	0.2	2.6	0.5	0.3	0.0	5.6	3.3	2.0	4.2	13.5	25.3	0.0	0.0	0.0	0.8	23.2	4.7	0.4	0.0	4.7	0.0	2.9	1.0	12.1	7.2	0.0	0.0	10.1	0.2	0.5	0.0	0.7	0.3	3.1	0.0	4.1	4.0	1.4	5.3	0.4	0.1	0.1	1.0	9.2	0.0	0.4
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359498-42412949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 279.2;skeletal muscle: 905.9;tongue: 377.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 512.5;Late spermatids: 183.6;Melanocytes: 482.0;Oligodendrocytes: 220.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	27	"SK-MEL-30: 238.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040052	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA040052: AB_2676821"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	13.5	8.8	136.1	4.0	206.6	47.6	14.1	194.2	243.3	18.8	113.0	13.3	3.1	11.2	163.7	14.5	13.7	4.5	16.1	142.9	159.9	93.6	36.9	21.5	7.0	212.0	194.9	15.7	8.7	2.4	11.3	3.0	212.1	16.0	5.3	7.5	18.6	5.2	905.9	54.9	14.0	4.7	155.2	19.1	8.9	30.8	187.8	3.4	10.7	377.4	5.1	11.7	15.5	279.2	0.5	0.3	0.6	1.1	8.8	6.1	0.6	2.6	1.9	0.5	0.8	1.2	0.5	0.2	0.9	1.6	0.4	3.7	0.4	3.5	0.3	0.9	0.8	0.8	0.8	4.1	0.6	1.0	1.5	4.7	3.7	0.8	0.7	1.5	0.1	0.7	0.2	1.8	0.7	0.1	0.2	1.2	0.4	0.2	0.9	1.1	0.4	1.9	1.9	1.3	0.4	0.1	0.2	0.5	238.0	1.0	0.0	5.4	0.9	0.3	0.4	2.6	0.7	1.5	2.1	0.2	0.4	2.4	1.8	0.5	1.0	0.1	0.7	0.2	0.8	0.3	0.1	0.3	0.5	0.5	0.1	0.9	0.9	0.6	0.1	0.5	0.4	0.6	136.1	206.6	194.2	243.3	142.9	159.9	212.0	194.9	212.1	155.2	187.8	279.2	0.5	12.8	34.5	16.0	2.9	20.1	0.8	2.2	3.4	2.2	0.4	0.3	0.4	1.5	4.4	1.8	2.1	0.7	1.4	2.0	1.9	0.1	512.5	0.5	0.6	2.2	0.0	0.0	4.0	0.0	0.6	1.6	3.6	0.7	1.3	0.4	2.2	8.7	32.7	0.0	5.2	1.8	2.0	4.4	11.6	183.6	5.3	2.9	482.0	13.1	2.5	3.7	2.1	4.5	220.2	0.0	5.4	3.4	0.6	0.9	2.4	59.5	2.6	3.9	0.0	13.8	1.6	15.9	4.7	1.6	8.5	3.3	1.8	1.2	2.3	0.8
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871553-10923075	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 110.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	20.3	17.1	24.7	19.6	26.6	22.7	17.6	18.9	34.1	30.6	17.2	28.4	17.3	31.7	7.8	36.7	23.4	14.7	25.4	27.6	23.7	18.8	20.1	16.4	19.8	22.8	21.8	21.9	22.3	11.5	14.8	20.4	22.6	20.2	14.3	6.4	20.2	17.5	110.5	22.6	20.9	21.3	19.9	18.6	20.3	45.4	22.6	10.9	13.4	72.4	15.4	26.3	28.0	26.0	62.5	46.8	64.9	88.3	52.5	71.1	63.2	42.8	75.6	63.9	61.0	73.4	21.8	85.2	52.4	77.4	32.1	58.0	65.4	66.2	40.1	98.4	52.7	26.5	29.1	89.9	44.8	39.3	33.9	49.0	42.4	43.8	52.4	35.9	82.1	67.9	65.8	79.2	38.2	116.7	70.0	34.3	81.4	40.7	74.8	97.5	32.8	100.7	38.9	29.7	47.0	45.1	30.7	36.2	43.6	31.7	38.4	35.3	48.7	75.4	43.2	72.3	54.0	75.0	64.1	77.2	51.1	63.8	35.3	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	24.7	26.6	18.9	34.1	27.6	23.7	22.8	21.8	22.6	19.9	22.6	26.0	12.9	9.6	12.2	7.2	11.6	7.8	5.9	4.1	12.0	36.4	14.0	13.7	1.1	14.3	6.5	9.2	52.1	18.5	6.4	42.3	7.9	13.4	32.7	20.1	30.8	12.7	27.6	30.7	12.9	19.7	33.1	13.8	13.7	25.4	1.3	17.8	12.8	27.8	26.7	45.4	10.6	24.9	4.1	20.0	10.9	23.5	28.3	14.8	5.4	5.6	23.9	8.7	4.1	10.6	5.8	24.8	27.2	19.2	11.7	14.1	22.6	9.2	7.4	21.1	6.6	19.6	13.0	23.8	17.5	25.7	7.0	12.0	6.5	6.6	25.7	11.8
CASTOR2	"GATSL1, GATSL2"	ENSG00000274070	"Cytosolic arginine sensor for mTORC1 subunit 2"	A6NHX0	7	74964705-75031528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.3;skeletal muscle: 48.5;tongue: 26.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.3;Endometrial ciliated cells: 7.4;Endometrial stromal cells: 2.1;Glandular and luminal cells: 5.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057229	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"			"HPA057229: AB_2683374"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-5)"	"unprognostic (1.28e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-3)"	1.5	1.9	19.9	0.7	16.8	4.7	1.2	11.3	21.4	1.3	0.0	1.4	1.7	2.1	1.6	1.4	1.8	1.6	3.1	21.9	12.8	1.2	0.7	1.2	0.6	24.4	18.2	3.9	3.2	1.7	1.8	2.0	28.3	1.9	0.6	5.3	2.0	2.4	48.5	2.7	1.4	1.8	11.6	0.8	1.0	2.1	18.6	2.1	0.7	26.2	1.1	0.9	1.4	13.0	2.6	18.9	3.5	12.1	6.7	2.1	7.3	2.4	1.5	0.9	1.2	8.8	1.0	0.7	2.0	4.9	2.4	1.2	4.7	1.7	1.2	2.0	3.1	1.5	8.0	15.5	2.6	0.7	2.5	5.8	0.9	2.8	0.3	1.2	3.1	5.8	2.8	1.0	1.1	8.5	3.6	4.1	6.3	7.1	1.7	7.5	3.0	2.5	8.5	4.2	8.8	5.9	3.2	5.4	0.8	4.9	3.9	0.8	3.9	2.0	4.1	5.5	0.9	1.7	3.7	3.3	1.7	2.8	1.1	1.7	0.2	0.8	0.4	0.2	0.3	0.1	0.2	0.3	0.0	0.2	0.2	0.3	1.8	0.3	0.2	0.2	0.7	0.2	19.9	16.8	11.3	21.4	21.9	12.8	24.4	18.2	28.3	11.6	18.6	13.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	7.4	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0
CCDC28B	"MGC1203, RP4-622L5.5"	ENSG00000160050	"Coiled-coil domain containing 28B"	Q9BUN5	1	32200595-32205453	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 225.3;tongue: 75.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 90.1;monocytes: 65.5;NK-cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 124.9"	"Low region specificity"	"Detected in all"			HPA028589	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA028589: AB_10602175"	"prognostic favorable (2.92e-4)"	"unprognostic (6.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.87e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.07e-2)"	3.8	13.9	14.3	7.1	12.9	6.8	3.3	14.5	18.7	6.6	12.1	7.6	1.7	5.3	1.7	5.5	5.6	4.9	20.8	13.2	13.3	6.5	2.4	3.9	14.1	12.8	13.3	6.0	5.6	19.2	21.1	5.0	12.2	5.3	2.5	5.1	3.6	4.1	225.3	2.7	4.3	6.2	12.6	5.4	3.9	20.8	15.8	12.4	6.3	75.0	9.5	5.0	4.3	13.1	10.6	4.5	20.8	22.7	6.8	8.5	1.2	8.2	11.9	13.2	9.3	9.0	13.2	23.3	14.2	9.3	1.7	0.5	18.7	9.2	2.6	27.0	25.5	29.9	20.7	4.1	10.1	0.2	13.7	10.5	3.5	15.5	0.2	9.2	19.3	40.5	20.5	0.5	9.6	1.3	43.2	8.7	29.4	2.8	5.8	46.5	10.4	19.2	12.2	0.0	45.6	22.9	11.9	3.2	16.3	12.0	12.0	11.5	11.4	7.1	9.5	8.7	7.6	2.1	1.6	0.9	11.7	43.9	10.3	9.7	13.7	3.0	36.3	6.9	17.6	22.0	19.4	34.3	30.6	31.5	28.4	29.3	1.9	46.7	2.1	37.1	26.9	21.8	14.3	12.9	14.5	18.7	13.2	13.3	12.8	13.3	12.2	12.6	15.8	13.1	10.5	0.0	6.1	3.9	11.1	9.1	4.4	17.9	5.7	33.3	9.6	12.7	16.1	11.5	5.3	12.9	22.9	1.9	25.8	1.6	35.2	17.5	13.8	8.1	18.1	15.2	90.1	30.7	3.1	7.6	4.0	19.0	5.6	5.1	3.8	8.0	12.1	0.6	11.7	23.5	3.9	5.7	54.9	4.2	39.2	32.8	20.2	5.7	17.8	0.0	65.5	23.9	106.1	5.5	1.7	7.8	1.7	17.0	1.8	3.4	0.3	4.9	4.2	45.9	0.0	12.5	18.0	3.9	13.3	3.5	7.7	2.2	15.3	48.1	3.4	2.6
CCSER2	"FAM190B, KIAA1128"	ENSG00000107771	"Coiled-coil serine rich protein 2"	Q9H7U1	10	84328586-84518521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 1945.3;Late spermatids: 5466.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037481, HPA037482"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA037481: AB_10672385, HPA037482: AB_10671501"	"unprognostic (4.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.74e-2)"	20.1	10.0	22.4	9.4	22.1	9.6	13.7	28.6	23.1	18.4	15.8	20.7	11.5	18.9	15.3	27.8	10.2	12.2	55.7	22.4	28.3	11.6	12.7	16.5	12.1	31.0	25.1	13.6	11.8	11.4	6.6	10.7	32.2	14.6	12.2	18.5	9.5	15.5	66.2	13.3	11.3	24.7	25.4	10.3	10.8	63.1	31.0	16.3	24.5	62.9	11.3	16.5	11.0	26.8	17.1	13.0	15.2	33.7	21.4	35.1	10.7	20.2	33.1	12.3	23.8	7.4	17.7	11.4	12.9	37.1	19.7	14.2	11.5	12.8	18.4	37.5	7.2	4.1	5.8	9.3	20.1	6.1	8.3	17.4	18.1	19.8	62.2	31.5	33.7	21.0	5.4	33.6	22.2	10.6	10.6	4.3	6.6	5.9	10.3	10.6	7.8	4.2	11.0	17.8	4.6	8.4	11.1	7.3	34.7	20.9	13.4	3.0	30.5	36.7	16.6	18.2	21.5	33.5	12.2	9.0	23.7	7.7	16.2	4.9	4.3	7.7	19.4	3.9	19.8	7.5	14.3	18.2	4.1	6.9	12.8	13.8	5.9	20.3	3.2	6.2	9.6	8.5	22.4	22.1	28.6	23.1	22.4	28.3	31.0	25.1	32.2	25.4	31.0	26.8	50.9	41.7	40.8	120.2	28.8	35.3	57.8	28.1	22.8	87.0	43.7	43.1	218.6	12.8	32.6	16.5	31.3	24.9	101.2	16.1	37.2	31.3	1945.3	21.2	33.9	54.1	16.3	3.0	146.7	45.8	19.3	52.2	21.4	28.8	14.5	28.5	37.1	24.0	20.9	62.2	142.5	28.9	22.4	21.4	66.2	5466.2	51.6	29.2	26.6	124.6	39.5	58.5	81.4	209.6	222.3	34.1	13.8	59.8	42.1	55.4	49.6	26.1	22.0	55.9	13.1	61.8	65.3	103.6	84.0	36.4	47.0	68.4	90.4	30.0	21.4	67.2
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766336-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 179.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.1;Horizontal cells: 52.2;Inhibitory neurons: 57.2;Oligodendrocytes: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660"	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (8.74e-4)"	46.1	28.1	68.5	14.8	69.5	7.3	29.7	71.0	99.6	33.4	26.8	40.1	10.0	39.9	24.5	14.5	30.5	19.2	61.6	69.9	80.4	24.9	47.3	25.2	13.2	104.7	77.9	38.9	18.7	14.6	23.8	21.5	107.2	25.8	10.6	43.4	14.8	32.6	179.1	13.4	19.2	32.4	71.5	26.9	21.8	11.2	91.6	14.5	16.8	99.2	10.7	29.4	21.0	80.2	8.1	79.8	29.5	36.9	153.3	95.2	8.7	65.2	76.1	32.3	46.3	5.5	10.2	29.3	154.0	114.6	24.2	13.0	40.4	44.4	26.6	68.5	31.9	12.7	17.8	8.2	41.2	21.4	23.3	90.3	14.5	24.0	45.4	50.3	38.6	22.4	8.9	74.9	41.1	17.3	18.9	31.1	12.4	6.9	42.7	18.8	24.2	40.5	31.7	5.4	38.9	19.9	25.8	21.9	29.6	21.6	6.2	36.6	45.8	47.5	14.4	62.2	48.0	62.6	112.3	28.3	59.6	42.3	36.4	7.3	8.6	5.9	6.2	7.6	5.4	4.5	5.8	6.3	8.1	4.8	5.5	6.0	2.1	7.2	12.5	5.8	4.4	7.0	68.5	69.5	71.0	99.6	69.9	80.4	104.7	77.9	107.2	71.5	91.6	80.2	14.1	16.0	7.8	21.5	8.2	3.1	2.3	3.6	4.6	26.8	3.7	3.2	42.8	11.5	6.4	12.9	18.8	10.1	7.4	2.0	5.9	4.4	0.3	5.6	10.1	13.8	8.4	6.5	49.1	5.3	3.9	15.9	7.1	3.6	7.6	12.6	17.2	26.6	10.2	52.2	57.2	2.9	8.2	16.4	6.8	2.8	20.8	8.6	10.6	23.4	8.1	18.2	2.1	21.6	60.7	3.6	3.1	30.1	12.5	3.4	5.3	11.3	5.0	18.7	0.0	15.9	12.0	2.8	4.9	3.3	1.3	13.5	6.4	11.8	3.3	1.3
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171748-89195492	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 24.4;skeletal muscle: 57.0"	"Cell type enriched"	"Detected in some"	13	"Skeletal myocytes: 76.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	15	"cerebellum: 24.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 145.8"	"Region enriched"	"Detected in many"	7	"cerebellum: 15.7"	"Region enriched"	"Detected in some"	17	"cerebellum: 18.7"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		870000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.0	0.2	0.1	0.0	0.2	0.0	0.0	24.4	0.8	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	1.3	0.4	0.0	0.1	0.8	0.2	1.4	0.0	0.1	0.7	1.6	0.4	0.0	0.0	0.9	0.0	57.0	0.1	0.0	0.0	0.3	1.2	0.2	0.6	0.1	0.0	0.0	5.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.7	0.0	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	31.5	0.1	0.0	0.1	0.0	0.2	0.3	0.0	145.8	0.3	0.0	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	24.4	0.8	0.0	0.1	0.1	0.8	1.6	0.3	0.1	0.6	0.2	0.0	2.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.1	1.2	0.0	0.1	0.0	0.3	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.0	76.1	0.4	1.5	5.5	0.0	0.0	0.1	0.2	0.8	0.1	0.1
CDKN2AIPNL	"C2AIL, MGC13017"	ENSG00000237190	"CDKN2A interacting protein N-terminal like"	Q96HQ2	5	134402065-134411881	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043966	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043966: AB_2678750"	"unprognostic (7.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.79e-2)"	15.5	23.7	25.8	11.0	27.2	17.0	14.2	25.8	30.6	11.4	20.0	16.8	19.2	12.3	15.6	12.8	11.7	9.4	35.5	27.8	28.2	20.9	17.3	10.8	16.6	29.4	25.2	12.7	33.0	19.7	19.3	11.4	29.3	13.9	13.9	24.3	18.3	10.4	81.7	14.9	17.4	10.0	25.2	14.5	19.2	19.7	27.8	19.0	21.0	42.9	15.8	15.7	11.8	25.7	71.2	42.1	44.1	95.4	22.5	30.5	46.1	37.8	21.5	47.2	52.1	73.1	41.8	47.1	50.3	25.5	68.0	23.0	59.2	93.0	50.8	67.4	89.5	44.1	45.0	43.8	37.8	30.8	25.8	24.5	44.6	59.4	46.3	37.9	49.7	75.3	42.4	54.3	35.4	41.2	50.6	58.2	77.6	37.3	53.1	43.0	46.5	58.3	44.2	23.9	58.7	64.5	50.8	14.1	69.1	49.3	63.1	55.2	33.4	55.8	37.0	44.7	53.7	38.8	69.2	50.2	65.2	53.7	58.7	10.5	16.7	12.4	17.8	18.2	22.7	30.1	22.9	17.7	20.2	28.1	21.7	21.6	4.6	17.8	20.9	24.2	25.3	15.2	25.8	27.2	25.8	30.6	27.8	28.2	29.4	25.2	29.3	25.2	27.8	25.7	21.3	3.2	15.6	3.3	23.7	13.5	16.6	33.6	13.6	21.9	23.9	20.2	50.7	18.6	14.1	9.2	14.6	37.8	17.4	15.3	58.7	28.6	22.0	17.3	16.4	22.7	31.0	34.5	8.8	36.3	40.4	17.2	8.6	12.3	15.2	34.7	22.1	12.6	24.6	15.2	9.1	21.2	36.7	19.4	15.4	46.1	22.1	14.2	23.2	3.7	31.3	30.1	15.5	3.5	7.0	26.0	17.4	19.9	22.6	11.9	30.0	45.4	10.7	26.8	19.7	15.6	22.4	35.1	32.3	18.6	15.3	20.2	17.6	23.5	22.9	14.4
CEP68	KIAA0582	ENSG00000011523	"Centrosomal protein 68"	Q76N32	2	65056366-65087004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040493, HPA040620"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA040493: AB_10673411, HPA040620: AB_10794144"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.84e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.71e-1)"	15.9	5.8	11.2	6.9	11.3	4.6	14.1	13.8	11.6	15.3	8.5	12.1	5.5	16.9	6.1	9.8	13.7	10.1	13.9	12.3	9.5	7.1	2.6	7.8	10.0	10.5	9.2	21.6	9.1	9.9	5.9	10.2	10.9	11.0	7.0	7.4	10.7	12.3	26.7	11.8	7.5	14.3	8.1	9.2	8.1	6.0	10.1	10.6	9.6	27.7	8.5	10.3	10.5	11.0	3.9	6.9	13.2	9.7	11.6	13.0	24.2	3.7	6.5	5.6	4.9	5.4	3.4	6.6	4.5	6.7	5.7	5.3	8.7	5.6	5.8	8.0	7.5	9.0	2.5	6.5	3.2	5.1	6.1	12.3	7.8	5.1	7.1	9.8	16.1	13.5	8.4	20.7	7.1	4.5	8.6	9.4	13.3	7.1	5.5	8.9	15.9	7.8	5.0	5.1	23.1	15.7	7.3	5.3	7.9	8.0	3.1	3.3	6.4	5.2	7.1	8.2	3.7	22.4	6.5	15.3	2.8	3.9	6.4	0.9	1.3	0.3	2.3	2.5	2.6	2.6	5.4	4.3	3.5	3.6	8.3	5.2	1.1	4.4	5.0	7.2	4.4	2.5	11.2	11.3	13.8	11.6	12.3	9.5	10.5	9.2	10.9	8.1	10.1	11.0	72.0	28.9	10.9	17.9	13.2	7.1	14.2	15.5	22.2	26.7	11.8	13.6	16.7	8.6	15.5	9.2	25.0	15.4	15.4	3.6	9.8	10.3	3.7	11.2	22.2	47.1	13.1	7.2	28.8	21.4	7.5	17.8	9.2	19.8	6.3	24.9	28.5	6.9	9.4	23.5	31.6	5.8	8.2	7.2	14.4	6.2	37.9	18.9	7.2	22.5	18.4	15.5	8.2	22.6	21.2	8.9	4.3	27.1	6.9	8.9	2.8	9.0	15.0	21.3	32.9	30.5	18.5	11.6	23.9	10.1	5.8	34.1	16.1	9.9	11.2	7.3
CFAP61	"C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156"	ENSG00000089101	"Cilia and flagella associated protein 61"	Q8NHU2	20	20052514-20360703	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 16.1;skeletal muscle: 28.6;testis: 15.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 88.7;Excitatory neurons: 20.6;Late spermatids: 73.2;Spermatocytes: 17.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.7;HMC-1: 2.6;SCLC-21H: 5.1;SK-MEL-30: 2.2;U-87 MG: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009079	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA009079: AB_1078344"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (3.67e-3)"	"unprognostic (8.58e-4)"	"unprognostic (8.24e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.76e-4)"	"unprognostic (2.77e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.06e-1)"	0.1	0.7	1.4	0.0	2.2	0.0	0.2	0.9	1.2	0.6	16.1	0.1	0.0	0.7	0.9	0.1	12.2	0.1	12.4	2.2	3.2	0.7	0.0	1.3	0.1	5.3	7.3	0.3	0.3	0.5	3.6	0.0	3.9	0.3	0.0	1.8	0.2	0.2	28.6	0.5	0.0	0.1	4.3	0.0	0.1	15.5	3.7	0.1	0.7	10.2	0.1	0.0	0.1	2.6	0.2	0.5	0.1	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.4	4.7	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.5	0.7	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.8	0.4	0.0	5.1	0.0	0.1	0.3	2.2	0.0	0.4	0.0	0.4	0.0	0.2	0.3	0.2	0.7	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.4	2.2	0.9	1.2	2.2	3.2	5.3	7.3	3.9	4.3	3.7	2.6	0.0	0.0	0.5	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	12.7	0.0	2.5	1.8	4.2	0.0	1.4	0.0	0.0	0.0	88.7	12.1	0.3	0.1	0.0	0.0	20.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	73.2	0.6	0.2	0.0	1.0	0.0	0.0	0.0	3.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	8.7	0.5	0.0	0.6	0.1	17.3	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956512	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 68.6;skeletal muscle: 68.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2;Exocrine glandular cells: 27.8;Gastric mucus-secreting cells: 33.6;Pancreatic endocrine cells: 19.3;Plasma cells: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 109.5;HHSteC: 80.7;hTCEpi: 130.8;SK-MEL-30: 95.0;U-266/70: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	Mitochondria		"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	9.1	0.6	12.3	1.4	12.0	1.8	0.9	11.1	30.7	2.1	7.1	1.9	2.0	0.7	1.5	23.3	1.7	1.8	2.4	11.4	16.6	4.0	11.5	2.0	0.9	13.0	14.5	0.7	68.6	1.4	1.9	0.8	16.9	1.3	0.8	1.1	5.1	1.0	68.4	1.6	1.4	0.8	12.6	0.9	14.8	0.7	17.6	0.5	1.5	11.7	3.0	4.3	3.7	16.6	9.1	6.0	1.5	27.2	4.3	3.2	11.1	53.5	109.5	5.8	15.5	15.1	2.2	2.8	4.1	4.8	17.2	6.0	12.0	4.4	4.1	10.4	2.5	2.5	1.6	0.0	80.7	7.3	0.1	36.1	130.8	17.1	23.2	1.8	5.4	62.3	7.7	12.5	4.8	5.5	5.3	0.1	4.9	31.0	21.3	4.8	0.1	12.8	3.0	3.5	5.3	7.9	1.6	9.5	95.0	3.3	3.6	51.1	1.8	1.3	16.1	1.5	9.4	81.1	19.0	11.0	4.8	10.3	12.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	12.3	12.0	11.1	30.7	11.4	16.6	13.0	14.5	16.9	12.6	17.6	16.6	6.2	0.0	2.0	0.3	3.1	2.8	3.8	11.5	3.4	2.6	2.2	2.4	4.6	4.3	6.5	0.0	2.1	0.3	2.6	8.0	35.2	6.4	0.1	1.8	0.4	2.7	3.5	3.2	1.3	27.8	0.3	0.6	33.6	2.1	0.0	0.4	1.8	0.7	0.4	0.0	1.5	8.0	6.1	0.3	1.5	0.0	0.3	0.8	5.4	0.0	1.0	0.5	0.0	0.5	0.2	19.3	2.3	0.0	21.4	6.5	0.8	0.3	3.3	0.4	0.0	0.3	3.2	1.1	1.1	1.5	4.3	3.4	1.6	0.5	4.8	14.6
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	42.4	44.8	48.1	36.5	54.1	62.5	44.2	54.7	56.0	52.5	48.3	44.2	30.3	45.2	36.2	50.3	47.5	21.9	63.3	47.8	51.1	66.5	54.8	39.3	46.6	51.9	50.7	55.2	63.4	35.9	48.7	33.4	52.2	48.4	32.7	59.9	44.4	29.6	124.4	52.6	46.8	30.5	50.0	65.4	47.9	37.6	49.6	65.7	55.8	68.4	44.4	45.1	47.9	63.5	74.3	63.9	106.2	65.0	45.2	33.1	84.3	51.2	47.0	71.3	61.2	71.6	72.9	83.5	75.6	48.0	46.6	66.8	103.4	74.7	46.9	97.8	95.7	65.5	102.2	60.0	56.1	101.8	78.8	38.5	84.8	69.0	97.5	59.2	57.7	89.4	82.1	62.2	54.1	94.3	109.8	102.6	123.6	106.9	79.1	67.5	65.0	92.5	69.8	100.5	64.3	74.5	54.6	77.8	91.6	69.9	83.7	138.6	50.0	47.7	70.4	60.7	83.8	86.2	77.8	95.5	50.1	81.9	56.8	84.9	42.9	40.9	46.0	44.8	46.2	46.2	45.3	45.3	54.4	43.3	45.2	41.0	30.8	35.1	43.0	41.7	51.9	46.4	48.1	54.1	54.7	56.0	47.8	51.1	51.9	50.7	52.2	50.0	49.6	63.5	46.4	32.1	37.3	32.3	50.1	63.0	103.6	59.7	37.5	40.8	45.6	33.5	74.1	57.2	43.5	53.3	33.3	91.7	47.7	49.2	50.9	69.5	34.9	50.6	42.6	54.2	60.3	81.9	16.1	64.8	121.9	47.1	42.3	63.4	46.3	59.7	43.9	41.2	69.7	43.7	17.6	56.4	42.7	48.9	38.2	18.0	44.7	40.9	35.6	14.0	69.3	44.0	52.5	16.6	40.1	61.3	58.1	42.2	48.2	101.8	48.4	49.0	33.2	57.5	19.7	34.9	59.7	125.2	115.2	46.5	61.7	128.6	45.7	57.9	52.3	110.2
CIART	"BC017397, C1orf51, CHRONO"	ENSG00000159208	"Circadian associated repressor of transcription"	Q8N365	1	150282543-150287093	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.7;Bipolar cells: 43.1;Cone photoreceptor cells: 102.2;Muller glia cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.2;memory CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.4;Karpas-707: 36.8;U-266/84: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027515, HPA054349"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA027515: AB_10600757, HPA054349: AB_2682457"	"unprognostic (1.77e-1)"	"unprognostic (5.63e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.42e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.34e-2)"	6.9	13.5	15.1	3.1	22.2	0.4	7.5	20.1	19.9	6.7	17.8	22.8	3.3	9.6	9.3	8.2	10.2	4.5	29.4	15.4	15.8	10.1	13.7	5.8	2.6	13.3	14.8	10.1	5.0	32.0	17.7	2.7	13.7	9.4	2.8	22.2	17.8	23.9	54.2	40.5	6.4	9.0	13.2	2.8	13.8	9.8	16.7	2.0	19.0	46.4	3.5	11.8	8.3	14.1	0.2	1.0	6.7	3.4	3.0	1.3	6.6	4.8	11.8	6.2	8.2	1.8	26.4	0.1	8.3	10.4	14.1	4.5	0.2	4.8	9.3	0.1	0.6	0.2	0.4	0.1	10.5	1.6	3.7	4.0	7.1	15.8	3.2	14.4	1.2	0.1	0.2	36.8	3.6	21.8	0.0	0.8	8.9	4.9	19.9	1.1	0.0	0.3	6.2	1.0	4.1	1.5	7.9	0.7	14.6	1.7	6.7	0.6	2.1	17.3	0.2	0.7	10.5	8.2	29.6	0.2	16.0	0.1	10.5	0.0	0.0	0.0	0.1	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.1	15.1	22.2	20.1	19.9	15.4	15.8	13.3	14.8	13.7	13.2	16.7	14.1	2.8	0.0	1.5	5.5	0.6	0.0	5.5	0.0	30.7	43.1	5.5	7.7	7.3	4.3	1.3	0.0	102.2	0.2	0.6	0.4	9.8	3.2	0.6	2.9	2.5	3.0	2.4	0.0	3.1	1.5	0.1	4.8	3.6	2.1	0.0	3.5	0.7	4.2	1.3	6.7	3.9	0.9	0.0	0.3	0.0	1.4	5.3	1.9	0.0	0.0	1.0	28.2	0.0	1.5	1.1	4.1	1.2	9.4	0.2	4.4	7.7	3.9	0.7	18.1	0.0	4.6	4.5	7.2	10.9	11.2	0.0	0.0	0.9	4.1	0.7	2.7
CIPC	KIAA1737	ENSG00000198894	"CLOCK interacting pacemaker"	Q9C0C6	14	77098126-77117287	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.1"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000644			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA000644: AB_1079206"	"unprognostic (3.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.77e-10)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-1)"	13.2	9.6	41.3	8.4	53.0	4.2	15.8	48.0	41.1	16.8	24.7	26.8	10.3	14.6	13.5	22.1	30.4	9.0	39.8	46.5	44.1	14.2	15.4	11.1	8.4	47.5	48.2	9.1	9.7	29.5	13.5	9.0	43.9	25.5	19.9	41.2	20.5	24.8	132.1	15.4	11.4	16.5	42.3	9.1	11.4	11.7	53.3	10.3	20.4	82.4	10.1	17.2	15.5	49.6	9.4	12.6	25.4	16.8	10.1	8.0	15.4	6.0	9.4	10.9	9.8	10.3	19.4	23.3	5.9	9.7	9.6	14.3	23.7	9.4	14.3	12.3	6.4	14.9	9.8	9.5	9.7	8.4	10.7	9.4	17.9	10.6	6.5	14.1	12.7	19.2	14.0	8.8	8.1	21.4	20.2	10.2	10.6	21.3	10.9	20.2	11.3	14.0	11.0	16.1	35.9	13.4	11.0	17.4	14.9	10.7	27.2	8.6	14.9	7.0	15.1	10.0	7.6	8.4	7.1	11.1	13.2	7.1	14.8	4.3	4.5	1.6	2.6	5.1	4.1	7.9	3.6	2.7	5.4	7.1	3.8	2.8	5.5	5.5	3.8	2.0	4.1	3.6	41.3	53.0	48.0	41.1	46.5	44.1	47.5	48.2	43.9	42.3	53.3	49.6	8.5	16.0	18.4	33.6	4.7	9.1	8.2	5.3	12.5	29.3	18.3	12.6	49.9	8.6	12.6	11.0	58.4	7.4	5.5	43.5	9.8	4.2	11.0	39.8	9.2	7.0	17.4	6.5	16.4	5.6	5.0	5.6	9.2	20.3	1.3	5.8	7.1	29.5	15.2	11.8	20.2	14.8	30.5	16.0	6.6	15.8	4.1	7.2	8.8	9.4	5.8	22.8	2.1	21.1	58.7	5.1	12.4	14.3	4.2	8.3	18.1	6.0	30.5	36.4	13.1	7.9	9.3	19.9	9.1	10.4	9.8	13.5	3.1	7.1	13.7	7.1
CLIP4	"FLJ21069, RSNL2"	ENSG00000115295	"CAP-Gly domain containing linker protein family member 4"	Q8N3C7	2	29097705-29189643	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 169.2;Inhibitory neurons: 142.8;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 25.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 83.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043366, HPA056246"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA043366: AB_10963051, HPA056246: AB_2683078"	"unprognostic (1.97e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.62e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-2)"	19.3	9.8	15.1	9.5	24.7	1.9	14.2	20.6	19.7	14.3	18.3	20.8	4.8	13.7	8.7	23.4	15.5	13.4	30.0	15.2	18.9	9.0	4.5	18.7	10.2	20.6	21.8	22.7	6.3	14.3	20.0	16.4	20.9	16.6	7.0	17.9	13.9	15.2	71.9	30.9	10.7	18.6	18.6	10.0	10.2	17.5	18.1	13.5	33.5	43.8	10.7	20.8	19.9	31.4	82.3	22.6	3.4	12.1	31.4	47.0	0.1	31.8	54.4	17.5	19.9	0.7	52.7	10.2	15.9	55.1	69.9	33.0	3.6	24.7	24.8	18.9	5.4	0.0	29.1	1.2	79.7	0.0	16.2	33.3	61.3	23.2	83.8	62.8	12.4	7.4	0.5	31.5	26.7	0.6	7.9	3.6	0.9	4.8	5.0	0.1	20.1	1.6	32.0	14.4	5.3	13.7	27.6	11.2	29.0	3.3	0.0	4.9	39.4	4.1	31.6	13.7	13.8	16.2	0.1	0.1	19.0	0.0	12.7	2.5	6.1	0.2	7.9	14.8	12.4	1.4	6.1	8.4	2.4	0.5	6.9	6.8	1.2	5.6	25.9	0.0	2.3	5.6	15.1	24.7	20.6	19.7	15.2	18.9	20.6	21.8	20.9	18.6	18.1	31.4	0.9	64.1	15.0	78.7	7.2	17.1	27.6	26.8	30.1	31.0	11.4	8.9	76.2	0.0	18.5	12.9	29.2	6.7	18.6	0.1	3.9	10.7	169.2	16.1	8.4	2.5	0.0	2.5	75.1	9.1	1.7	26.5	4.1	12.9	5.1	13.1	1.4	1.8	9.9	20.2	142.8	0.0	8.2	36.1	6.0	91.1	27.4	25.9	8.8	15.9	17.5	18.7	19.6	130.2	247.2	22.1	0.0	24.0	30.9	25.8	0.0	5.9	32.1	17.9	13.1	24.2	9.2	9.4	1.6	29.7	27.3	21.5	21.9	16.4	0.2	24.2
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog"	Q9BQ75	3	99817837-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 215.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	24.5	33.1	23.0	15.8	21.7	20.8	23.4	26.7	30.1	22.4	17.8	21.0	8.6	21.8	9.7	15.8	20.9	10.5	28.2	21.8	20.9	20.7	15.0	15.8	17.1	22.8	20.1	23.6	26.7	21.8	24.5	11.6	19.6	16.0	11.6	24.6	14.0	13.3	69.4	17.4	12.6	13.2	17.9	13.8	16.4	30.3	21.3	16.7	14.8	29.9	15.0	24.5	18.1	21.7	116.2	51.0	50.0	72.6	34.7	40.1	51.0	53.5	28.8	93.3	77.0	64.1	37.5	126.3	90.6	28.2	82.4	68.4	70.3	60.2	120.3	66.8	66.5	99.9	32.9	53.2	62.6	137.0	51.3	28.2	56.7	71.4	116.6	30.3	65.2	100.9	63.5	78.1	67.0	78.8	110.3	126.4	73.0	109.4	126.1	49.1	81.3	134.1	57.2	27.5	139.9	58.9	52.8	42.5	125.0	47.8	51.4	84.0	18.5	73.6	207.4	43.3	109.8	56.3	121.1	244.9	49.1	149.4	124.8	1.0	11.0	2.3	22.2	27.3	32.0	57.3	32.8	30.3	23.8	55.7	41.3	42.0	4.1	28.6	25.1	62.1	33.9	18.2	23.0	21.7	26.7	30.1	21.8	20.9	22.8	20.1	19.6	17.9	21.3	21.7	26.7	6.4	19.4	48.6	41.3	62.2	37.4	45.5	26.2	32.8	43.8	40.4	41.7	42.9	23.2	62.5	18.8	41.7	25.1	8.5	97.8	42.1	165.0	21.7	56.8	38.7	15.0	30.9	154.3	47.7	56.6	44.3	9.7	19.8	62.1	47.7	24.7	61.4	27.2	127.9	132.8	14.4	16.2	7.9	45.5	215.8	50.7	18.7	37.4	58.1	12.8	28.0	19.6	114.1	116.2	35.8	4.6	58.6	36.2	82.8	1.1	87.9	22.4	27.0	26.3	67.3	50.1	163.4	146.1	21.3	66.1	21.9	30.1	54.1	22.6	27.0
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 94.1;skeletal muscle: 129.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Fibroblasts: 22.4;Muller glia cells: 83.6;Paneth cells: 30.6"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 109.3;SH-SY5Y: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved					NA	NA		55000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	60.0	10.3	67.2	1.3	91.9	0.0	49.7	81.5	69.0	29.7	16.3	7.6	3.3	2.8	2.6	3.9	13.0	6.3	39.0	54.3	58.5	2.9	12.4	3.8	1.0	57.0	82.8	5.2	2.2	0.2	9.7	5.2	62.2	11.0	2.2	13.9	11.3	7.7	129.7	11.5	8.7	0.7	49.8	30.6	7.0	7.2	94.1	5.1	13.7	35.1	0.4	5.6	17.1	47.4	0.0	0.0	109.3	0.0	13.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	3.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	52.1	0.1	0.1	0.0	1.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	91.9	81.5	69.0	54.3	58.5	57.0	82.8	62.2	49.8	94.1	47.4	0.9	0.0	0.0	57.1	0.0	3.6	1.1	0.0	1.2	19.3	11.9	1.5	1.3	8.6	0.0	0.0	6.2	0.9	0.1	6.5	1.9	0.1	4.3	0.1	2.4	0.3	0.0	0.0	4.1	0.0	0.6	22.4	0.0	0.1	0.0	0.0	2.5	1.4	1.4	3.3	9.3	0.5	0.0	0.0	2.7	1.9	9.9	0.1	3.6	2.8	0.0	83.6	0.0	15.1	0.5	0.0	30.6	2.2	0.3	0.2	14.1	0.1	0.0	3.2	0.0	1.2	1.9	5.5	19.8	0.3	2.4	2.3	0.2	0.0	0.5	0.3
COA8	"APOP-1, APOPT1, C14orf153, MGC2562"	ENSG00000256053	"Cytochrome c oxidase assembly factor 8"	Q96IL0	14	103562960-103607523	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.2"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 62.6;Cytotrophoblasts: 75.7;Extravillous trophoblasts: 54.9;Hofbauer cells: 85.8;Syncytiotrophoblasts: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.83e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.99e-1)"	21.1	13.4	21.9	12.5	21.9	12.1	19.8	23.0	25.5	17.6	22.3	26.9	19.3	15.8	18.5	20.3	13.8	15.4	32.0	22.6	21.8	22.8	18.5	14.6	17.0	22.9	22.0	14.8	24.2	14.8	11.3	16.3	22.7	15.4	19.1	9.5	24.8	15.4	122.2	21.2	16.4	16.4	21.4	12.0	20.1	56.2	21.6	11.3	25.7	77.0	16.9	20.5	15.2	24.6	27.5	19.2	17.1	36.5	39.6	45.2	32.2	29.3	31.7	34.7	41.5	23.3	43.9	24.2	29.6	38.7	33.0	37.9	14.6	33.2	46.4	36.8	19.5	9.9	19.3	18.5	47.8	22.0	21.6	33.9	56.4	22.9	53.6	39.3	38.3	26.8	22.2	34.8	37.9	37.8	21.2	28.8	24.9	66.4	71.9	18.3	19.0	22.8	49.1	26.5	34.1	18.1	21.3	26.8	60.0	23.9	41.1	25.6	28.2	30.6	19.9	46.0	40.7	15.3	31.7	30.3	41.9	22.2	33.0	45.6	25.9	34.3	23.4	24.9	21.8	29.5	22.5	24.0	20.8	30.2	20.8	23.2	15.2	31.4	23.3	20.0	30.4	23.7	21.9	21.9	23.0	25.5	22.6	21.8	22.9	22.0	22.7	21.4	21.6	24.6	15.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	75.7	8.4	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	54.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	69.4	1.4	0.0	0.0	0.0
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.2;skeletal muscle: 131.6;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	3.0	1.0	83.8	1.4	96.7	0.0	14.8	62.0	91.1	4.8	41.6	13.3	18.9	2.2	2.1	13.6	19.1	5.8	54.8	81.8	67.9	12.9	19.6	13.8	0.2	76.6	88.3	2.8	18.4	31.5	12.8	4.7	69.2	14.4	10.9	23.3	47.3	4.2	131.6	27.5	21.5	2.7	66.6	0.3	17.6	3.0	89.8	1.3	8.3	107.9	1.0	1.8	5.8	118.2	12.4	8.8	0.2	0.3	0.0	0.0	33.7	0.0	0.0	0.0	0.0	24.1	18.2	0.0	0.9	0.0	1.4	21.1	12.0	0.0	0.0	0.0	9.6	0.0	57.0	4.7	0.0	0.0	0.1	1.5	2.3	0.0	0.0	0.0	0.0	1.6	6.5	0.2	0.2	7.9	0.1	0.1	9.0	53.4	8.0	0.1	0.5	45.5	17.4	0.0	11.0	0.2	3.2	26.2	3.9	32.6	16.6	0.1	0.0	0.0	9.8	0.3	0.9	0.0	34.1	0.1	0.1	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	83.8	96.7	62.0	91.1	81.8	67.9	76.6	88.3	69.2	66.6	89.8	118.2	1.4	38.5	19.6	48.0	1.0	17.8	3.4	1.2	4.0	2.3	38.0	34.7	76.2	28.6	13.2	9.2	58.4	23.3	4.6	59.4	0.0	21.5	3.8	65.9	3.3	2.2	18.6	0.0	198.7	9.7	9.2	7.7	35.7	74.6	10.1	4.6	0.4	29.7	2.2	0.0	96.6	35.2	4.1	0.8	1.7	3.1	0.6	0.9	16.0	10.3	1.1	94.4	0.0	353.9	548.8	23.2	35.0	0.4	0.2	25.3	76.8	18.6	31.4	73.6	0.0	10.5	1.5	0.7	8.8	6.8	35.7	40.2	1.7	11.2	14.4	7.3
COG4	"COD1, DKFZP586E1519"	ENSG00000103051	"Component of oligomeric golgi complex 4"		16	70480568-70523560	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040924, HPA042539"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA040924: AB_2677203, HPA042539: AB_2678044"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.79e-1)"	17.8	22.0	25.3	12.8	27.2	14.2	15.7	27.8	27.0	20.2	29.0	20.3	10.5	17.4	11.1	30.1	19.7	12.8	25.7	25.3	26.5	16.9	16.9	18.3	15.4	26.9	26.3	18.8	10.6	27.9	19.0	19.8	26.6	14.4	16.6	14.5	17.1	16.5	67.7	23.8	16.3	19.2	25.9	17.9	17.4	19.2	27.7	22.3	15.9	49.4	17.7	18.5	20.7	28.3	37.3	59.9	47.1	31.3	62.6	43.7	53.0	41.0	53.7	51.0	43.9	48.3	66.7	25.0	57.7	64.9	35.5	53.4	60.8	65.3	70.9	21.5	36.7	23.1	59.8	47.5	36.7	15.3	15.0	51.9	41.9	66.1	40.6	59.7	51.7	31.6	55.9	18.1	57.6	75.9	25.1	23.4	45.2	50.4	30.9	46.8	31.2	57.4	42.3	31.0	43.9	45.5	80.7	30.5	24.3	48.0	77.9	26.4	49.7	46.3	29.1	35.3	29.8	19.1	26.2	78.0	50.7	15.8	46.1	20.6	26.4	23.8	19.7	28.8	14.4	11.8	19.3	17.9	32.8	14.6	16.9	15.7	13.8	14.4	34.4	15.2	24.4	25.1	25.3	27.2	27.8	27.0	25.3	26.5	26.9	26.3	26.6	25.9	27.7	28.3	13.6	16.0	16.0	21.9	11.0	9.1	12.1	22.6	11.4	24.5	9.2	8.0	23.3	2.8	21.1	3.7	14.6	47.7	13.1	20.8	9.8	23.4	3.1	11.9	13.0	16.8	12.6	12.6	10.9	16.0	26.8	16.5	18.8	13.4	8.8	28.7	16.8	17.8	24.7	8.4	13.0	18.0	24.4	14.1	8.9	6.7	14.6	11.1	8.8	7.5	14.7	29.3	12.3	19.6	19.1	17.6	21.0	19.2	12.3	6.3	21.7	13.8	18.5	29.9	32.9	14.0	18.6	37.5	25.7	13.1	10.7	39.0	12.9	37.3	19.4	8.9
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088969-100092187	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	71.3	85.5	98.5	48.7	103.0	51.8	68.6	102.5	102.0	87.1	99.5	101.3	44.1	86.5	84.0	90.6	78.1	52.9	112.9	101.9	100.7	70.8	71.6	56.5	50.3	99.3	98.4	74.8	60.2	100.8	79.2	64.0	100.4	68.8	57.8	61.4	65.0	74.2	147.3	61.8	58.4	78.5	101.7	63.1	78.4	57.4	98.7	63.1	61.5	152.8	60.6	90.5	74.7	105.0	167.6	233.4	136.2	163.5	116.1	138.4	86.6	147.7	223.5	239.7	174.9	191.9	153.8	114.4	186.1	242.2	267.3	124.1	155.1	247.9	240.4	114.9	242.6	98.2	215.9	149.3	243.3	112.1	97.6	137.5	161.4	259.2	273.9	159.5	333.0	172.7	142.7	160.5	286.4	413.7	251.6	164.8	124.0	241.3	273.2	117.6	226.6	275.4	193.6	153.8	213.4	158.6	152.7	298.5	114.1	176.4	123.7	109.2	177.9	231.3	211.1	280.5	264.8	118.1	140.2	235.3	175.5	150.0	350.6	231.8	187.8	168.2	178.8	206.6	180.7	168.0	176.8	170.9	211.3	170.3	137.4	153.6	73.5	163.5	194.6	157.8	225.8	146.6	98.5	103.0	102.5	102.0	101.9	100.7	99.3	98.4	100.4	101.7	98.7	105.0	87.8	51.3	44.2	24.8	73.4	110.6	118.1	208.1	70.0	108.3	62.8	76.3	166.3	88.6	117.2	86.5	52.1	197.3	84.2	55.1	211.3	138.3	76.5	61.6	103.4	94.9	75.3	69.0	20.9	113.5	133.7	116.0	52.5	48.3	90.7	100.5	90.3	63.2	128.8	95.9	21.0	67.4	158.7	69.6	82.5	197.1	127.7	55.1	156.5	13.1	101.4	147.0	115.4	17.6	24.0	115.1	64.7	125.3	84.3	95.0	84.2	214.2	117.9	127.1	98.6	76.3	261.5	80.5	100.2	81.2	100.3	137.9	82.7	137.9	87.1	96.1
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085882-237100474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 451.5;U-138 MG: 536.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	51.2	47.8	58.1	36.0	62.8	41.2	42.0	61.2	67.3	42.8	54.9	36.3	17.0	44.1	38.1	26.8	37.4	42.4	83.7	64.5	76.1	51.9	34.4	29.4	32.5	59.4	59.4	48.2	22.6	64.1	37.5	43.7	62.4	34.1	24.7	91.8	27.7	35.9	172.9	30.4	23.8	54.1	62.2	24.1	30.3	47.2	64.0	48.7	37.2	118.1	32.9	52.0	32.5	63.2	58.9	48.6	103.5	51.8	289.5	226.1	69.2	100.7	99.0	100.3	110.7	31.9	57.9	39.9	37.6	110.0	159.5	43.3	102.4	136.1	138.8	94.9	66.2	58.0	57.5	113.8	199.4	76.3	33.3	376.9	153.0	101.2	451.5	124.6	119.4	84.7	81.9	37.4	320.9	55.7	94.7	77.7	91.7	63.0	70.2	71.7	123.3	79.9	124.7	46.4	50.8	87.3	60.3	51.2	155.4	82.4	59.5	61.4	127.4	536.9	91.1	106.1	110.7	71.1	64.0	127.9	167.4	46.0	138.7	59.1	45.2	56.1	57.1	53.3	70.9	68.3	60.4	65.8	55.7	56.9	58.3	60.7	14.1	72.2	58.0	40.2	70.7	70.5	58.1	62.8	61.2	67.3	64.5	76.1	59.4	59.4	62.4	62.2	64.0	63.2	46.8	32.1	24.4	13.1	38.5	75.5	50.0	97.1	39.9	55.2	32.3	26.8	114.2	31.5	44.4	33.1	27.1	61.6	32.5	12.5	142.8	65.1	34.7	45.0	41.2	52.2	21.0	39.6	20.6	40.8	79.3	85.7	23.0	28.7	42.6	38.9	38.9	23.5	61.0	35.3	20.1	16.5	95.6	29.6	59.3	21.1	72.7	24.2	126.3	11.2	44.6	98.2	39.1	15.1	20.6	52.6	16.7	75.6	44.4	44.9	22.6	96.9	55.3	63.0	59.2	44.7	69.8	98.1	116.1	33.6	64.5	44.5	44.5	50.0	21.0	41.8
COX7B		ENSG00000131174	"Cytochrome c oxidase subunit 7B"	P24311	X	77899440-77907376	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1122.9;tongue: 756.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2237.0;Distal tubular cells: 2283.3;Proximal tubular cells: 1865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058041	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA058041: AB_2683587"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.10e-2)"	"prognostic favorable (6.80e-6)"	"unprognostic (8.58e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (2.43e-4)"	99.1	94.8	198.6	74.5	200.9	205.6	81.5	218.2	376.7	46.2	228.4	176.5	182.4	50.2	94.4	72.1	55.3	42.0	326.8	202.2	214.7	222.6	181.5	45.7	64.3	203.2	202.9	38.7	49.1	301.3	21.3	53.6	205.4	61.6	158.5	184.1	93.5	65.9	1122.9	42.8	156.7	74.8	205.0	51.3	125.1	19.1	208.4	96.6	54.3	756.7	76.3	87.8	19.6	207.3	242.8	239.4	257.8	214.6	111.8	90.1	179.5	159.7	78.8	101.8	113.1	259.6	213.0	158.6	271.8	96.1	333.1	302.5	298.7	183.6	112.7	138.9	372.7	218.5	441.3	343.5	104.2	441.1	185.5	133.0	137.0	154.2	129.9	173.0	113.0	186.1	186.3	409.8	118.6	282.6	350.6	445.5	253.4	972.4	614.5	250.5	297.0	594.4	344.6	420.8	177.3	158.1	305.8	396.8	334.2	209.0	148.7	295.0	149.7	91.1	222.0	232.6	167.7	157.9	407.0	364.8	212.2	504.2	130.5	212.5	226.7	168.6	152.7	326.5	165.2	213.6	166.5	174.8	303.7	146.3	155.7	185.6	142.8	205.9	316.1	213.2	238.6	261.1	198.6	200.9	218.2	376.7	202.2	214.7	203.2	202.9	205.4	205.0	208.4	207.3	238.9	134.6	178.0	28.1	247.7	297.5	297.2	1151.7	225.9	111.4	204.5	244.9	2237.0	487.6	463.6	369.6	35.5	412.9	272.2	1219.8	2283.3	504.6	20.8	424.0	243.9	210.0	516.0	428.5	11.2	395.7	424.2	227.2	382.8	356.4	226.3	134.7	194.5	1179.5	718.3	47.1	14.8	922.1	734.5	438.9	432.1	43.1	199.4	368.3	538.9	10.3	488.1	214.0	258.5	12.5	19.5	425.5	1090.3	176.4	297.3	307.7	1516.9	1865.2	314.0	174.3	210.4	274.2	315.4	81.4	108.8	583.4	345.5	591.7	258.4	166.9	978.4	472.5
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457373	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	20.4	19.0	31.4	13.8	30.8	20.1	19.2	29.9	35.1	18.7	23.6	16.7	14.0	16.8	11.7	20.4	15.7	11.3	17.4	30.1	30.4	17.3	20.2	15.4	23.7	35.5	31.6	18.8	29.9	8.3	18.4	16.7	32.1	19.1	10.7	7.2	19.8	12.3	36.1	20.4	16.1	11.1	30.4	22.0	20.0	32.0	32.3	16.1	13.9	18.0	19.9	16.0	17.4	30.4	40.0	33.9	55.4	44.9	22.4	25.5	66.8	25.8	31.5	38.8	50.5	56.0	52.0	56.4	34.2	25.2	48.2	34.0	39.1	40.5	35.4	41.9	41.6	27.0	41.4	54.4	117.2	49.4	33.3	46.8	34.0	40.7	60.4	28.1	35.8	40.1	70.8	64.8	36.2	95.6	99.6	88.9	51.3	53.0	47.7	40.8	37.0	66.8	24.2	36.1	43.3	50.6	29.4	60.9	61.6	58.2	25.3	51.8	20.0	36.5	50.1	64.3	50.0	59.9	68.6	83.3	28.1	48.1	44.1	1.2	3.4	2.6	3.3	3.0	4.4	8.2	5.0	6.1	4.1	8.4	6.3	5.6	1.3	4.4	2.1	5.4	8.2	3.0	31.4	30.8	29.9	35.1	30.1	30.4	35.5	31.6	32.1	30.4	32.3	30.4	11.6	6.4	8.9	6.2	11.2	8.8	16.4	10.6	9.6	4.6	11.9	10.3	10.4	14.3	8.6	1.8	10.4	55.9	17.7	8.7	15.6	15.6	3.0	4.9	9.3	11.0	7.7	15.6	10.7	17.1	33.1	12.7	5.1	5.3	12.7	27.0	8.2	8.2	21.5	6.7	14.7	10.6	14.2	10.1	13.5	7.8	27.4	8.7	8.8	5.6	18.5	10.7	14.4	6.0	8.1	13.9	6.0	17.3	14.7	28.6	10.1	20.2	4.3	6.9	19.7	23.7	16.4	20.9	19.8	9.3	9.2	45.4	10.7	25.1	12.6	14.9
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211445-1249953	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	76.1	88.1	92.3	86.1	91.2	71.5	72.7	96.6	104.3	94.7	73.6	94.6	91.0	98.4	47.5	85.0	89.2	61.4	100.0	92.7	98.1	88.4	109.2	82.6	108.7	99.2	94.1	93.5	141.1	58.8	140.0	45.7	94.6	94.8	41.9	38.8	90.9	50.8	170.1	74.3	97.1	48.1	77.1	118.7	79.5	47.3	90.0	98.1	86.2	91.5	62.4	87.5	79.8	89.8	108.5	156.8	118.4	146.6	81.5	58.6	101.7	83.4	76.8	101.8	102.8	135.0	255.1	131.0	93.8	97.5	156.6	84.1	72.3	109.9	30.4	101.0	86.6	119.1	185.6	177.1	135.7	108.4	163.3	101.3	82.5	86.5	49.8	97.8	76.8	147.1	138.1	219.6	56.9	178.1	351.4	338.3	140.5	87.8	148.4	244.4	71.4	173.2	65.8	135.9	222.0	138.1	79.6	85.2	114.5	70.9	187.2	164.5	99.7	168.5	94.2	97.8	182.1	157.7	164.3	155.2	133.4	166.4	135.6	12.6	15.6	17.4	31.8	23.1	24.0	20.1	22.3	27.4	20.6	19.3	17.1	25.1	12.7	23.9	23.9	34.6	20.9	16.1	92.3	91.2	96.6	104.3	92.7	98.1	99.2	94.1	94.6	77.1	90.0	89.8	33.3	41.7	39.0	17.9	36.8	34.2	21.1	22.1	13.1	32.1	52.0	39.5	54.9	37.1	19.2	36.8	4.2	25.4	72.4	57.2	11.7	29.4	4.0	34.0	46.4	35.7	46.1	42.3	19.4	40.6	32.0	37.5	37.8	41.6	24.1	31.2	45.0	85.0	43.0	40.4	21.2	49.7	20.3	72.9	31.8	5.5	45.1	37.7	46.2	21.5	45.9	46.8	82.4	19.6	17.7	45.0	35.7	35.7	42.0	36.9	42.8	37.4	25.7	17.8	6.6	31.2	32.9	10.8	13.4	30.3	37.8	19.8	41.1	32.0	57.5	27.9
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955412	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Oligodendrocytes: 117.9;Rod photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 21.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 21.7"	"Cell line enhanced"	"Detected in many"		"T-47d: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	20.5	19.2	19.1	13.9	29.5	8.6	17.2	23.2	22.8	31.5	20.6	40.9	7.6	24.7	7.9	32.4	32.4	19.7	38.8	16.6	22.5	25.1	6.1	21.2	7.5	29.5	27.5	9.5	19.0	11.3	21.6	11.9	24.0	24.4	10.6	30.4	30.9	26.3	86.6	11.7	13.2	25.6	21.9	10.6	23.2	3.2	27.8	5.5	18.2	39.7	5.5	31.3	21.2	33.8	27.1	81.7	83.7	15.1	13.5	24.4	2.8	18.8	37.6	38.5	27.7	15.1	100.9	0.4	74.3	36.2	32.6	21.2	9.3	40.1	13.7	52.8	15.8	0.9	58.4	12.6	32.1	0.3	6.3	25.2	23.7	22.5	18.9	33.8	18.8	0.5	1.1	0.4	35.8	15.2	1.4	0.6	2.9	30.7	22.5	2.8	21.6	4.0	25.8	17.5	34.5	18.9	7.9	8.4	32.0	14.2	116.8	2.9	24.2	101.9	63.4	28.2	42.4	0.0	0.4	0.4	44.3	3.7	83.3	0.7	0.5	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.2	1.9	21.7	0.0	0.2	19.1	29.5	23.2	22.8	16.6	22.5	29.5	27.5	24.0	21.9	27.8	33.8	14.1	19.2	5.9	22.5	0.9	4.1	15.6	6.5	13.1	47.1	11.5	11.6	16.1	17.2	10.4	22.0	64.6	0.7	30.9	6.2	7.9	20.3	0.4	24.6	6.3	10.7	3.5	0.0	4.8	26.3	0.4	15.8	10.2	22.9	0.0	10.0	3.9	3.4	17.3	10.1	13.0	4.5	18.3	11.3	7.3	2.9	6.8	12.9	5.4	30.9	4.3	31.8	0.0	31.2	117.9	27.7	2.1	5.3	0.1	21.8	0.7	8.6	17.6	64.8	6.6	26.6	15.3	0.0	1.3	19.0	2.4	0.7	0.7	1.6	4.2	17.3
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432584	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: AB_2677694"	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	45.6	66.6	84.3	28.3	86.0	29.8	42.3	89.4	91.2	49.5	80.5	64.7	19.8	53.4	33.7	30.7	48.3	31.5	91.8	84.4	89.0	55.8	44.9	38.1	33.2	85.1	84.1	56.3	41.0	58.9	45.5	27.8	86.2	48.1	23.3	31.1	40.8	37.3	119.4	37.5	34.2	42.5	83.8	42.8	48.0	38.4	88.1	43.2	42.2	119.2	30.4	48.2	37.7	87.2	53.8	58.2	98.3	120.0	77.3	95.8	35.8	42.4	147.8	95.6	71.6	18.9	56.5	94.4	91.7	76.3	41.7	54.7	65.0	97.3	50.5	75.5	66.4	58.7	50.1	20.8	130.4	45.2	38.0	116.2	89.9	93.6	95.3	187.0	100.1	108.5	46.6	96.5	109.4	58.8	110.2	101.6	35.4	44.1	37.9	124.6	115.0	49.9	101.9	24.8	49.7	113.0	29.6	31.6	96.8	41.5	94.3	71.7	59.5	48.2	45.4	60.6	62.9	112.3	93.2	63.3	84.4	154.2	41.4	98.9	111.5	84.4	69.2	91.5	77.3	80.5	66.9	72.4	112.0	89.5	66.2	63.2	43.0	93.0	58.0	97.9	84.3	86.7	84.3	86.0	89.4	91.2	84.4	89.0	85.1	84.1	86.2	83.8	88.1	87.2	56.6	32.1	21.9	10.7	36.1	31.7	49.0	73.1	44.9	54.7	58.8	81.0	56.8	40.0	37.4	46.0	25.0	66.9	40.6	24.0	80.3	70.0	21.0	28.3	52.9	46.4	55.7	35.7	12.2	46.6	33.2	58.5	31.6	26.6	51.4	89.6	59.3	49.9	75.1	67.3	16.0	36.4	63.1	49.1	47.7	42.2	57.2	44.3	51.6	3.7	97.0	94.7	44.3	13.6	23.4	40.0	32.0	60.2	45.4	38.3	34.5	151.7	28.1	47.5	39.5	46.5	164.9	56.6	31.3	42.6	33.8	45.6	38.7	92.5	39.3	41.9
CZIB	"C1orf123, FLJ20580"	ENSG00000162384	"CXXC motif containing zinc binding protein"	Q9NWV4	1	53214099-53220634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 29.2;Cardiomyocytes: 45.8;Cytotrophoblasts: 60.7;Extravillous trophoblasts: 76.7;Fibroblasts: 22.2;Hofbauer cells: 66.5;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	55.8	35.5	56.1	22.3	58.0	21.9	49.4	57.2	74.6	53.6	56.9	66.5	22.5	57.1	39.8	32.3	52.3	30.2	52.5	57.7	56.6	39.4	43.5	33.1	30.0	57.9	56.6	47.2	25.1	34.6	28.5	30.6	57.0	41.0	34.8	21.6	24.8	45.4	76.5	26.2	31.6	59.2	57.1	32.5	40.3	31.0	57.4	36.3	35.1	65.3	29.7	57.7	37.6	59.0	32.6	34.7	44.7	41.0	101.6	129.1	39.4	47.8	50.4	47.3	50.8	29.6	27.5	50.1	39.0	58.1	45.8	12.6	27.9	46.9	57.0	65.0	47.5	51.0	24.9	45.0	100.0	59.5	32.1	84.6	50.3	50.6	53.3	71.5	78.5	61.0	53.7	13.7	60.1	54.6	73.5	55.6	74.8	39.7	54.3	52.8	56.8	39.7	55.8	32.6	37.6	36.1	45.1	40.9	47.7	72.2	29.2	59.8	49.3	54.5	31.9	38.2	47.2	19.5	30.7	57.3	43.9	58.5	42.8	60.7	56.6	58.6	50.9	72.3	46.9	46.9	49.8	53.6	68.8	45.1	55.0	54.9	22.8	59.0	60.3	46.3	68.2	51.1	56.1	58.0	57.2	74.6	57.7	56.6	57.9	56.6	57.0	57.1	57.4	59.0	29.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	60.7	8.2	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	76.7	22.2	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	46.7	1.3	0.0	0.0	0.0
DBP	DABP	ENSG00000105516	"D-box binding PAR bZIP transcription factor"	Q10586	19	48630030-48637379	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 318.3;Horizontal cells: 215.4;Muller glia cells: 194.2;Rod photoreceptor cells: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 61.7;NB-4: 235.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.49e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (3.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.24e-3)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.61e-2)"	12.4	53.0	22.5	6.6	34.6	7.5	12.6	35.7	32.9	12.9	9.7	18.7	19.2	13.2	7.2	21.1	11.6	6.0	18.3	21.9	23.4	17.9	24.7	9.8	14.6	21.3	24.5	33.5	14.0	15.6	34.9	2.8	18.6	16.8	3.8	32.6	42.2	13.8	57.1	58.1	15.5	4.5	23.5	19.1	16.4	16.4	29.0	13.6	34.4	7.7	8.4	8.8	16.3	20.5	4.3	7.3	3.6	17.6	2.6	3.4	3.8	1.0	9.8	3.0	7.4	4.6	39.7	8.5	4.8	4.8	3.6	9.8	12.6	2.5	2.5	8.9	6.0	17.2	6.1	2.4	12.9	10.6	12.5	12.1	2.3	0.5	2.0	21.1	0.6	17.9	1.3	61.7	2.7	5.9	32.8	235.3	2.5	11.3	4.9	15.8	2.9	22.2	1.5	1.3	11.7	14.7	5.5	26.5	15.6	1.6	4.8	10.5	1.1	6.5	17.8	3.4	1.9	28.4	50.7	15.6	3.1	15.0	3.9	3.3	3.0	4.9	1.9	3.5	3.9	2.7	3.2	1.6	4.1	1.7	2.5	3.1	0.1	0.7	1.9	3.5	3.7	1.1	22.5	34.6	35.7	32.9	21.9	23.4	21.3	24.5	18.6	23.5	29.0	20.5	14.1	12.8	6.2	9.4	21.7	21.9	15.3	3.1	52.3	318.3	17.2	23.5	4.7	12.8	3.2	7.3	87.6	5.2	15.9	8.0	45.0	5.8	1.4	9.0	25.4	10.8	1.8	6.9	4.2	5.6	1.9	25.5	7.1	13.1	0.0	17.6	10.4	10.0	10.9	215.4	5.7	8.1	6.1	15.1	9.6	3.3	16.8	19.4	17.8	1.9	12.9	194.2	32.0	1.5	4.8	3.0	11.3	25.6	6.8	7.8	63.7	26.6	1.3	108.4	0.0	22.8	13.6	1.3	8.4	32.2	22.6	1.6	20.8	85.8	7.5	18.3
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	43.3	40.0	90.5	27.0	94.7	23.7	37.4	76.4	113.2	44.3	20.8	51.3	22.2	51.4	17.0	42.6	38.7	28.2	82.6	99.9	80.1	27.6	18.2	36.0	22.8	110.9	85.1	39.2	28.6	118.0	61.2	32.6	112.6	30.0	25.5	43.5	56.3	38.0	87.6	44.2	32.2	49.9	76.0	26.5	39.5	51.3	101.9	34.7	31.3	63.4	24.6	47.6	39.0	116.2	65.0	74.7	68.4	71.9	122.5	90.7	55.2	102.0	105.2	127.0	89.9	99.9	48.6	88.8	40.8	213.0	70.1	63.5	84.3	129.5	96.1	111.2	85.0	92.5	55.6	84.7	94.4	50.7	109.3	109.6	62.0	138.3	82.3	86.9	110.3	79.4	40.3	61.4	97.3	55.6	92.8	52.5	74.0	78.6	78.3	82.3	120.1	63.8	70.2	39.6	83.3	74.1	57.1	67.7	60.6	59.0	43.5	36.5	84.3	115.0	82.7	50.0	77.2	37.8	32.7	78.9	107.6	81.4	82.5	8.3	11.3	12.7	14.4	13.0	11.7	10.1	8.2	10.8	11.2	6.8	5.6	6.3	9.2	9.2	15.6	8.8	7.7	16.5	90.5	94.7	76.4	113.2	99.9	80.1	110.9	85.1	112.6	76.0	101.9	116.2	28.6	32.1	25.4	9.8	23.2	10.1	10.3	19.1	25.6	27.2	19.6	17.8	56.4	18.6	20.0	29.5	25.0	29.8	19.4	41.0	19.6	22.5	7.3	21.5	32.8	26.6	16.7	27.3	28.4	19.9	27.1	25.1	49.5	27.8	29.2	30.8	29.6	19.9	28.8	90.9	26.7	31.8	24.4	21.0	11.3	9.3	44.7	21.2	16.0	8.4	27.3	14.9	23.7	12.1	29.7	26.6	33.6	51.9	24.7	9.6	34.2	19.6	19.4	45.5	19.7	28.3	30.0	40.6	38.5	29.0	11.8	25.2	20.0	33.9	24.9	10.7
DCTN2	"DCTN-50, RBP50"	ENSG00000175203	"Dynactin subunit 2"	Q13561	12	57529633-57547224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039715, HPA040040"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		630000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA039715: AB_10795154, HPA040040: AB_10794870"	"unprognostic (1.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.38e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.41e-3)"	85.7	99.7	76.3	40.7	80.5	44.6	76.7	88.6	86.1	91.3	62.5	104.6	44.6	98.3	61.8	120.2	71.9	43.6	102.3	81.4	87.9	84.9	50.7	71.7	43.3	91.1	85.1	75.8	116.0	78.2	75.7	52.4	95.5	66.4	73.5	61.3	82.9	65.4	155.2	103.7	75.9	93.3	82.1	64.2	94.9	51.9	82.7	61.4	69.9	102.7	71.4	79.6	89.8	89.9	94.9	109.4	129.1	90.3	194.7	200.0	69.4	104.7	191.7	205.0	149.6	87.2	79.0	95.5	114.1	172.5	83.8	70.8	106.0	136.4	162.0	108.7	119.1	84.8	48.4	69.9	139.3	58.7	60.0	186.3	213.8	131.5	225.1	245.6	201.9	102.0	127.7	126.6	189.5	107.4	89.3	71.8	62.4	56.2	124.0	77.2	101.0	91.4	158.1	92.3	173.2	125.8	98.3	85.2	96.7	104.0	138.5	54.4	153.5	110.6	95.6	69.1	66.7	94.6	91.6	93.8	106.4	73.8	121.2	47.9	48.5	43.7	38.0	54.2	39.3	32.9	37.9	38.0	49.2	30.3	28.1	34.3	22.5	35.1	50.3	37.5	45.5	62.8	76.3	80.5	88.6	86.1	81.4	87.9	91.1	85.1	95.5	82.1	82.7	89.9	82.6	48.1	30.2	20.2	47.5	64.9	87.2	105.1	58.6	84.3	64.7	76.7	70.9	65.8	60.0	35.0	31.3	118.2	53.5	83.4	80.3	162.7	105.5	42.9	58.6	74.0	49.1	53.6	27.9	227.5	122.1	73.6	80.5	52.4	36.2	70.8	69.9	31.7	102.6	72.3	32.6	70.3	83.4	51.8	54.2	265.5	77.9	52.8	76.5	15.0	153.5	141.9	57.7	23.1	28.2	200.4	85.5	73.0	60.9	85.3	121.1	115.8	40.9	67.8	92.1	59.4	107.6	122.7	37.1	93.6	68.5	163.4	52.6	92.3	94.5	89.5
DDHD2	"KIAA0725, SAMWD1, SPG54"	ENSG00000085788	"DDHD domain containing 2"	O94830	8	38225218-38275558	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015202, HPA023143, HPA023147"	Supported		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Centriolar satellite"	"CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535"	"unprognostic (1.49e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.49e-1)"	28.9	18.1	27.3	14.4	32.1	14.9	19.4	33.8	39.7	22.0	23.5	20.1	19.6	20.9	23.3	20.9	19.1	17.5	27.7	30.1	29.3	21.6	12.1	16.9	19.8	32.1	27.7	28.9	22.2	21.1	18.3	15.2	35.1	22.6	16.7	31.7	18.3	29.3	32.0	16.8	22.2	18.2	30.7	17.2	15.0	22.7	32.4	19.5	18.7	35.8	22.3	17.6	17.7	38.8	57.7	26.1	58.3	28.3	21.8	30.6	18.4	18.1	33.0	42.5	38.4	30.8	22.6	22.8	24.1	32.8	26.3	22.7	33.9	34.1	64.9	19.8	22.6	83.0	36.0	29.9	19.6	9.6	12.8	16.0	26.4	26.4	26.8	27.0	51.5	31.2	59.6	24.5	27.3	12.3	66.6	14.7	13.2	9.5	15.1	34.0	50.1	16.5	22.5	34.8	21.2	32.0	44.4	21.9	22.2	18.2	26.3	26.1	46.6	24.8	31.1	24.3	28.4	25.7	25.8	54.0	39.5	18.4	35.3	2.5	3.9	4.7	10.6	4.9	11.8	9.8	9.6	11.9	6.5	15.2	10.2	7.5	0.3	16.5	3.5	3.8	15.6	7.3	27.3	32.1	33.8	39.7	30.1	29.3	32.1	27.7	35.1	30.7	32.4	38.8	15.4	22.4	7.0	20.5	17.3	13.8	10.6	8.2	14.2	27.9	12.7	7.4	23.9	8.6	8.4	20.2	18.8	12.1	16.2	7.2	23.5	11.6	4.5	9.7	13.4	13.8	15.7	25.2	51.3	11.0	11.5	13.6	12.8	12.4	21.0	22.8	12.5	5.5	7.4	53.8	51.2	9.3	6.1	8.4	11.2	10.8	20.2	7.7	19.6	21.5	13.0	19.9	16.5	35.7	46.9	16.2	6.2	20.7	24.0	10.2	23.8	10.0	5.4	5.9	6.6	17.6	13.6	30.9	35.3	8.7	10.7	6.4	17.9	13.4	8.9	7.7
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 125.4;Excitatory neurons: 219.3;Inhibitory neurons: 269.9;Oligodendrocyte precursor cells: 216.2;Oligodendrocytes: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: AB_2683979"	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	12.7	7.7	13.8	3.7	18.3	0.2	8.3	18.8	19.9	11.0	0.0	22.1	4.5	12.1	5.4	9.1	8.8	8.6	14.1	13.6	10.7	14.7	8.9	4.9	2.4	16.8	14.6	13.3	8.0	8.1	6.2	4.6	17.4	8.4	4.4	9.4	4.2	9.1	34.5	4.8	7.0	12.4	7.2	3.3	7.3	7.2	18.1	2.1	5.3	20.8	1.5	10.5	7.5	32.6	0.7	6.3	11.5	6.1	19.0	20.5	9.5	13.9	8.6	10.5	8.5	1.8	1.9	0.5	3.6	22.5	2.7	0.1	7.1	1.2	6.4	0.3	6.4	0.1	4.5	2.0	9.2	0.0	8.6	16.9	5.5	6.6	0.0	16.4	2.3	0.1	0.0	1.2	8.0	17.4	0.7	0.0	3.0	5.4	2.6	9.9	4.8	2.0	7.5	7.2	5.8	8.2	2.4	5.0	20.1	6.0	6.6	0.0	0.1	11.1	2.9	33.3	4.6	0.8	14.3	7.2	13.9	0.3	6.4	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	13.8	18.3	18.8	19.9	13.6	10.7	16.8	14.6	17.4	7.2	18.1	32.6	12.6	9.6	5.8	125.4	4.0	7.9	5.4	2.2	7.4	18.6	11.8	10.0	30.3	17.2	4.7	3.7	22.9	5.2	0.6	2.2	0.0	8.5	19.0	7.9	18.5	7.8	10.8	0.0	219.3	4.0	5.8	15.4	10.2	8.8	20.3	16.3	10.4	24.2	6.2	1.7	269.9	6.2	2.0	3.5	5.2	6.1	11.5	3.6	23.2	44.0	0.6	19.4	1.0	216.2	421.7	7.7	1.3	19.5	0.9	7.7	10.2	17.0	5.3	20.5	6.6	22.7	17.6	21.7	22.5	4.3	3.8	3.8	2.0	5.6	5.7	8.9
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	82.7	66.0	112.4	55.9	119.0	183.2	87.0	124.0	219.8	76.0	125.6	103.7	43.5	81.5	109.4	117.0	73.8	50.5	121.0	119.5	122.2	73.3	49.8	69.9	54.8	122.8	122.8	76.6	43.6	57.6	65.2	73.7	123.7	58.1	49.2	87.4	74.8	70.5	328.3	132.7	56.9	73.3	120.3	59.3	62.1	118.2	118.5	81.1	52.6	177.5	68.0	92.7	90.8	139.5	179.8	106.7	127.0	130.9	126.3	113.1	117.6	196.2	159.8	179.1	194.4	146.4	176.0	68.7	359.2	146.9	162.4	111.9	87.3	137.8	275.3	138.3	119.6	123.1	61.7	104.6	116.1	92.4	99.4	100.2	130.7	136.1	64.2	178.9	135.6	72.2	203.8	66.9	232.5	121.7	232.4	181.0	255.7	126.1	141.2	122.7	91.1	96.0	148.9	108.1	76.5	201.2	153.5	119.3	151.2	259.6	87.2	129.8	170.0	113.0	85.4	270.6	172.0	126.1	193.1	80.9	160.1	208.7	146.4	345.1	160.8	201.9	133.8	168.2	135.2	134.8	120.8	138.4	120.2	124.0	152.0	141.7	287.8	148.0	206.3	109.9	159.6	247.0	112.4	119.0	124.0	219.8	119.5	122.2	122.8	122.8	123.7	120.3	118.5	139.5	225.2	48.1	62.7	41.1	150.9	756.7	640.9	632.6	182.7	100.4	281.8	175.9	115.0	62.9	206.8	97.5	81.3	276.9	287.0	143.0	193.7	134.9	105.8	225.6	125.2	178.8	193.5	131.1	49.4	69.4	241.8	159.8	66.8	296.3	212.7	70.5	101.4	46.7	164.7	94.2	56.4	149.8	223.8	133.7	803.5	126.4	151.0	339.2	282.8	60.9	313.6	122.7	173.0	37.2	73.5	138.5	132.4	202.3	132.9	413.2	82.4	196.1	253.8	104.0	98.6	146.0	198.8	319.4	504.8	204.1	960.5	508.1	288.0	111.4	155.1	876.8
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475593-54651169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.0;tongue: 24.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 110.7;Distal tubular cells: 39.2;Excitatory neurons: 49.7;Horizontal cells: 38.7;Inhibitory neurons: 79.6;Muller glia cells: 63.9;Oligodendrocyte precursor cells: 58.3"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;ASC diff: 13.1;ASC TERT1: 11.0;hTEC/SVTERT24-B: 13.7;U-138 MG: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	2.9	1.9	14.6	1.7	14.2	0.0	1.9	13.4	15.6	1.1	13.0	1.4	0.3	1.7	0.3	1.7	12.2	9.8	18.4	15.4	16.9	5.2	2.3	1.0	0.6	15.9	14.7	0.9	1.2	0.2	1.1	1.8	18.6	0.9	0.7	11.7	1.4	0.8	46.0	0.5	0.7	2.8	13.9	0.3	0.8	1.7	15.3	0.4	5.1	24.3	0.4	4.7	0.9	13.3	0.0	0.0	32.9	0.0	13.1	11.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	4.3	0.0	13.7	0.0	0.6	1.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	3.6	7.0	0.0	8.6	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	51.3	3.2	1.4	0.0	0.0	0.0	0.1	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	14.2	13.4	15.6	15.4	16.9	15.9	14.7	18.6	13.9	15.3	13.3	4.8	0.0	0.0	110.7	0.3	0.3	2.3	0.0	0.0	12.3	6.7	6.2	7.3	12.8	0.0	11.0	6.2	0.3	0.1	0.0	39.2	17.7	2.3	0.4	1.5	3.3	0.0	0.0	49.7	1.2	0.6	14.4	0.0	10.6	0.0	28.6	17.5	0.0	29.0	38.7	79.6	0.0	0.0	0.6	2.5	4.5	2.5	0.6	0.0	9.4	14.5	63.9	0.0	58.3	2.1	2.2	0.0	1.2	0.1	2.0	0.0	0.2	0.0	8.1	0.0	2.8	5.3	3.7	1.5	0.0	0.4	0.8	0.2	1.6	0.0	0.9
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DVL1		ENSG00000107404	"Dishevelled segment polarity protein 1"	O14640	1	1335276-1349418	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 230.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011538, HPA073607"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB011538: AB_2093326, HPA073607: "	"unprognostic (2.67e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.81e-3)"	"unprognostic (5.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-2)"	32.8	49.9	50.6	11.8	44.4	9.6	34.0	32.0	71.4	42.9	23.1	50.4	28.8	37.6	8.3	65.0	42.7	11.7	74.9	51.6	31.9	38.2	56.8	35.4	9.5	42.2	37.7	43.0	63.9	21.2	43.7	15.0	35.4	39.4	5.8	8.1	61.8	14.3	230.1	51.5	32.4	7.9	31.9	28.9	53.1	61.9	37.9	6.8	38.3	69.9	4.7	43.6	46.2	41.1	81.5	40.7	16.5	35.2	15.7	19.1	40.5	48.3	22.8	37.3	18.7	31.7	99.3	25.3	70.8	21.5	20.6	48.9	13.2	49.1	5.8	31.4	76.6	14.4	78.4	58.1	33.6	22.5	21.7	16.3	29.6	50.2	34.2	31.7	12.9	33.9	56.5	17.5	15.6	32.6	21.8	37.4	26.3	29.0	154.3	36.9	13.0	44.7	27.5	12.6	64.3	43.8	23.3	62.6	66.6	5.9	34.8	37.4	25.8	21.2	55.0	82.4	82.2	27.6	12.1	32.1	62.2	31.3	13.7	0.1	0.3	0.0	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.1	0.1	50.6	44.4	32.0	71.4	51.6	31.9	42.2	37.7	35.4	31.9	37.9	41.1	20.5	19.2	14.8	12.1	4.4	13.8	5.5	8.8	6.2	33.2	19.0	16.3	25.5	8.6	10.1	7.3	6.2	10.7	6.9	32.1	3.9	11.3	1.1	13.4	14.2	12.0	12.1	1.3	11.0	20.4	14.9	11.5	31.6	18.8	1.3	15.8	6.1	21.8	5.1	32.0	10.2	17.6	4.1	5.7	6.8	3.0	13.1	4.9	7.2	9.4	2.6	23.5	1.0	6.0	14.3	52.3	20.8	10.5	5.1	16.6	21.0	5.8	9.1	22.1	13.1	12.2	10.8	14.2	13.3	15.3	15.5	11.4	4.5	25.4	24.3	12.6
E2F6	E2F-6	ENSG00000169016	"E2F transcription factor 6"	O75461	2	11444375-11466177	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 7.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA075185			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA075185: AB_2732282"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.58e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	5.5	5.2	5.0	2.5	5.3	3.8	4.3	5.1	6.2	3.3	5.1	4.5	2.8	5.4	3.9	2.7	4.9	3.1	7.6	4.8	5.8	2.6	2.8	3.0	2.4	5.3	5.4	4.7	4.6	3.4	5.0	3.1	5.1	3.3	2.2	3.5	3.6	3.4	14.6	3.7	3.6	4.4	5.1	3.2	4.9	2.8	5.2	2.5	2.7	11.5	1.9	4.0	3.0	5.2	4.2	5.2	10.7	6.0	4.8	3.9	8.0	4.0	7.1	4.6	4.2	10.3	5.6	8.2	4.5	4.6	9.3	3.1	7.6	5.9	4.8	10.6	11.3	14.9	4.0	12.8	9.4	15.4	14.7	6.7	5.5	5.0	5.9	3.9	4.2	7.1	11.3	15.3	3.7	10.1	8.9	16.9	15.3	5.1	6.7	15.6	12.1	8.4	5.0	3.7	9.2	19.1	4.6	6.7	18.8	4.6	6.2	7.7	3.5	6.6	8.5	4.2	9.0	22.0	17.4	19.9	7.2	14.5	10.3	7.8	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.0	5.3	5.1	6.2	4.8	5.8	5.3	5.4	5.1	5.1	5.2	5.2	15.7	6.4	4.8	7.2	8.4	24.3	23.6	10.6	13.6	12.4	14.5	9.7	9.0	10.0	8.4	3.7	16.7	17.3	8.5	3.4	7.9	11.7	1.4	11.0	14.1	12.2	6.7	3.4	13.9	11.0	13.9	14.3	13.3	14.0	0.0	13.6	8.6	8.8	12.5	13.5	14.9	4.7	8.2	5.4	11.5	2.6	8.7	11.3	17.8	6.5	7.0	10.1	5.2	3.5	20.8	9.4	3.7	11.3	6.1	21.3	5.3	8.4	4.1	11.8	0.0	22.2	12.3	15.7	48.2	8.2	21.9	22.2	8.4	11.7	6.0	16.7
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Approved	Nucleoplasm		Yes	No		5400	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	41.6	34.1	33.8	23.5	43.7	28.6	31.8	33.9	52.9	31.6	31.6	34.0	32.1	28.4	23.6	28.7	26.5	19.9	44.4	52.7	30.6	31.0	28.2	31.0	21.6	32.0	31.9	33.0	38.4	40.6	32.7	24.0	33.7	34.3	29.6	28.3	32.0	25.6	245.0	32.4	29.6	28.5	26.1	22.4	31.2	35.6	31.4	16.2	32.4	97.1	21.2	31.6	30.9	40.1	58.9	53.1	35.0	37.7	81.6	81.1	57.5	70.8	60.4	57.0	39.1	49.7	35.6	59.3	32.5	62.6	46.5	83.7	45.1	47.4	52.7	65.4	28.3	36.6	64.5	72.0	60.4	68.9	38.2	74.2	48.8	57.3	84.4	64.6	58.8	14.7	85.4	81.1	47.1	49.5	0.3	39.9	68.6	74.7	44.1	33.4	107.2	35.7	48.9	52.2	66.7	31.7	60.5	64.1	46.2	37.6	50.5	36.4	64.7	38.1	43.6	57.5	65.5	71.2	144.9	71.3	55.7	27.8	36.0	2.7	5.8	1.9	4.6	6.0	5.3	3.9	4.7	5.3	8.1	4.2	2.8	4.9	1.7	4.8	4.5	3.6	4.1	2.9	33.8	43.7	33.9	52.9	52.7	30.6	32.0	31.9	33.7	26.1	31.4	40.1	24.6	57.7	63.9	0.0	5.3	0.0	0.0	0.0	0.0	0.0	19.0	14.7	0.0	0.0	32.8	12.9	0.0	17.3	11.6	0.0	9.8	21.0	0.0	19.3	32.0	12.1	0.0	0.0	0.0	21.7	11.4	12.5	0.0	26.2	24.0	30.6	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	25.7	0.0	0.0	4.9	0.0	0.0	14.4	24.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.2	6.5	29.2	0.0	0.0
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488013-63499239	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1638.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 347.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	0.9	32.7	59.3	1.4	81.3	0.0	1.7	17.1	347.2	2.8	0.0	5.1	0.7	0.3	1.1	9.7	0.4	2.4	358.0	73.4	97.3	1.3	3.0	0.8	0.6	95.0	2.9	0.5	6.5	16.2	111.5	0.0	76.3	9.6	0.4	37.2	19.5	0.8	1638.0	6.8	1.9	0.8	0.0	0.3	8.5	1.2	30.7	0.2	0.7	320.7	0.1	2.2	1.8	125.0	0.5	71.0	0.8	16.8	0.0	0.6	7.9	10.0	1.3	51.6	16.3	9.8	41.5	0.0	110.4	0.5	13.4	38.8	240.0	0.7	115.9	0.5	13.1	0.0	24.1	4.1	2.9	0.0	13.4	1.4	2.2	0.1	1.0	0.2	0.0	0.0	3.4	0.2	0.5	405.9	1.4	0.5	11.4	95.6	96.5	8.0	0.2	10.2	2.4	3.9	187.0	89.9	90.0	12.6	1.6	2.2	157.2	3.8	0.0	0.3	202.9	0.7	1.8	0.3	0.9	1.4	0.9	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	59.3	81.3	17.1	347.2	73.4	97.3	95.0	2.9	76.3	0.0	30.7	125.0	0.1	0.0	0.0	9.4	0.7	0.4	0.9	0.0	0.0	130.8	11.8	4.6	125.5	1.5	0.6	0.0	12.5	0.0	1.1	0.4	0.0	1.3	0.2	0.5	0.3	2.2	0.0	0.0	35.5	0.2	0.2	3.6	4.6	1.4	5.7	1.0	1.1	0.1	0.0	269.2	37.2	0.0	0.0	0.3	0.7	0.5	0.0	0.6	0.0	15.0	0.0	11.7	0.0	14.6	12.7	0.3	0.0	0.0	0.3	2.6	0.0	0.5	0.0	50.9	0.0	49.9	3.4	0.0	0.3	0.0	1.8	0.0	1.5	0.0	0.5	1.1
EEPD1	KIAA1706	ENSG00000122547	"Endonuclease/exonuclease/phosphatase family domain containing 1"	Q7L9B9	7	36153254-36301538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 88.0;Oligodendrocytes: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 51.8;neutrophil: 46.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 51.8;T-cells: 23.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.3;PC-3: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053668			Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Vesicles	"HPA053668: AB_2682223"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.89e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.59e-2)"	19.5	5.2	9.8	4.0	12.5	8.1	18.3	10.6	14.2	10.2	7.3	12.0	9.9	7.7	3.6	7.1	7.3	11.7	11.1	10.4	10.6	5.9	24.0	8.1	4.6	12.0	12.8	8.5	11.5	2.2	4.4	4.0	12.7	12.5	3.8	1.5	4.1	3.4	46.9	12.8	11.5	5.6	10.3	10.8	17.0	5.3	13.0	12.8	3.1	12.8	3.0	10.9	9.1	19.2	2.2	5.9	1.8	5.6	16.2	3.5	0.1	1.5	7.2	1.1	2.0	1.2	4.5	5.9	1.8	2.2	16.8	2.4	2.4	2.8	1.0	18.3	4.0	0.7	0.5	11.0	1.5	0.9	5.5	7.3	1.7	0.7	0.4	4.5	0.1	4.4	7.3	0.6	1.2	2.3	6.1	14.6	8.2	7.4	22.4	1.6	2.0	1.3	3.6	4.7	4.4	3.1	0.5	0.8	2.2	3.2	1.8	7.0	0.5	2.2	6.5	1.5	1.7	4.3	5.1	0.0	5.4	3.8	1.4	23.1	5.9	51.8	3.0	3.6	5.2	0.3	23.0	6.6	3.2	0.0	5.0	1.5	46.4	3.9	1.6	2.9	11.6	4.2	9.8	12.5	10.6	14.2	10.4	10.6	12.0	12.8	12.7	10.3	13.0	19.2	32.4	0.0	0.5	30.0	1.3	2.7	14.7	1.8	1.8	4.2	4.9	7.2	4.0	34.3	2.1	0.0	20.9	0.2	0.9	10.8	5.9	26.2	17.4	8.4	3.0	14.8	9.6	1.3	28.4	7.4	0.3	4.0	20.9	7.2	8.9	0.9	3.9	16.9	25.3	6.7	88.0	6.2	0.0	5.8	5.5	3.6	5.0	9.8	3.6	45.0	3.8	2.0	0.0	1.5	175.4	16.9	12.6	16.6	0.7	8.7	19.4	1.9	2.6	1.4	6.6	2.1	6.6	0.7	5.4	4.2	4.0	0.5	3.3	6.4	6.2	10.2
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231422287	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 190.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 29.1"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 29.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavorable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	32.8	35.6	37.5	18.1	40.8	20.0	23.9	38.8	43.2	26.3	31.6	30.0	34.0	30.8	24.5	33.6	24.2	28.2	58.7	39.9	37.2	38.8	56.5	19.1	21.1	41.6	39.0	37.5	40.0	39.0	9.3	42.6	36.8	23.8	26.1	49.9	22.0	30.3	190.7	48.6	35.5	27.6	40.9	27.6	19.1	17.1	43.4	16.7	25.5	153.4	21.3	27.0	12.0	40.9	54.2	59.9	17.5	33.7	44.8	29.4	15.8	22.7	42.2	36.3	49.4	41.3	48.0	15.5	41.7	42.4	31.7	25.1	26.8	30.1	61.0	18.6	42.5	6.7	23.5	37.7	31.5	38.5	8.1	25.4	27.5	24.9	34.2	58.6	49.3	18.5	33.9	37.9	38.3	12.2	8.9	14.4	18.4	33.4	21.0	20.0	21.7	22.7	48.0	23.4	15.9	45.3	32.9	41.4	83.1	11.2	22.4	112.8	54.3	44.3	20.8	40.5	47.2	65.7	46.4	14.7	60.4	14.0	59.4	4.2	0.5	3.1	1.2	1.0	0.7	0.7	0.9	0.8	0.8	0.7	1.0	1.8	29.1	1.6	1.8	0.7	0.5	0.4	37.5	40.8	38.8	43.2	39.9	37.2	41.6	39.0	36.8	40.9	43.4	40.9	64.7	19.2	23.2	36.6	19.8	58.5	15.0	10.7	33.0	32.3	19.4	13.3	111.9	67.2	11.6	18.4	37.5	16.2	16.6	57.6	35.2	37.8	1.2	18.5	20.2	60.6	12.7	8.2	43.9	36.2	34.2	25.9	15.3	21.2	10.1	55.6	28.9	70.6	16.9	62.2	52.6	24.6	16.2	24.1	45.3	5.0	16.1	29.8	26.6	44.0	19.0	56.9	12.3	46.3	48.3	36.6	30.9	23.0	23.9	15.1	43.2	52.3	13.5	44.0	19.7	36.4	36.6	13.1	20.9	24.9	57.5	10.4	24.9	16.0	23.5	21.3
EIF2B4	"DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta"	ENSG00000115211	"Eukaryotic translation initiation factor 2B subunit delta"	Q9UI10	2	27364352-27370457	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 196.4;Late spermatids: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032234, HPA039993, HPA068855"	Approved		Approved	"Nuclear membrane,Actin filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Actin filaments"	"CAB032234: AB_668909, HPA039993: AB_2676790, HPA068855: "	"unprognostic (2.26e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.64e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (5.46e-8)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-2)"	21.4	24.8	23.3	15.2	24.3	10.7	20.7	24.0	23.8	21.3	22.5	31.7	14.6	21.0	16.9	27.8	20.3	13.4	28.0	23.2	23.7	18.2	21.5	18.1	17.2	24.4	24.3	19.8	31.4	20.4	20.3	18.8	24.0	25.4	18.4	19.3	24.6	20.8	51.8	29.3	18.4	22.8	23.2	18.6	24.7	38.1	24.4	18.9	18.1	35.2	22.9	24.1	21.4	24.1	38.7	59.8	44.3	34.6	58.4	42.7	48.4	41.0	43.7	55.7	37.3	89.2	16.9	49.7	38.7	48.7	46.6	27.6	62.5	50.8	36.2	37.4	40.7	61.7	39.3	104.5	51.1	58.2	23.0	41.3	51.1	69.2	51.6	40.4	53.3	37.2	59.5	24.9	53.0	35.2	28.8	61.7	49.1	59.8	38.9	52.9	69.9	43.2	50.0	32.7	34.3	37.4	34.1	53.8	42.6	39.6	31.3	23.4	52.8	40.1	47.0	35.4	49.7	50.9	65.7	74.7	33.9	47.9	38.6	56.6	53.9	38.8	32.1	48.1	44.6	31.1	31.6	32.6	52.5	25.3	30.2	32.9	7.7	30.8	52.2	38.6	43.8	43.2	23.3	24.3	24.0	23.8	23.2	23.7	24.4	24.3	24.0	23.2	24.4	24.1	19.9	12.8	14.8	9.8	17.5	35.9	18.9	32.0	15.4	22.6	28.0	18.7	33.0	14.3	27.0	22.0	66.7	40.9	27.8	23.4	19.6	29.0	196.4	22.3	23.9	19.9	24.0	8.2	6.6	33.4	25.0	24.6	14.8	17.6	31.6	16.9	25.7	34.4	24.3	10.1	6.5	24.8	28.5	20.7	28.0	299.6	23.3	16.5	23.2	2.8	29.5	23.2	16.5	6.0	8.8	26.7	27.1	24.8	28.4	21.2	23.0	27.6	24.9	58.9	19.7	17.0	34.9	71.5	38.9	14.5	34.8	46.1	24.3	23.8	20.5	14.4
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789897	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1600000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	178.4	288.5	277.5	105.8	302.9	7.3	243.4	328.0	388.2	274.5	251.6	282.5	143.3	325.0	196.3	178.1	322.0	205.3	383.9	309.0	331.3	287.8	202.6	156.2	192.3	275.4	254.5	606.8	272.1	189.2	292.5	218.8	290.2	249.7	179.7	310.3	213.5	262.9	675.3	93.7	165.7	252.8	270.6	159.0	196.0	155.3	316.9	178.0	293.8	553.2	170.0	224.3	186.8	275.6	95.4	44.6	179.1	30.2	624.9	589.3	59.3	158.9	138.5	159.1	202.1	159.9	34.2	200.0	812.8	213.7	283.4	146.8	255.2	66.5	272.0	182.6	134.8	304.8	54.4	214.5	249.6	68.3	209.0	402.5	291.8	47.8	368.3	764.1	275.2	161.6	109.6	311.9	496.8	14.2	112.5	31.2	183.7	337.0	199.4	143.3	124.1	122.2	305.9	110.4	331.8	71.9	241.4	175.4	356.9	427.3	269.6	244.3	205.6	122.8	63.0	123.9	87.7	252.1	374.8	85.9	86.9	71.0	63.9	233.4	78.5	88.5	125.8	87.5	200.8	245.4	183.2	154.5	91.0	203.0	273.4	224.2	50.5	169.6	125.3	85.4	187.3	282.3	277.5	302.9	328.0	388.2	309.0	331.3	275.4	254.5	290.2	270.6	316.9	275.6	265.3	118.6	220.2	68.6	416.9	690.3	770.9	595.8	412.6	267.4	396.7	308.2	271.3	327.5	447.9	261.1	64.6	450.1	370.8	306.7	661.2	254.3	33.0	287.9	297.5	319.2	407.8	221.4	146.8	94.5	251.2	367.8	250.2	344.2	312.1	267.2	258.1	142.4	226.6	390.3	138.0	372.9	455.7	228.6	385.2	56.8	385.8	242.9	345.1	92.8	318.1	383.9	256.4	73.9	118.7	136.0	410.8	472.8	235.7	737.4	567.9	665.2	337.8	192.8	236.7	409.7	489.9	223.8	165.4	314.8	618.0	615.5	449.2	345.6	380.1	879.5
ELMOD3	"DFNB88, FLJ21977, RBED1, RBM29"	ENSG00000115459	"ELMO domain containing 3"	Q96FG2	2	85354394-85391752	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012126	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA012126: AB_1848130"	"unprognostic (1.90e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.63e-2)"	"prognostic favorable (6.16e-6)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (5.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.85e-5)"	11.1	8.2	7.0	3.7	7.4	2.7	8.7	6.6	8.0	7.2	5.1	7.6	4.9	5.6	5.9	5.0	6.9	6.1	5.3	5.9	6.4	6.0	8.8	4.9	5.4	6.9	6.8	6.5	6.0	8.9	6.6	6.1	6.2	8.4	4.9	3.1	6.2	7.0	12.1	5.1	5.6	6.7	6.4	6.6	7.1	2.7	6.7	5.4	6.3	10.2	5.0	7.3	6.3	7.0	4.9	6.0	6.7	10.0	20.9	9.2	4.0	8.6	6.7	12.6	11.7	5.0	2.4	3.7	6.7	7.2	15.9	5.1	9.7	11.9	11.4	13.0	6.7	6.5	3.4	3.7	10.9	4.9	8.2	9.6	10.6	12.1	13.6	10.6	9.1	7.4	6.6	4.2	11.9	3.9	7.2	2.9	3.3	9.8	6.4	5.2	13.9	3.5	5.8	3.0	6.3	3.3	5.3	7.3	7.9	7.6	4.0	3.5	4.8	9.1	4.9	7.9	8.0	5.0	9.9	4.9	9.1	5.7	9.4	6.5	2.7	8.0	5.0	1.9	2.7	3.1	3.2	2.0	3.2	2.6	2.7	4.8	2.5	5.0	4.5	0.9	5.5	2.8	7.0	7.4	6.6	8.0	5.9	6.4	6.9	6.8	6.2	6.4	6.7	7.0	9.0	6.4	8.4	36.9	15.7	4.7	10.0	13.0	8.6	27.2	10.7	7.6	5.2	10.0	16.7	11.0	29.2	15.2	9.8	17.3	7.9	8.6	5.6	4.6	6.9	9.5	8.4	7.4	24.3	9.1	5.9	10.0	12.8	4.0	8.9	20.7	12.5	7.5	8.6	30.3	21.4	11.4	14.2	10.0	9.3	5.6	19.3	9.5	17.8	18.7	16.5	14.1	28.8	28.6	49.7	10.4	15.3	23.7	7.7	10.8	24.9	7.1	11.7	30.9	19.7	10.0	8.0	19.7	10.9	6.7	6.5	12.4	14.0	18.3	12.7	9.4
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 74.3;Glandular and luminal cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	13.6	13.0	17.3	11.0	19.0	6.6	16.6	19.0	20.3	26.1	14.1	13.8	9.7	22.6	11.3	12.2	16.1	15.4	16.3	19.2	19.8	17.5	21.0	12.1	16.3	18.2	17.4	16.1	10.9	16.8	11.6	12.0	18.5	13.4	15.6	12.4	9.8	19.2	27.9	12.0	11.1	14.9	18.0	13.7	10.7	14.2	20.1	14.6	18.3	26.5	19.5	13.6	10.6	19.6	34.5	36.3	26.1	21.7	28.9	27.8	17.6	17.7	26.6	31.9	31.2	23.9	14.7	60.0	24.6	27.7	31.3	21.5	26.3	34.3	41.2	11.2	12.4	38.0	21.9	41.3	27.7	21.4	27.5	32.7	48.4	24.4	36.5	26.2	32.4	41.3	46.2	34.8	32.9	20.9	47.3	30.1	28.9	29.5	12.0	34.4	24.4	24.2	33.8	25.5	13.6	25.5	18.1	14.4	28.4	21.3	29.2	24.2	25.7	23.6	35.2	26.8	26.5	14.4	25.9	45.2	26.7	24.7	26.8	20.2	16.1	12.9	25.0	22.2	28.7	17.9	21.8	26.0	18.3	21.2	18.7	22.1	3.8	25.0	27.0	17.3	23.5	19.1	17.3	19.0	19.0	20.3	19.2	19.8	18.2	17.4	18.5	18.0	20.1	19.6	8.8	3.2	12.7	26.4	14.4	2.7	7.1	10.2	10.8	8.5	6.8	8.9	16.6	7.2	11.1	7.3	22.9	15.1	12.5	6.3	7.9	12.5	7.4	74.3	25.0	10.1	1.2	9.4	32.2	9.9	14.8	9.5	9.7	125.2	8.2	12.8	10.4	19.0	14.9	15.2	38.7	7.0	0.0	13.2	4.0	4.8	8.4	9.6	1.8	31.9	9.6	8.7	24.7	49.3	45.9	9.3	11.3	10.1	11.0	7.6	9.9	13.1	10.6	12.2	0.0	9.5	8.4	20.2	17.7	6.9	2.4	10.4	13.7	15.6	10.5	5.4
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513712	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	13.5	27.0	21.3	14.3	22.8	11.5	15.8	23.6	23.6	14.5	24.3	16.2	15.2	17.2	23.1	15.5	16.9	14.7	19.6	21.0	21.6	17.5	21.3	12.1	21.9	22.8	22.2	21.7	14.8	21.1	15.1	14.4	22.7	19.4	13.9	8.7	16.4	17.7	35.6	16.6	13.4	18.0	22.2	15.7	15.7	21.1	22.9	24.6	19.3	29.0	20.5	16.0	13.3	23.7	37.6	36.4	45.3	46.8	34.9	32.0	26.5	43.4	29.7	54.2	48.6	35.1	38.4	68.7	27.1	37.6	51.3	22.1	43.6	62.5	33.0	39.9	34.4	62.6	55.5	40.4	38.5	49.1	38.5	34.9	33.2	61.4	38.3	31.5	47.3	58.8	67.1	21.7	54.1	44.0	59.8	56.7	55.1	35.4	57.9	29.2	22.3	42.2	38.4	33.9	40.3	40.9	36.9	29.8	25.8	36.0	40.8	41.1	32.8	57.3	41.9	28.9	56.9	44.8	63.5	64.9	28.4	58.8	58.4	19.7	20.4	15.1	31.8	18.9	25.2	33.4	29.4	32.9	25.9	35.2	28.3	28.9	2.8	35.3	13.7	33.9	38.5	25.6	21.3	22.8	23.6	23.6	21.0	21.6	22.8	22.2	22.7	22.2	22.9	23.7	19.3	6.4	12.3	8.8	24.9	8.4	15.2	35.7	19.4	21.7	20.3	22.4	23.0	24.3	20.0	33.1	14.6	44.0	27.8	16.0	60.7	28.1	8.3	15.3	19.4	22.6	17.4	30.3	9.4	23.6	39.6	23.4	17.9	14.0	22.2	56.3	30.0	28.5	28.6	38.7	11.9	15.0	40.7	14.5	8.3	14.5	23.0	17.4	16.0	9.4	21.7	43.7	48.4	5.5	11.7	21.3	12.7	30.5	23.1	10.9	22.9	51.1	15.7	26.0	6.6	14.2	22.6	47.2	22.4	15.6	8.4	26.8	23.9	58.4	21.7	10.4
EMC4	"FLJ90746, MGC24415, PIG17, TMEM85"	ENSG00000128463	"ER membrane protein complex subunit 4"	Q5J8M3	15	34225013-34230156	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053440	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA053440: AB_2682151"	"unprognostic (8.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.97e-2)"	76.1	68.1	83.8	48.8	86.5	58.7	68.4	90.3	103.7	69.3	92.0	69.1	55.1	67.0	102.9	78.3	67.8	52.3	86.4	87.6	88.8	67.9	91.3	57.3	55.4	87.2	85.2	66.2	90.7	83.0	60.3	59.2	88.4	62.3	58.2	65.4	79.0	63.7	214.4	63.9	57.1	58.8	86.9	49.1	69.8	49.4	85.7	58.1	60.6	136.7	54.2	59.2	71.4	95.2	123.1	248.2	103.9	135.1	133.2	119.6	95.0	137.7	156.9	166.0	143.4	162.0	106.1	48.5	177.7	160.0	145.6	229.4	107.0	135.3	118.7	148.3	103.7	91.9	219.4	154.8	161.0	139.8	87.8	121.4	126.3	121.4	136.0	118.1	139.8	144.6	117.0	186.6	147.1	137.9	109.9	149.9	116.9	165.0	163.5	102.0	94.7	138.3	161.0	186.9	137.1	166.4	101.7	148.3	77.6	74.8	99.3	164.7	106.5	151.3	103.8	131.8	142.7	162.8	251.5	122.0	184.5	164.1	131.1	256.5	158.6	176.9	154.5	173.9	170.0	237.2	170.6	185.8	162.6	187.7	172.2	168.8	88.5	197.8	200.2	166.6	216.1	277.6	83.8	86.5	90.3	103.7	87.6	88.8	87.2	85.2	88.4	86.9	85.7	95.2	75.3	54.5	67.7	8.8	67.9	91.5	103.7	206.5	55.8	35.8	83.7	104.1	58.7	58.6	132.4	66.2	18.8	150.6	62.5	39.5	125.2	180.3	121.8	67.6	55.1	86.1	52.0	38.7	14.1	172.3	173.6	87.8	36.7	69.1	88.0	63.2	64.2	78.6	113.7	18.5	15.4	62.8	166.8	48.5	73.2	27.4	100.6	56.5	101.4	13.1	87.9	98.4	76.2	15.1	16.9	184.0	65.4	90.7	117.9	89.6	71.8	117.5	133.3	42.8	85.5	81.4	123.2	169.7	91.9	60.2	110.0	141.7	68.8	69.7	66.4	125.4
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847648	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.2;skeletal muscle: 13.9;skin 1: 10.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Region enriched"	"Detected in many"	6	"midbrain: 18.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2"	"Region enriched"	"Detected in single"	5	"midbrain: 4.9"	"Region enriched"	"Detected in some"	6	"midbrain: 23.6"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	3.5	0.2	0.1	0.0	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	18.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	13.9	10.4	0.0	0.0	0.5	0.0	0.0	0.1	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.5	4.0	0.2	0.6	0.2	16.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	4.7	0.5	0.6	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.0	9.9	1.0	11.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.5	0.7	18.2	3.2	0.5	1.4	0.5	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	5.6	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.4	0.1	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0
ENDOG		ENSG00000167136	"Endonuclease G"	Q14249	9	128818500-128822676	"Plasma proteins, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.2"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 111.4;Late spermatids: 147.4;Respiratory ciliated cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021335, HPA021830"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021335: AB_1848151, HPA021830: AB_1848152"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.86e-2)"	"prognostic favorable (5.12e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.06e-7)"	"unprognostic (1.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	11.2	18.8	19.7	2.9	20.0	4.4	11.9	23.7	25.1	9.3	27.0	16.8	12.5	9.3	1.8	17.5	12.6	1.7	52.2	20.1	22.5	24.3	52.9	9.9	3.3	23.4	20.8	8.1	22.5	12.0	13.7	3.6	19.5	14.9	5.7	2.0	14.9	7.0	135.2	13.6	11.5	3.0	20.3	9.2	18.4	20.6	22.6	3.8	11.9	59.1	3.1	11.8	11.0	22.9	14.2	15.3	3.9	20.7	10.0	8.5	17.5	13.4	6.9	12.4	8.6	9.3	11.2	4.6	11.9	8.8	7.7	39.6	12.5	11.8	2.2	9.0	22.4	8.0	14.6	16.7	4.5	24.8	29.3	8.9	14.1	7.5	5.1	7.6	9.6	15.2	25.4	7.1	7.9	20.9	19.4	51.1	9.7	24.6	56.4	22.9	4.5	48.2	18.8	5.1	34.0	33.8	30.0	27.2	7.4	2.6	26.1	12.2	9.8	8.7	5.2	12.5	10.2	22.2	3.3	8.9	17.5	17.6	9.1	0.0	1.1	0.7	1.3	2.0	1.2	1.5	1.3	0.6	1.8	2.8	1.2	1.4	0.0	1.3	0.9	3.6	0.6	0.6	19.7	20.0	23.7	25.1	20.1	22.5	23.4	20.8	19.5	20.3	22.6	22.9	19.0	9.6	5.5	13.1	11.4	8.8	26.9	12.8	6.2	14.0	28.7	21.7	0.6	20.0	16.8	23.9	4.2	31.9	26.9	55.1	101.8	6.0	97.1	111.4	15.1	9.3	14.4	16.8	4.6	7.9	34.4	14.9	21.4	30.1	1.3	93.0	10.0	80.3	20.0	11.8	8.3	27.2	18.3	17.7	7.7	147.4	18.6	15.6	10.6	4.7	6.4	37.2	10.3	3.0	7.8	7.8	24.1	18.8	11.0	18.4	52.0	108.2	115.1	13.1	6.6	23.7	19.0	74.9	6.6	19.1	14.5	10.1	14.5	44.5	36.6	23.3
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130622325-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane"	"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	6.4	7.6	6.4	5.6	9.2	3.3	6.4	5.5	6.9	6.9	5.0	4.9	4.1	8.8	5.4	7.2	7.6	6.6	10.8	6.1	8.0	4.3	5.4	5.1	8.2	7.5	6.7	7.9	3.8	7.8	1.7	5.9	6.4	6.1	5.3	2.8	4.6	8.0	6.7	4.4	4.7	8.2	6.2	7.3	5.6	5.9	7.6	8.6	6.3	8.3	9.5	6.9	3.0	9.2	15.7	12.9	16.2	7.4	15.3	13.2	7.3	12.6	15.3	8.5	5.3	6.0	12.9	11.3	30.1	11.6	11.4	10.9	11.4	13.0	10.7	15.3	12.1	24.6	7.4	6.6	10.6	20.2	16.6	10.7	19.3	10.1	11.3	4.0	12.8	9.9	17.1	8.6	7.0	21.4	13.2	3.7	9.0	20.8	16.0	8.7	10.4	12.9	10.0	10.5	5.5	9.6	12.2	7.2	17.0	6.1	4.6	10.1	10.5	8.3	4.9	13.2	26.4	9.2	4.9	7.6	23.6	19.2	13.8	7.0	11.1	12.9	9.4	14.1	9.6	11.7	10.5	9.7	10.8	11.9	11.2	9.7	1.8	10.8	7.7	5.8	12.4	9.3	6.4	9.2	5.5	6.9	6.1	8.0	7.5	6.7	6.4	6.2	7.6	9.2	11.8	3.2	7.4	15.0	11.5	4.2	6.9	5.1	19.4	4.4	8.1	5.3	13.0	5.7	7.5	3.7	0.0	6.2	7.9	4.9	7.9	8.0	1.0	8.3	13.3	8.6	4.8	11.6	18.7	9.3	5.5	9.7	10.7	5.4	6.3	7.4	7.5	12.3	6.9	3.3	31.2	6.7	14.2	21.3	7.7	2.2	5.6	12.6	8.8	23.4	18.4	4.3	19.6	51.3	132.2	10.1	2.6	6.4	11.9	6.4	4.5	8.4	13.1	8.3	6.6	11.6	9.5	11.4	10.6	13.8	4.8	7.3	11.1	7.6	5.7	5.7
EPDR1	"EPDR, MERP-1, MERP1, UCC1"	ENSG00000086289	"Ependymin related 1"	Q9UM22	7	37683843-37951936	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 95.5;Peritubular cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-937: 122.2;WM-115: 114.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026298, HPA072321"	Enhanced				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"CAB026298: AB_425991, HPA072321: "	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.00e-4)"	23.1	40.3	46.3	4.2	41.4	4.5	11.3	38.4	82.3	38.5	27.3	10.5	13.4	41.7	13.6	8.4	28.1	10.1	27.4	45.4	67.5	16.4	10.9	27.1	4.9	81.9	50.4	34.0	9.4	8.0	9.4	4.9	83.2	34.5	8.4	14.3	13.8	41.0	122.9	3.2	13.2	29.9	50.9	17.2	5.7	13.0	58.5	11.4	31.0	72.1	3.0	8.8	17.0	38.9	0.2	77.9	6.4	0.1	57.9	20.8	0.1	5.9	0.0	3.0	9.1	7.7	5.1	0.0	84.2	86.0	88.7	0.2	1.8	0.7	0.0	0.1	9.8	34.9	10.2	49.5	0.5	29.1	0.2	35.1	0.0	21.1	0.4	20.0	0.0	34.3	0.0	25.2	51.6	5.1	11.3	25.1	24.0	0.0	11.6	35.2	22.3	30.6	47.3	19.3	8.4	29.3	0.0	3.8	28.2	15.3	0.1	20.4	0.0	16.6	27.8	46.6	36.7	33.8	15.4	0.5	75.5	122.2	114.7	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.8	0.0	2.2	0.0	0.1	46.3	41.4	38.4	82.3	45.4	67.5	81.9	50.4	83.2	50.9	58.5	38.9	6.4	32.1	46.2	12.7	1.4	1.3	7.8	3.5	1.2	5.7	1.1	10.5	20.7	7.2	12.7	1.8	0.0	0.5	6.8	5.1	17.6	10.0	0.3	5.5	31.8	2.4	3.6	25.6	36.9	8.0	0.2	15.0	1.5	5.9	2.5	95.5	7.5	10.7	3.1	11.8	39.3	5.1	0.0	1.6	2.0	2.1	28.3	3.1	28.4	14.0	14.2	13.3	2.1	24.6	13.0	19.7	6.9	98.9	0.2	14.6	19.3	14.8	5.7	7.2	6.6	46.4	23.9	0.3	1.8	0.5	0.3	0.1	1.2	28.7	6.4	2.6
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A glucan phosphatase, laforin"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Glycogen storage disease, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.8;tongue: 79.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Early spermatids: 33.0;Excitatory neurons: 30.4;Inhibitory neurons: 50.7;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.2"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.8	6.0	11.4	1.5	11.7	1.8	3.2	11.9	17.8	3.1	7.3	17.2	3.2	6.0	4.3	9.3	4.4	3.6	24.4	11.6	12.6	8.5	5.7	3.0	3.3	11.9	11.5	5.7	2.4	5.2	3.8	1.5	11.1	6.1	2.9	12.1	3.1	8.8	76.8	2.1	3.8	6.3	10.3	2.1	5.3	3.0	11.5	4.8	3.9	79.5	2.6	9.8	2.7	13.3	1.3	2.1	3.4	6.6	8.6	2.3	1.6	3.1	3.8	2.9	3.5	1.7	1.7	23.2	2.7	3.8	3.5	1.8	1.3	1.6	2.6	9.3	1.9	3.6	2.5	2.7	4.8	12.7	2.4	2.0	7.0	1.7	0.7	3.8	2.0	5.0	1.8	5.4	3.8	3.1	8.4	3.2	3.9	3.2	1.9	4.8	3.1	6.7	2.5	1.8	6.3	6.4	5.5	3.3	7.8	3.1	1.9	7.3	4.6	2.9	1.1	2.7	2.6	4.1	4.6	8.6	2.6	2.8	4.8	0.0	0.0	0.0	0.1	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.9	0.1	1.9	0.1	0.3	0.0	0.3	11.4	11.7	11.9	17.8	11.6	12.6	11.9	11.5	11.1	10.3	11.5	13.3	3.9	6.4	1.5	66.9	4.4	0.9	1.0	0.8	0.6	8.4	3.5	2.2	27.8	2.8	2.2	1.8	6.2	1.0	1.9	0.2	11.7	1.0	33.0	1.9	3.6	2.2	1.2	4.4	30.4	2.3	0.7	2.3	1.1	1.4	2.5	6.0	1.4	6.6	2.3	30.3	50.7	1.5	2.0	3.3	1.4	19.8	3.1	3.1	7.2	15.9	1.7	7.9	2.1	56.8	60.1	1.2	1.7	2.2	1.7	1.5	0.5	7.1	2.2	6.3	0.0	6.2	2.4	4.9	1.6	0.8	0.4	0.4	1.8	5.1	1.2	0.3
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920154-13952348	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 140.7;Late spermatids: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB000156: , HPA045828: AB_2679463"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	2.7	3.9	4.7	3.3	5.2	2.5	2.8	6.7	5.4	3.3	4.3	1.9	1.7	3.3	2.8	2.9	3.5	3.0	3.6	4.3	4.9	2.9	3.2	2.7	3.3	5.1	4.8	4.3	2.7	3.9	1.6	2.6	4.9	3.6	2.2	4.1	2.8	2.9	18.5	3.0	1.9	3.6	4.4	3.7	2.6	5.5	5.4	4.2	4.4	3.3	2.9	2.6	1.5	6.8	4.7	5.5	5.3	7.5	8.7	8.1	4.0	6.1	6.4	5.4	6.8	2.1	4.5	7.8	8.6	5.4	4.8	5.8	8.0	4.1	8.3	10.7	4.7	3.8	6.7	5.2	7.9	5.2	4.2	6.1	5.7	7.1	6.0	5.3	7.2	4.6	6.1	8.8	7.6	3.9	7.0	3.4	3.9	2.4	3.1	7.8	10.8	9.7	3.3	3.2	4.3	5.1	7.5	6.0	5.8	4.2	7.5	3.9	7.9	7.8	5.7	7.0	5.4	7.9	9.9	5.2	7.6	6.2	8.1	4.9	2.3	2.3	2.6	2.7	2.9	2.5	2.4	2.0	2.3	3.1	2.4	2.6	2.7	3.6	2.4	3.2	2.5	1.1	4.7	5.2	6.7	5.4	4.3	4.9	5.1	4.8	4.9	4.4	5.4	6.8	14.0	19.2	13.5	16.6	11.3	4.8	6.1	18.3	10.2	0.0	10.0	9.5	8.6	14.3	12.7	5.5	0.0	17.3	9.7	3.3	9.8	11.6	140.7	18.6	19.0	13.5	9.6	12.0	20.4	8.4	6.2	13.0	5.1	7.4	1.3	17.8	17.2	17.7	11.7	0.0	21.2	4.8	10.2	13.6	6.5	117.9	14.9	11.4	10.6	8.4	14.4	0.0	17.5	12.1	20.1	9.9	1.7	21.1	14.4	10.2	4.4	13.3	26.1	0.0	26.3	17.3	12.2	49.4	28.9	9.2	5.5	12.3	11.8	18.0	6.0	4.7
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397359	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	12.9	19.4	18.6	14.1	20.2	17.4	14.0	18.9	26.1	12.5	15.1	13.3	11.4	11.3	4.2	21.4	15.1	6.6	16.8	18.8	17.8	9.9	21.7	7.3	22.0	20.8	18.4	14.3	28.6	5.9	7.2	7.4	19.2	11.0	7.2	2.3	16.4	8.4	41.7	23.0	10.8	7.2	19.0	14.3	13.6	11.4	18.3	14.8	11.6	23.1	11.8	14.7	13.9	22.1	58.2	123.5	15.1	48.8	10.7	13.5	39.4	24.5	13.1	44.6	37.0	72.5	47.5	92.9	64.8	12.9	22.8	25.1	33.1	31.3	12.2	66.7	117.3	42.7	45.5	55.7	32.1	76.7	41.8	16.3	69.0	35.6	33.8	12.1	21.1	57.7	57.5	70.2	14.2	88.1	70.2	58.6	56.6	85.2	59.9	66.9	40.9	94.8	17.6	43.1	64.4	47.8	34.6	62.4	68.2	10.5	31.1	95.6	16.2	45.9	37.4	30.1	76.9	109.6	138.5	106.3	34.9	116.0	39.0	15.2	68.2	1.9	41.3	77.7	47.9	66.0	43.3	40.9	110.1	74.0	63.2	55.4	5.0	62.1	48.6	118.7	37.0	48.6	18.6	20.2	18.9	26.1	18.8	17.8	20.8	18.4	19.2	19.0	18.3	22.1	16.1	3.2	4.8	2.3	21.3	30.5	29.0	29.6	44.9	5.5	30.1	44.2	8.4	22.8	16.9	18.4	4.2	28.4	23.5	12.7	37.2	21.7	9.1	5.5	16.7	11.1	8.5	28.0	5.0	21.4	124.0	13.1	16.3	9.1	5.1	24.7	7.1	20.3	28.8	6.7	4.8	18.4	20.3	11.8	13.3	8.5	16.8	18.9	14.2	2.8	18.9	7.0	18.6	4.0	4.3	17.2	15.3	12.4	21.3	28.0	6.6	34.9	12.7	4.1	6.6	17.8	16.0	17.0	33.1	47.4	33.2	21.2	17.0	31.5	34.2	23.8
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAHD2B	DKFZp434N062	ENSG00000144199	"Fumarylacetoacetate hydrolase domain containing 2B"	Q6P2I3	2	97083583-97094882	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 235.0;Late spermatids: 212.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 8.8;NK-cells: 16.2;T-cells: 15.5"	"Low cell line specificity"	"Detected in many"											"HPA042145, HPA044987"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA042145: AB_2677873, HPA044987: AB_2679170"	"unprognostic (6.55e-3)"	"unprognostic (5.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (9.03e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.84e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.04e-1)"	10.7	7.1	24.5	3.2	28.2	3.5	12.8	29.5	25.2	16.6	21.1	14.5	2.5	17.6	38.1	7.4	17.2	4.2	30.0	23.7	28.8	12.6	4.0	7.9	5.7	27.8	25.8	23.6	14.4	11.1	10.3	1.7	28.9	10.9	5.5	6.8	10.8	6.8	30.3	13.6	8.2	11.2	29.6	6.8	24.7	46.8	28.6	4.2	3.9	45.9	7.7	14.3	12.2	33.1	5.0	6.0	8.2	16.8	8.0	9.5	13.0	4.3	5.0	7.3	6.7	5.6	7.7	9.6	3.7	1.7	13.7	5.2	12.0	9.6	4.1	12.5	22.1	10.5	7.6	4.5	25.6	11.9	6.5	12.8	10.0	0.9	15.5	3.4	7.8	37.0	18.3	22.9	0.5	0.0	14.5	35.5	8.1	2.2	16.7	14.0	2.3	34.5	8.1	8.3	1.8	7.1	14.7	3.8	21.5	15.3	16.1	9.4	1.3	0.8	13.7	1.0	4.2	15.1	21.1	25.4	1.2	30.5	10.1	0.0	0.2	0.2	11.3	0.3	15.5	8.8	11.0	11.1	1.8	4.2	7.5	9.7	0.2	16.2	0.1	2.9	15.0	4.8	24.5	28.2	29.5	25.2	23.7	28.8	27.8	25.8	28.9	29.6	28.6	33.1	8.2	6.4	11.1	11.1	6.1	6.5	11.5	5.9	9.6	6.3	17.9	21.0	42.3	4.3	8.0	5.5	2.1	2.1	5.8	1.1	27.4	7.3	235.0	2.3	6.5	7.8	1.8	5.5	10.4	4.3	1.0	13.5	30.1	1.2	5.7	18.5	8.2	2.3	3.5	5.0	12.1	3.3	6.1	1.6	2.6	212.6	17.1	2.2	30.2	2.8	1.6	21.7	9.2	2.5	8.0	6.9	1.2	17.0	17.3	7.7	0.2	3.8	4.6	5.8	0.0	9.7	10.5	24.5	7.3	7.3	7.1	1.0	8.2	11.1	4.4	8.3
FAM168B	"KIAA0280L, MANI"	ENSG00000152102	"Family with sequence similarity 168 member B"	A1KXE4	2	131047876-131093460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043778, HPA061659"	Enhanced					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043778: AB_10964889, HPA061659: AB_2684577"	"unprognostic (8.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.30e-5)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.35e-3)"	41.5	33.7	55.5	26.8	67.7	46.2	32.1	49.8	60.1	35.4	32.6	54.2	26.3	51.4	26.5	34.4	37.9	23.7	43.4	57.5	52.1	38.4	30.9	27.6	27.8	51.4	53.6	46.9	30.1	46.7	20.3	29.4	54.0	37.5	31.9	48.6	28.1	46.8	69.9	29.9	34.3	40.8	54.7	24.2	36.3	26.8	60.1	38.5	36.2	52.9	31.3	47.6	28.0	55.8	74.1	47.6	98.2	67.7	82.2	62.4	74.0	75.2	54.9	46.3	39.7	88.1	40.0	78.6	61.1	79.8	31.8	57.1	83.8	83.8	66.2	64.8	62.3	72.1	49.8	67.4	83.0	84.8	58.6	63.6	82.4	94.5	81.0	62.3	65.5	72.3	70.3	28.9	72.2	53.4	68.0	55.3	61.6	60.2	57.5	85.0	82.5	70.2	63.7	84.0	71.3	100.0	58.2	58.8	80.1	46.0	52.4	79.2	70.8	77.3	78.9	58.0	73.9	67.9	81.2	98.1	65.9	49.3	70.7	2.5	2.2	4.3	4.4	1.5	4.0	3.0	3.6	3.7	2.0	3.0	4.7	3.4	2.1	2.5	3.4	3.3	3.2	2.8	55.5	67.7	49.8	60.1	57.5	52.1	51.4	53.6	54.0	54.7	60.1	55.8	24.4	35.3	27.4	25.1	19.0	22.8	18.3	24.5	16.5	32.2	28.6	23.6	51.4	24.3	21.6	35.0	37.5	27.0	22.5	38.8	5.9	24.8	12.3	28.0	21.6	22.8	31.8	13.3	47.9	30.8	24.8	23.8	19.4	29.0	19.0	34.7	22.1	39.8	20.1	30.3	52.2	29.8	14.2	25.1	16.0	11.1	29.2	19.2	24.9	28.1	20.9	27.0	14.4	18.6	38.8	38.0	25.3	49.7	25.1	33.3	27.3	26.8	19.5	42.3	13.1	27.5	27.4	18.2	22.8	20.0	25.1	38.3	19.0	23.2	36.7	31.0
FAM184B	KIAA1276	ENSG00000047662	"Family with sequence similarity 184 member B"	Q9ULE4	4	17629306-17781621	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.0;retina: 1.7;skeletal muscle: 4.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.0;Horizontal cells: 32.0;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 27.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044119, HPA048458"	Enhanced					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA044119: AB_2678817, HPA048458: AB_2680401"	"unprognostic (1.20e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.13e-4)"	"unprognostic (2.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-4)"	0.0	0.1	1.8	0.1	1.9	0.2	0.1	1.2	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.7	0.3	0.0	0.0	0.1	2.0	1.6	0.0	0.0	0.1	0.0	0.0	1.8	0.1	0.2	1.7	0.1	0.0	4.2	0.2	0.0	0.0	1.0	0.1	0.0	0.1	1.6	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.9	1.2	2.0	1.9	1.7	2.0	1.6	1.8	1.0	1.6	1.6	1.1	0.0	2.0	4.2	3.8	4.5	5.2	0.2	2.8	33.0	2.7	2.0	0.6	2.8	0.8	0.0	14.6	4.8	1.7	2.4	0.0	1.1	0.8	1.1	2.2	2.7	4.2	2.7	15.5	1.0	3.9	2.8	0.0	2.8	13.4	3.6	0.4	2.4	1.2	32.0	23.0	1.8	0.0	2.2	8.2	1.7	11.5	1.5	3.6	1.9	0.0	19.8	2.1	75.9	7.1	1.5	0.5	7.5	0.4	7.0	0.0	1.1	0.2	27.1	0.0	9.7	2.2	9.1	9.5	0.9	9.7	5.3	4.8	3.4	0.6	5.4
FAM189A2	"C9orf61, X123"	ENSG00000135063	"Family with sequence similarity 189 member A2"	Q15884	9	69324567-69392558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.3;thyroid gland: 58.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 157.0;Astrocytes: 256.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;NTERA-2: 5.1;RPTEC TERT1: 1.8;RT4: 2.3;SK-MEL-30: 5.0;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029411, HPA057207"	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA029411: AB_10602338, HPA057207: AB_2683369"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.16e-6)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.75e-5)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-1)"	6.0	4.7	12.8	0.4	15.0	0.0	13.7	15.8	11.2	26.0	9.2	7.1	1.2	6.8	1.7	5.2	6.8	1.6	13.3	12.2	15.7	4.7	0.2	22.3	0.6	20.1	16.7	24.6	7.3	6.0	7.6	1.5	17.1	11.1	1.1	4.4	6.2	3.4	48.3	12.4	4.0	4.9	16.3	0.4	13.7	1.3	19.8	5.6	58.2	9.0	0.9	7.9	4.6	15.1	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.7	0.7	0.0	0.0	0.6	1.6	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.1	0.3	0.0	0.0	0.1	0.0	1.8	2.3	0.0	0.0	0.0	0.0	5.0	1.9	0.1	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	15.0	15.8	11.2	12.2	15.7	20.1	16.7	17.1	16.3	19.8	15.1	12.1	157.0	23.3	256.3	0.4	3.3	4.9	1.9	7.4	2.1	18.4	39.6	14.6	0.0	26.9	1.8	0.0	1.2	0.4	1.5	0.0	0.9	0.1	19.9	2.8	8.0	0.0	0.0	0.7	0.6	0.1	1.7	11.7	33.0	0.0	2.0	2.2	0.0	0.3	0.0	3.9	0.4	0.0	0.3	1.3	0.0	0.0	0.4	19.6	20.6	0.0	35.1	0.0	7.1	2.1	3.5	1.2	0.0	0.2	3.7	0.2	0.2	2.3	1.0	0.0	3.8	3.8	0.1	0.6	1.9	2.4	0.3	1.0	0.7	0.7	1.8
FAM220A	"ACPIN1, C7orf70, MGC12966, SIPAR"	ENSG00000178397	"Family with sequence similarity 220 member A"	Q7Z4H9	7	6329411-6348981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 89.7;testis: 55.9"	"Group enriched"	"Detected in many"	13	"Early spermatids: 280.0;Late spermatids: 363.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055050			Approved	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA055050: AB_2682684"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (3.71e-2)"	7.1	8.6	13.6	6.9	14.7	2.6	8.3	17.5	17.0	9.1	9.3	6.2	5.4	10.3	7.4	11.5	7.6	7.6	13.8	15.3	13.6	8.2	6.4	6.2	9.9	11.7	12.7	10.7	9.8	19.2	0.6	7.9	12.4	8.0	5.3	11.5	8.4	8.3	89.7	10.1	4.9	9.3	12.5	7.9	6.1	55.9	13.7	12.0	11.7	39.1	10.4	9.6	0.5	13.4	26.9	16.6	11.9	28.0	27.0	22.7	13.1	13.4	16.6	15.9	18.5	10.5	14.6	22.2	15.1	15.9	31.8	19.2	18.2	11.3	20.6	15.5	11.7	7.3	10.0	12.6	29.2	13.5	10.8	12.7	37.5	11.9	28.5	15.3	15.0	16.4	14.6	20.7	13.9	20.9	8.4	24.7	27.8	14.0	21.4	21.6	17.9	18.7	14.7	9.6	12.1	21.0	18.8	23.0	28.6	23.9	22.1	34.9	11.4	12.5	28.5	20.6	17.5	19.7	37.2	23.2	14.6	24.1	39.3	6.6	4.2	8.0	4.7	3.5	4.4	9.1	5.4	6.5	7.7	7.7	8.4	6.8	2.0	12.9	3.8	6.8	6.6	3.7	13.6	14.7	17.5	17.0	15.3	13.6	11.7	12.7	12.4	12.5	13.7	13.4	4.1	3.2	1.1	1.3	8.1	7.8	4.9	6.2	12.0	2.9	6.0	6.9	9.2	0.0	8.2	1.8	6.2	6.3	5.4	3.8	1.9	4.9	280.0	6.0	5.5	4.6	6.1	7.8	4.7	4.8	7.5	6.8	7.7	4.8	1.3	4.4	6.4	3.5	6.2	0.0	4.7	4.2	4.1	6.8	10.5	363.4	8.4	7.4	3.6	2.8	7.1	5.2	6.2	4.0	3.9	4.8	2.1	13.2	3.9	5.5	3.3	2.8	3.4	2.3	0.0	6.3	5.4	23.7	11.4	10.3	10.1	8.2	5.2	3.9	3.4	6.7
FAM50A	"9F, DXS9928E, HXC-26, XAP5"	ENSG00000071859	"Family with sequence similarity 50 member A"	Q14320	X	154444141-154450654	"Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003585	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA003585: AB_1080603"	"unprognostic (1.95e-1)"	"prognostic favorable (2.05e-4)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.64e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-1)"	63.8	59.6	59.0	34.7	63.2	35.6	54.7	61.9	66.2	46.7	58.6	67.9	35.4	46.9	50.5	36.1	40.0	24.2	71.0	59.8	58.9	58.3	51.0	53.2	26.7	65.8	61.7	36.0	50.4	45.7	60.2	35.9	66.7	54.3	27.3	26.5	44.9	34.6	102.4	38.1	46.5	36.9	59.8	51.3	53.6	17.1	64.5	31.5	51.7	57.3	24.7	58.9	41.4	67.1	120.7	145.9	48.0	68.8	174.2	124.7	94.7	152.6	136.0	145.2	219.8	134.2	54.9	6.2	154.6	161.6	211.5	46.2	113.4	106.0	111.8	87.5	72.7	38.6	178.6	86.0	253.4	35.1	109.0	143.2	75.0	224.6	114.4	104.9	120.7	44.5	50.4	94.6	142.9	81.8	41.8	46.0	32.3	105.1	90.7	60.2	120.2	86.4	92.8	119.2	85.6	61.1	55.8	88.4	190.1	81.8	77.0	67.4	149.4	99.8	81.5	165.6	191.3	218.0	134.6	43.0	134.9	120.7	113.6	34.5	54.4	42.1	43.8	72.1	59.3	34.4	45.8	42.2	50.7	30.1	24.8	34.3	30.0	41.7	79.4	38.7	53.5	33.5	59.0	63.2	61.9	66.2	59.8	58.9	65.8	61.7	66.7	59.8	64.5	67.1	60.0	35.3	54.4	14.4	38.2	26.0	42.8	17.9	23.3	65.6	33.5	36.1	88.1	52.9	19.0	29.5	27.1	70.5	50.5	96.0	56.7	53.2	1.8	50.0	71.0	48.7	63.3	56.4	7.3	68.1	109.8	61.0	69.3	68.8	47.0	40.3	41.0	42.6	145.1	47.1	7.4	87.7	18.3	62.3	69.1	5.5	77.9	81.3	32.0	8.4	70.6	80.0	62.8	3.5	17.2	69.8	95.1	79.7	51.6	52.1	123.1	112.1	18.5	68.2	32.9	50.5	76.4	8.3	17.8	29.7	25.9	121.6	62.2	65.0	59.7	45.3
FAM89B	"LRAP25, MTVR1"	ENSG00000176973	"Family with sequence similarity 89 member B"	Q8N5H3	11	65572349-65574198	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046895	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"			"HPA046895: AB_2679858"	"unprognostic (1.16e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.09e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.07e-3)"	"prognostic unfavorable (9.48e-5)"	"unprognostic (3.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.12e-2)"	39.9	33.8	59.0	19.8	54.9	22.5	34.2	53.9	84.7	46.1	40.2	70.7	13.7	47.7	13.0	46.2	42.7	24.8	56.7	60.7	46.6	39.6	36.0	39.7	25.8	52.2	50.6	43.8	76.2	23.2	22.9	14.6	52.9	50.3	10.9	3.2	47.0	24.2	129.7	44.1	34.4	23.0	50.8	48.3	45.0	18.4	53.8	31.3	26.1	95.1	19.4	54.0	43.1	55.9	16.6	26.3	38.4	47.8	45.7	52.5	12.5	29.3	26.2	21.4	12.7	15.8	18.2	11.2	38.7	45.9	23.7	28.1	16.3	17.5	5.0	38.0	43.6	21.3	18.8	9.0	27.8	10.5	38.7	41.1	34.8	17.7	12.2	68.3	57.5	26.2	24.2	73.3	30.7	24.6	48.1	37.1	17.2	16.1	61.2	59.2	5.9	49.6	24.1	15.2	43.5	57.6	21.5	30.8	50.0	11.7	31.1	15.7	37.9	45.6	23.9	44.6	15.5	36.3	61.3	7.4	39.9	15.7	33.2	7.8	5.7	11.6	5.0	10.5	6.8	2.6	6.3	6.4	5.0	2.3	5.3	5.4	8.5	5.8	14.0	5.5	10.1	3.5	59.0	54.9	53.9	84.7	60.7	46.6	52.2	50.6	52.9	50.8	53.8	55.9	45.3	9.6	3.9	9.8	33.4	47.4	32.8	4.3	18.8	10.1	67.0	57.8	10.7	21.5	5.3	23.9	2.1	27.7	63.9	27.2	13.7	23.6	10.4	19.7	33.3	39.7	29.2	36.7	13.6	27.5	19.9	32.8	10.7	20.3	4.5	26.5	43.5	27.6	32.5	16.8	10.9	15.2	2.0	40.6	48.8	27.8	26.4	47.1	44.4	13.1	27.1	29.1	73.2	9.0	10.6	33.3	21.7	30.1	43.6	31.8	16.1	14.9	4.2	8.7	46.0	22.3	48.8	2.9	13.1	19.1	57.4	22.3	46.5	26.2	16.6	48.5
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576380	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 29.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 28.6;Inhibitory neurons: 28.2;Late spermatids: 45.7;Oligodendrocyte precursor cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.1;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 24.0;HHSteC: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	2.9	8.0	5.9	3.2	6.2	0.8	2.4	2.6	7.4	3.3	3.9	7.4	1.8	4.5	10.7	3.2	2.5	2.7	3.9	9.0	6.4	3.8	3.6	2.3	5.5	3.6	5.1	2.5	6.6	3.8	16.4	2.0	4.4	3.3	1.8	1.6	8.5	2.9	29.8	1.9	4.7	3.2	3.6	10.0	3.2	9.4	6.8	2.0	7.6	13.9	5.3	3.0	2.7	5.6	2.3	5.6	24.0	6.2	11.1	3.9	2.0	4.2	7.6	5.3	7.7	3.2	1.5	14.4	1.4	4.6	2.1	0.2	8.8	2.1	3.8	8.2	5.8	2.9	5.3	2.8	33.8	7.9	1.0	9.0	1.7	4.7	3.1	3.4	7.5	1.4	10.4	3.9	9.4	2.0	3.0	2.6	11.2	3.3	2.1	5.5	10.4	1.8	3.0	1.5	5.1	12.8	2.8	3.4	3.2	7.1	1.4	8.0	6.1	3.7	6.3	3.4	3.1	4.5	3.9	2.3	3.1	3.0	3.5	0.0	0.0	0.0	0.2	0.0	0.2	2.1	0.4	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.2	5.9	6.2	2.6	7.4	9.0	6.4	3.6	5.1	4.4	3.6	6.8	5.6	0.7	0.0	1.1	12.4	6.7	0.3	0.1	0.4	0.6	3.9	1.2	0.8	1.7	2.8	0.5	1.8	4.2	0.3	0.3	0.1	0.0	1.1	34.8	1.1	4.3	1.4	5.4	0.4	28.6	1.5	0.8	1.8	0.5	1.3	0.0	1.9	3.9	1.2	4.1	3.3	28.2	0.5	2.0	0.3	0.0	45.7	0.9	0.6	1.8	4.7	0.7	1.6	0.0	16.6	7.0	1.2	0.2	1.5	5.7	0.9	0.2	1.3	1.1	1.0	0.0	3.1	1.0	4.2	1.9	0.7	0.6	0.3	1.3	5.0	0.3	0.3
FBXO42	"Fbx42, KIAA1332"	ENSG00000037637	"F-box protein 42"	Q6P3S6	1	16246840-16352480	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025071	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA025071: AB_1848461"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (3.22e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.78e-3)"	"unprognostic (3.91e-2)"	14.1	12.6	17.4	8.8	16.4	9.3	12.9	20.0	18.0	21.7	14.7	15.1	7.6	19.8	12.9	18.2	18.6	11.8	16.9	16.5	17.6	11.8	14.2	13.6	12.5	16.9	16.3	18.2	15.3	14.0	16.2	12.1	17.8	19.3	10.6	16.7	13.5	15.0	22.6	28.1	11.1	17.9	14.9	13.7	12.1	11.6	16.8	18.1	14.6	22.3	14.3	18.9	17.9	16.4	15.4	8.2	19.4	19.8	23.1	15.0	8.5	15.6	23.5	22.0	21.4	7.7	13.9	16.2	13.6	21.7	15.1	13.6	19.8	14.8	17.9	18.7	9.3	15.2	12.5	8.8	27.5	18.1	19.0	16.1	33.5	19.4	27.8	20.0	22.3	20.0	16.5	22.1	15.8	10.5	17.5	15.8	8.5	20.3	9.2	19.6	11.9	14.5	14.8	4.3	18.3	12.0	17.6	14.6	18.8	17.7	11.9	14.0	14.0	11.1	9.8	18.4	12.3	10.9	11.9	16.3	14.7	23.5	15.6	9.0	11.8	18.5	11.7	16.3	8.7	8.5	8.7	7.5	14.0	14.1	9.8	8.7	10.5	12.4	12.7	6.1	12.4	7.9	17.4	16.4	20.0	18.0	16.5	17.6	16.9	16.3	17.8	14.9	16.8	16.4	9.2	12.8	11.8	47.0	16.0	25.9	6.1	13.5	22.2	21.7	7.1	7.1	20.6	15.7	9.4	12.9	45.9	11.0	16.6	6.7	0.0	8.5	9.4	21.7	15.5	9.9	10.7	10.8	63.9	7.6	15.6	14.7	11.7	33.1	2.5	12.8	9.7	9.6	13.8	28.6	65.9	5.6	10.2	15.1	28.1	10.2	14.9	13.4	1.8	35.6	19.2	11.0	15.5	60.8	53.0	8.4	7.6	11.3	17.7	10.4	8.8	3.8	6.4	20.4	13.1	23.1	13.4	13.5	9.7	18.9	34.7	26.3	16.0	9.8	8.3	5.5
FBXW4	"dactylin, Fbw4, SHFM3"	ENSG00000107829	"F-box and WD repeat domain containing 4"	P57775	10	101610664-101695295	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043496	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA043496: AB_2678514"	"unprognostic (4.31e-2)"	"unprognostic (5.43e-3)"	"unprognostic (8.40e-3)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (4.67e-4)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (2.94e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.85e-2)"	38.4	30.4	89.9	10.4	96.6	16.0	34.8	83.5	96.3	33.2	71.3	59.9	16.5	26.7	29.6	38.7	28.9	12.9	62.4	80.9	81.1	36.4	34.9	35.8	18.0	92.3	92.1	30.2	44.2	47.0	46.7	16.4	87.8	49.1	16.5	14.2	41.4	26.8	80.0	49.7	31.5	14.7	94.8	30.1	40.8	22.8	94.2	18.1	40.2	44.4	17.9	49.0	32.9	98.0	22.1	25.7	4.0	28.9	20.1	16.5	18.9	11.3	31.1	12.8	10.0	12.0	22.9	25.1	17.5	23.4	13.1	13.4	11.0	16.7	4.3	26.8	15.2	6.0	9.1	26.1	35.7	10.0	7.6	15.2	52.0	6.9	42.8	29.8	11.0	17.6	6.2	15.3	14.2	45.9	11.4	14.2	11.3	11.4	12.3	9.4	29.6	10.7	25.1	14.7	12.3	21.6	21.8	8.1	20.7	6.0	33.6	17.8	11.8	13.8	1.8	5.8	11.5	31.9	15.4	11.1	11.3	12.7	8.1	1.3	1.4	2.2	4.3	0.8	2.6	3.8	4.3	4.2	1.1	4.8	4.5	3.7	0.2	4.2	1.4	4.1	1.4	1.2	89.9	96.6	83.5	96.3	80.9	81.1	92.3	92.1	87.8	94.8	94.2	98.0	13.6	3.2	36.9	45.4	14.0	11.2	16.4	11.9	6.8	28.5	25.7	21.8	35.8	12.8	11.1	11.0	18.8	17.0	24.4	29.1	3.9	15.2	50.2	15.3	16.3	10.0	20.4	7.0	57.5	26.1	9.2	11.3	17.3	27.2	5.1	32.3	8.9	24.7	8.8	37.0	55.7	27.8	14.2	8.6	7.4	28.9	14.3	8.7	14.2	55.3	10.7	29.9	15.5	54.8	70.3	19.4	24.4	17.0	14.1	22.2	21.1	13.3	7.5	22.7	13.1	15.4	14.7	4.9	6.0	11.3	12.5	15.6	16.9	10.9	21.7	18.7
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	53.0	39.1	48.2	21.0	51.6	16.5	35.9	48.2	68.6	26.9	42.8	34.5	22.1	33.1	18.9	31.7	23.8	23.6	46.7	49.2	48.4	33.6	29.4	27.1	24.3	49.5	46.3	27.6	10.8	20.3	14.2	46.8	48.2	23.5	27.9	26.5	17.1	32.5	108.1	17.0	28.5	41.1	50.1	30.3	21.9	20.8	49.6	18.2	23.9	78.5	19.5	29.1	24.3	56.3	64.9	37.1	49.4	22.3	91.3	122.1	39.5	157.1	76.5	90.7	56.0	24.6	21.5	39.1	94.7	199.2	41.0	25.1	42.4	54.3	98.5	9.3	24.7	31.7	12.2	43.5	44.4	32.9	8.5	119.9	44.2	57.8	69.6	61.2	131.0	9.5	35.4	12.0	170.2	22.7	19.6	27.5	27.1	33.9	57.8	16.9	44.3	14.0	72.9	57.6	1.9	45.7	38.7	31.9	37.8	51.7	11.3	39.1	161.2	59.7	32.9	33.4	92.9	9.8	11.5	26.6	58.9	22.4	84.8	2.5	3.5	5.1	1.7	3.4	1.0	1.6	1.3	1.0	3.5	1.0	1.5	0.7	4.2	3.2	2.3	15.6	1.4	0.8	48.2	51.6	48.2	68.6	49.2	48.4	49.5	46.3	48.2	50.1	49.6	56.3	109.4	54.5	37.5	25.8	23.7	31.4	94.7	45.5	41.5	52.5	31.7	33.1	43.1	17.2	70.2	58.8	45.9	96.4	61.1	57.6	56.7	80.3	5.6	38.4	44.7	100.9	24.0	15.3	45.4	30.6	87.6	50.7	27.0	64.3	24.1	66.0	97.5	37.2	93.7	21.9	22.9	28.8	38.7	88.1	65.4	10.7	54.3	64.6	56.9	45.0	56.0	97.1	35.0	23.1	50.5	74.4	41.4	66.2	17.9	99.1	65.6	45.1	35.9	36.3	59.2	64.0	51.2	12.1	34.9	24.0	32.1	180.1	24.2	47.2	37.7	140.6
FGF13	"FGF2, FHF2, FLJ30672, LINC00889"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614727-139222777	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.0;parathyroid gland: 49.5;skeletal muscle: 67.3;tongue: 52.3"	"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 432.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 43.0;fHDF/TERT166: 38.1;HAP1: 39.8;RPMI-8226: 34.4;U-2197: 69.3;WM-115: 37.5"					"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	18.5	2.6	17.8	2.9	18.9	4.1	6.6	4.0	30.2	11.3	4.9	7.0	4.0	10.7	3.4	6.6	3.6	6.1	1.9	39.4	20.7	7.4	1.8	2.3	5.3	12.4	15.2	8.8	1.1	49.5	4.2	13.3	50.0	17.6	4.8	11.3	11.2	4.9	67.3	1.8	4.7	6.6	11.3	6.2	5.3	4.1	21.9	0.9	5.2	52.3	2.2	6.0	4.3	14.6	0.1	0.5	43.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.7	38.1	0.3	2.7	39.8	0.1	0.0	0.3	11.1	0.2	0.3	1.6	1.5	0.3	0.5	0.6	1.0	0.1	0.0	0.2	0.0	2.5	1.8	12.4	4.4	0.3	0.1	0.3	4.4	0.1	14.3	6.6	2.8	34.4	6.3	0.2	0.1	0.2	0.0	0.3	26.8	21.0	0.1	0.2	0.8	1.3	1.8	69.3	19.1	16.2	9.8	0.1	15.3	12.8	37.5	1.6	0.2	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	3.7	0.1	0.2	0.4	0.1	0.0	17.8	18.9	4.0	30.2	39.4	20.7	12.4	15.2	50.0	11.3	21.9	14.6	9.7	0.0	0.0	12.7	0.1	0.4	3.0	0.3	2.8	3.6	18.3	4.1	2.6	10.0	3.0	7.3	0.0	0.2	0.0	0.5	17.6	4.2	0.0	7.7	5.0	3.6	2.4	0.0	43.5	5.8	0.3	6.1	3.1	20.5	0.0	1.4	1.4	0.1	29.3	0.0	432.5	0.8	6.1	3.7	1.4	1.4	26.1	0.6	1.8	62.8	0.6	44.8	0.0	14.1	2.4	3.8	6.7	24.5	0.1	16.9	0.0	2.9	1.8	4.2	32.9	18.0	13.7	0.0	3.7	0.1	0.9	0.1	0.3	0.8	0.3	1.0
FKBP3	"FKBP-25, FKBP25"	ENSG00000100442	"FKBP prolyl isomerase 3"	Q00688	14	45115599-45135319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 424.4;tongue: 372.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 377.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		1300000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	40.9	46.8	100.3	35.8	102.3	38.4	50.0	110.1	122.1	38.1	91.8	49.4	44.7	31.4	64.8	54.7	31.4	29.8	109.5	101.9	100.6	66.5	69.7	27.6	53.7	100.7	99.3	35.3	32.8	55.5	56.6	46.9	100.1	57.7	49.1	82.3	37.1	37.9	424.4	38.3	47.8	39.2	99.8	39.9	38.0	52.9	101.4	59.6	40.1	372.0	57.7	43.3	38.6	105.8	161.0	175.3	249.0	132.4	109.0	117.8	98.3	96.2	110.3	149.3	163.5	154.8	134.1	85.1	98.9	110.0	84.1	130.0	188.4	124.8	211.7	123.7	111.0	69.8	138.8	202.6	107.1	122.2	72.8	112.0	127.5	87.2	80.1	136.8	198.0	131.9	102.9	62.1	179.9	196.9	197.5	163.0	126.7	178.3	164.5	187.0	183.7	102.9	242.2	183.7	151.2	59.2	154.8	94.5	156.0	186.4	222.6	89.9	128.7	113.0	195.6	59.9	75.1	104.0	198.8	132.5	68.3	83.0	108.1	23.4	22.4	22.1	18.7	27.3	22.8	29.7	25.0	25.7	33.3	21.8	23.4	26.7	3.6	24.2	29.4	43.0	30.8	20.2	100.3	102.3	110.1	122.1	101.9	100.6	100.7	99.3	100.1	99.8	101.4	105.8	48.3	41.7	46.6	25.8	45.3	47.8	94.4	205.5	45.5	79.3	39.9	46.7	202.5	48.6	101.4	93.8	10.4	320.9	51.2	56.4	252.4	131.1	212.7	55.0	83.3	58.5	56.1	50.9	49.7	73.0	135.4	70.0	36.7	68.1	53.7	75.6	38.2	91.1	131.1	40.4	44.5	71.2	124.1	39.9	43.0	377.4	80.8	53.7	69.4	17.8	110.7	80.7	50.4	21.1	34.3	88.4	53.7	97.8	58.0	76.4	91.8	220.1	73.5	67.4	105.2	71.3	118.5	154.0	111.2	65.0	47.9	165.0	48.8	84.1	96.1	77.6
FUNDC2	"DC44, HCBP6"	ENSG00000165775	"FUN14 domain containing 2"	Q9BWH2	X	155025980-155060304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.3;tongue: 19.5"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1375.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059129	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA059129: AB_2683915"	"unprognostic (2.23e-1)"	"prognostic favorable (9.20e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.07e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (6.56e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.81e-1)"	3.7	3.6	3.3	1.6	3.6	3.3	3.2	4.4	3.5	3.6	3.8	4.0	2.0	3.3	3.5	2.4	3.7	2.8	10.4	3.4	3.6	4.4	2.5	2.5	2.5	3.9	3.6	6.5	7.7	4.3	3.0	2.5	4.0	3.3	2.5	3.1	3.3	2.9	18.3	1.5	2.1	4.0	3.8	1.9	3.2	2.5	3.9	2.8	3.1	19.5	2.2	3.0	2.5	3.4	5.3	2.7	4.9	3.7	6.5	5.0	3.7	3.1	3.6	3.8	7.7	2.8	2.1	7.0	7.7	4.0	2.9	2.2	5.3	4.3	2.6	3.6	6.2	2.2	3.8	1.6	2.9	4.6	2.8	5.6	6.5	3.1	2.7	2.5	2.6	3.0	2.9	4.9	4.0	2.4	3.4	2.6	3.3	4.3	6.4	2.9	3.5	7.0	3.9	2.1	2.6	5.5	2.6	2.7	3.9	2.4	2.8	4.4	2.7	2.8	4.0	5.1	4.9	3.0	5.4	7.3	2.8	5.7	2.3	1.5	2.1	2.1	2.5	2.3	2.3	2.5	2.3	2.4	2.7	2.2	2.4	2.6	0.1	1.7	2.8	2.4	2.6	3.3	3.3	3.6	4.4	3.5	3.4	3.6	3.9	3.6	4.0	3.8	3.9	3.4	92.7	44.8	43.5	8.8	77.4	72.3	109.7	85.1	68.3	39.6	65.1	77.8	141.8	85.8	46.8	64.4	6.2	71.1	67.4	28.7	223.0	116.3	297.0	43.4	49.9	73.8	47.8	84.6	5.5	113.7	95.3	109.2	35.7	45.2	68.9	69.8	48.9	76.1	81.8	45.4	7.1	48.8	61.1	55.4	52.6	1375.2	107.8	66.2	67.6	5.6	60.0	109.3	64.9	7.5	12.8	104.9	35.4	76.3	104.7	142.4	78.2	193.0	39.5	49.2	26.3	141.6	90.9	31.6	46.2	54.6	60.1	79.9	69.4	54.3	51.1	85.8
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 788.7;tongue: 451.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 986.2;Late spermatids: 1759.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol		NA	NA		15000	"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	35.8	40.1	54.8	22.4	65.0	48.1	31.9	62.9	76.0	36.6	54.2	49.1	21.2	41.4	26.3	40.0	33.3	25.6	118.9	51.5	66.1	26.8	33.9	24.6	30.0	63.7	60.6	49.2	34.3	32.5	25.5	39.0	64.9	38.0	20.1	42.2	29.7	32.6	788.7	21.9	22.4	36.2	60.5	23.1	32.3	132.4	60.8	50.5	31.4	451.3	30.5	38.5	28.3	93.2	144.2	65.8	138.8	108.5	104.6	118.4	62.7	111.9	114.0	123.1	120.5	97.5	70.9	73.3	179.8	77.7	193.9	67.6	113.3	68.8	171.0	97.4	76.1	74.3	88.9	112.7	110.8	46.6	58.5	125.7	77.0	62.3	147.8	183.7	126.1	70.5	60.7	86.0	157.1	52.2	89.4	78.3	156.8	88.8	71.2	61.0	177.5	78.6	95.4	44.6	58.4	74.6	96.8	110.9	149.9	193.7	154.7	88.5	101.3	92.0	102.3	58.1	223.3	79.0	108.9	86.9	96.0	65.9	120.2	9.4	12.6	10.0	11.7	13.7	12.2	12.9	12.3	10.6	14.4	9.1	15.5	12.9	10.9	11.6	10.4	10.2	22.2	9.6	54.8	65.0	62.9	76.0	51.5	66.1	63.7	60.6	64.9	60.5	60.8	93.2	89.1	64.1	75.0	58.1	81.1	78.4	97.6	68.5	78.6	72.6	67.7	72.3	224.6	48.6	74.8	35.0	56.3	96.8	93.5	28.9	58.7	84.5	986.2	158.2	132.1	78.1	53.8	105.6	75.6	75.8	99.5	78.6	33.6	114.8	126.6	106.3	62.4	70.2	67.9	87.5	87.8	36.1	40.7	76.6	58.7	1759.0	84.2	73.2	49.8	48.7	138.5	97.5	52.5	86.5	137.5	73.3	39.2	76.0	74.3	68.8	62.1	106.8	104.1	86.5	32.9	116.3	89.1	318.6	113.5	57.9	70.6	61.2	87.3	97.4	42.8	67.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FZD9	"CD349, FZD3"	ENSG00000188763	"Frizzled class receptor 9"	O00144	7	73433778-73436120	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6;skeletal muscle: 7.1;testis: 4.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 8.0;Late spermatids: 14.2;Muller glia cells: 5.2;Oligodendrocyte precursor cells: 15.1;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in many"	5	"melanoma: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.5;MCF7: 2.0;NTERA-2: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (9.60e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.90e-5)"	"unprognostic (8.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.21e-2)"	1.2	0.3	3.8	0.0	2.5	0.5	0.5	2.6	3.9	0.2	2.0	0.2	0.3	0.3	0.0	0.4	0.3	0.0	0.2	2.6	2.9	0.2	0.1	0.2	0.0	4.4	3.6	0.0	0.9	0.4	3.1	0.3	3.5	2.2	0.0	0.1	1.1	0.1	7.1	0.6	0.8	0.0	2.4	0.3	0.3	4.6	4.6	0.1	0.4	0.5	0.0	0.2	0.2	2.7	0.3	1.4	1.5	1.7	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	0.6	0.1	0.7	0.0	0.0	0.0	4.5	0.0	0.3	0.5	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	2.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.4	1.3	0.9	1.0	0.2	0.9	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	2.5	2.6	3.9	2.6	2.9	4.4	3.6	3.5	2.4	4.6	2.7	0.0	0.0	0.0	1.0	0.0	0.6	0.7	0.2	1.2	0.3	0.8	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	8.0	0.1	0.2	0.9	0.0	0.0	0.2	0.4	0.3	0.3	0.0	0.9	0.0	0.7	0.0	0.0	1.0	0.0	0.4	0.4	2.0	0.3	0.4	14.2	0.0	0.2	0.0	1.9	0.6	5.2	0.0	15.1	0.7	0.1	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.7	6.6	0.1	0.4	0.3	0.4	0.5	1.1	0.0	0.0	0.0	0.3	0.4
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6534512-6538374	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 27580.7;tongue: 18892.5"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 10357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"CAB005197, CAB016392, HPA040067, HPA061280, CAB079968"	Supported		Enhanced	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		1400000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	1219.9	1815.8	2605.9	1191.3	2589.5	4608.5	1042.3	2869.0	3067.8	1163.8	2419.2	1720.0	1480.8	1080.9	769.9	2973.8	1042.8	1161.3	5572.8	2630.1	2880.0	2323.2	2557.9	1137.9	1388.3	2845.2	2861.3	1087.0	652.0	1616.0	1338.7	1190.6	2828.4	1241.0	1586.6	2386.8	1835.8	1238.7	27580.7	1775.5	1457.5	1424.4	2670.8	1208.5	1215.5	693.0	2985.1	1570.9	1022.1	18892.5	1861.0	1889.0	1672.9	2741.6	6063.0	10247.9	3109.5	4709.2	3026.2	5018.7	6516.0	4716.2	7218.1	7172.8	7491.2	7211.3	4091.6	7540.8	878.2	5947.4	4904.2	3359.8	3372.7	10829.1	5432.4	6263.1	3229.5	4224.9	5857.5	6279.2	3890.9	6710.2	3046.1	4089.0	3521.7	6553.0	7609.7	15565.8	7762.7	5052.4	2215.9	1484.1	8670.0	11849.8	7303.1	3247.3	10995.7	7254.7	3950.7	5849.8	5505.7	3512.8	7909.6	7115.9	2088.3	3331.0	4243.1	10206.4	5984.0	8874.7	1657.2	4311.2	4794.3	5049.0	5907.2	2717.1	7931.5	3178.4	2544.6	9374.4	10632.2	4050.5	8040.5	2575.4	4295.8	737.9	1325.8	2011.2	1171.4	1046.9	1364.8	1333.1	3253.6	652.5	757.6	886.9	1981.4	1227.8	1900.6	474.6	2126.1	6812.0	2605.9	2589.5	2869.0	3067.8	2630.1	2880.0	2845.2	2861.3	2828.4	2670.8	2985.1	2741.6	1036.7	237.2	259.5	228.2	1086.9	1818.8	2223.4	7367.5	4070.9	1157.6	1794.6	3689.2	40.4	1263.9	2213.7	1022.5	417.0	4237.7	1032.7	2579.6	3463.0	5198.9	759.8	770.1	702.4	1597.4	1324.3	1180.6	112.1	3794.5	10357.8	1127.1	1068.8	1021.8	562.3	2063.7	1242.9	1742.3	3895.3	2348.7	145.8	2351.2	2543.1	2586.7	2494.4	2257.7	889.4	2134.0	4220.8	86.2	3422.3	6177.9	1045.4	98.5	196.2	5681.8	3001.4	1026.9	2668.2	1714.0	5714.0	7286.7	864.3	1435.2	1150.4	1744.7	2827.8	429.9	476.2	3605.2	1600.7	4694.0	1514.9	1839.0	3140.9	2882.4
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 12.9;testis: 5.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Low region specificity"	"Detected in single"			HPA055783	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.7	0.2	0.9	1.1	0.0	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37840041	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.2;skeletal muscle: 10.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 3.3;Skeletal myocytes: 11.5;Spermatogonia: 3.4;Theca cells: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 41.4;SuSa: 12.6;U-87 MG: 12.6;WM-115: 46.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.8"	"Low region specificity"	"Detected in some"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	0.1	0.4	2.3	1.6	1.5	0.1	0.3	5.8	1.4	0.8	0.0	8.2	1.4	1.3	2.5	0.9	0.9	0.9	0.8	0.6	1.6	0.9	0.7	0.0	0.1	0.7	3.1	3.6	0.0	0.0	0.1	5.0	1.0	1.3	2.4	0.3	0.2	4.5	10.1	1.3	2.0	2.1	0.2	0.4	1.6	0.4	6.1	0.1	0.1	4.3	0.0	0.7	0.8	2.9	0.0	0.0	0.1	0.1	1.8	1.0	0.0	5.5	3.4	1.1	1.6	0.0	0.1	0.1	0.0	7.4	0.1	0.2	0.0	0.1	2.2	0.0	0.2	0.0	0.4	0.5	0.2	0.1	0.1	1.8	0.1	41.4	0.0	1.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.4	0.1	0.0	0.1	9.0	0.0	0.0	0.2	0.5	0.0	0.3	0.2	2.7	12.6	0.1	0.0	0.0	5.5	0.0	1.4	6.2	4.0	0.0	0.0	12.6	0.0	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.5	5.8	1.4	0.6	1.6	0.7	3.1	1.0	0.2	6.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.6	0.6	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.1	3.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.1	0.0	0.0	11.5	1.8	0.9	3.4	0.0	0.3	0.1	0.0	2.6	0.0	0.5
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872856	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 60.9;Inhibitory neurons: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1900000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	13.2	13.8	37.0	11.8	35.8	5.5	15.4	43.4	43.8	25.6	53.2	19.1	16.0	19.3	29.1	10.1	21.1	18.2	22.3	38.6	33.3	24.9	16.8	14.4	18.2	34.3	28.9	24.1	27.1	22.9	40.5	13.7	33.6	24.8	14.9	22.7	30.8	22.6	67.5	17.9	20.1	14.9	22.5	15.4	22.1	10.1	32.0	15.8	28.8	13.8	13.6	19.7	18.0	35.4	5.2	7.7	38.5	39.5	29.7	26.4	34.2	21.7	21.9	17.5	26.0	40.6	25.5	0.0	25.1	17.1	17.8	3.6	16.8	9.5	11.5	1.8	29.9	15.9	16.0	21.3	26.5	0.8	24.9	38.5	10.6	19.7	9.1	52.2	1.5	20.3	12.0	2.8	12.2	9.1	4.2	8.1	8.9	9.1	3.8	0.1	26.3	25.9	25.3	7.7	22.4	26.1	11.2	17.6	28.2	14.4	13.5	14.2	0.6	59.8	23.6	5.7	12.6	29.6	4.2	1.9	70.4	1.5	22.4	1.4	2.8	1.5	6.9	2.0	2.0	6.1	5.8	2.6	2.5	5.4	11.5	8.2	0.3	3.0	0.7	1.4	5.1	1.8	37.0	35.8	43.4	43.8	38.6	33.3	34.3	28.9	33.6	22.5	32.0	35.4	2.0	3.2	2.7	23.2	6.4	7.4	18.1	14.8	9.1	40.2	9.6	5.8	1.9	32.9	11.1	18.4	12.5	24.2	2.2	14.2	0.0	16.1	3.2	3.3	7.6	2.1	10.8	1.7	60.9	5.6	12.3	14.0	23.4	4.5	2.5	9.0	1.4	12.1	4.5	40.4	58.0	15.2	38.7	3.2	4.4	1.8	12.5	3.2	10.6	17.8	2.8	9.7	4.1	31.2	25.5	6.3	17.8	7.9	1.9	9.3	11.9	6.1	7.2	19.3	6.6	16.0	9.4	13.9	15.5	5.7	4.3	16.8	7.2	17.0	17.9	13.9
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1443.6"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	753.5	76.0	694.3	156.9	746.5	232.9	573.5	717.5	1237.1	161.4	583.2	157.8	24.4	116.7	115.7	218.7	224.3	105.4	129.7	676.6	764.7	65.3	280.7	221.7	75.2	891.0	783.7	303.0	204.7	32.3	70.5	176.6	767.0	103.4	92.5	891.1	233.5	96.0	1443.6	231.4	148.2	124.1	725.0	216.4	648.2	87.1	811.4	97.0	257.4	472.0	103.2	185.5	292.0	810.4	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	694.3	746.5	717.5	1237.1	676.6	764.7	891.0	783.7	767.0	725.0	811.4	810.4	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238587-16295549	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 358.6;tongue: 205.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Endometrial ciliated cells: 118.2;Erythroid cells: 367.1;Melanocytes: 92.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 14.9;monocytes: 5.0;NK-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"HEL: 193.1;HMC-1: 314.7;SK-MEL-30: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		950000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	10.0	23.3	28.5	2.8	31.9	29.7	6.5	32.4	21.6	6.6	35.7	15.5	2.7	13.3	16.5	5.3	56.9	3.7	101.7	19.6	38.2	25.5	5.9	9.1	2.5	36.8	45.6	38.0	18.3	14.2	24.9	7.8	35.0	63.1	3.4	2.2	21.5	9.0	358.6	12.4	6.0	9.9	39.7	12.5	36.5	52.3	41.3	6.5	4.4	205.0	1.6	5.2	3.7	33.2	0.0	0.0	0.3	0.0	2.7	2.1	0.1	3.9	15.7	27.2	55.2	1.6	0.4	0.0	8.8	6.0	19.1	0.1	6.7	0.8	4.5	0.0	5.0	193.1	0.1	0.0	11.8	0.8	314.7	3.7	2.8	8.5	0.0	22.2	49.5	0.7	43.9	0.3	4.8	3.8	0.2	4.1	2.0	0.2	7.5	0.0	41.9	0.0	36.1	5.4	9.4	1.2	1.9	3.2	74.4	12.1	3.0	1.4	12.5	0.4	0.2	1.3	7.5	2.3	0.0	0.0	0.9	20.3	21.8	14.9	3.3	0.4	0.7	5.0	1.2	0.2	0.1	0.5	1.5	1.5	0.0	0.2	3.3	9.6	1.7	1.5	0.0	16.0	28.5	31.9	32.4	21.6	19.6	38.2	36.8	45.6	35.0	39.7	41.3	33.2	4.6	0.0	0.0	8.8	1.3	5.1	30.2	0.7	0.6	0.7	5.3	3.8	52.8	35.8	2.7	20.2	0.0	25.3	0.6	1.4	86.1	12.4	16.0	118.2	8.7	6.8	7.8	367.1	3.8	4.9	2.8	10.2	9.2	78.9	55.3	38.9	17.9	5.0	8.9	0.0	11.5	3.2	4.1	6.4	2.1	16.3	34.5	47.4	92.5	2.8	9.2	9.8	2.1	3.0	1.7	3.0	1.2	80.9	1.4	69.9	2.2	15.5	6.4	0.8	0.0	12.6	7.4	6.5	17.2	1.3	1.8	6.8	3.5	19.4	3.8	8.3
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 151.1;Late spermatids: 95.5;Oligodendrocyte precursor cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.3;eosinophil: 1.7;intermediate monocyte: 1.6;myeloid DC: 2.7;neutrophil: 1.1;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 1.7;monocytes: 3.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		620000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	8.2	5.7	13.3	8.1	17.7	13.4	16.2	15.2	18.6	10.3	6.5	18.6	14.4	6.8	5.2	20.3	18.2	8.9	6.2	19.8	16.3	8.0	3.4	11.4	7.0	13.5	16.2	8.6	6.8	20.5	5.5	6.7	13.1	10.9	18.0	9.6	14.9	7.1	24.7	12.5	15.7	6.1	14.5	8.5	17.4	5.5	18.5	6.1	12.2	14.3	8.6	14.3	9.5	13.6	39.0	27.2	15.3	24.5	32.6	39.6	0.1	48.0	31.2	32.1	38.6	53.9	35.7	8.4	31.9	27.4	13.2	44.5	28.9	44.5	41.4	23.9	9.5	6.0	46.9	0.0	12.0	11.2	12.6	19.5	15.4	55.6	27.1	20.6	24.1	3.7	12.0	1.9	41.7	24.4	0.3	1.0	28.7	15.2	31.0	12.3	9.8	9.2	41.8	50.7	27.3	9.9	45.0	34.4	30.4	25.9	10.9	30.8	22.8	5.7	26.9	26.5	36.5	1.3	0.3	0.4	32.9	3.0	47.1	0.3	3.3	1.7	0.3	1.6	0.5	0.1	0.1	0.4	2.7	0.2	0.3	0.2	1.1	0.4	2.3	0.3	0.5	1.5	13.3	17.7	15.2	18.6	19.8	16.3	13.5	16.2	13.1	14.5	18.5	13.6	12.1	19.2	12.3	151.1	7.8	20.0	23.3	24.9	21.1	5.5	23.4	12.8	13.1	7.2	19.8	22.0	6.2	9.6	6.2	52.1	1.9	9.5	84.8	12.3	6.1	11.3	17.4	6.9	27.9	13.4	15.2	9.2	30.5	23.3	12.7	13.0	10.4	3.4	21.3	5.0	46.9	17.1	10.2	18.6	18.7	95.5	12.2	21.0	24.9	61.8	10.8	4.2	4.1	148.3	48.7	16.2	17.4	7.2	5.6	66.7	16.0	3.9	18.2	11.1	0.0	8.3	12.3	2.6	3.2	41.7	21.5	11.1	7.6	7.0	19.4	77.8
GPKOW	"GPATC5, GPATCH5, Mos2, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113407-49123735	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	17.6	15.9	21.5	11.7	22.6	16.1	16.4	22.7	21.8	14.7	14.0	17.0	14.3	16.9	11.8	14.7	15.1	10.3	18.6	19.8	21.2	15.5	14.5	13.8	14.9	24.2	23.6	13.6	12.1	19.0	17.2	13.8	23.9	12.7	12.6	11.9	13.8	16.5	34.8	20.4	14.1	13.8	22.4	15.4	15.5	7.2	25.2	17.7	13.4	25.4	14.4	16.2	14.2	24.4	36.5	38.1	24.9	20.9	21.6	18.6	27.0	23.1	25.9	36.0	38.0	27.9	35.5	15.2	17.4	28.6	36.8	25.2	27.9	27.3	23.4	32.2	29.8	15.8	31.4	19.9	25.8	18.9	32.1	20.4	34.3	28.8	29.2	21.1	27.4	30.0	19.8	23.1	23.8	59.5	26.0	31.5	17.6	19.5	30.0	32.2	27.4	41.5	18.5	45.8	20.8	24.1	26.9	25.2	25.4	26.1	48.5	24.5	30.7	20.7	31.2	30.4	22.1	35.4	26.1	20.7	26.7	31.1	32.7	26.2	22.3	28.9	37.2	31.4	30.3	20.5	28.6	27.8	22.6	34.8	24.3	22.4	17.3	25.0	35.9	20.8	31.1	20.2	21.5	22.6	22.7	21.8	19.8	21.2	24.2	23.6	23.9	22.4	25.2	24.4	10.9	19.2	11.0	7.2	10.5	8.0	14.1	21.8	4.6	14.8	6.4	5.5	13.1	21.5	19.1	7.3	4.2	28.4	16.3	16.2	15.6	26.2	1.1	15.6	10.0	13.4	7.8	22.5	2.8	25.2	20.5	11.7	14.3	10.6	11.4	10.4	11.7	14.5	16.7	5.0	2.8	12.1	18.3	10.9	9.3	1.7	15.5	8.7	5.4	2.8	13.2	20.9	28.8	2.0	3.9	25.6	23.2	15.1	9.4	9.4	19.5	20.5	12.7	13.4	39.5	12.9	13.0	9.9	18.4	6.1	9.9	43.8	16.7	10.6	11.0	12.8
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884362-46931289	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 267.4;skeletal muscle: 176.4;tongue: 184.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 159.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	56.8	10.4	51.6	4.0	49.9	3.8	17.0	49.1	56.9	5.2	38.4	7.7	1.7	3.7	31.4	77.8	7.6	9.8	7.9	51.3	45.7	23.5	103.7	2.1	4.3	69.8	45.9	2.3	267.4	8.3	13.0	3.1	63.9	24.2	4.9	6.9	48.8	10.9	176.4	37.8	3.9	3.1	60.2	2.3	58.6	15.0	54.9	7.7	7.6	184.5	13.4	2.7	7.7	64.5	42.6	19.0	23.8	90.6	32.7	7.0	43.1	28.9	10.9	30.7	19.2	65.3	17.6	29.9	24.7	20.7	15.6	33.6	43.3	42.8	20.4	14.0	21.1	10.5	10.8	159.9	22.4	75.6	9.5	15.2	37.0	30.0	46.3	20.3	15.1	56.1	8.7	23.3	10.3	75.8	15.1	62.9	25.3	52.2	54.2	0.3	26.3	71.1	12.4	21.0	73.7	37.7	14.9	76.4	39.0	9.4	19.6	67.6	11.3	21.1	40.9	14.2	23.4	110.2	36.9	87.1	32.6	48.3	11.7	0.4	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	51.6	49.9	49.1	56.9	51.3	45.7	69.8	45.9	63.9	60.2	54.9	64.5	1.3	6.4	3.4	54.9	4.8	15.9	4.9	6.8	64.3	14.5	6.7	8.4	14.9	8.6	9.1	18.4	22.9	9.2	0.3	10.2	11.7	7.0	9.6	12.2	7.2	2.3	13.1	5.2	16.7	30.2	44.8	7.5	37.2	37.5	3.8	14.9	5.0	123.9	3.8	6.7	18.8	13.4	6.1	3.2	7.3	22.9	4.7	2.3	8.8	1.0	1.1	42.5	1.0	13.6	26.0	25.6	5.2	15.4	7.9	12.4	2.0	38.6	5.4	5.9	0.0	5.2	3.6	2.5	17.3	53.1	16.3	83.3	1.4	2.6	6.3	4.2
GREB1L	"C18orf6, FLJ13687, KIAA1772"	ENSG00000141449	"GREB1 like retinoic acid receptor coactivator"	Q9C091	18	21242242-21525417	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 9.2"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 95.2;Inhibitory neurons: 39.2;Leydig cells: 46.0;Oligodendrocytes: 252.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 50.7;BEWO: 100.9;CACO-2: 45.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041647, HPA044218"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA041647: AB_2677597, HPA044218: AB_2678859"	"unprognostic (1.88e-3)"	"unprognostic (9.01e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.30e-8)"	"unprognostic (4.72e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-1)"	2.6	1.4	5.5	0.1	4.3	0.2	3.3	3.5	3.6	1.2	0.0	0.6	0.1	2.6	2.8	0.2	4.4	0.1	5.3	2.6	8.1	0.4	1.8	0.2	0.1	4.0	4.7	3.7	0.1	0.3	1.2	2.1	4.1	1.6	0.1	3.1	0.5	2.9	9.2	1.3	0.5	0.8	1.7	0.0	0.6	6.2	6.4	0.0	3.8	6.8	0.0	0.1	0.7	4.4	0.0	0.9	50.7	0.0	11.4	0.0	100.9	2.4	2.4	4.3	3.8	45.7	3.7	0.1	5.1	7.6	0.1	9.7	19.4	2.4	7.5	0.7	9.3	0.0	13.4	0.4	0.3	0.0	0.0	0.0	0.7	0.1	9.3	0.5	0.0	1.4	0.0	0.3	10.5	3.5	0.2	0.2	4.9	0.4	6.0	0.2	0.0	2.0	4.8	8.7	3.2	0.0	0.1	1.6	0.2	13.2	2.7	0.2	20.9	0.5	2.9	4.9	0.0	0.1	0.7	0.0	2.2	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	4.3	3.5	3.6	2.6	8.1	4.0	4.7	4.1	1.7	6.4	4.4	0.4	0.0	0.5	0.7	0.4	0.1	0.1	1.0	0.0	32.3	3.1	1.1	13.4	0.0	1.1	3.7	2.1	3.2	1.8	0.1	0.0	0.2	8.3	2.2	3.4	0.5	0.0	0.0	23.1	0.4	13.2	6.2	0.0	7.0	0.0	95.2	0.0	3.1	0.5	0.0	39.2	0.2	0.0	0.0	1.1	17.9	46.0	0.3	1.8	2.8	0.1	0.8	2.1	8.0	252.5	2.8	0.0	35.7	0.0	0.6	0.3	0.0	2.3	1.6	6.6	2.8	2.3	4.3	5.6	0.0	0.9	1.5	0.3	10.5	1.5	0.2
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"	Q9C0E4	3	14489107-14556075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13.3;skeletal muscle: 35.8;tongue: 12.5"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 89.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	1.1	1.1	3.0	0.7	2.7	0.0	1.0	0.0	6.2	1.1	0.0	0.8	0.4	1.1	0.4	2.2	0.8	1.2	13.3	0.2	3.5	2.3	0.3	0.4	0.4	2.9	5.8	3.4	0.5	0.3	1.0	3.9	2.1	0.9	1.0	0.3	0.9	0.4	35.8	2.0	1.0	1.0	1.7	1.6	4.5	0.7	9.6	0.3	0.8	12.5	0.7	1.0	1.2	1.8	0.1	0.9	0.0	0.0	0.3	0.2	0.0	0.3	3.1	0.3	1.9	1.2	0.0	0.0	0.7	0.2	0.5	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	1.5	6.1	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.3	0.0	1.0	1.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	6.2	0.2	3.5	2.9	5.8	2.1	1.7	9.6	1.8	2.3	0.0	0.5	2.3	0.1	0.0	0.1	0.0	1.2	14.9	0.1	1.3	8.5	0.0	0.6	0.0	14.6	0.0	0.7	0.1	0.0	0.0	3.0	2.1	1.4	0.8	4.2	0.0	3.0	0.2	0.0	2.0	2.0	4.9	0.0	0.0	1.1	0.0	0.1	0.0	89.0	0.1	0.0	0.0	0.0	5.2	4.1	0.7	0.0	2.8	0.0	0.5	0.0	0.5	0.9	0.0	0.0	2.2	0.3	0.1	0.0	0.2	0.0	21.9	19.7	4.3	14.7	0.1	0.8	0.2	0.0	0.1	0.3	1.1	0.0	0.0
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958706-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	53.2	55.0	71.5	53.5	73.6	53.5	47.1	73.7	114.9	42.0	73.4	66.9	52.3	30.8	45.8	44.8	45.2	57.8	86.6	70.8	76.3	76.2	51.3	33.9	55.8	72.4	72.6	28.2	30.8	65.3	37.1	32.5	72.7	94.6	65.4	39.0	38.3	41.6	231.2	31.1	46.7	48.7	72.9	33.6	49.8	61.9	72.3	49.7	40.2	168.0	58.1	61.1	27.5	74.9	85.8	154.0	166.5	155.7	59.9	121.9	145.4	143.8	105.1	131.9	109.2	229.0	74.7	121.1	137.8	132.9	30.4	38.6	141.1	120.0	145.5	175.9	205.3	234.2	145.9	347.5	113.4	360.9	190.8	121.4	103.3	115.2	112.8	89.7	155.2	154.3	281.7	79.4	246.8	166.5	198.6	371.4	169.9	109.6	121.0	183.2	95.6	109.7	221.5	214.7	105.4	148.5	107.0	16.8	133.0	98.6	58.7	244.2	163.0	38.2	112.0	260.5	232.3	51.7	127.2	235.9	39.7	208.1	191.3	112.6	116.9	71.0	104.2	170.7	117.9	164.1	130.0	131.0	158.3	133.7	100.9	118.9	18.5	116.2	141.1	173.4	292.4	167.5	71.5	73.6	73.7	114.9	70.8	76.3	72.4	72.6	72.7	72.9	72.3	74.9	58.0	70.5	47.1	12.7	67.1	30.3	70.9	169.2	34.1	37.6	85.3	90.4	279.1	203.0	99.5	104.8	16.7	94.6	75.0	138.8	305.2	190.4	169.1	119.1	82.0	66.0	109.8	86.9	4.9	293.0	251.1	66.4	47.9	167.8	54.4	71.2	55.6	94.5	284.6	26.9	6.7	98.6	144.5	79.8	50.1	223.9	65.0	104.5	55.2	6.5	172.4	133.2	81.4	7.1	13.4	210.8	125.2	68.4	78.3	126.9	118.9	404.7	74.9	37.0	65.7	63.5	88.1	153.1	105.8	72.5	29.7	90.4	72.3	120.2	121.4	117.8
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022625-3024286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 511.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 396.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 376.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	82.6	98.5	174.5	20.9	178.9	17.9	74.8	164.1	248.1	124.9	129.3	131.5	30.4	140.6	29.2	59.0	81.7	43.1	138.7	172.0	182.0	180.5	48.2	72.0	24.2	181.5	182.7	86.7	44.0	40.9	97.7	32.1	185.2	102.8	18.8	21.6	50.6	87.4	511.6	76.3	53.1	47.5	154.0	45.9	65.6	36.6	181.0	17.0	68.0	196.2	18.3	85.2	103.0	174.1	59.6	175.6	32.5	38.1	123.0	160.9	33.4	26.0	115.0	57.8	161.2	37.9	75.8	49.2	66.1	108.3	52.8	81.0	32.7	121.5	26.3	62.7	88.4	21.3	132.2	65.5	105.2	37.3	39.5	205.7	73.9	62.1	63.4	376.5	81.5	33.0	30.4	81.6	63.3	63.0	20.1	53.0	70.5	34.7	36.5	70.1	31.3	124.6	209.4	13.7	57.3	48.4	54.7	70.7	78.5	77.5	48.6	28.1	35.5	98.4	256.8	85.8	50.7	53.0	59.1	40.7	42.9	22.1	23.8	5.3	36.3	16.3	20.1	28.2	19.3	23.2	25.5	21.7	44.9	21.7	18.5	22.9	8.0	25.8	26.5	22.1	36.7	17.9	174.5	178.9	164.1	248.1	172.0	182.0	181.5	182.7	185.2	154.0	181.0	174.1	51.3	57.7	15.0	17.9	30.7	85.4	58.0	123.7	92.2	29.3	45.2	80.0	45.8	47.1	37.4	198.6	6.2	116.2	23.7	53.7	240.7	49.7	5.2	38.0	56.0	38.3	43.7	37.0	19.3	26.5	120.7	98.4	34.1	45.3	40.0	26.1	60.3	45.9	117.9	20.2	19.8	40.9	40.7	57.5	57.0	15.8	96.3	42.2	64.0	13.1	51.0	52.6	39.1	6.6	19.0	26.7	55.4	178.3	35.0	37.8	114.2	396.2	28.4	28.1	124.9	39.7	149.2	15.2	44.3	69.5	65.8	53.9	35.0	26.7	45.9	41.3
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 58.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 62.0;Early spermatids: 69.9;Excitatory neurons: 118.1;Inhibitory neurons: 84.9;Late spermatids: 59.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 85.5;Oligodendrocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 32.0;neutrophil: 47.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 47.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 49.1;MOLT-4: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	4.4	6.3	9.3	5.0	12.0	17.0	3.8	0.6	13.4	7.5	0.1	29.0	2.7	9.1	2.5	8.0	6.7	7.1	5.2	9.0	6.5	3.7	2.4	3.9	3.5	9.9	6.1	7.5	3.7	2.7	6.5	1.5	11.2	5.6	3.4	2.4	3.3	5.9	58.2	5.9	7.2	6.2	2.3	5.6	7.2	9.2	6.7	9.7	4.2	35.6	2.5	10.0	4.5	10.1	3.2	5.8	4.1	6.1	4.5	3.9	5.9	3.0	2.3	2.3	1.7	2.9	7.5	2.0	1.9	3.4	3.6	3.4	4.0	2.0	1.4	12.8	1.8	3.1	5.1	5.8	3.8	5.5	4.6	4.4	2.6	4.6	3.3	2.3	2.4	49.1	3.7	4.5	2.7	4.7	48.1	10.7	4.0	6.0	2.8	7.6	7.2	4.0	5.3	4.4	4.6	6.4	5.3	2.5	16.2	2.6	1.0	17.9	1.9	5.0	0.4	6.8	4.6	3.3	3.2	3.1	6.9	6.9	7.4	32.0	10.2	2.3	1.0	3.3	1.2	0.2	1.1	1.0	1.0	0.1	0.5	0.5	47.7	3.2	1.7	0.6	1.7	1.1	9.3	12.0	0.6	13.4	9.0	6.5	9.9	6.1	11.2	2.3	6.7	10.1	8.6	3.2	7.4	62.0	5.2	7.9	2.9	3.0	8.6	12.2	6.2	4.8	13.3	7.2	2.9	11.0	2.1	1.5	12.8	4.1	0.0	2.8	69.9	7.0	15.1	7.1	6.0	6.1	118.1	2.2	1.7	14.0	7.7	7.4	2.5	6.6	11.7	6.7	3.2	16.8	84.9	5.2	2.0	17.2	10.0	59.0	11.8	10.3	5.4	38.4	14.9	8.6	15.5	85.5	124.0	1.9	1.6	12.4	7.0	6.4	5.0	1.6	2.6	7.1	0.0	18.7	6.5	2.8	3.3	11.1	9.7	1.4	12.2	4.9	6.4	2.7
HEATR5A	"C14orf125, DKFZP434I1735"	ENSG00000129493	"HEAT repeat containing 5A"	Q86XA9	14	31291788-31420550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 120.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 120.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049539	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA049539: AB_2680809"	"unprognostic (2.63e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.47e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.11e-6)"	"unprognostic (1.00e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.00e-2)"	8.6	11.1	8.9	8.9	12.5	7.0	8.0	11.0	8.8	9.6	9.7	14.1	10.3	7.3	5.8	10.0	8.9	7.4	16.3	8.2	12.9	10.2	8.7	8.9	5.7	13.8	11.6	6.2	4.8	9.1	7.5	12.1	15.5	5.8	11.4	7.4	8.0	5.7	12.1	4.2	12.0	10.3	10.1	8.0	7.5	8.2	10.5	3.5	7.6	20.3	6.7	10.9	6.6	18.5	28.3	43.3	12.2	15.7	29.0	27.3	25.3	33.6	28.3	18.0	18.3	17.4	21.1	15.1	31.4	50.7	10.8	18.6	23.2	10.3	25.5	11.5	21.4	11.4	56.5	73.8	16.9	21.9	15.8	12.8	5.5	15.4	14.6	14.1	22.8	6.9	23.4	15.2	21.0	25.2	8.2	9.4	9.3	17.8	25.2	4.7	24.1	8.6	11.9	17.5	5.1	15.3	77.2	35.3	78.4	17.0	20.0	6.2	35.4	13.1	19.6	22.5	13.6	14.9	42.3	23.8	3.9	12.0	19.5	120.4	11.8	47.3	2.7	11.7	1.6	4.7	1.9	2.4	8.2	3.6	1.6	2.9	38.4	3.7	18.1	3.7	2.0	4.6	8.9	12.5	11.0	8.8	8.2	12.9	13.8	11.6	15.5	10.1	10.5	18.5	7.8	28.9	20.2	58.4	7.5	5.9	2.4	6.3	5.2	12.1	9.9	5.5	17.0	5.7	15.5	18.4	14.6	13.1	2.7	33.5	1.9	11.7	3.5	16.3	9.0	8.7	6.7	2.5	27.1	11.7	10.8	13.1	9.7	7.4	11.4	6.9	10.4	14.8	10.6	1.7	38.8	13.5	10.2	14.8	10.8	1.3	12.2	13.6	10.6	42.2	15.1	19.2	1.0	67.8	96.6	17.6	22.4	11.7	10.1	6.3	17.3	8.9	21.8	9.3	0.0	18.1	9.6	21.7	13.2	10.0	7.2	18.1	5.9	11.4	13.1	4.9
HINT3	"FLJ33126, HINT4"	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956770-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 352.2;Spermatocytes: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavorable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	18.1	23.4	31.2	12.6	33.9	12.3	23.0	31.0	43.3	18.3	22.8	19.6	15.7	16.6	17.8	22.3	16.4	16.2	28.4	29.4	31.4	22.2	28.3	21.0	11.3	33.9	32.1	14.7	19.3	30.6	14.4	14.5	33.8	29.7	17.6	15.3	25.5	22.4	112.8	17.5	16.0	17.3	36.6	10.5	24.8	12.3	32.5	13.6	23.5	84.6	11.4	18.4	10.8	38.0	13.2	10.3	14.1	29.5	5.5	14.8	17.5	14.1	20.2	10.6	11.0	25.6	7.2	28.4	25.5	9.4	23.7	19.5	18.2	11.9	12.3	27.4	23.5	12.0	15.1	21.6	25.4	19.2	19.6	11.8	25.9	10.7	27.0	27.3	16.1	21.0	38.3	18.7	10.6	20.1	15.5	13.7	4.8	27.1	9.9	12.8	9.7	9.7	21.8	24.0	28.2	17.4	12.9	18.0	67.8	10.2	18.4	28.9	11.4	7.2	10.1	34.8	20.3	27.1	33.3	18.2	20.4	18.1	9.5	12.5	9.3	8.9	4.4	5.9	4.6	7.0	5.9	4.8	7.7	6.3	6.0	5.3	11.2	5.9	8.6	4.3	6.3	5.3	31.2	33.9	31.0	43.3	29.4	31.4	33.9	32.1	33.8	36.6	32.5	38.0	11.7	80.1	61.2	11.8	16.7	18.1	10.2	22.1	24.5	21.8	26.5	18.4	38.7	10.0	29.8	16.5	8.4	19.2	13.4	17.2	33.2	29.3	352.2	23.6	11.5	12.3	16.3	6.9	27.0	20.2	6.4	13.7	19.4	25.8	9.5	15.2	10.4	17.5	27.2	6.7	29.8	25.1	20.3	15.3	14.6	78.3	9.9	19.3	21.4	5.6	17.3	43.4	11.3	21.6	40.0	21.4	28.7	17.3	8.1	20.9	15.3	28.0	25.7	25.4	6.6	18.3	15.1	110.7	40.2	21.5	17.3	26.4	11.3	14.6	18.5	19.9
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffold protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 125.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 76.4;Muller glia cells: 72.6;Proximal tubular cells: 84.2;Theca cells: 322.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 15.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 353.6;THP-1: 420.0;U-266/84: 375.4"	"Region enriched"	"Detected in all"	6	"cerebellum: 189.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	33.1	29.6	33.3	9.9	41.9	22.3	26.2	76.9	44.6	31.7	41.1	27.0	7.0	24.6	6.4	15.3	16.7	16.5	25.0	40.4	35.1	52.2	6.1	25.6	7.9	42.3	40.9	20.1	12.4	37.5	8.6	14.7	42.8	21.9	6.0	5.9	27.6	9.4	114.5	35.4	14.4	10.6	39.4	125.1	17.0	9.2	41.6	7.4	49.3	18.6	3.8	29.7	26.0	45.5	112.1	28.5	53.1	44.4	48.3	48.6	26.2	108.1	94.9	106.4	53.4	14.6	41.8	0.9	49.9	122.1	76.1	68.6	18.4	140.4	58.9	4.0	11.0	0.1	9.7	27.5	44.9	21.5	1.7	39.3	89.4	59.0	79.1	113.0	130.3	7.9	3.2	28.6	78.1	30.3	1.9	353.6	27.3	6.1	115.5	55.2	16.2	53.4	38.2	28.3	0.2	44.8	26.6	31.2	78.5	10.2	14.0	420.0	105.3	94.0	42.0	114.5	132.2	274.2	375.4	93.6	148.0	270.6	69.8	0.1	15.0	2.9	0.1	5.3	0.0	2.3	0.8	0.3	1.3	2.7	0.1	0.0	5.8	0.0	1.6	0.2	0.8	4.2	33.3	41.9	76.9	44.6	40.4	35.1	42.3	40.9	42.8	39.4	41.6	45.5	21.7	3.2	0.0	9.4	9.3	11.9	22.4	24.4	6.8	2.2	14.3	22.5	4.1	2.8	8.0	12.9	0.0	1.0	0.6	0.1	11.7	22.9	2.0	4.3	18.7	38.0	1.8	0.4	0.3	13.6	2.4	20.5	0.0	6.3	10.2	34.8	21.8	0.7	76.4	1.7	3.9	0.9	22.4	16.2	7.6	1.7	13.7	32.2	12.4	1.9	8.3	72.6	0.0	1.0	13.4	42.0	0.0	10.9	13.8	25.2	0.0	84.2	3.6	4.1	0.0	14.4	27.8	4.7	6.7	4.2	14.5	1.1	2.5	322.4	0.3	21.4
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
HSPB8	"CMT2L, E2IG1, H11, HSP22"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119171555-119224855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 897.3"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 599.1;Syncytiotrophoblasts: 1340.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 89.6;HeLa: 66.0;MCF7: 130.5;U-87 MG: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoplasm	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	57.0	13.9	172.2	34.4	172.6	0.0	33.4	179.5	141.8	58.1	147.0	381.0	8.9	114.4	10.1	163.2	58.7	43.1	469.3	147.8	231.0	63.3	4.8	95.7	11.4	188.3	206.1	23.4	30.8	183.1	17.5	92.1	193.0	143.5	35.8	28.2	50.8	289.0	897.3	70.5	50.5	114.1	211.5	56.2	110.4	12.0	193.6	40.3	29.2	448.5	98.7	239.2	100.1	235.5	21.1	16.1	0.3	0.0	14.4	11.5	60.2	32.5	28.7	5.9	0.3	40.0	0.6	0.1	89.6	42.4	48.0	2.4	0.3	0.0	0.6	0.1	1.2	0.0	66.0	3.2	11.2	0.0	0.1	14.1	4.1	22.3	1.3	21.6	12.3	0.0	0.2	0.0	13.0	130.5	0.0	0.2	5.7	0.0	23.0	0.0	22.9	2.9	38.3	6.2	0.4	1.0	13.5	1.6	6.8	50.5	29.0	0.2	20.4	15.8	39.8	21.7	1.7	0.0	0.2	0.2	67.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.2	172.6	179.5	141.8	147.8	231.0	188.3	206.1	193.0	211.5	193.6	235.5	2.7	44.8	48.2	42.1	0.7	102.3	108.5	4.5	126.3	0.7	95.2	17.5	599.1	7.2	5.4	5.5	8.4	149.1	1.0	0.0	0.0	59.7	12.2	98.1	20.2	27.4	0.0	0.0	6.2	11.4	17.5	82.2	5.6	142.7	1.3	0.0	25.4	0.0	19.4	1.7	6.6	0.0	2.0	1.0	9.4	11.0	1.5	1.6	12.4	2.8	1.0	51.7	0.0	0.0	0.9	12.9	0.0	0.4	0.3	24.6	0.0	52.0	3.1	2.1	6.6	39.8	76.9	0.9	0.2	38.0	28.7	1340.0	3.5	0.1	0.2	72.7
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1"	Q7Z6Z7	X	53532096-53686728	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 507.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		73000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	37.7	46.1	55.6	21.1	57.4	26.7	37.4	57.6	69.6	39.8	42.0	49.4	17.6	45.6	52.6	48.4	40.7	18.5	57.1	62.6	61.3	45.2	41.8	36.1	26.6	58.7	67.8	54.0	45.9	43.2	54.2	24.0	73.2	38.4	22.7	40.0	38.9	28.6	101.0	59.3	40.2	28.8	49.1	42.5	45.5	43.0	65.1	41.2	42.9	58.1	30.3	44.6	40.2	57.2	166.8	100.4	64.0	45.4	109.2	64.8	78.5	48.8	62.6	50.2	52.3	77.0	52.2	86.6	32.3	89.4	90.4	77.8	145.6	81.8	68.3	125.6	64.6	69.1	91.9	60.5	100.2	104.5	40.6	62.4	59.8	120.8	137.6	49.7	88.3	66.4	70.3	54.5	66.3	102.4	57.0	58.2	87.7	45.4	71.3	52.0	87.9	52.8	84.0	113.3	53.1	38.4	137.7	60.5	44.1	118.7	87.0	50.1	113.8	46.0	65.8	66.5	62.9	47.3	50.2	73.1	49.2	100.1	67.6	2.8	2.3	4.3	3.3	1.9	4.0	2.4	3.1	3.5	3.3	2.4	2.2	2.2	1.9	3.5	3.8	3.5	2.9	1.9	55.6	57.4	57.6	69.6	62.6	61.3	58.7	67.8	73.2	49.1	65.1	57.2	41.4	51.3	46.1	70.2	41.9	30.1	32.6	30.4	44.9	57.8	37.0	35.6	110.4	37.1	35.4	40.5	50.1	31.0	40.0	29.2	1.9	42.8	28.6	45.6	59.8	38.3	47.6	47.7	94.4	35.4	34.8	38.6	57.1	69.6	22.1	507.7	32.9	48.1	24.8	82.4	85.8	28.1	18.3	31.4	30.8	32.8	28.3	34.1	26.6	59.0	43.7	22.6	35.0	83.9	95.3	49.3	20.5	39.1	50.9	44.1	27.1	14.7	35.7	33.3	13.1	69.6	56.4	34.5	44.6	53.3	41.6	37.9	46.7	114.1	31.7	42.0
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381484-65422947	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;skeletal muscle: 10.6;tongue: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		64000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	0.9	2.5	5.6	2.4	6.9	0.0	0.5	5.8	2.5	3.4	0.0	0.8	0.5	1.4	4.2	1.6	1.7	4.2	0.9	2.9	7.2	0.1	0.0	0.2	0.6	11.2	9.4	8.5	0.1	0.3	0.9	5.6	6.8	0.4	0.6	0.8	0.5	0.4	10.6	0.8	0.8	1.0	6.9	0.2	1.1	0.6	11.3	0.7	1.9	14.0	0.6	2.1	2.0	4.5	0.0	4.4	9.4	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.5	8.1	0.0	4.5	0.3	0.0	0.0	2.3	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.8	7.2	0.0	0.0	0.0	2.3	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.9	5.8	2.5	2.9	7.2	11.2	9.4	6.8	6.9	11.3	4.5	0.2	0.0	0.0	18.6	0.0	2.3	0.0	0.0	0.0	7.7	0.2	0.5	2.2	0.0	0.0	3.7	31.3	0.4	0.1	0.0	0.0	0.4	0.4	0.0	2.1	0.3	0.0	0.0	0.9	0.0	0.6	14.7	1.1	0.0	0.0	8.8	0.0	0.0	0.7	0.0	6.3	0.0	0.0	0.0	2.5	1.4	34.8	0.3	5.4	14.0	0.0	1.0	1.0	17.6	1.0	0.3	0.0	4.1	0.1	0.1	0.0	0.7	0.0	12.2	6.6	29.8	1.0	0.8	2.6	0.1	1.1	0.8	0.3	7.0	0.0	0.0
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332460	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.46e-6)"	9.4	8.2	9.1	4.7	9.8	4.8	8.3	9.2	10.9	7.2	11.7	6.8	4.8	8.1	7.3	10.2	11.6	8.6	5.6	9.2	9.5	6.8	6.6	11.3	12.2	10.5	9.9	6.1	6.2	13.5	4.0	8.2	10.0	7.9	6.8	12.3	8.9	9.3	13.7	11.4	4.9	12.7	9.7	10.5	5.5	3.2	10.1	10.8	9.4	24.3	11.6	11.1	6.8	10.2	6.2	15.7	8.0	13.6	17.3	18.9	5.8	9.2	18.2	15.2	17.2	3.1	13.9	14.1	10.0	16.5	12.5	5.6	8.4	18.3	17.8	9.8	10.8	17.8	7.8	5.9	20.9	6.1	24.0	12.3	13.7	15.0	19.1	36.1	20.7	11.6	12.8	6.9	34.6	5.1	13.9	11.3	6.1	18.9	6.0	11.1	15.3	10.0	19.6	5.7	1.3	4.7	6.4	6.4	11.7	10.0	8.7	23.6	13.6	7.2	3.9	13.9	6.1	2.8	4.0	10.3	13.8	7.6	16.7	7.4	5.0	5.6	4.6	4.1	4.3	4.4	5.1	5.5	3.7	4.8	4.8	4.7	5.2	5.1	5.5	8.5	5.9	2.9	9.1	9.8	9.2	10.9	9.2	9.5	10.5	9.9	10.0	9.7	10.1	10.2	31.3	12.8	26.9	19.2	28.4	24.3	34.1	13.9	25.6	12.7	20.6	15.5	8.8	14.3	15.4	16.5	135.5	10.4	34.1	15.9	1.9	13.4	2.3	13.9	15.6	27.4	11.4	10.1	19.7	13.6	5.3	12.4	21.9	16.5	38.0	24.0	19.6	12.0	18.6	18.5	20.6	16.4	8.2	32.3	24.0	3.4	16.4	23.4	19.6	58.1	33.7	8.7	47.4	17.1	30.2	16.6	15.0	12.8	18.2	31.9	13.2	5.5	20.2	47.9	6.6	13.1	11.4	4.8	7.0	17.8	29.1	15.2	24.3	6.2	14.1	30.8
IL17D	"FLJ30846, IL-17D, IL-27, IL27"	ENSG00000172458	"Interleukin 17D"	Q8TAD2	13	20702127-20723098	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 79.8;skeletal muscle: 131.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.0;Early spermatids: 19.3;Excitatory neurons: 17.5;Late spermatids: 35.0;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 20.6"	"Group enriched"	"Detected in many"	9	"glioma: 10.8;melanoma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	25000		"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.97e-2)"	8.4	5.7	71.9	1.6	79.7	0.4	6.4	68.7	58.7	15.2	21.6	5.6	9.4	6.5	1.1	8.9	5.0	5.1	11.6	66.0	70.9	2.6	0.8	6.2	1.2	79.1	62.2	9.3	5.9	0.4	8.9	1.6	61.8	5.5	0.5	10.6	4.3	1.6	131.1	5.4	5.7	1.2	79.6	0.9	4.4	3.9	68.2	0.2	7.6	24.5	0.3	5.4	9.9	79.8	16.5	2.2	3.5	7.6	8.1	4.6	18.3	4.5	1.1	0.4	0.8	7.6	8.7	11.0	0.8	0.4	5.3	8.5	1.5	0.1	0.2	4.0	12.2	0.8	0.7	9.1	1.0	12.2	2.4	6.3	0.1	0.6	0.0	6.9	5.0	15.3	4.5	0.0	3.0	15.9	13.6	10.0	10.7	19.2	2.6	17.8	8.6	1.3	0.2	14.1	20.7	6.7	2.6	3.8	18.3	6.1	9.6	10.4	27.1	1.7	3.0	1.4	5.7	2.0	1.7	2.9	4.0	5.7	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	71.9	79.7	68.7	58.7	66.0	70.9	79.1	62.2	61.8	79.6	68.2	79.8	0.7	0.0	0.0	64.0	0.2	2.4	0.3	0.0	1.2	1.2	0.4	0.4	1.0	0.0	0.0	0.0	0.0	1.1	0.3	0.7	0.0	0.1	19.3	0.2	1.6	0.6	0.0	0.4	17.5	0.2	7.4	7.6	0.0	0.7	0.0	0.9	1.4	0.0	0.4	0.0	12.2	0.1	0.0	0.3	1.9	35.0	11.5	0.2	8.8	2.8	0.0	20.2	0.0	20.6	12.5	0.2	0.1	1.2	0.0	0.5	0.2	0.2	0.0	4.9	0.0	9.4	2.0	8.6	0.6	0.0	2.0	1.1	0.3	0.1	0.3	0.2
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170402-238203708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	20.5	17.4	24.3	15.1	25.6	29.0	19.5	26.5	26.9	26.2	22.3	30.8	14.6	25.1	15.3	23.2	23.4	8.7	24.2	23.8	24.9	26.0	26.2	18.6	20.5	24.9	24.2	24.5	20.6	13.1	26.5	12.9	24.1	25.2	12.9	13.0	17.3	14.5	41.4	22.4	23.3	16.1	23.9	25.9	21.4	23.1	24.6	17.9	23.9	18.3	18.1	26.6	21.8	27.4	40.5	25.6	36.9	36.3	28.1	18.6	37.9	41.5	27.9	40.9	35.4	23.7	20.9	25.8	10.5	30.1	48.8	33.8	48.1	34.4	41.2	46.6	49.8	66.7	26.0	52.7	43.3	43.7	50.3	19.6	23.3	43.6	43.6	20.2	31.1	34.0	52.4	16.1	35.4	48.1	43.4	58.0	34.8	37.4	25.9	52.6	75.6	23.7	30.4	18.8	54.1	26.7	28.2	29.6	68.9	27.9	23.3	43.7	28.9	39.7	36.7	53.5	45.1	28.6	31.4	46.7	32.5	47.3	34.3	43.4	19.8	27.1	28.2	25.6	25.4	24.7	24.9	26.4	27.7	24.0	28.8	22.9	7.3	24.8	21.4	20.9	30.7	23.0	24.3	25.6	26.5	26.9	23.8	24.9	24.9	24.2	24.1	23.9	24.6	27.4	27.7	12.8	22.0	43.8	35.4	27.0	29.1	30.8	25.0	28.9	19.4	21.6	23.1	17.2	19.6	25.8	29.2	41.2	51.5	22.4	43.0	27.9	8.1	17.1	20.6	21.5	19.1	64.2	37.7	28.5	43.7	26.7	29.0	16.1	33.7	43.5	22.1	19.2	34.4	38.7	33.2	24.0	16.2	17.0	22.0	12.6	28.3	24.0	30.2	25.3	34.0	25.1	57.7	36.7	72.2	24.8	16.2	29.3	33.6	29.7	24.1	33.4	19.3	28.6	32.9	29.2	47.4	54.4	70.8	29.2	28.7	40.4	36.6	23.0	27.4	23.5
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537787-132783480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 6.7"	"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 250.8"	"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	22.5	16.9	26.8	12.0	85.5	9.5	17.3	56.9	30.4	29.6	10.9	54.2	19.2	49.5	19.5	29.6	30.7	15.2	75.0	20.4	21.3	14.1	14.6	25.1	8.4	20.5	37.7	19.5	12.8	12.2	14.7	28.8	20.4	24.5	16.7	16.9	13.5	23.6	75.4	22.9	23.4	42.1	17.5	13.9	27.6	22.9	50.5	6.8	14.1	50.3	7.3	35.5	22.7	27.0	35.4	13.7	22.6	21.9	33.8	23.7	18.4	36.4	27.9	23.3	15.4	32.6	14.0	3.1	13.7	38.8	15.1	19.5	24.8	15.2	27.9	10.8	14.4	5.1	17.3	44.7	24.3	12.9	11.9	16.0	14.9	15.0	28.2	18.6	16.3	6.6	7.6	18.2	12.6	28.3	3.6	40.9	10.5	21.0	24.3	7.6	14.9	5.6	19.4	19.9	5.4	18.5	18.3	26.5	22.6	20.5	17.2	30.4	13.7	14.9	17.2	20.1	21.6	3.6	18.4	11.0	14.4	8.6	6.5	6.7	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.3	26.8	85.5	56.9	30.4	20.4	21.3	20.5	37.7	20.4	17.5	50.5	27.0	14.7	9.6	19.7	14.7	4.5	5.4	4.4	1.9	0.0	10.5	7.1	5.3	10.1	4.3	6.4	7.3	0.0	3.9	5.0	24.8	0.0	6.5	12.3	2.8	22.8	10.0	6.1	3.2	33.5	9.2	3.7	5.6	6.6	5.9	8.8	8.6	15.0	17.9	2.9	8.4	25.2	9.9	2.0	7.2	12.0	17.0	7.2	6.9	1.8	19.7	4.1	9.6	0.0	18.1	29.2	12.1	11.5	11.7	2.5	6.5	13.8	4.3	2.5	5.2	6.6	6.5	24.3	6.3	7.3	2.8	5.8	2.5	2.7	10.7	13.9	8.6
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721662-33746905	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 308.1;tongue: 83.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	1.4	0.7	4.8	0.4	15.5	0.0	1.3	12.2	9.5	1.9	5.7	6.8	0.4	3.8	0.1	6.5	1.2	0.1	29.6	5.9	8.8	6.0	18.8	5.2	0.1	14.7	13.1	0.5	0.6	0.0	0.5	4.7	15.0	5.3	0.6	0.9	2.7	1.6	308.1	0.7	2.3	1.8	7.0	3.3	1.6	0.2	12.4	0.5	12.9	83.3	0.0	2.4	1.9	27.1	0.1	0.0	0.5	0.0	0.0	0.1	3.6	0.1	0.4	0.3	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	21.9	0.0	0.1	7.9	1.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.5	5.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	12.2	9.5	5.9	8.8	14.7	13.1	15.0	7.0	12.4	27.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	8.5	0.4	0.4	11.2	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.2	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	8.9	0.3	10.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.0	0.4	6.6	51.7	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946950-43968022	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.1;skeletal muscle: 128.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Late spermatids: 91.1;Oligodendrocytes: 79.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	11.9	22.6	67.6	9.8	94.1	9.6	11.7	80.4	82.5	15.8	49.3	20.8	9.2	18.9	13.8	20.0	14.1	9.3	44.7	66.5	69.4	26.8	18.9	12.2	9.8	84.6	85.8	13.4	13.7	27.5	26.4	10.2	79.2	18.9	10.1	23.9	15.8	16.1	128.3	14.9	14.0	15.7	70.2	15.4	16.8	48.5	95.9	14.2	21.2	74.1	10.4	18.0	15.2	122.1	22.2	17.7	17.5	27.8	46.5	24.0	14.6	20.8	19.3	30.5	23.2	13.6	11.0	23.1	21.0	27.3	19.3	24.3	31.7	36.7	20.1	23.6	27.1	24.1	34.0	18.9	32.7	16.2	21.6	24.6	36.7	39.6	24.6	22.8	20.5	17.7	24.6	20.7	24.6	15.4	16.5	21.3	16.1	18.9	29.4	22.6	22.0	24.2	22.4	21.2	27.8	12.9	19.5	32.5	27.5	22.7	20.4	22.3	16.8	30.3	18.1	26.7	23.9	23.0	30.4	11.0	19.3	34.6	26.9	0.0	1.4	1.2	2.0	1.6	1.7	1.1	1.3	2.0	2.3	0.8	1.1	1.5	0.5	1.9	1.6	2.3	1.7	1.0	67.6	94.1	80.4	82.5	66.5	69.4	84.6	85.8	79.2	70.2	95.9	122.1	4.2	0.0	2.0	13.1	7.4	3.3	3.2	9.1	2.8	18.9	5.6	4.1	23.4	12.8	6.3	11.0	8.4	6.4	5.1	8.6	1.9	7.3	53.5	8.0	5.6	5.8	3.0	4.8	9.8	4.2	3.7	5.2	6.1	6.0	0.0	12.6	3.6	11.5	16.3	28.6	8.8	5.3	12.2	8.3	3.3	91.1	8.4	5.8	8.8	1.9	7.1	11.6	4.1	5.5	79.2	5.9	1.1	15.8	6.2	4.3	9.1	18.2	8.6	8.7	0.0	6.4	10.4	32.4	12.3	7.1	4.3	4.1	3.6	8.4	7.3	3.8
ITGA10		ENSG00000143127	"Integrin subunit alpha 10"	O75578	1	145891208-145910111	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Endothelial cells: 22.7;Hepatic stellate cells: 55.3;Horizontal cells: 20.2;Late spermatids: 44.8;Microglial cells: 19.7"	"Cancer enriched"	"Detected in many"	4	"melanoma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 50.7;HSkMC: 46.3;hTERT-HME1: 41.0;LHCN-M2: 72.6;TIME: 125.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"prognostic favorable (7.18e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.37e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.48e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.58e-6)"	"unprognostic (2.77e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.57e-2)"	3.8	2.0	4.2	0.8	4.3	0.2	8.3	4.4	5.8	6.9	10.5	4.6	1.4	4.0	2.1	2.1	4.5	1.4	8.3	4.2	4.3	3.0	1.8	16.5	0.9	4.1	4.4	3.6	1.6	0.7	5.8	1.9	4.2	5.0	0.7	3.8	5.3	0.7	13.6	2.9	5.7	1.9	4.3	2.0	4.6	2.8	4.7	0.5	5.6	2.8	0.9	6.6	3.5	3.7	0.0	1.4	0.2	0.3	1.3	50.7	0.0	0.6	14.2	0.2	0.6	0.0	0.7	0.3	0.8	0.3	0.1	0.3	0.4	1.3	0.5	0.6	0.1	0.2	0.0	0.5	9.2	0.2	0.7	46.3	2.7	1.9	41.0	19.4	23.5	1.5	0.1	0.2	72.6	0.3	0.1	0.5	0.2	1.1	1.1	0.3	0.1	0.0	0.8	0.2	0.1	0.0	0.1	0.0	0.6	0.5	0.8	0.3	125.7	22.2	0.3	0.3	0.3	0.2	0.8	0.1	2.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.3	4.4	5.8	4.2	4.3	4.1	4.4	4.2	4.3	4.7	3.7	7.3	0.0	3.7	0.7	1.8	2.3	6.3	0.6	0.6	10.5	10.2	16.5	4.3	0.0	2.8	7.3	8.4	0.8	2.7	0.4	0.0	0.1	36.0	1.1	1.3	22.7	0.0	0.0	3.9	0.2	0.5	4.2	2.0	1.4	0.0	0.2	55.3	0.8	0.6	20.2	4.0	0.2	0.0	0.6	2.2	44.8	0.9	1.2	0.0	19.7	0.6	0.6	2.1	2.5	0.8	0.0	0.1	0.7	0.1	3.6	0.2	0.0	0.4	7.3	0.0	4.8	3.9	5.8	1.9	2.0	2.7	0.8	1.8	0.4	0.7	1.3
KAT14	"ATAC2, CRP2BP, CSRP2BP, dJ717M23.1, PRO1194"	ENSG00000149474	"Lysine acetyltransferase 14"	Q9H8E8	20	18137228-18188387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 17.5;Extravillous trophoblasts: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068443	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA068443: AB_2685990"	"unprognostic (4.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.60e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.96e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (4.51e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	6.4	8.4	8.9	4.5	9.5	2.0	7.9	8.9	9.9	7.6	7.6	9.8	8.8	7.8	10.5	7.1	9.4	5.2	7.3	9.8	9.0	9.0	8.3	4.7	7.4	8.0	8.3	10.8	8.0	10.3	7.9	8.3	7.9	7.5	8.8	7.2	7.9	8.0	20.8	9.9	8.5	7.7	8.3	7.7	11.2	8.6	10.3	11.3	8.3	16.6	7.8	8.8	7.4	9.3	8.9	12.9	10.1	9.7	13.4	11.2	87.5	8.4	12.1	11.2	11.1	46.7	11.8	20.7	5.1	7.0	15.9	10.8	10.3	8.9	8.9	8.0	4.1	13.0	3.6	7.4	11.0	12.4	8.5	9.2	16.1	6.7	12.7	10.0	9.1	16.9	7.4	10.6	11.1	10.7	22.1	7.0	14.9	20.4	12.2	11.1	25.1	8.2	10.7	5.3	13.8	8.7	10.8	24.8	13.8	9.2	10.4	11.1	7.7	10.5	4.1	7.4	6.3	9.2	19.0	11.1	3.4	6.0	11.3	0.6	5.7	1.8	9.1	5.7	10.8	7.9	9.2	10.8	8.5	9.8	12.9	10.0	0.5	10.7	11.1	5.9	5.9	8.4	8.9	9.5	8.9	9.9	9.8	9.0	8.0	8.3	7.9	8.3	10.3	9.3	3.1	9.6	6.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.3	3.9	0.0	0.0	4.3	1.8	0.0	17.5	1.6	0.0	1.9	4.5	0.0	6.9	5.8	2.1	0.0	0.0	0.0	6.4	38.2	2.3	0.0	5.8	3.8	8.3	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.0	0.0	6.9	4.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	4.1	1.6	7.9	0.0	0.0
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31114489-31131393	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.9;Late spermatids: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA066324: AB_2685658"	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	28.8	30.9	40.4	17.8	41.6	32.9	31.3	50.6	50.4	40.8	38.2	36.9	16.6	39.2	46.5	21.1	41.7	14.7	42.0	41.5	41.6	28.4	29.0	31.3	24.6	42.0	41.3	60.7	31.8	37.4	31.0	20.4	41.3	32.0	17.3	27.5	34.7	23.7	49.8	33.8	30.2	25.5	40.0	39.7	28.2	32.8	41.6	39.6	35.5	49.8	23.3	30.9	31.0	43.1	18.1	27.4	33.5	10.7	38.5	28.9	34.3	16.0	29.6	24.7	26.8	13.6	38.1	42.3	24.5	19.6	22.8	22.5	53.6	26.4	24.1	35.8	35.0	18.7	21.5	43.3	34.5	30.5	31.9	27.9	51.4	18.5	52.4	33.2	23.6	44.1	49.5	33.7	13.1	51.4	47.4	57.2	38.0	43.1	15.9	75.1	28.1	49.5	20.1	10.7	35.2	35.9	9.4	25.9	14.1	20.7	28.6	49.6	14.7	11.0	22.2	12.1	11.6	32.4	34.8	24.2	16.0	40.7	16.3	8.0	7.4	29.9	3.0	4.1	3.7	3.6	3.6	4.1	6.6	2.9	4.6	3.3	28.4	3.2	8.3	2.7	2.4	3.4	40.4	41.6	50.6	50.4	41.5	41.6	42.0	41.3	41.3	40.0	41.6	43.1	26.2	19.2	18.2	16.0	30.4	20.8	41.9	18.1	34.7	19.0	21.5	26.2	16.8	21.5	21.0	9.2	14.6	30.5	20.9	17.8	21.5	21.9	113.9	17.5	18.2	21.8	24.6	29.5	16.4	26.6	21.7	29.4	17.9	18.0	27.3	33.9	23.2	12.4	29.1	32.0	18.6	21.2	18.3	30.1	25.4	147.5	53.7	28.1	24.9	12.2	32.6	41.0	15.5	11.1	13.2	15.0	25.8	54.2	16.5	35.2	25.1	17.5	11.8	26.9	26.3	32.8	30.6	27.5	26.2	20.6	15.6	45.4	24.6	24.5	22.9	23.2
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium inwardly rectifying channel subfamily J member 11"	Q14654	11	17385248-17389331	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 134.7;tongue: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.1;Collecting duct cells: 5.5;Enteroendocrine cells: 4.2;Excitatory neurons: 5.5;Inhibitory neurons: 5.9;Oligodendrocyte precursor cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.6;HEK 293: 12.3;MCF7: 10.0;SCLC-21H: 8.5;U-266/84: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048891	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favorable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.7	0.6	5.1	0.4	8.3	0.2	3.0	12.4	11.9	0.6	0.0	1.1	1.0	0.9	1.6	1.5	0.7	0.5	13.8	5.3	4.2	4.7	1.5	2.5	0.8	8.0	3.4	0.3	11.3	5.0	7.4	0.1	8.2	2.2	0.4	1.3	2.2	2.4	134.7	1.5	1.3	0.1	2.6	1.6	13.1	0.6	6.4	0.3	5.1	40.7	0.5	0.9	0.4	5.9	1.5	2.1	0.2	4.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	2.0	0.2	6.6	0.2	0.0	0.3	0.3	4.1	0.1	0.2	1.6	12.3	3.4	0.9	0.5	0.1	0.5	0.3	0.1	0.2	0.0	0.1	0.1	0.0	5.6	3.5	3.6	0.0	10.0	0.7	0.1	1.1	4.0	0.3	1.3	1.6	2.0	0.3	0.9	8.5	0.7	0.0	3.4	0.0	0.0	4.2	0.2	0.0	0.0	1.1	0.0	0.0	0.2	6.5	0.8	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	8.3	12.4	11.9	5.3	4.2	8.0	3.4	8.2	2.6	6.4	5.9	1.5	0.0	2.7	3.3	0.1	0.0	0.1	0.0	0.0	2.1	2.6	0.9	14.1	0.0	0.6	5.5	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.3	0.3	4.2	0.0	5.5	0.4	0.0	0.9	0.0	0.6	0.0	0.2	0.4	1.3	0.1	0.0	5.9	0.9	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.0	0.8	0.1	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.7	0.0	1.3	0.2	0.2	0.3	1.0	0.0	0.0	0.0	0.1	0.4	0.2
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 25.5;skeletal muscle: 69.1;tongue: 25.7"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 89.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.3	1.1	2.9	0.6	2.2	0.4	0.8	25.5	3.3	1.2	0.0	0.9	0.1	0.5	0.6	1.4	2.1	0.4	6.4	1.5	2.9	1.3	0.1	1.9	0.1	4.0	6.0	0.4	0.2	5.5	0.8	0.4	3.1	0.6	0.3	1.3	0.7	0.6	69.1	3.6	0.4	0.6	1.1	1.2	1.1	0.8	10.8	0.1	1.1	25.7	1.0	0.7	0.5	1.4	0.0	0.7	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	4.3	0.0	0.6	1.1	0.0	0.0	4.8	0.2	2.5	0.0	1.1	5.2	0.0	0.0	2.0	0.0	0.3	4.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.2	25.5	3.3	1.5	2.9	4.0	6.0	3.1	1.1	10.8	1.4	1.4	0.0	0.0	0.7	0.0	1.5	0.0	2.3	0.0	2.9	0.0	0.3	14.3	0.0	1.2	1.8	0.0	0.0	0.1	1.1	1.9	0.0	0.5	0.4	0.5	3.4	1.2	0.0	2.8	0.0	0.0	3.4	0.5	1.8	0.0	0.0	6.8	0.1	0.2	89.2	5.7	1.4	4.1	0.0	1.2	0.5	7.5	0.1	0.0	2.8	0.0	10.2	0.0	0.0	0.2	0.0	0.5	4.1	0.0	0.2	0.0	0.8	0.1	1.5	0.0	3.0	0.7	0.6	2.5	0.0	2.3	0.1	0.5	0.0	1.8	0.2
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486125-10503558	"Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.98e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.06e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	31.3	41.2	54.8	20.5	61.6	20.4	30.3	61.8	60.9	32.7	49.7	37.6	26.5	31.3	22.2	55.4	28.9	24.3	60.7	53.2	59.4	32.5	60.9	25.3	23.2	61.4	60.5	25.3	32.8	24.3	30.0	17.0	60.3	36.8	16.5	16.4	34.7	24.9	178.2	38.7	27.5	18.7	58.8	32.2	33.2	20.5	59.6	23.0	35.6	75.7	18.5	41.4	36.3	68.4	58.0	102.8	27.2	35.1	55.8	45.4	30.3	48.1	35.9	46.6	41.6	73.7	54.2	82.9	122.9	53.3	34.8	49.7	55.6	36.9	23.7	78.3	61.7	126.3	29.9	87.9	54.5	65.4	63.9	50.0	51.0	53.5	25.1	39.1	46.3	23.7	79.1	135.4	41.6	79.9	46.1	177.8	80.8	54.2	88.6	84.6	34.8	95.1	30.4	67.4	75.3	40.4	66.8	42.4	42.1	23.9	37.8	82.3	56.5	72.9	41.0	86.0	57.0	86.8	113.0	81.1	58.0	78.5	56.0	36.4	37.9	41.4	55.3	33.8	53.1	26.3	38.5	52.0	45.4	11.7	23.6	33.7	20.9	42.5	34.6	31.4	50.2	41.8	54.8	61.6	61.8	60.9	53.2	59.4	61.4	60.5	60.3	58.8	59.6	68.4	18.3	28.9	20.8	5.5	13.8	21.9	24.4	40.3	27.9	21.5	15.7	11.4	24.0	21.5	25.4	11.0	8.4	27.3	11.6	33.2	13.7	32.8	27.5	13.4	17.1	27.8	26.9	45.2	5.3	36.3	25.2	23.5	18.8	13.3	12.0	22.8	35.3	34.4	29.0	26.9	5.9	21.4	40.7	15.1	13.4	43.9	29.2	16.1	10.6	3.7	41.8	43.0	7.2	11.6	18.3	29.8	27.1	25.9	26.6	33.3	36.8	24.9	17.2	13.9	13.1	17.7	22.4	21.2	16.6	34.7	22.0	26.8	20.1	29.6	31.5	24.8
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127438406-127459389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.6;skeletal muscle: 28.3"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	16.8	2.3	16.9	0.9	18.4	0.0	3.7	20.1	32.6	4.3	8.0	9.7	0.9	2.9	1.8	6.2	2.0	1.6	2.1	18.2	17.4	1.2	0.7	13.2	0.3	16.7	16.9	2.5	0.8	0.0	13.9	0.3	17.2	4.3	3.6	8.7	1.8	1.1	28.3	1.0	4.3	1.8	18.0	2.0	5.4	4.0	17.7	0.3	0.9	10.4	0.2	6.0	3.6	19.6	0.0	2.1	10.4	0.0	0.8	1.7	0.0	0.2	1.3	1.1	2.7	0.0	0.0	0.0	0.0	0.2	7.0	0.0	1.0	0.0	1.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	4.3	0.0	0.9	0.0	1.2	0.0	0.0	1.2	0.0	4.7	0.0	4.8	0.0	0.0	0.0	2.6	0.0	0.2	0.0	33.3	17.8	0.0	0.0	0.2	0.0	0.0	1.1	0.0	5.3	0.8	0.0	1.9	0.0	0.0	0.0	4.7	0.3	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	18.4	20.1	32.6	18.2	17.4	16.7	16.9	17.2	18.0	17.7	19.6	0.4	93.0	27.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	8.4	0.0	0.0	0.0	0.3	0.3	0.6	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	3.6	1.1	0.0	34.3	0.5	1.0	0.1	0.0	0.0	0.1	0.1	3.4	0.0	0.0
KIF13A	bA500C11.2	ENSG00000137177	"Kinesin family member 13A"	Q9H1H9	6	17759183-17987635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.5"	"Group enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 831.4;Oligodendrocytes: 453.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029253, HPA029254"	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA029253: AB_10611115, HPA029254: AB_10602094"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (2.96e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.77e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.44e-2)"	24.1	20.0	23.9	10.3	29.7	19.4	21.3	25.9	24.4	23.6	31.2	29.4	27.4	25.4	13.1	20.1	18.9	17.7	47.8	21.2	22.9	14.1	16.0	25.3	5.3	24.6	25.8	20.2	14.7	21.2	11.9	11.9	25.3	23.7	25.4	21.6	17.2	18.6	104.5	28.6	23.5	22.4	21.5	8.1	14.5	8.6	27.1	8.3	27.9	72.5	7.4	29.9	24.3	33.9	24.8	18.0	21.3	13.1	28.4	27.0	25.3	33.6	57.0	28.9	29.5	6.5	5.9	0.2	26.3	58.4	36.5	24.3	16.3	42.6	36.2	2.5	9.8	10.6	44.9	32.1	18.9	0.4	10.3	21.5	34.9	31.3	47.1	37.2	23.8	0.1	39.5	0.3	31.8	10.0	0.1	1.5	16.9	5.7	11.0	12.6	29.1	0.2	18.1	62.1	5.8	11.5	27.7	20.6	38.4	36.7	29.9	1.5	16.8	52.6	15.2	17.4	31.8	0.2	0.1	0.2	18.9	0.8	39.2	2.1	1.3	1.2	0.0	1.1	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	5.9	0.1	0.5	0.1	0.0	0.2	23.9	29.7	25.9	24.4	21.2	22.9	24.6	25.8	25.3	21.5	27.1	33.9	29.9	35.3	44.4	149.5	4.3	57.2	39.6	9.2	21.1	32.9	20.5	23.1	67.7	17.2	12.8	20.2	18.8	4.1	2.8	20.3	11.7	5.9	20.9	14.5	27.9	28.6	12.5	20.4	134.4	8.7	4.0	24.0	13.7	16.5	5.1	9.7	15.4	25.5	11.9	5.0	42.2	27.2	6.1	22.3	14.7	10.5	15.5	18.9	17.8	105.9	21.1	37.6	5.2	831.4	453.8	9.2	27.4	24.8	0.6	38.4	18.2	10.9	23.5	26.8	26.3	32.7	35.3	6.8	14.9	8.1	45.6	9.0	2.2	2.9	32.7	38.0
KIF1C	"SAX2, SPAX2, SPG58"	ENSG00000129250	"Kinesin family member 1C"	O43896	17	4997950-5028401	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 244.8;choroid plexus: 142.7;heart muscle: 185.0;skeletal muscle: 561.0;tongue: 389.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 315.4;Distal enterocytes: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024602, HPA045020"	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA024602: AB_1852480, HPA045020: AB_2679187"	"unprognostic (3.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.90e-3)"	"prognostic favorable (2.26e-9)"	"unprognostic (1.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.10e-3)"	54.6	18.6	200.1	25.1	230.9	6.3	36.3	184.0	210.0	33.9	142.7	63.3	53.3	44.4	7.9	75.7	31.5	28.0	185.0	164.4	175.0	37.9	46.4	49.6	10.0	219.0	216.9	24.1	51.6	55.1	10.5	18.6	197.0	36.4	33.2	4.3	38.3	36.7	561.0	53.4	51.4	36.3	200.7	26.5	51.2	17.7	200.8	11.3	38.7	389.2	16.7	51.4	37.3	244.8	104.1	97.6	32.2	69.4	74.5	44.5	51.0	80.8	64.3	63.2	38.3	70.7	24.5	16.6	46.7	127.2	41.2	105.3	58.4	107.2	44.6	40.2	68.7	12.0	124.1	57.4	50.7	4.9	34.6	46.0	109.9	85.2	58.0	59.6	87.2	14.5	45.9	28.4	62.6	61.5	14.7	8.0	25.1	68.1	63.4	15.1	54.1	17.2	55.7	71.9	7.8	15.3	114.2	63.0	34.9	30.6	62.0	14.9	185.5	84.8	63.7	62.2	99.3	10.8	9.9	8.9	62.6	20.9	43.0	0.5	0.4	0.7	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.4	0.2	0.2	1.2	0.3	0.2	0.2	0.3	0.1	200.1	230.9	184.0	210.0	164.4	175.0	219.0	216.9	197.0	200.7	200.8	244.8	24.8	54.5	50.6	6.5	6.8	16.8	19.0	25.6	12.5	12.5	24.8	14.2	315.4	48.6	28.1	25.8	0.0	14.8	6.5	168.9	19.6	32.2	71.6	13.0	15.1	37.8	14.4	4.4	5.7	43.1	14.0	21.9	51.0	29.3	12.7	21.6	37.1	82.7	16.1	23.5	7.3	77.3	12.2	18.5	11.0	32.1	16.8	11.9	16.0	10.3	16.1	7.7	6.2	4.5	5.0	63.0	83.8	42.5	11.4	44.1	92.9	42.9	18.4	5.8	6.6	35.0	35.1	18.7	23.6	21.3	20.2	23.3	7.9	12.4	65.4	36.6
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 395.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 552.0;Late spermatids: 1588.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	52.5	64.9	161.4	33.9	170.8	48.6	52.7	144.2	203.3	48.5	139.0	75.0	40.1	44.5	56.3	49.5	53.0	37.4	105.7	178.2	143.8	53.2	73.0	43.2	45.4	150.6	153.9	55.6	51.1	54.6	68.8	59.2	156.5	56.8	40.7	48.2	60.6	47.8	395.9	51.4	48.6	43.3	140.5	54.0	64.8	192.2	158.6	67.1	49.7	203.9	44.8	49.8	46.2	157.1	119.1	36.0	117.1	197.3	79.0	59.4	83.8	52.6	67.7	100.7	109.4	104.5	60.6	117.0	58.7	77.3	37.8	61.6	126.1	67.8	68.5	62.8	171.3	146.0	102.1	109.7	77.4	86.5	99.7	95.8	67.1	77.6	45.2	77.9	98.7	131.1	180.7	80.9	38.4	147.3	142.3	148.9	153.4	297.3	38.0	137.2	86.0	141.4	62.3	67.9	216.1	168.8	55.8	63.2	93.1	75.7	109.8	247.6	58.8	45.7	83.9	50.8	52.9	88.0	118.8	170.9	19.9	122.7	39.4	42.3	83.5	100.3	62.0	78.9	51.9	41.6	50.8	56.0	90.7	39.6	65.6	51.8	40.4	54.7	63.3	49.8	59.5	76.5	161.4	170.8	144.2	203.3	178.2	143.8	150.6	153.9	156.5	140.5	158.6	157.1	21.3	12.8	17.0	10.4	26.7	18.7	32.9	33.5	14.8	31.9	37.8	33.7	40.3	37.1	19.1	18.4	14.6	99.6	32.7	34.8	86.1	61.7	552.0	19.2	19.0	30.4	52.3	59.3	29.1	54.7	115.1	36.2	20.9	18.8	13.4	50.7	32.5	28.4	63.8	32.0	22.0	43.7	34.6	47.0	22.7	1588.3	44.7	31.8	33.8	11.2	54.7	55.4	55.6	11.6	14.8	46.3	44.3	59.0	31.7	44.4	72.6	55.3	16.9	25.9	52.6	30.4	32.2	180.8	35.6	22.8	20.6	107.0	28.3	71.4	53.7	36.7
KLHL21	KIAA0469	ENSG00000162413	"Kelch like family member 21"	Q9UJP4	1	6590724-6614607	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 169.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 104.8;Suprabasal keratinocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 21.4;neutrophil: 63.0"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 63.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051364, HPA059307"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	Centrosome		"HPA051364: AB_2681455, HPA059307: "	"unprognostic (6.13e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.33e-3)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.19e-2)"	30.5	29.5	31.3	12.6	37.3	25.5	24.6	33.6	35.9	27.2	73.1	44.7	6.9	35.3	8.7	36.4	24.2	14.4	53.3	32.1	31.5	28.2	22.2	16.4	9.2	41.0	44.0	28.6	33.3	21.5	30.1	6.9	37.4	31.7	5.0	7.6	33.3	28.3	169.9	37.0	15.9	16.4	30.7	17.2	30.0	15.2	35.5	9.7	18.7	101.3	7.6	46.5	25.0	44.3	25.8	15.1	7.5	24.3	41.5	25.8	19.5	35.5	28.1	23.0	13.7	44.1	16.1	0.9	30.8	21.9	20.7	41.7	16.6	39.2	12.8	54.8	26.8	29.7	27.8	40.3	34.4	17.8	17.5	28.9	13.0	52.3	17.6	21.6	9.9	14.8	33.3	23.1	19.0	8.9	18.4	15.7	13.8	13.1	55.5	28.0	31.3	32.3	13.5	7.8	30.2	7.5	27.8	22.0	62.8	6.5	14.5	21.0	33.3	74.4	9.1	68.9	86.1	26.2	35.2	18.0	72.2	33.1	28.4	8.4	6.2	21.4	7.1	2.6	6.2	4.5	6.6	7.0	3.8	2.6	5.3	5.3	63.0	2.9	2.3	3.4	8.2	6.1	31.3	37.3	33.6	35.9	32.1	31.5	41.0	44.0	37.4	30.7	35.5	44.3	11.6	3.2	5.1	19.6	8.9	71.2	46.9	22.3	63.2	4.1	47.1	44.4	68.3	7.2	10.7	9.2	4.2	5.1	15.6	10.1	7.9	12.0	2.7	19.6	14.9	15.6	3.0	2.1	8.2	12.9	7.0	24.7	31.1	35.3	0.0	6.4	7.1	23.6	5.6	5.0	8.9	5.6	14.2	10.4	30.1	7.6	10.8	17.1	26.6	8.4	7.6	12.2	4.1	6.6	14.1	20.0	7.3	15.1	12.6	43.1	5.3	7.6	14.0	5.9	13.1	32.2	25.2	2.0	10.9	104.8	72.0	6.4	15.3	9.2	5.5	31.3
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495844	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.1;Excitatory neurons: 42.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	13.7	14.2	24.1	10.2	23.0	11.3	11.9	25.9	25.1	20.5	18.2	16.6	7.7	20.4	17.2	8.0	17.9	13.6	14.2	22.9	21.4	15.6	10.8	11.8	17.6	18.0	18.1	22.3	16.5	22.9	19.6	11.6	18.7	18.7	10.6	15.3	14.0	18.0	22.1	11.7	10.4	21.7	14.8	15.6	12.2	10.2	23.1	8.0	20.8	18.0	20.7	13.4	10.9	21.2	17.1	16.5	37.5	29.9	30.6	35.5	9.0	21.4	37.6	21.0	23.6	8.2	6.4	11.9	7.0	37.3	16.9	21.3	25.6	9.2	18.1	25.9	15.1	12.6	17.4	8.3	30.6	2.6	11.7	26.9	14.2	19.3	12.4	26.8	31.3	9.1	32.7	11.4	20.7	25.9	2.5	15.6	6.3	14.1	11.4	23.5	13.8	0.5	12.3	19.9	19.9	20.3	23.0	16.9	15.8	12.3	15.7	9.3	14.2	25.1	12.2	17.5	8.9	6.4	7.4	7.9	13.5	11.1	16.6	8.9	4.6	19.3	8.1	6.3	6.4	8.3	10.2	7.5	15.5	6.2	7.7	8.3	10.6	16.6	8.3	5.6	19.2	6.5	24.1	23.0	25.9	25.1	22.9	21.4	18.0	18.1	18.7	14.8	23.1	21.2	4.6	0.0	3.7	41.1	8.2	1.7	2.8	8.4	4.0	11.7	4.3	5.2	4.8	10.0	5.3	9.2	4.2	17.9	5.2	2.9	3.9	8.4	0.8	3.2	7.1	4.8	3.0	1.3	42.9	2.6	6.6	9.2	5.1	3.9	5.1	14.2	4.2	6.3	7.9	13.5	51.1	5.2	12.2	5.7	4.9	1.8	12.2	4.8	1.8	16.9	4.2	13.9	7.2	41.2	26.8	5.6	3.5	19.9	5.4	3.9	3.0	10.9	4.3	6.7	6.6	4.7	5.3	17.3	15.4	2.8	1.4	13.4	7.8	17.7	3.8	1.8
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859158-87863533	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 5.7;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 5.0;Karpas-707: 5.1"									HPA074502			Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.0	0.7	1.0	0.6	0.7	0.5	0.6	1.5	1.6	0.7	0.6	0.9	0.4	0.5	1.0	0.4	1.4	0.4	0.5	0.7	0.9	0.9	0.9	0.4	0.8	0.5	0.6	0.4	0.2	0.5	0.5	0.6	0.6	0.4	0.8	1.0	0.3	0.5	4.5	0.4	0.4	0.5	0.3	0.8	0.6	1.0	0.6	1.0	0.7	0.5	0.8	0.3	0.3	1.5	0.8	1.0	1.1	0.7	0.5	0.3	0.8	0.7	0.9	0.5	0.7	0.6	2.6	2.0	0.3	0.2	0.5	0.9	0.7	0.8	0.4	0.5	0.3	0.7	1.5	0.6	0.6	1.4	0.5	0.6	0.8	0.7	0.8	0.9	0.3	5.0	0.4	5.1	0.5	1.8	4.1	1.6	0.4	0.6	0.5	2.6	0.1	2.6	0.4	0.8	0.4	1.0	0.9	0.6	0.1	0.7	1.6	1.2	0.3	0.5	0.3	0.9	0.3	2.9	3.3	2.9	0.9	2.9	0.6	1.6	0.3	0.6	0.2	0.5	0.4	0.4	0.3	0.3	0.3	0.5	0.4	0.3	2.5	0.6	0.8	0.5	0.2	0.2	1.0	0.7	1.5	1.6	0.7	0.9	0.5	0.6	0.6	0.3	0.6	1.5	0.6	0.0	0.0	0.3	0.5	0.1	0.3	0.2	0.6	1.7	1.0	1.3	2.7	1.5	1.3	0.0	0.0	0.7	2.0	3.0	0.0	0.2	3.9	0.8	0.9	0.6	0.0	0.8	0.4	0.2	0.4	1.1	3.6	0.4	5.7	0.3	0.7	0.4	0.3	3.3	0.5	1.8	0.0	1.3	0.0	2.0	0.0	0.6	0.0	0.0	0.3	1.6	0.0	0.0	0.1	0.3	2.5	0.0	0.2	0.3	1.8	1.9	2.3	1.0	6.6	1.1	2.9	0.3	1.2	0.6	0.4	0.5	0.7	0.3	1.3	0.2
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436641	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 363.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	12.7	11.2	16.7	7.3	25.7	16.4	12.9	16.7	15.7	15.3	5.5	13.1	5.7	14.3	13.7	14.1	11.9	7.7	10.2	13.0	18.9	8.9	10.4	12.7	8.1	25.3	19.4	16.8	18.5	12.4	12.1	10.3	20.6	9.3	7.6	21.7	14.2	9.0	25.9	17.6	12.8	7.5	12.2	12.2	15.2	13.4	19.1	16.1	14.6	16.9	9.5	11.3	12.7	28.6	13.4	6.1	11.6	11.7	19.0	13.9	10.2	4.7	6.4	5.0	5.5	10.9	4.7	22.4	8.9	11.3	9.2	5.2	14.3	7.5	9.2	12.7	6.5	14.0	7.3	4.5	8.9	22.9	12.8	6.6	9.1	7.1	8.2	7.2	8.4	9.7	22.5	15.0	11.7	12.7	14.8	11.1	6.8	8.5	7.9	9.5	12.3	8.4	5.8	10.9	19.6	12.8	13.4	15.8	6.3	10.6	4.6	15.7	12.8	8.0	4.4	9.0	8.9	15.3	7.7	22.4	10.7	14.7	8.4	6.1	3.0	4.4	1.9	2.7	1.6	6.9	2.0	1.5	1.4	3.9	1.9	1.4	15.2	2.2	2.6	3.7	1.3	0.8	16.7	25.7	16.7	15.7	13.0	18.9	25.3	19.4	20.6	12.2	19.1	28.6	62.4	76.9	71.9	292.8	75.0	89.1	38.3	31.5	62.0	89.0	59.6	35.2	65.8	44.3	72.4	46.0	173.0	38.0	61.9	61.7	5.9	37.6	32.1	94.4	92.1	58.9	67.9	55.5	180.7	33.1	51.7	58.3	89.2	200.5	65.2	52.8	56.7	46.0	33.7	80.8	172.2	53.5	42.7	54.7	79.6	17.3	67.4	90.5	42.7	202.4	77.1	57.7	59.8	299.6	363.2	37.6	49.0	60.2	90.3	53.6	36.3	14.7	46.9	73.0	26.3	83.0	55.5	42.3	33.9	80.9	96.3	127.2	76.8	54.8	39.1	61.4
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		55000	"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.83e-5)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	81.6	77.7	90.8	52.8	98.9	36.1	81.6	92.8	106.3	61.4	165.0	97.4	43.4	58.1	97.1	72.7	53.2	58.6	134.6	81.0	94.2	104.0	106.6	67.0	61.8	100.2	95.3	63.9	67.2	143.0	67.4	69.4	100.7	77.5	90.8	127.9	73.5	73.5	378.2	137.6	53.2	60.3	95.2	53.4	61.1	145.1	99.4	54.7	107.7	281.6	61.0	113.1	55.2	110.3	200.5	133.4	100.3	106.5	132.8	127.3	140.2	159.7	127.3	97.2	85.2	89.4	233.9	152.8	213.4	166.7	102.7	347.2	122.5	138.2	162.7	251.9	65.2	109.1	223.0	174.4	126.3	160.3	83.3	119.1	124.6	122.1	208.4	208.3	161.9	122.2	107.4	88.1	189.0	154.6	141.3	95.0	76.8	91.1	194.3	109.6	258.2	73.5	244.8	307.0	122.4	100.0	245.8	113.2	143.2	201.7	115.3	101.7	230.0	193.9	250.4	100.0	151.2	38.9	55.9	110.4	229.4	93.4	109.5	117.0	42.7	48.0	56.2	40.3	54.7	95.6	69.4	65.8	44.0	106.6	71.1	62.1	29.6	64.9	52.6	185.8	48.4	16.0	90.8	98.9	92.8	106.3	81.0	94.2	100.2	95.3	100.7	95.2	99.4	110.3	363.1	307.7	239.8	72.5	171.7	654.5	285.8	215.6	270.9	206.5	460.6	348.7	852.7	270.2	214.7	428.6	360.7	155.1	194.9	575.2	31.3	249.7	721.9	351.3	186.6	345.0	224.0	165.3	93.9	304.0	199.1	211.9	95.3	298.1	134.9	384.5	295.9	401.7	116.8	326.4	112.1	226.4	207.5	181.3	261.6	377.9	248.5	168.9	172.5	104.9	194.3	449.2	142.2	90.0	139.8	341.2	325.7	441.6	184.6	283.5	152.6	109.3	319.3	400.9	335.2	333.5	292.1	694.3	386.4	217.8	723.0	164.7	168.3	162.4	282.4	328.0
LARS1	"FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase 1"	Q9P2J5	5	146110566-146182696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	35.4	37.0	40.0	26.6	42.0	20.2	46.3	42.8	48.9	33.9	44.0	34.4	18.4	33.9	35.4	35.0	34.8	18.7	38.5	40.4	44.3	34.6	25.6	26.4	29.7	42.3	42.9	37.2	49.7	34.7	37.0	22.2	41.8	35.6	34.8	34.7	40.0	28.3	70.6	31.7	28.1	33.4	43.1	35.7	29.8	23.9	43.2	32.7	34.7	58.8	34.8	35.6	30.9	46.2	56.1	59.5	65.9	125.9	88.0	95.7	102.5	45.5	57.8	71.4	92.4	66.1	59.8	67.8	32.7	91.2	72.6	52.9	107.2	116.5	106.4	45.2	88.2	65.5	76.0	58.5	122.7	101.4	51.9	83.7	153.6	92.0	173.3	73.2	87.7	108.0	67.4	121.3	83.4	56.9	102.8	116.1	126.8	63.8	86.8	75.0	62.0	101.9	73.6	44.1	77.7	97.3	50.2	111.6	221.2	76.6	103.1	159.3	63.4	61.2	44.3	56.7	89.4	79.3	82.3	86.3	89.8	164.1	79.1	1.1	11.8	5.4	14.5	19.2	19.6	18.9	16.6	14.9	21.2	15.5	21.2	21.9	0.7	19.2	16.7	16.6	19.6	14.9	40.0	42.0	42.8	48.9	40.4	44.3	42.3	42.9	41.8	43.1	43.2	46.2	26.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.7	0.0	0.0	0.0	0.0	39.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	40.3	16.6	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	33.0	2.8	0.0	0.0	0.0
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 26.5"	"Cell type enriched"	"Detected in single"	5	"Skeletal myocytes: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.6;pons and medulla: 3.0"	"Group enriched"	"Detected in some"	18	"cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.5	0.4	2.5	4.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111731-25178231	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	17.5	27.3	41.5	13.3	43.2	19.9	22.5	41.1	44.5	23.9	36.5	22.0	16.8	21.2	31.1	22.8	20.5	13.6	36.1	45.1	42.8	26.9	10.9	14.9	16.7	39.9	39.0	28.1	47.2	32.0	32.9	24.1	42.4	20.8	21.3	21.8	21.2	21.3	52.3	28.2	17.1	18.5	40.2	16.2	22.5	35.4	43.4	21.3	18.6	36.2	20.2	18.1	20.6	43.0	40.3	36.3	33.9	47.2	30.2	42.9	34.9	24.7	40.5	35.7	45.9	46.4	35.7	24.4	34.1	37.6	44.2	20.1	35.9	34.3	47.9	24.9	53.3	13.5	35.4	77.3	67.9	32.0	20.9	48.7	37.7	39.9	41.4	51.3	32.3	54.0	21.5	31.2	39.5	102.3	37.9	60.6	52.1	25.3	37.0	44.3	30.9	47.7	40.7	27.9	55.5	34.1	29.0	45.8	58.2	39.9	46.0	14.9	19.1	34.6	24.3	23.4	25.0	39.8	43.9	25.8	42.3	27.5	26.6	33.4	36.5	46.2	39.4	33.5	43.3	42.0	47.8	42.1	35.0	31.6	42.8	39.2	14.6	33.6	37.6	18.1	82.9	42.2	41.5	43.2	41.1	44.5	45.1	42.8	39.9	39.0	42.4	40.2	43.4	43.0	21.0	16.0	19.8	15.3	23.5	24.1	31.1	55.6	33.6	25.7	39.3	42.0	34.8	15.7	29.6	33.1	2.1	164.5	20.9	60.5	49.0	51.7	76.5	22.7	31.4	22.7	51.4	29.5	29.0	66.7	69.4	29.1	20.9	20.2	9.5	197.7	23.2	9.5	46.8	23.5	30.1	46.9	38.7	33.9	20.0	137.5	26.1	27.0	33.8	17.8	31.3	32.0	32.0	28.1	31.7	46.7	45.1	24.0	28.9	34.6	79.4	90.0	30.0	26.1	26.3	22.9	67.7	67.3	52.9	35.6	31.8	163.8	29.6	78.7	43.7	34.7
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439798-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;fallopian tube: 16.8;placenta: 19.0;skeletal muscle: 22.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 37.1;SH-SY5Y: 104.5"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 34.1"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	1.4	1.6	2.7	0.4	7.6	0.0	1.5	4.6	4.7	1.5	0.1	3.3	5.1	4.0	1.1	0.1	16.8	0.4	0.2	2.9	5.7	0.8	0.9	0.9	0.1	9.5	5.2	0.7	0.0	0.2	1.0	19.0	9.0	1.2	3.6	0.2	1.9	7.3	22.3	2.9	5.5	0.2	6.0	0.0	2.3	0.1	5.6	0.1	0.3	0.8	1.7	0.1	0.4	19.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.5	0.0	11.9	0.0	1.0	37.1	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	12.2	1.6	2.4	0.0	0.0	0.0	14.6	0.2	104.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	7.6	4.6	4.7	2.9	5.7	9.5	5.2	9.0	6.0	5.6	19.2	0.0	0.0	0.0	1.3	0.2	0.9	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	55.2	0.0	1.2	0.0	0.0	0.6	35.7	5.3	0.5	4.9	0.0	6.8	0.0	2.3	1.4	0.0	84.4	0.0	0.0	0.0	1.0	6.4	0.0	12.3	3.0	0.0	0.0	1.6	0.2	0.0	0.4	1.8	0.0	0.0	0.0	0.0	45.2	105.0	0.1	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	3.4	0.0	0.0	0.0	1.3	26.4	0.5	0.0	20.3	0.0
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39459004-39485109	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.0;Late spermatids: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	5.4	7.5	5.9	3.0	6.5	6.6	5.7	7.6	9.8	5.1	5.9	6.4	5.5	4.6	5.3	6.7	6.1	3.6	11.1	6.2	6.7	8.7	8.6	2.9	5.1	6.3	6.4	10.0	6.8	6.5	4.0	3.3	6.8	4.1	6.4	5.4	4.3	3.1	27.2	5.7	5.2	5.2	5.5	3.6	6.3	9.8	6.2	4.3	4.2	21.0	4.2	5.8	4.7	8.3	5.7	4.5	5.4	5.2	11.5	11.4	4.8	6.6	3.7	6.1	4.1	6.8	7.8	20.8	7.3	2.5	15.2	4.9	15.9	9.1	8.0	2.4	4.0	8.8	2.3	7.0	10.4	19.1	5.5	10.8	14.6	7.1	22.4	13.4	7.0	12.7	21.1	5.2	7.5	3.6	10.9	24.9	7.3	15.3	14.2	9.1	15.2	12.9	7.1	2.9	6.0	4.8	3.8	4.9	22.5	7.6	5.6	8.8	2.6	4.7	10.6	6.3	15.5	9.9	15.8	14.3	7.2	22.2	4.0	2.5	6.4	3.9	5.7	7.6	12.7	10.0	8.1	8.0	6.2	7.6	16.2	11.6	3.4	7.7	5.6	5.5	5.7	4.7	5.9	6.5	7.6	9.8	6.2	6.7	6.3	6.4	6.8	5.5	6.2	8.3	11.0	9.6	12.6	14.0	12.9	9.7	11.6	17.4	12.0	25.8	15.7	17.3	20.1	17.2	12.7	18.4	10.4	24.0	22.6	12.9	21.5	13.2	86.0	11.2	15.8	10.3	18.1	12.4	11.9	6.4	18.2	10.4	9.2	10.3	17.7	19.0	11.4	19.0	17.5	10.1	18.8	13.5	18.3	13.5	7.8	100.1	10.2	11.4	1.8	6.5	17.6	15.4	16.5	14.6	22.9	10.3	10.1	12.4	5.8	6.6	18.3	32.6	14.1	26.7	0.0	10.8	20.5	64.9	25.1	13.7	9.2	9.6	14.2	19.0	18.4	8.8
LIMCH1	"DKFZP686A01247, LIMCH1A, LMO7B"	ENSG00000064042	"LIM and calponin homology domains 1"	Q9UPQ0	4	41359607-41700044	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 203.9;tongue: 277.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 650.7;Excitatory neurons: 434.8;Inhibitory neurons: 551.3;Oligodendrocytes: 1102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 1.3"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 106.2;HeLa: 180.0;hTERT-RPE1: 146.9;RT4: 181.0;SiHa: 102.5;WM-115: 144.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004184, HPA063840"	Uncertain		Approved	"Actin filaments"		NA	NA		5600	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Actin filaments"		"HPA004184: AB_1078673, HPA063840: AB_2685133"	"prognostic unfavorable (5.55e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.82e-7)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.24e-3)"	42.6	36.4	70.3	4.9	111.3	0.2	22.0	92.2	88.0	11.4	13.5	9.2	4.5	6.4	5.8	17.2	17.3	21.7	96.2	68.6	82.1	29.0	11.8	121.5	2.4	93.9	103.9	35.6	10.5	71.7	16.2	9.5	98.6	55.5	7.4	35.7	72.4	24.7	203.9	12.2	7.2	10.3	90.8	107.8	10.0	9.5	88.8	7.3	41.1	277.5	3.3	25.3	7.6	135.4	2.4	26.7	40.3	2.7	0.1	0.1	3.9	33.9	17.1	33.2	16.7	4.1	10.5	0.1	106.2	90.5	1.0	18.8	23.1	15.6	37.2	0.2	3.1	0.1	180.0	0.2	33.4	0.0	0.2	0.6	44.5	0.0	10.3	146.9	3.3	0.0	0.0	0.1	9.6	14.9	0.1	0.1	2.8	5.8	2.9	0.0	49.2	0.7	27.9	181.0	37.9	76.8	102.5	40.2	0.6	32.2	3.0	0.2	0.1	0.4	38.6	9.3	26.0	0.1	0.1	0.3	2.6	0.0	144.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	111.3	92.2	88.0	68.6	82.1	93.9	103.9	98.6	90.8	88.8	135.4	101.4	650.7	211.5	205.3	0.8	39.0	50.9	5.9	33.6	32.1	80.0	32.3	242.4	28.6	90.1	95.6	37.5	16.4	0.4	4.8	21.5	40.3	107.7	31.0	10.6	77.6	9.6	0.0	434.8	14.0	45.7	51.8	16.3	44.3	5.1	13.8	128.5	11.5	13.0	0.0	551.3	11.7	6.1	13.3	30.9	29.0	1.8	5.2	14.2	121.8	19.5	82.6	0.0	64.8	1102.9	5.5	9.3	7.5	0.3	103.3	4.4	10.6	75.7	69.7	0.0	37.5	12.9	5.0	15.6	25.2	30.5	46.1	2.8	67.9	5.5	52.8
LIN7B	"LIN-7B, MALS-2, VELI2"	ENSG00000104863	"Lin-7 homolog B, crumbs cell polarity complex component"	Q9HAP6	19	49114324-49118460	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in all"		"Spermatogonia: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.02e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.69e-2)"	4.0	6.4	22.7	1.5	22.4	1.8	4.8	19.7	30.0	6.0	11.7	7.2	4.8	4.7	2.2	9.3	4.9	2.3	21.5	22.2	26.1	5.4	4.1	4.1	2.0	22.1	21.0	4.4	7.8	3.6	24.9	1.1	22.0	7.7	2.3	7.1	7.5	3.6	53.8	18.7	5.3	1.4	18.9	3.9	5.8	12.0	22.0	1.7	5.2	9.1	2.0	6.2	7.5	19.0	3.2	7.3	3.6	6.7	1.0	1.4	3.1	3.9	1.7	2.4	5.6	3.9	0.6	1.3	3.8	4.9	4.6	5.9	4.3	0.5	1.2	7.8	16.3	1.2	7.9	5.4	4.9	1.4	0.9	1.4	3.0	2.2	0.4	4.4	0.8	4.8	2.3	4.0	3.7	4.4	3.0	4.8	1.8	4.1	8.0	4.8	4.6	3.5	2.6	5.6	5.1	4.3	5.5	3.2	4.0	1.5	4.2	0.7	2.6	9.2	3.9	4.7	2.3	6.6	13.7	2.1	3.3	3.0	2.8	0.0	4.9	1.4	6.4	2.5	5.0	4.5	5.1	4.6	3.3	3.9	7.0	6.0	1.0	1.5	4.5	11.6	3.2	4.0	22.7	22.4	19.7	30.0	22.2	26.1	22.1	21.0	22.0	18.9	22.0	19.0	11.6	3.2	4.8	11.8	6.5	6.6	6.5	18.1	7.4	31.9	15.6	15.4	22.5	4.3	12.7	9.2	12.5	1.0	8.0	18.0	21.5	4.6	4.8	7.8	4.2	7.4	16.9	7.0	11.1	4.7	3.3	7.3	4.1	4.5	5.1	5.0	7.5	5.5	8.5	16.8	12.8	13.0	20.3	10.3	6.3	5.1	7.5	6.0	17.8	1.0	4.1	17.7	9.2	5.5	7.9	2.7	18.4	9.4	7.9	8.4	21.7	20.3	10.9	33.5	26.3	5.9	10.9	8.2	85.0	11.0	13.1	2.2	5.8	2.7	10.3	8.2
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151805419	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 21.3;tongue: 5.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4"	"Region enriched"	"Detected in many"	7	"spinal cord: 19.7"	HPA060781	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 80: Striated muscle - Unknown function"		"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA060781: AB_2684361"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.0	0.1	0.1	0.1	0.0	0.1	4.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.7	0.1	0.7	0.3	0.5	0.3	1.1	0.2	0.2	2.8	1.6	0.0	0.4	0.5	1.4	0.0	3.9	0.7	0.1	0.1	0.6	0.2	21.3	0.6	0.2	0.0	1.3	0.1	0.4	0.6	1.6	1.2	0.6	5.6	0.2	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.2	0.3	0.5	2.8	1.6	3.9	1.3	1.6	2.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
LMO1	"RBTN1, RHOM1, TTG1"	ENSG00000166407	"LIM domain only 1"	P25800	11	8224309-8268716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.8;skeletal muscle: 29.3;tongue: 12.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.5;Distal tubular cells: 27.4;Early spermatids: 60.7;Horizontal cells: 40.4"	"Cancer enriched"	"Detected in many"	6	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 33.8;SCLC-21H: 12.5;SH-SY5Y: 38.5;SiHa: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (3.74e-3)"	"unprognostic (1.45e-1)"		"unprognostic (4.75e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-1)"		"unprognostic (1.98e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.36e-12)"	"unprognostic (1.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.13e-2)"	0.1	1.2	2.4	0.1	2.3	0.0	0.3	4.1	3.4	0.0	1.1	0.2	0.2	0.1	1.6	0.3	0.1	0.0	1.1	3.2	3.2	3.5	0.0	0.0	0.0	5.3	9.8	0.1	0.8	0.0	2.3	0.1	5.2	0.1	0.0	2.0	0.3	0.0	29.3	7.3	0.0	0.2	1.9	0.5	0.7	2.2	5.3	0.0	0.1	12.4	0.0	0.3	0.1	2.4	0.1	0.9	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.1	0.5	0.0	0.0	0.0	1.5	0.0	33.8	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.3	0.0	4.3	0.0	0.0	0.0	0.6	1.4	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	38.5	7.9	4.4	0.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.1	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.3	4.1	3.4	3.2	3.2	5.3	9.8	5.2	1.9	5.3	2.4	0.1	0.0	0.0	3.3	0.0	18.5	0.1	0.3	1.8	7.1	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	27.4	0.1	60.7	0.1	0.1	0.4	0.0	0.0	1.1	1.2	8.4	0.1	0.0	0.5	1.3	0.2	0.0	0.0	0.2	40.4	0.6	0.0	0.0	0.0	0.4	6.8	0.0	0.2	0.0	11.2	0.0	0.5	0.0	3.0	0.3	2.0	1.1	0.4	0.1	0.1	0.0	0.2	2.3	4.0	0.0	0.5	0.7	0.6	1.3	0.3	3.4	0.3	0.0	0.0	0.0	0.0
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 305.6;tongue: 125.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 31.0;Early spermatids: 25.4;Hepatocytes: 17.5;Late spermatids: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	2.8	5.9	17.1	2.6	17.7	3.3	2.3	13.6	21.5	15.1	10.0	14.1	2.7	6.5	3.1	14.7	4.3	3.1	40.7	18.3	14.8	3.7	32.0	4.5	3.1	17.3	15.5	4.3	3.4	3.2	13.2	1.4	18.1	4.6	4.0	4.4	6.3	4.2	305.6	3.5	4.1	6.9	14.4	3.3	5.0	12.5	18.0	7.3	4.4	125.0	5.3	6.2	19.9	17.5	26.1	18.1	16.2	29.7	9.3	6.5	0.1	4.0	14.5	9.2	8.6	17.2	27.7	5.9	13.2	2.4	31.1	9.8	14.3	18.1	8.1	14.7	3.6	3.2	4.6	53.3	8.6	8.2	2.7	2.6	7.0	11.3	5.4	11.2	18.7	34.6	4.0	7.6	8.4	3.6	31.0	8.4	5.3	26.0	46.3	23.8	8.2	14.8	15.1	2.7	32.4	16.2	2.0	2.5	10.9	4.1	3.4	9.2	10.6	6.3	64.7	10.7	8.9	13.6	22.3	9.3	12.6	32.7	1.7	0.0	0.2	0.0	0.4	0.3	0.4	0.1	0.3	0.4	0.6	0.0	1.0	0.4	0.0	0.4	0.1	0.1	0.0	0.3	17.1	17.7	13.6	21.5	18.3	14.8	17.3	15.5	18.1	14.4	18.0	17.5	1.9	0.0	4.6	9.4	1.1	1.5	0.5	0.6	0.0	8.5	1.5	0.6	31.0	2.8	1.3	0.0	4.2	0.1	0.8	0.8	0.0	3.9	25.4	1.1	1.3	2.4	5.4	1.7	10.0	4.7	0.2	2.8	1.5	0.7	0.0	2.5	2.2	17.5	0.5	1.7	10.1	2.0	0.0	0.6	0.7	50.1	3.1	0.8	1.8	1.9	1.2	7.5	1.0	6.6	3.9	5.8	3.1	1.5	1.7	0.8	0.3	1.6	0.6	2.0	0.0	5.2	1.9	8.5	4.8	0.1	0.6	0.0	1.3	1.8	2.1	0.6
LRRC47	"KIAA1185, RP1-286D6.3"	ENSG00000130764	"Leucine rich repeat containing 47"	Q8N1G4	1	3778559-3796498	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008512, HPA012018"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		29000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli fibrillar center"		"HPA008512: AB_1853324, HPA012018: AB_1853322"	"unprognostic (2.25e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.25e-1)"	14.7	17.4	17.5	7.0	17.2	11.7	14.6	15.8	18.3	15.2	15.3	19.8	9.9	18.4	8.6	17.6	16.2	6.3	27.3	17.6	18.0	13.7	23.8	11.2	9.9	19.9	17.1	18.7	23.0	12.2	16.3	9.5	17.7	15.9	6.4	8.2	15.9	11.3	69.9	21.8	14.3	8.5	15.7	15.3	17.4	13.5	17.1	9.4	14.3	25.9	8.2	18.6	14.7	18.6	17.9	20.7	14.7	24.2	15.4	12.3	14.6	15.2	11.6	19.6	15.3	25.6	19.4	18.6	21.8	16.5	15.0	24.4	18.1	18.8	10.7	23.8	33.1	34.1	23.5	28.6	23.8	23.3	12.3	14.6	16.3	19.5	15.5	12.7	14.0	23.6	31.9	5.3	14.4	18.9	25.9	27.1	33.4	17.6	31.3	25.1	14.6	22.2	13.6	13.0	30.5	30.1	19.0	28.3	30.5	14.3	15.4	17.4	19.2	16.2	9.4	24.4	20.0	39.6	39.6	21.1	9.7	31.6	6.6	3.8	2.8	1.5	2.3	3.3	2.4	1.7	2.5	3.6	3.5	1.9	2.9	3.0	1.8	3.1	2.6	3.0	2.6	1.7	17.5	17.2	15.8	18.3	17.6	18.0	19.9	17.1	17.7	15.7	17.1	18.6	18.4	16.0	24.1	10.4	20.5	15.6	16.6	8.0	22.2	32.1	18.7	13.1	62.0	27.1	13.3	27.6	14.6	58.3	30.7	22.6	19.6	13.4	1.6	15.6	19.0	16.7	21.6	18.7	11.4	15.0	39.0	22.0	26.5	14.4	11.4	28.2	21.4	33.1	26.7	38.7	11.6	24.7	10.2	17.9	8.8	3.5	22.1	16.8	8.8	7.5	20.6	31.9	29.9	12.5	12.7	13.7	21.6	23.7	21.6	19.5	25.3	22.5	11.4	20.9	13.1	27.3	23.9	20.4	37.1	26.2	21.6	48.2	20.5	32.4	33.1	13.3
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397908	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	39.2	32.7	53.1	32.0	54.2	23.9	32.8	54.5	67.5	31.9	55.0	62.3	20.1	36.3	30.4	26.8	31.6	22.7	72.9	53.4	58.7	42.3	51.7	30.6	52.3	54.4	55.2	31.7	30.5	36.9	41.8	18.0	55.3	40.8	17.7	9.7	29.1	30.5	165.0	30.1	36.7	27.9	55.2	55.3	38.7	28.9	57.8	27.2	31.0	110.3	47.6	42.8	28.2	54.3	54.6	81.2	29.9	80.7	68.9	67.2	31.0	47.9	69.4	75.1	57.1	36.4	50.6	127.4	64.5	65.0	55.6	29.3	51.2	62.1	49.5	87.1	61.2	64.1	47.1	87.1	83.8	49.0	90.3	56.8	54.4	67.6	47.6	40.7	77.8	71.7	60.2	60.5	53.4	96.3	54.8	55.5	77.5	67.0	83.3	40.9	28.8	86.3	73.6	32.6	38.1	28.7	38.7	49.4	120.6	47.9	25.5	41.3	52.2	34.0	47.3	90.0	76.0	79.5	115.7	102.4	68.4	73.9	78.7	240.2	264.1	340.1	125.3	266.4	139.0	386.4	125.1	132.0	189.4	388.0	112.1	120.7	346.4	111.6	256.4	243.9	172.3	301.8	53.1	54.2	54.5	67.5	53.4	58.7	54.4	55.2	55.3	55.2	57.8	54.3	27.8	12.8	14.4	3.9	82.2	32.2	37.2	53.3	13.1	17.4	40.9	44.4	55.9	21.5	30.4	46.0	6.2	56.1	58.5	23.4	140.8	40.7	9.7	18.6	32.7	31.7	28.2	40.2	8.6	47.1	58.8	36.8	19.4	23.3	41.2	25.7	32.2	66.8	105.7	18.5	9.1	23.4	63.1	77.0	89.3	32.9	38.8	67.6	51.6	7.5	72.0	41.0	66.9	3.5	6.7	47.4	35.3	47.0	67.0	40.3	47.7	106.4	12.4	14.3	13.1	28.4	38.8	7.8	23.4	27.7	40.1	40.0	51.0	43.3	28.5	27.3
LYSMD1	"MGC35223, RP11-68I18.5, SB145"	ENSG00000163155	"LysM domain containing 1"	Q96S90	1	151159748-151165948	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028055, HPA064537"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA028055: AB_10601912, HPA064537: AB_2685281"	"unprognostic (1.71e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.26e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.31e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.47e-3)"	"unprognostic (6.33e-2)"	4.9	7.0	7.4	2.7	7.6	1.1	5.6	9.5	10.1	7.2	6.9	6.8	6.1	6.2	4.2	5.0	7.1	3.4	8.6	7.4	7.4	5.4	6.5	3.3	3.2	7.5	7.0	10.9	4.9	9.8	5.5	7.4	7.7	5.6	5.4	9.6	4.9	6.3	13.8	6.5	4.2	5.9	6.6	4.2	5.8	4.2	7.3	6.2	6.2	13.5	3.3	7.2	6.1	7.8	5.0	5.3	11.4	8.9	6.5	7.2	8.9	7.2	6.2	8.4	7.5	3.4	5.9	6.6	8.6	4.6	4.3	8.6	8.9	5.1	6.2	12.8	9.8	3.8	8.7	3.6	10.2	4.0	6.0	10.1	10.9	7.9	11.2	11.3	3.5	14.9	7.7	6.2	5.8	7.9	10.3	5.0	7.2	5.0	6.8	7.2	8.3	3.9	6.1	2.3	13.6	16.6	5.4	16.4	9.5	14.3	10.0	13.4	3.6	6.4	3.5	4.1	9.6	19.6	16.0	3.1	5.5	1.6	6.2	1.6	0.8	1.4	0.8	0.5	0.9	0.7	1.0	0.5	0.7	1.7	1.3	1.4	3.1	1.3	0.8	1.4	1.5	0.3	7.4	7.6	9.5	10.1	7.4	7.4	7.5	7.0	7.7	6.6	7.3	7.8	2.2	0.0	0.5	3.3	0.3	0.9	0.9	0.8	1.8	4.0	4.1	2.0	8.8	0.0	2.8	5.5	6.2	4.6	0.1	3.4	3.9	1.8	0.3	2.9	5.1	2.0	4.2	3.2	3.1	0.6	3.1	3.0	0.0	2.1	0.0	5.0	3.9	4.2	0.6	1.7	3.4	1.7	2.0	0.0	0.8	0.4	4.4	0.2	1.8	1.0	0.1	3.7	0.0	2.5	4.3	2.2	1.1	6.0	0.3	1.1	3.8	8.2	2.4	8.0	0.0	2.5	3.9	2.0	2.7	1.3	1.1	2.9	0.5	3.0	2.7	1.0
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 743.9"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038149, HPA038150"	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA		880000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	127.4	55.7	475.5	50.4	483.4	16.1	98.0	433.2	406.8	118.0	215.5	193.2	35.1	111.7	69.7	90.7	94.7	52.9	380.9	351.2	408.7	88.3	66.0	105.0	35.0	567.9	490.6	90.0	71.4	31.4	56.1	64.8	509.2	92.7	47.6	149.0	71.4	88.1	743.9	120.6	80.6	94.5	526.1	64.0	93.9	80.0	552.3	42.1	61.1	491.0	37.8	135.5	115.2	533.2	121.9	95.7	117.1	89.3	168.6	298.5	49.5	222.6	241.2	184.1	204.9	81.3	74.4	102.3	50.7	337.9	172.8	79.2	151.4	201.6	204.7	148.7	63.8	69.3	102.8	106.0	228.6	48.6	53.9	251.4	246.4	224.0	271.6	167.1	245.1	70.6	91.2	115.3	146.9	69.1	69.5	58.9	70.9	59.9	195.0	36.6	110.1	128.1	118.2	100.1	46.4	72.3	171.0	68.3	118.6	163.0	50.1	44.8	334.5	172.7	132.3	182.9	144.4	80.4	66.9	47.8	222.2	58.6	167.3	10.5	6.6	3.7	15.6	10.6	7.5	12.3	10.2	12.7	7.1	11.5	4.9	7.6	2.6	13.4	27.3	10.8	13.0	9.7	475.5	483.4	433.2	406.8	351.2	408.7	567.9	490.6	509.2	526.1	552.3	533.2	147.9	70.5	48.2	124.4	45.1	74.8	55.4	53.1	42.7	392.2	34.7	36.2	921.5	48.6	53.4	80.9	625.5	33.8	54.6	43.7	27.4	97.8	116.2	78.2	143.2	110.4	28.8	21.6	63.7	65.3	81.0	105.5	39.8	93.4	27.8	81.6	50.0	57.3	38.0	47.1	71.2	31.7	34.6	28.3	50.5	38.8	77.0	40.0	78.2	95.5	72.0	82.8	47.4	77.9	167.2	92.0	28.0	103.0	47.2	89.0	37.1	39.2	43.6	97.5	72.3	149.0	119.0	65.6	64.3	58.7	69.6	22.4	60.5	137.4	39.5	44.7
MAP7D1	"FLJ10350, FLJ39022, PARCC1, RPRC1"	ENSG00000116871	"MAP7 domain containing 1"	Q3KQU3	1	36155579-36180849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 286.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028075	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA028075: AB_10603778"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (6.00e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.32e-3)"	67.9	23.2	41.7	41.5	60.7	36.2	47.1	50.7	52.2	38.9	0.4	84.1	18.9	50.0	3.9	48.8	34.8	28.8	122.4	40.8	43.5	21.8	7.7	53.2	25.0	74.7	58.2	24.8	14.7	12.5	36.5	24.0	78.4	39.5	9.4	13.0	33.5	28.2	286.0	71.6	31.4	34.0	23.3	33.5	39.3	12.6	67.3	22.6	33.1	106.5	17.6	62.1	41.2	96.2	104.8	60.3	92.7	58.9	55.6	41.9	68.3	102.3	102.8	105.4	92.5	33.9	104.6	43.8	85.7	93.5	57.7	112.3	38.3	139.1	34.4	74.9	34.4	29.7	42.5	13.2	87.3	44.0	73.3	73.4	38.6	142.6	87.8	81.5	72.9	59.8	29.1	65.3	59.3	21.0	81.6	37.2	84.7	14.7	33.5	83.8	68.4	41.5	53.0	35.7	35.7	68.6	58.7	32.3	79.6	49.7	21.6	30.9	138.3	123.6	94.4	105.5	140.6	64.4	20.6	52.5	105.8	29.7	75.9	0.1	0.4	0.4	0.3	0.2	0.4	0.0	0.2	0.2	0.2	0.1	0.5	0.2	1.4	0.1	0.1	0.2	0.1	0.0	41.7	60.7	50.7	52.2	40.8	43.5	74.7	58.2	78.4	23.3	67.3	96.2	40.6	44.8	14.4	12.1	26.5	143.1	147.3	18.4	47.8	35.4	44.0	26.3	172.6	17.2	17.9	23.9	10.4	48.3	58.2	39.9	17.6	43.3	36.9	32.1	38.6	46.7	10.1	16.2	17.4	27.4	111.3	48.0	29.6	60.1	12.7	56.3	30.7	9.7	69.9	48.8	35.1	14.9	10.2	40.6	125.3	77.1	30.7	65.1	32.0	9.4	35.9	32.3	75.2	9.5	62.3	66.1	29.2	47.8	53.2	98.5	63.0	14.3	10.0	39.8	19.7	51.6	55.8	17.6	16.1	62.7	141.8	130.2	59.8	17.0	19.5	157.6
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261716	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 279.7;tongue: 120.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.1;Astrocytes: 22.9;Endothelial cells: 15.8;Hepatic stellate cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 31.6"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	11.0	2.3	15.6	3.8	16.5	1.3	7.9	15.5	21.2	11.4	9.2	4.7	3.5	19.0	9.8	6.3	11.2	4.4	15.7	15.1	16.5	10.7	1.4	6.8	4.1	17.1	14.9	10.6	1.8	4.3	25.1	4.1	14.6	10.0	1.1	1.4	4.3	6.9	279.7	1.5	4.4	8.6	14.6	4.3	5.0	4.6	15.2	0.9	3.2	120.9	1.4	6.0	5.9	13.9	23.2	13.9	5.3	16.3	12.4	13.5	7.5	17.5	15.1	28.2	18.3	19.6	7.2	45.1	23.4	19.6	16.8	15.4	24.3	3.4	5.5	12.8	34.0	29.2	46.7	24.9	37.7	28.4	54.5	29.8	6.0	7.2	0.0	16.8	33.2	4.0	26.3	38.5	13.4	12.8	0.0	35.4	15.9	7.6	22.5	41.4	14.2	43.9	17.5	3.0	18.0	6.5	13.3	0.5	22.1	4.2	7.1	29.6	18.7	28.5	26.1	6.6	11.2	9.3	7.3	24.5	7.2	24.7	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.6	16.5	15.5	21.2	15.1	16.5	17.1	14.9	14.6	14.6	15.2	13.9	23.1	0.0	3.2	22.9	1.6	0.8	0.7	3.3	1.2	5.5	1.2	1.3	8.8	4.3	0.8	0.0	0.0	0.3	0.9	0.3	1.9	0.5	0.3	0.6	10.0	15.8	1.8	1.7	9.8	0.0	2.8	5.3	2.6	0.7	10.8	0.6	20.7	0.9	6.3	1.7	6.5	0.2	8.2	2.2	0.8	1.9	6.5	2.2	0.0	6.5	0.6	8.1	0.0	5.0	0.9	0.5	0.0	3.8	2.8	3.6	0.4	8.0	0.9	2.2	6.6	3.3	3.0	0.7	12.1	0.8	0.6	0.4	2.2	3.2	0.3	0.2
MAPRE3	"EB3, RP3"	ENSG00000084764	"Microtubule associated protein RP/EB family member 3"	Q9UPY8	2	26970637-27027219	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 146.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 428.2;Late spermatids: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009263	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA009263: AB_1078716"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	24.0	23.1	100.7	7.3	102.4	1.3	23.6	73.5	133.2	26.6	50.8	25.4	7.2	24.8	10.4	12.2	42.2	12.6	45.2	108.8	105.2	30.4	37.6	17.8	5.9	94.4	82.9	46.1	14.7	36.8	101.7	10.8	98.1	26.1	9.8	70.5	18.3	15.0	146.6	43.3	10.5	12.9	66.5	15.8	23.2	56.4	107.0	7.6	24.4	56.8	6.5	22.0	19.0	95.8	19.8	15.2	13.6	24.0	24.4	13.5	3.9	15.3	12.2	12.7	12.9	5.7	25.8	0.0	14.4	19.1	33.5	10.1	7.6	16.3	7.5	16.5	18.7	2.9	8.1	1.3	22.4	2.3	36.5	11.1	28.5	6.4	11.9	34.6	3.1	1.7	19.4	15.1	7.7	9.0	0.1	1.0	6.0	69.2	23.9	0.1	0.3	2.0	8.8	13.0	34.4	17.0	10.6	7.5	11.0	8.9	8.0	1.4	3.3	11.1	11.4	16.0	13.7	11.5	4.4	0.1	39.9	1.5	22.6	0.2	1.3	0.3	0.7	1.4	0.4	0.6	0.3	0.2	0.8	0.3	0.5	0.1	3.5	0.5	1.7	0.0	0.1	0.7	100.7	102.4	73.5	133.2	108.8	105.2	94.4	82.9	98.1	66.5	107.0	95.8	13.7	3.2	2.8	25.8	2.6	8.8	21.8	15.2	11.4	44.0	6.4	8.8	8.3	5.7	6.6	3.7	25.0	1.4	1.6	32.3	17.6	11.5	428.2	64.7	11.2	5.5	25.1	2.5	43.7	4.6	4.6	11.2	11.2	4.1	38.1	13.8	14.3	8.6	2.1	58.9	45.0	1.9	18.3	2.8	4.5	311.4	12.8	4.6	7.2	5.6	0.8	69.3	4.1	26.2	27.4	12.0	8.4	11.7	2.7	9.6	0.2	6.8	48.8	44.6	32.9	10.2	14.0	21.0	14.4	6.5	13.8	18.9	3.4	38.6	3.0	15.0
MAU2	"KIAA0892, mau-2, MAU2L, MGC75361, SCC4"	ENSG00000129933	"MAU2 sister chromatid cohesion factor"	Q9Y6X3	19	19320829-19358754	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059897			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA059897: AB_2684154"	"unprognostic (3.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.57e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-3)"	"unprognostic (5.56e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	16.2	15.9	15.9	12.6	19.1	21.2	15.8	16.4	19.4	18.8	15.1	17.9	13.1	18.4	11.8	20.2	18.4	10.6	19.6	15.1	15.2	15.1	14.3	14.2	14.6	20.1	17.4	23.4	16.5	13.4	21.1	12.2	18.7	17.6	7.6	10.9	15.5	12.1	36.0	21.7	16.5	11.2	15.7	22.2	15.0	19.7	17.6	17.4	17.0	17.6	12.0	16.5	17.2	26.1	13.6	10.4	18.0	16.1	14.5	15.1	24.9	12.7	12.9	16.8	15.1	14.8	18.9	16.9	26.7	13.7	8.5	15.9	15.5	12.8	7.8	9.0	39.3	13.0	16.5	13.2	16.8	23.7	19.5	16.7	14.4	12.1	13.8	17.4	16.3	15.0	18.0	20.3	11.3	15.5	24.3	32.5	15.8	18.7	29.1	27.1	11.6	18.2	11.8	17.6	26.0	23.8	15.7	16.2	16.1	9.1	14.0	32.9	14.8	25.9	6.0	25.7	19.3	26.1	23.5	16.9	12.8	24.8	19.9	3.1	5.8	4.3	6.0	5.0	6.8	4.6	5.3	5.7	5.1	4.5	5.6	5.4	10.4	6.5	11.1	4.9	5.4	6.1	15.9	19.1	16.4	19.4	15.1	15.2	20.1	17.4	18.7	15.7	17.6	26.1	16.4	19.2	18.3	33.6	17.3	6.2	5.5	8.5	18.8	30.4	13.1	15.2	19.1	11.5	10.5	11.0	54.2	10.4	16.4	15.8	3.9	8.2	9.7	16.5	17.0	13.4	14.4	17.4	26.1	9.4	7.1	13.0	15.8	14.5	10.1	26.0	14.6	8.6	8.8	50.5	31.8	11.9	4.1	13.8	6.4	12.3	15.2	13.9	10.6	14.0	15.4	12.0	20.6	26.7	55.3	11.8	10.7	13.9	12.8	10.5	13.7	6.2	21.0	29.3	6.6	17.2	14.8	31.9	12.6	11.8	9.7	15.2	13.6	21.1	13.1	8.6
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria		NA	NA		600000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	14.2	12.5	13.0	11.5	16.0	10.3	13.0	13.9	13.6	11.6	14.1	19.4	14.8	12.0	8.4	14.9	13.2	6.7	21.3	12.1	11.5	15.8	15.5	13.3	9.9	18.6	15.7	16.8	17.6	15.4	12.1	9.4	15.9	14.2	15.4	8.1	13.0	10.3	37.5	18.9	16.9	9.6	14.0	14.3	15.4	4.9	16.1	10.4	14.0	29.2	10.8	14.3	11.0	16.6	31.6	36.0	14.3	17.9	38.8	26.2	11.2	18.7	23.8	19.5	14.2	28.4	19.9	13.6	11.1	26.4	55.6	38.7	17.3	28.0	19.9	8.4	8.4	26.3	14.6	45.5	21.4	16.6	10.6	26.7	23.4	33.2	19.6	19.4	20.1	17.6	30.2	10.1	19.3	28.5	25.3	14.1	9.2	15.7	19.6	18.8	19.9	13.7	20.8	31.2	10.7	11.2	21.3	41.0	18.1	20.3	21.9	15.3	30.5	26.5	9.7	31.7	22.1	20.7	26.6	9.4	10.5	20.1	13.7	1.7	2.1	2.0	1.4	1.6	1.0	1.1	1.1	1.1	1.4	1.3	1.2	1.2	1.9	1.8	1.9	1.7	0.9	1.6	13.0	16.0	13.9	13.6	12.1	11.5	18.6	15.7	15.9	14.0	16.1	16.6	16.6	57.7	48.5	24.8	17.3	2.2	13.9	3.7	19.4	34.0	19.9	13.2	61.0	58.6	21.7	29.5	16.7	33.6	22.5	100.0	13.7	25.9	1.1	16.1	27.5	26.8	34.7	17.1	13.6	30.5	27.5	22.8	25.0	16.6	8.8	36.5	44.3	45.7	25.5	45.4	15.9	32.6	2.0	37.7	2.9	3.2	30.7	20.7	1.8	15.9	32.4	20.7	20.6	12.5	19.9	32.7	29.5	28.2	14.2	18.1	42.8	19.6	16.2	33.7	32.9	26.2	17.5	6.2	4.1	15.6	2.0	18.1	16.7	27.5	57.9	16.6
METTL2A	"FLJ12760, METTL2"	ENSG00000087995	"Methyltransferase like 2A"	Q96IZ6	17	62423875-62453385	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (1.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.33e-3)"	"unprognostic (6.86e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.00e-1)"	2.5	3.5	2.7	2.3	2.6	1.9	2.6	3.2	3.0	1.8	2.9	3.1	1.8	2.5	2.4	3.1	2.5	1.7	3.7	2.8	2.9	2.5	3.0	2.3	2.5	2.5	2.5	2.7	3.7	2.6	1.8	2.0	2.6	2.2	2.6	2.7	2.8	1.2	6.4	3.9	2.4	1.9	2.4	2.5	2.9	1.7	2.7	1.8	3.2	2.8	2.4	2.1	2.1	3.0	3.9	3.8	5.3	8.5	2.9	3.7	4.2	4.2	2.6	4.2	2.7	2.6	3.7	4.6	2.2	2.9	1.7	4.2	9.2	4.3	5.7	4.4	7.6	9.2	3.1	3.0	4.8	11.2	4.0	3.4	5.2	2.8	5.4	3.6	2.4	5.9	9.5	4.3	3.8	4.9	11.9	5.1	7.1	5.0	5.1	7.8	15.5	4.4	3.6	4.4	5.4	12.2	2.4	4.9	6.3	2.3	9.9	6.6	5.3	4.5	5.8	4.2	6.8	5.2	6.4	5.7	7.8	6.1	5.7	1.8	1.0	0.9	1.9	1.0	1.6	1.4	1.5	1.5	0.6	1.9	1.4	1.8	2.1	2.4	1.1	1.7	1.5	0.8	2.7	2.6	3.2	3.0	2.8	2.9	2.5	2.5	2.6	2.4	2.7	3.0	10.9	25.6	12.1	4.2	9.2	9.2	17.0	21.5	7.4	17.0	9.1	9.1	11.1	12.8	20.3	12.9	18.8	21.8	9.2	11.1	23.5	19.3	9.7	10.8	11.6	9.0	7.2	9.4	6.8	14.5	14.3	10.3	10.7	11.4	3.8	14.9	7.1	10.8	13.0	5.0	7.1	9.8	10.2	4.4	8.1	5.3	5.0	5.4	3.6	0.0	6.9	14.5	12.3	4.5	5.7	16.0	15.6	13.2	17.7	20.9	8.5	15.0	19.7	16.4	13.1	13.4	11.6	23.3	11.8	11.9	14.2	15.7	8.9	17.2	15.3	24.0
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAPK interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 475.7;tongue: 551.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 367.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	87.2	50.2	70.5	51.3	78.0	133.6	39.5	109.2	131.2	41.9	80.6	55.2	47.4	24.7	47.8	114.5	38.1	26.7	54.8	67.2	65.4	27.6	71.2	51.8	66.8	80.3	70.7	34.5	191.9	34.5	39.6	35.3	74.6	38.6	30.0	35.7	133.8	39.7	475.7	63.8	57.3	21.8	68.2	80.2	55.1	21.6	75.7	34.5	54.6	551.1	58.6	39.9	60.9	91.0	64.9	71.8	30.1	66.3	219.5	79.0	65.1	37.3	27.1	26.5	26.8	45.5	111.8	88.2	50.7	77.4	27.9	78.4	38.4	110.9	12.0	122.1	34.4	36.8	62.1	49.2	367.4	72.3	61.6	84.1	262.0	50.8	107.2	61.9	63.5	59.2	62.0	155.4	18.6	37.7	42.8	59.3	78.6	49.6	78.1	81.8	8.6	113.1	48.1	41.2	39.9	48.2	89.0	125.1	166.4	33.5	52.7	89.5	96.5	9.5	37.5	38.5	46.0	238.9	97.0	85.7	78.2	53.5	17.9	4.4	9.2	9.8	8.1	10.2	7.5	16.9	8.4	9.4	7.7	15.0	5.4	6.6	41.7	9.5	13.6	9.2	12.5	3.6	70.5	78.0	109.2	131.2	67.2	65.4	80.3	70.7	74.6	68.2	75.7	91.0	102.2	38.5	56.5	9.8	91.4	82.5	105.6	84.5	50.1	55.7	99.0	103.5	54.5	38.6	65.5	36.8	25.0	23.5	106.5	155.3	9.8	27.3	8.7	60.2	28.0	51.9	150.2	80.2	5.6	56.6	47.2	45.0	57.6	76.2	29.2	14.5	82.5	60.3	36.9	42.1	5.9	104.1	46.8	52.5	134.6	13.0	20.2	68.0	56.9	8.4	41.8	63.6	30.9	6.0	5.2	47.2	86.6	20.3	55.4	94.2	98.8	18.6	55.2	47.5	19.7	132.6	48.7	18.1	19.5	97.8	117.2	56.5	69.3	18.1	79.7	114.0
MN1	"MGCR, MGCR1, MGCR1-PEN"	ENSG00000169184	"MN1 proto-oncogene, transcriptional regulator"	Q10571	22	27748277-27801756	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.7;skeletal muscle: 61.6;tongue: 42.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.1;Early spermatids: 22.3;Fibroblasts: 13.9;Langerhans cells: 11.2;Late spermatids: 15.2;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 30.7;HeLa: 12.7;hTERT-RPE1: 13.7;RH-30: 12.4;TIME: 20.1;U-2 OS: 16.3;U-2197: 17.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003072	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003072: AB_1079399"	"unprognostic (5.64e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.13e-7)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.21e-4)"	4.1	0.8	6.0	1.6	20.7	1.3	2.3	6.4	9.5	2.2	0.5	6.1	0.8	2.7	1.0	3.6	4.3	3.0	6.7	1.9	5.3	0.9	0.4	3.3	0.1	4.3	13.0	9.6	0.7	0.1	2.7	1.3	6.8	2.3	0.9	1.8	2.7	1.2	61.6	1.8	2.1	2.5	2.1	0.4	4.0	0.8	8.5	0.3	2.1	42.6	0.7	3.3	3.5	3.1	0.0	1.5	30.7	0.9	0.6	1.3	0.0	0.7	1.1	0.0	0.0	0.0	0.1	0.0	3.1	5.7	1.3	2.7	1.5	1.8	0.0	0.0	0.8	0.0	12.7	0.0	0.7	0.0	0.3	0.1	3.5	0.7	3.0	13.7	0.3	0.0	0.0	0.2	1.0	0.0	0.0	0.4	4.0	0.0	2.8	5.3	12.4	0.0	0.4	0.0	0.1	0.4	2.7	0.0	0.0	7.5	0.3	0.1	20.1	1.0	16.3	17.9	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.0	20.7	6.4	9.5	1.9	5.3	4.3	13.0	6.8	2.1	8.5	3.1	2.1	3.2	2.3	12.1	0.3	4.2	0.1	2.6	3.4	8.4	1.8	0.6	7.4	1.5	0.7	0.0	0.0	0.1	0.2	0.0	0.0	1.4	22.3	1.4	1.0	6.6	0.0	0.0	6.4	1.0	0.1	13.9	0.5	3.1	0.0	0.6	2.5	0.6	0.3	0.0	9.6	0.0	2.0	1.4	11.2	15.2	5.0	2.7	0.0	2.8	0.3	3.9	0.0	13.0	4.3	2.8	0.0	10.1	1.3	0.2	0.0	0.1	0.1	0.7	0.0	2.4	2.3	0.4	1.1	1.9	2.7	0.0	0.3	0.4	0.0	0.2
MNAT1	"MAT1, RNF66"	ENSG00000020426	"MNAT1 component of CDK activating kinase"	P51948	14	60734742-60969965	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 365.2;Inhibitory neurons: 223.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000701, HPA001154, CAB004495"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212"	"unprognostic (4.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.34e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.14e-3)"	21.5	20.4	25.0	9.5	26.9	14.0	25.8	27.8	31.6	21.0	16.7	18.5	8.8	18.1	18.9	16.8	24.7	14.1	21.0	25.3	26.0	27.0	23.5	14.3	13.5	22.9	22.9	22.4	14.7	55.3	22.2	16.0	22.2	20.8	12.7	29.2	25.7	15.7	79.9	13.0	10.7	19.3	21.3	11.6	16.8	12.2	27.2	26.1	18.3	65.3	17.3	19.8	16.4	28.7	203.9	38.5	47.0	33.3	53.5	58.6	51.3	73.1	78.4	87.5	70.2	30.9	69.4	48.6	53.9	53.9	47.3	63.2	53.0	84.1	124.7	61.0	55.0	32.9	36.2	45.9	66.4	77.0	16.8	36.0	60.5	56.5	62.1	84.1	84.6	69.6	49.6	45.3	98.5	69.5	48.2	48.2	25.8	38.3	85.1	49.4	127.9	30.9	102.9	94.3	41.9	28.5	56.0	46.6	71.7	54.0	72.2	37.0	64.9	66.8	70.7	31.8	55.6	19.7	17.8	70.4	53.9	12.9	49.4	12.2	6.1	22.3	14.3	8.6	14.7	26.9	15.3	15.3	11.9	19.8	17.6	17.8	0.5	34.6	10.1	46.6	13.6	6.6	25.0	26.9	27.8	31.6	25.3	26.0	22.9	22.9	22.2	21.3	27.2	28.7	30.1	32.1	25.5	91.1	31.1	24.9	59.4	88.3	23.3	43.0	28.0	35.6	58.4	22.8	50.8	29.5	31.3	50.6	51.1	6.1	80.3	35.2	6.1	85.6	34.6	28.9	17.4	14.5	365.2	44.5	36.3	33.9	25.5	60.4	32.9	23.3	18.5	23.3	20.2	23.5	223.4	13.8	52.9	6.9	10.7	6.9	30.1	13.3	14.2	119.9	12.6	50.3	44.3	196.6	148.1	59.3	9.3	30.5	30.1	48.1	4.3	74.3	81.4	59.2	52.6	77.5	52.2	50.9	41.2	26.6	18.2	36.0	35.3	26.9	16.0	44.2
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	32.3	19.6	34.7	19.2	36.3	24.2	28.3	37.8	39.7	27.4	36.2	61.1	18.0	30.7	36.5	51.9	34.4	27.8	43.5	35.3	36.5	18.6	20.0	24.7	26.8	36.1	36.8	28.1	32.8	34.9	11.2	25.7	36.5	32.5	34.8	14.6	35.2	42.3	50.9	50.0	28.6	49.0	36.1	25.1	27.9	14.2	37.1	34.1	24.2	70.4	27.0	39.9	31.6	37.8	29.3	31.2	18.3	15.7	44.2	30.8	17.1	22.5	30.9	40.4	31.8	20.1	39.0	20.9	16.7	50.6	26.0	34.8	28.1	48.6	24.3	28.8	44.3	16.0	11.7	26.2	30.2	21.2	24.2	25.1	57.9	21.9	25.3	32.7	43.6	27.0	26.3	21.2	20.7	20.6	27.4	37.7	23.0	54.3	29.4	19.9	19.0	22.2	34.4	26.9	34.6	37.3	27.3	34.0	27.9	23.0	15.9	21.3	37.7	25.6	13.1	8.3	14.5	21.6	22.3	21.8	17.9	20.3	19.8	9.7	8.7	11.9	16.2	9.2	13.6	8.1	14.1	13.7	10.6	11.0	11.6	10.2	7.1	12.1	13.4	7.5	15.3	10.6	34.7	36.3	37.8	39.7	35.3	36.5	36.1	36.8	36.5	36.1	37.1	37.8	84.8	6.4	10.0	6.5	20.2	82.2	30.1	39.4	12.0	18.4	27.8	33.3	14.8	12.8	18.4	7.3	12.5	31.1	64.5	58.6	27.4	33.5	24.3	18.9	17.7	58.2	20.9	36.2	15.2	38.5	31.0	23.3	16.8	29.2	24.8	20.3	33.9	9.0	26.4	43.7	10.9	32.8	32.6	18.2	39.3	12.1	23.9	28.1	56.9	11.2	29.4	21.5	81.4	6.6	14.8	39.6	63.2	51.1	17.0	48.6	54.3	23.9	12.9	21.4	85.5	20.8	68.3	29.8	41.1	13.7	82.0	59.4	36.4	20.2	27.7	37.6
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	227.9	291.8	348.2	126.4	355.0	108.2	209.1	360.6	382.1	222.2	330.6	254.2	147.1	254.8	207.9	189.0	221.4	134.3	260.4	335.9	359.7	266.1	245.3	203.4	114.8	409.8	362.8	243.2	156.1	260.7	262.1	194.2	367.5	193.0	132.7	165.7	164.8	207.0	372.3	179.8	163.4	215.1	358.3	181.3	196.1	154.7	359.7	131.0	177.7	308.2	132.8	220.3	194.6	389.3	344.4	371.8	311.7	360.9	373.9	336.6	245.7	444.2	407.3	401.1	398.9	368.7	362.7	214.4	333.0	411.9	455.0	192.2	425.4	462.3	482.5	85.4	306.6	319.6	430.5	405.8	349.7	241.6	151.2	351.0	416.2	369.2	371.6	380.2	452.2	185.9	427.9	136.4	401.2	432.5	182.2	565.1	387.7	297.6	472.6	233.6	564.5	182.3	490.3	255.6	488.0	381.6	287.7	204.2	429.7	270.4	569.8	291.2	408.6	350.3	235.2	262.6	592.2	196.8	266.4	351.5	362.5	507.6	347.7	202.0	186.2	163.2	126.9	154.0	127.9	89.4	125.3	127.0	177.8	94.8	127.8	126.3	198.6	137.1	153.1	143.8	147.1	196.4	348.2	355.0	360.6	382.1	335.9	359.7	409.8	362.8	367.5	358.3	359.7	389.3	141.8	160.3	158.9	14.4	84.7	188.5	262.6	155.6	130.9	113.9	148.6	155.2	227.0	163.0	124.4	88.3	16.7	547.5	103.7	83.8	219.2	241.8	43.1	161.8	184.2	196.4	178.1	123.1	18.7	204.2	312.7	197.2	69.8	166.8	150.4	141.4	171.4	179.7	200.4	111.0	20.9	129.7	130.2	144.4	114.1	65.1	314.0	106.8	126.3	12.2	158.5	270.7	113.3	12.5	33.7	189.0	121.3	304.6	61.1	257.3	168.0	252.6	126.0	111.5	216.9	230.7	197.7	349.3	211.8	126.3	173.8	322.2	121.4	337.1	138.3	236.7
MRPL10	"L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8"	ENSG00000159111	"Mitochondrial ribosomal protein L10"	Q7Z7H8	17	47823272-47831541	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021234, HPA029885"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA021234: AB_1854098, HPA029885: AB_2673233"	"unprognostic (6.84e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.87e-2)"	32.1	32.8	35.6	14.4	36.6	24.7	29.7	36.9	39.7	30.1	33.2	40.9	25.6	31.4	22.8	27.1	29.8	21.9	58.1	34.9	36.7	31.2	29.9	20.1	26.2	36.5	36.0	48.8	41.0	28.9	17.3	23.2	36.2	24.8	23.1	21.7	22.1	25.5	64.2	23.8	26.7	26.5	35.7	28.2	36.2	20.1	37.4	25.9	23.1	52.4	26.9	37.9	25.4	36.8	36.8	80.0	33.4	33.0	78.3	71.3	61.6	32.2	54.0	54.2	46.4	155.7	49.2	59.1	71.9	42.0	36.0	33.6	48.3	62.6	48.0	57.6	76.4	47.2	41.7	110.0	67.4	42.8	25.5	80.8	53.2	64.4	90.7	63.7	52.9	58.4	64.8	56.6	42.3	73.3	43.2	55.0	55.1	64.0	76.5	34.7	63.7	66.5	59.9	35.8	39.2	63.2	23.9	26.9	68.7	62.9	81.2	45.5	32.3	47.5	39.0	32.3	45.1	100.1	82.4	48.0	41.4	32.3	32.4	29.8	37.3	18.5	61.6	39.6	59.1	31.8	42.4	55.3	43.0	36.6	35.6	42.2	14.5	26.6	32.9	26.0	52.5	42.0	35.6	36.6	36.9	39.7	34.9	36.7	36.5	36.0	36.2	35.7	37.4	36.8	17.1	6.4	13.6	4.2	19.2	12.5	20.8	42.5	27.9	15.3	25.3	31.5	31.5	20.0	19.5	14.7	6.2	90.5	50.9	17.9	46.9	43.8	22.0	7.9	16.3	21.7	8.5	30.3	5.4	54.7	60.0	23.3	20.4	11.0	8.8	31.8	20.7	15.6	41.7	32.0	6.6	20.7	32.6	31.4	10.8	30.5	24.5	17.3	16.0	2.8	31.8	24.4	44.3	7.1	8.2	40.4	14.7	24.0	22.8	18.4	30.8	47.5	6.1	13.7	6.6	17.5	28.0	23.2	29.2	24.1	12.5	77.3	48.5	49.4	31.9	18.8
MTLN	"LEMP, LINC00116, MOXI, MPM, NCRNA00116, SMIM37"	ENSG00000175701	Mitoregulin	Q8NCU8	2	110211529-110245420	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 229.3;skeletal muscle: 784.7;tongue: 280.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 27.4;Cytotrophoblasts: 43.7;Extravillous trophoblasts: 32.8;Hofbauer cells: 78.4;Syncytiotrophoblasts: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (3.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.49e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.08e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.95e-2)"	66.5	68.9	67.3	22.2	71.2	10.1	51.1	80.5	103.8	42.0	63.5	73.9	41.6	58.0	52.1	63.5	41.6	9.2	229.3	68.8	77.2	69.8	78.0	40.2	15.9	75.8	71.4	33.6	46.2	37.0	41.3	12.9	75.6	48.6	12.4	11.0	43.9	34.0	784.7	44.6	46.8	16.7	70.4	44.4	57.3	25.7	78.1	18.5	48.0	280.3	12.0	55.7	46.1	75.6	0.4	125.0	13.3	15.3	14.7	17.5	81.1	49.9	38.6	58.7	39.2	86.0	39.7	16.9	95.0	13.8	81.4	52.9	13.2	57.5	9.6	72.0	51.4	10.1	30.5	73.3	61.2	35.6	50.3	45.6	67.8	48.8	0.0	31.8	52.9	50.2	28.6	40.6	28.1	130.0	49.8	121.6	34.1	39.9	36.9	5.5	28.0	51.9	37.2	77.9	29.5	19.4	27.7	95.2	57.1	8.9	26.4	59.2	41.0	57.7	81.3	56.9	75.9	67.8	48.0	5.3	60.0	56.1	42.1	9.6	101.9	13.8	109.6	112.1	125.1	104.0	123.5	118.7	110.6	115.0	129.1	129.1	5.6	85.9	67.6	150.2	119.0	77.4	67.3	71.2	80.5	103.8	68.8	77.2	75.8	71.4	75.6	70.4	78.1	75.6	27.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	8.7	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	32.8	11.8	0.0	0.0	0.0	0.0	0.0	0.0	78.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	20.2	1.5	0.0	0.0	0.0
MTRNR2L4		ENSG00000232196	"MT-RNR2 like 4"	P0CJ71	16	3370979-3372668	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 293.5"	"Cell type enriched"	"Detected in some"	14	"Cardiomyocytes: 154.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 168.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 168.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 48.8;HaCaT: 51.3;HeLa: 88.0"														"Secreted to blood"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (8.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	18.0	52.7	25.5	10.8	25.5	9.4	2.4	27.1	54.2	1.1	25.6	14.7	20.7	4.7	2.2	10.8	2.3	3.4	66.0	28.2	25.6	31.8	17.1	5.7	3.8	27.7	25.5	4.8	13.8	1.7	0.3	6.4	26.8	7.3	9.1	7.3	17.0	2.8	293.5	9.7	21.7	3.4	25.7	9.1	19.1	12.2	25.7	0.2	1.8	3.2	3.3	1.4	0.1	26.9	13.8	8.8	2.6	48.8	1.1	1.6	15.0	7.3	0.4	0.9	0.7	4.2	28.7	10.2	14.5	0.4	0.3	51.3	0.1	0.5	0.4	7.8	5.0	9.0	88.0	36.6	0.2	3.0	23.5	1.0	0.7	0.2	0.5	1.1	0.1	1.1	6.9	13.6	1.5	3.0	6.4	23.8	4.0	0.5	1.7	11.6	6.9	9.2	2.1	10.2	5.7	13.0	4.6	11.6	19.1	0.8	16.1	22.7	6.6	15.4	13.5	18.0	5.3	7.1	2.5	9.7	10.6	22.8	3.7	62.3	25.6	72.1	4.9	12.9	5.5	14.3	6.2	6.4	11.1	16.5	6.9	8.7	168.2	8.6	13.4	13.4	7.7	23.3	25.5	25.5	27.1	54.2	28.2	25.6	27.7	25.5	26.8	25.7	25.7	26.9	0.2	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	0.2	0.1	154.2	2.8	0.0	1.8	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.1	0.2	3.1	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.5	0.0	0.6	0.7	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.8	0.0	10.4	0.0	0.0	0.0	2.5	3.3	1.0	0.3	0.0	0.3	0.1	0.4	0.1	0.0	1.4
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli, Microtubules"		"HPA067903: AB_2685921, HPA069795: AB_2686198"	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	52.9	39.0	65.6	13.4	100.4	0.3	45.0	97.4	81.7	34.5	59.3	36.6	32.6	31.4	22.6	38.0	28.7	37.9	85.6	66.0	76.9	26.2	56.8	40.4	9.0	106.4	90.8	51.4	98.2	65.2	22.9	70.0	104.2	31.9	39.1	56.9	49.9	24.7	106.2	26.0	33.4	38.2	75.7	16.1	42.2	12.2	87.6	22.8	27.3	167.4	14.5	35.8	31.0	151.1	21.9	115.7	18.5	100.1	0.1	0.6	33.2	1.1	7.8	0.6	2.3	8.7	7.8	2.8	8.5	0.0	4.8	22.2	30.8	10.9	1.1	15.8	13.2	0.0	19.2	55.8	6.6	0.0	0.4	9.1	16.4	2.4	33.3	0.0	296.8	7.7	0.0	43.3	0.1	5.7	4.4	5.7	26.5	44.1	2.9	0.1	17.0	11.5	5.9	44.4	9.2	2.2	14.8	26.6	84.7	11.0	19.2	0.3	61.4	0.1	24.0	0.1	0.2	5.9	3.5	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	65.6	100.4	97.4	81.7	66.0	76.9	106.4	90.8	104.2	75.7	87.6	151.1	408.9	70.5	281.0	139.1	2.9	21.0	56.4	38.9	58.1	0.0	42.7	31.6	141.6	55.8	88.4	20.2	0.0	23.8	1.6	58.5	11.7	50.1	18.5	71.4	53.8	154.5	15.0	0.0	6.1	174.2	40.0	83.8	94.8	144.2	9.5	7.6	29.3	71.2	58.2	0.0	81.8	47.3	22.4	4.1	16.1	24.5	76.4	9.0	28.4	174.3	2.7	0.0	2.1	39.2	469.2	56.5	19.1	57.2	15.3	77.9	52.4	10.4	49.4	0.0	19.7	69.7	60.1	2.4	8.3	45.3	20.3	54.0	7.1	79.8	49.3	81.3
MUSTN1	Mustang	ENSG00000272573	"Musculoskeletal, embryonic nuclear protein 1"	Q8IVN3	3	52833114-52835019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1689.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Skeletal myocytes: 1.0;Smooth muscle cells: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;Hep G2: 8.0;HSkMC: 4.8;RH-30: 4.4"															NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.79e-2)"	"unprognostic (3.73e-2)"			"unprognostic (4.11e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.88e-2)"	86.1	10.1	107.0	9.3	118.7	6.5	46.4	106.9	177.9	89.1	105.7	27.2	8.4	44.6	49.0	44.9	52.1	42.5	142.5	104.2	105.8	17.5	12.5	31.0	5.4	107.2	107.4	37.6	6.6	1.6	12.1	4.5	110.3	43.8	21.2	0.8	26.3	59.3	1689.2	28.7	26.7	30.6	99.9	10.9	22.1	4.3	118.5	5.7	31.1	305.6	3.9	54.5	65.7	105.1	0.0	0.0	4.7	0.0	0.5	2.1	1.9	0.0	0.5	0.2	0.5	0.0	0.5	0.0	0.0	1.4	0.2	0.4	0.6	1.3	0.4	0.1	0.5	0.0	1.4	8.0	0.3	1.0	0.4	4.8	1.0	0.6	0.7	0.9	1.2	0.9	0.0	0.0	0.3	0.1	0.4	1.6	0.1	0.6	1.0	0.3	4.4	0.0	0.9	0.0	0.2	0.3	0.3	0.4	0.4	2.0	0.1	2.6	0.0	0.6	0.2	1.0	0.2	0.0	0.0	0.3	0.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	107.0	118.7	106.9	177.9	104.2	105.8	107.2	107.4	110.3	99.9	118.5	105.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
MYL6B	MLC1SA	ENSG00000196465	"Myosin light chain 6B"	P14649	12	56152256-56159647	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 635.0;tongue: 390.4"	"Group enriched"	"Detected in all"	4	"Early spermatids: 340.7;Late spermatids: 1215.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 18.4"	"Group enriched"	"Detected in all"	5	"B-cells: 6.3;dendritic cells: 18.4;T-cells: 14.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038887, HPA046859, HPA063034"	Enhanced					NA	NA		7200000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.29e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-2)"	22.7	27.3	133.2	13.8	134.3	17.0	23.8	125.1	177.1	39.5	110.9	23.1	7.5	27.1	34.5	23.4	36.3	27.6	44.8	135.2	133.9	41.4	17.0	16.3	21.9	126.5	128.9	54.3	12.7	77.5	72.0	14.1	130.4	36.2	10.2	23.6	23.1	21.2	635.0	20.4	14.4	22.8	124.0	16.2	18.2	140.0	129.2	43.1	29.3	390.4	25.8	19.0	26.4	125.3	34.1	57.4	152.1	146.4	31.6	112.7	106.0	39.0	170.0	150.8	146.4	41.3	55.4	56.6	83.6	83.9	57.8	19.1	72.2	94.4	80.6	102.9	104.9	59.6	54.8	73.6	99.5	43.7	40.0	189.4	37.6	140.0	54.1	320.2	165.6	134.8	64.2	56.6	126.0	44.5	121.0	145.3	128.3	32.1	97.5	125.7	94.4	75.1	117.0	22.7	139.3	204.6	43.1	52.6	80.4	110.6	43.0	74.0	93.2	88.3	75.1	46.1	84.8	79.9	49.2	47.5	94.7	43.9	98.8	0.9	2.8	0.9	2.0	2.7	1.1	6.3	4.0	3.3	6.4	4.0	3.0	2.5	2.1	2.3	1.1	18.4	14.9	4.3	133.2	134.3	125.1	177.1	135.2	133.9	126.5	128.9	130.4	124.0	129.2	125.3	29.4	67.3	32.4	13.4	28.2	33.1	54.6	72.4	67.7	59.6	67.4	101.7	17.6	38.6	30.6	110.3	25.0	34.2	24.1	21.5	150.6	50.4	340.7	83.0	58.9	44.0	157.4	24.6	18.9	20.2	68.3	55.3	26.0	93.1	12.7	134.9	53.9	32.2	43.5	33.7	23.7	35.0	46.8	22.3	25.0	1215.9	80.8	19.1	40.9	6.5	47.7	149.9	4.1	11.6	7.6	26.9	19.5	66.5	44.2	39.4	28.0	156.4	23.9	51.4	52.6	63.2	53.0	126.4	54.4	71.3	25.4	22.6	15.6	52.2	32.7	47.9
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071122-29180398	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 404.2;tongue: 124.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 33.6;Oligodendrocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019646	Supported					NA	NA		3400000	"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	9.2	4.0	16.0	7.5	36.0	12.9	10.5	13.3	28.0	13.1	0.0	16.4	14.1	15.3	2.9	19.0	10.6	10.4	95.5	11.9	18.3	5.7	20.4	7.2	6.6	37.2	27.1	7.1	14.8	8.4	5.4	4.5	38.4	10.6	5.9	3.8	15.9	5.9	404.2	20.6	14.4	7.6	8.7	6.3	14.4	5.1	35.6	4.1	7.8	124.0	4.8	12.4	14.4	56.3	29.6	40.9	15.5	8.0	4.0	7.0	24.8	13.8	13.7	11.8	8.2	10.3	20.5	3.1	15.2	10.0	17.3	33.2	6.0	23.1	4.6	34.4	11.4	2.6	12.9	11.3	6.1	3.7	3.6	8.1	13.2	7.2	3.2	19.5	4.3	12.3	37.1	5.3	5.9	10.2	10.8	2.9	3.2	60.1	9.0	37.3	17.3	9.1	9.0	21.7	8.1	8.3	13.7	45.5	9.8	10.2	10.6	4.4	5.0	7.7	9.3	5.2	9.6	10.0	18.1	5.9	9.7	2.6	20.9	0.6	0.2	0.4	0.3	0.3	0.4	0.1	0.3	0.3	0.3	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.2	0.1	16.0	36.0	13.3	28.0	11.9	18.3	37.2	27.1	38.4	8.7	35.6	56.3	14.8	12.8	7.0	13.4	5.4	1.0	1.0	0.5	10.8	7.1	3.7	3.3	33.6	2.8	8.3	1.8	10.4	0.4	2.8	8.6	0.0	2.9	1.4	1.9	4.4	8.1	2.4	9.0	13.6	1.4	2.7	4.9	21.4	2.3	1.3	15.3	2.2	5.0	1.1	1.7	13.3	4.0	0.0	0.6	1.3	0.6	2.1	6.1	0.0	9.4	2.0	2.6	2.1	14.6	38.8	4.2	5.1	3.0	6.8	1.0	5.0	1.7	1.7	4.2	0.0	4.7	2.0	1.3	1.3	9.5	0.9	0.3	5.5	3.2	4.1	1.1
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366666-34376898	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 55.5;Exocrine glandular cells: 11.8;Pancreatic endocrine cells: 10.3;Proximal tubular cells: 9.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.4;SK-BR-3: 56.8;T-47d: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	8.1	6.2	30.6	3.4	30.3	2.0	3.4	27.1	31.5	1.7	16.8	19.0	27.3	2.7	1.9	5.3	4.5	6.1	3.9	28.4	28.2	14.5	41.5	3.2	1.5	34.0	33.5	1.0	11.1	1.5	5.5	19.8	28.7	3.2	16.2	3.4	5.6	5.2	84.2	3.7	25.8	4.4	24.5	1.4	15.0	1.3	31.8	1.1	1.9	39.2	1.8	3.1	2.4	24.2	8.1	5.5	9.2	5.6	3.8	1.2	19.7	1.4	1.1	0.8	1.3	13.9	8.3	4.4	15.9	1.4	4.0	16.4	6.7	15.5	1.1	1.4	3.6	0.8	24.6	35.4	0.5	0.8	2.7	1.8	7.2	2.6	3.0	4.3	3.8	3.3	1.1	4.2	2.0	13.4	2.5	1.2	5.5	27.4	4.4	4.0	4.6	1.3	4.9	2.9	1.3	13.0	10.8	56.8	0.9	7.8	52.8	1.3	3.2	1.8	11.0	1.6	3.5	2.8	6.5	1.6	1.6	3.1	1.6	0.4	0.1	0.2	0.7	0.1	0.5	0.2	0.4	0.4	0.0	0.2	0.2	0.3	0.3	0.4	0.1	0.1	0.6	0.1	30.6	30.3	27.1	31.5	28.4	28.2	34.0	33.5	28.7	24.5	31.8	24.2	3.9	9.6	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	2.5	3.7	0.0	55.5	0.3	0.0	1.9	5.7	0.0	3.4	0.7	2.1	0.0	0.0	0.0	11.8	3.6	1.1	0.0	2.0	1.3	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	9.2	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	17.4	0.3	0.1	0.0	0.0
N6AMT1	"C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	2.4	5.0	4.9	2.5	5.6	0.9	5.0	4.8	5.3	6.2	4.8	3.4	3.2	6.4	6.1	2.5	4.7	2.8	5.3	4.5	5.3	4.9	2.8	2.5	3.4	5.7	5.0	7.9	2.9	5.7	4.4	6.4	5.6	4.6	3.4	8.4	3.1	4.0	6.1	3.8	2.8	3.5	4.7	3.6	3.1	3.7	5.0	2.2	5.3	5.6	3.3	3.9	4.1	8.8	2.8	2.5	6.2	8.6	5.1	5.6	4.8	6.1	2.5	3.5	2.0	3.2	5.0	3.1	3.0	3.3	6.2	3.3	5.4	3.0	4.3	4.0	4.1	6.7	4.2	4.0	4.5	4.0	2.5	2.9	6.4	3.5	2.4	6.3	2.6	3.8	8.4	5.5	7.3	2.9	1.9	3.2	7.9	6.0	3.5	2.8	5.9	2.4	6.0	4.1	4.7	6.6	5.5	1.9	2.3	5.6	2.7	3.5	5.4	2.9	5.2	5.4	3.7	3.3	4.0	1.7	4.6	10.4	5.5	0.3	0.4	0.6	0.5	0.7	0.6	0.7	1.0	0.7	0.6	0.6	1.4	1.0	0.1	1.4	0.5	0.5	0.4	0.5	4.9	5.6	4.8	5.3	4.5	5.3	5.7	5.0	5.6	4.7	5.0	8.8	7.8	3.2	5.4	5.2	7.1	1.9	5.8	10.3	1.8	10.8	6.3	6.5	17.0	7.2	8.7	12.9	8.4	18.3	4.0	1.5	7.9	11.0	2.9	10.7	9.6	6.9	0.0	13.0	4.6	6.4	12.2	7.9	8.6	4.2	1.3	15.1	5.3	3.5	7.2	10.1	5.1	3.0	10.2	1.3	0.9	4.5	9.6	2.6	1.8	1.0	2.7	11.1	4.1	6.6	15.1	7.7	4.3	10.1	1.2	4.5	2.5	9.3	15.8	10.5	0.0	7.7	8.9	4.5	10.5	4.2	3.7	14.9	5.1	20.1	3.1	4.8
NABP2	"hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1"	ENSG00000139579	"Nucleic acid binding protein 2"	Q9BQ15	12	56222015-56229854	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044615, HPA057213"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044615: AB_10795884, HPA057213: AB_2683371"	"unprognostic (1.45e-1)"	"prognostic favorable (8.35e-6)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (7.44e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-2)"	21.7	39.4	31.6	17.9	34.3	18.8	20.7	33.5	39.5	21.2	28.9	27.1	23.0	23.6	19.0	21.7	21.2	14.9	23.3	31.8	33.4	25.8	23.1	15.4	20.1	33.2	33.2	24.5	34.6	21.8	24.9	8.4	33.0	20.5	19.4	24.8	17.3	18.0	59.2	21.1	23.0	16.2	32.2	18.0	23.5	24.4	35.4	17.5	19.6	32.2	19.6	25.5	18.5	34.5	74.8	75.9	70.3	78.4	30.8	33.1	13.8	43.5	36.6	63.0	37.9	45.8	65.7	56.3	85.8	41.1	44.6	57.8	66.5	56.1	48.0	107.1	64.1	94.7	49.2	36.0	32.4	67.9	89.0	28.6	44.5	75.4	60.3	53.5	41.9	69.0	50.1	94.9	46.2	67.4	94.1	78.6	51.8	45.0	74.3	83.2	65.2	84.9	31.3	30.4	89.1	65.6	69.0	86.3	62.5	11.2	98.9	60.8	29.8	43.8	41.3	92.0	81.2	64.2	104.5	36.1	81.0	63.9	82.9	33.0	15.6	14.9	26.5	22.7	29.6	26.4	21.9	23.9	21.4	21.2	13.4	22.4	3.0	42.7	25.9	21.6	34.3	16.6	31.6	34.3	33.5	39.5	31.8	33.4	33.2	33.2	33.0	32.2	35.4	34.5	17.2	16.0	18.9	5.2	17.5	18.6	18.5	25.0	21.1	15.3	22.5	27.1	9.6	31.5	12.0	23.9	2.1	28.4	13.6	27.3	49.0	36.7	88.4	11.3	17.1	20.7	18.0	30.3	6.7	70.8	40.0	20.6	13.7	13.4	17.7	17.6	22.9	22.5	31.2	15.2	6.6	27.5	16.2	17.7	20.3	243.5	23.6	16.0	32.0	1.9	27.6	35.8	33.0	2.5	6.4	38.4	22.7	34.3	30.9	13.3	41.6	43.1	11.6	14.8	19.7	23.2	22.9	20.2	25.0	22.1	17.0	15.2	20.1	23.0	37.9	15.1
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029714-119033730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	9.5	11.3	7.4	0.3	7.3	0.2	8.3	7.4	7.7	1.9	5.0	2.9	0.3	2.1	1.7	1.0	1.0	0.2	10.3	5.9	11.8	4.6	0.3	1.1	0.4	8.8	8.9	0.3	2.2	0.3	2.8	6.3	8.5	1.0	0.4	4.1	1.3	0.9	38.6	1.6	0.9	1.8	7.1	0.3	3.4	1.9	9.2	0.3	7.1	1.7	0.3	3.3	1.0	10.9	16.4	1.3	2.2	0.4	7.4	1.1	9.7	0.4	0.5	0.4	0.2	2.0	5.6	8.7	2.2	0.1	0.0	5.8	2.7	2.9	0.7	2.6	6.6	0.2	3.8	1.8	3.5	1.0	0.0	1.5	11.7	0.1	1.6	2.4	0.4	3.0	1.7	1.0	0.5	2.3	2.2	2.8	7.1	3.4	1.3	0.0	2.7	5.9	3.1	1.3	6.3	80.4	4.7	46.7	37.4	12.2	7.4	4.7	0.5	0.0	3.4	0.1	0.8	2.4	8.6	3.2	0.7	2.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	7.4	7.3	7.4	7.7	5.9	11.8	8.8	8.9	8.5	7.1	9.2	10.9	5.7	6.4	1.1	2.0	1.3	0.8	5.0	1.3	0.6	4.1	10.2	6.1	11.3	1.5	1.2	1.8	10.4	6.5	6.3	4.4	0.0	0.6	0.2	3.9	2.8	1.7	3.0	0.0	0.5	0.2	0.4	4.0	1.1	3.7	0.0	2.6	0.7	0.1	0.7	1.7	2.3	3.8	0.0	0.0	2.1	0.1	1.8	0.9	0.0	0.0	0.0	14.7	1.0	2.0	0.2	0.3	0.1	0.7	1.6	2.9	0.2	0.5	1.2	2.1	0.0	7.7	3.9	0.4	1.0	0.8	1.3	1.0	2.9	0.7	2.1	1.3
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1885.3;salivary gland: 2081.6;skeletal muscle: 1828.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"myeloid DC: 204.4"	"Lineage enriched"	"Detected in all"	11	"dendritic cells: 204.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 57.0;HMC-1: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	192.0	400.6	1613.1	27.4	1885.3	2.8	321.6	1623.2	1666.4	395.4	1189.8	198.3	72.1	229.7	260.3	229.5	305.0	130.7	327.2	1551.7	1590.0	150.1	544.4	115.5	48.6	1690.6	1686.1	476.1	93.7	278.5	88.5	45.3	1581.9	171.3	111.0	134.1	2081.6	208.0	1828.7	220.3	125.4	127.7	1584.5	152.0	130.9	33.3	1752.7	40.1	99.9	1591.4	100.4	158.0	265.8	1597.9	10.9	2.3	6.8	12.6	1.1	0.0	1.0	0.2	4.5	3.9	2.2	15.1	20.0	0.6	4.0	0.3	6.2	17.6	30.3	6.3	5.4	0.1	10.9	14.3	2.2	57.0	1.3	1.3	39.0	11.8	13.1	0.9	1.9	6.3	0.0	12.6	29.0	1.2	0.6	9.4	5.0	4.0	17.9	35.2	0.8	14.6	0.7	3.7	7.6	27.4	0.1	19.4	3.0	3.3	14.4	17.3	26.6	8.2	0.0	1.2	20.8	0.4	0.4	6.1	4.8	0.3	1.8	0.3	4.7	0.0	6.5	0.7	8.3	1.5	11.4	6.4	12.6	11.9	204.4	4.4	18.7	14.0	1.4	3.0	0.1	7.0	9.4	15.3	1613.1	1885.3	1623.2	1666.4	1551.7	1590.0	1690.6	1686.1	1581.9	1584.5	1752.7	1597.9	98.0	0.0	11.9	379.0	6.7	28.7	83.7	86.4	12.0	6.3	240.7	201.2	180.2	151.5	110.9	40.5	10.4	11.5	9.1	81.4	485.2	104.9	6.3	33.3	11.0	53.9	33.5	8.4	1.1	21.7	0.7	62.3	18.8	40.2	48.8	79.0	164.2	214.9	20.7	3.3	3.9	77.4	57.0	30.8	137.6	14.4	348.6	30.4	321.9	47.8	8.7	548.0	1.0	42.7	71.0	16.3	37.9	166.3	1.2	68.5	18.5	41.3	70.8	15.5	598.2	167.7	162.8	1.7	5.5	21.6	30.4	21.6	11.9	66.8	118.9	155.9
NDUFB11	"ESSS, Np15, NP17.3"	ENSG00000147123	"NADH:ubiquinone oxidoreductase subunit B11"	Q9NX14	X	47142216-47145038	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 717.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030367	Supported		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030367: AB_10603882"	"unprognostic (2.20e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.46e-3)"	71.1	133.8	136.0	73.2	141.2	133.2	89.8	147.7	170.6	74.6	158.5	112.5	96.7	54.4	104.6	95.2	84.1	46.2	251.4	140.3	142.3	108.9	164.4	62.2	90.3	144.7	139.0	58.5	158.2	122.9	92.7	62.4	142.0	73.9	98.2	59.2	128.2	79.2	717.0	76.1	96.1	72.2	138.3	74.5	97.8	26.8	146.3	97.8	95.6	378.4	106.3	68.0	66.5	139.3	173.5	297.9	198.7	242.4	173.6	166.1	221.1	125.2	180.5	231.5	224.4	292.6	224.2	218.5	101.8	163.4	222.3	216.2	267.0	157.3	162.0	212.4	663.1	129.5	371.2	271.3	184.7	203.2	188.2	176.9	140.0	191.2	126.8	137.8	193.9	286.8	158.6	282.6	139.3	437.2	269.1	622.5	308.5	219.2	517.2	259.7	210.9	513.6	254.0	210.1	391.2	283.1	231.9	289.2	198.8	259.8	418.2	279.7	130.3	152.7	190.5	239.1	149.0	244.0	270.0	258.5	155.0	138.4	204.2	255.4	410.3	188.6	294.2	306.5	362.1	541.7	408.9	342.6	491.6	470.0	454.3	359.3	84.9	279.7	233.8	636.5	476.3	626.1	136.0	141.2	147.7	170.6	140.3	142.3	144.7	139.0	142.0	138.3	146.3	139.3	154.0	105.8	132.5	16.6	270.9	259.5	252.1	514.5	267.5	89.2	343.7	520.1	236.6	265.9	284.7	290.6	37.5	456.9	227.6	400.0	583.0	314.9	5.2	193.4	229.7	165.6	330.7	246.3	10.2	369.1	429.2	192.1	200.8	267.1	194.1	219.2	203.8	657.2	391.0	55.5	16.7	495.1	333.7	321.7	290.9	16.3	181.7	229.1	265.1	12.2	336.9	238.9	183.4	14.1	25.3	291.8	391.2	176.4	445.1	258.6	360.1	756.8	180.9	109.8	164.3	157.6	248.9	16.8	36.9	358.0	290.5	450.9	228.9	342.6	447.4	334.9
NDUFS6	CI-13kA	ENSG00000145494	"NADH:ubiquinone oxidoreductase subunit S6"	O75380	5	1801407-1816048	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 615.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 972.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1796.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064221	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA064221: AB_2685217"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.04e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.02e-1)"	110.8	84.1	111.5	83.9	111.9	116.4	51.0	116.6	146.9	44.8	117.4	123.2	146.4	48.4	51.9	79.8	50.2	38.9	265.4	110.3	123.2	96.0	116.5	51.8	75.2	116.1	114.2	42.4	107.7	122.5	40.9	57.2	115.3	70.8	68.1	49.3	110.9	57.3	615.4	69.8	115.4	51.5	110.4	71.2	106.5	56.5	115.5	70.4	51.1	304.4	61.6	58.1	41.9	115.2	241.2	487.3	206.4	310.5	81.7	74.9	483.3	180.6	108.8	161.7	139.8	556.8	291.0	344.0	531.4	117.6	261.5	247.6	174.3	221.5	91.9	404.3	576.4	250.4	1796.7	476.9	155.0	320.8	230.0	106.8	157.4	136.0	103.7	85.0	158.6	226.8	344.6	314.2	181.6	607.0	433.4	679.5	218.8	355.9	678.9	345.0	211.5	477.9	162.9	388.6	237.1	213.7	638.5	507.5	275.2	110.3	341.1	403.3	206.2	221.6	386.0	201.5	355.1	283.2	512.4	443.0	250.5	511.4	243.6	239.5	283.7	233.5	207.5	342.7	207.9	246.2	213.6	209.2	349.1	197.9	177.9	196.9	124.8	218.9	307.5	347.1	261.1	261.5	111.5	111.9	116.6	146.9	110.3	123.2	116.1	114.2	115.3	110.4	115.5	115.2	166.4	67.3	107.6	12.7	129.7	125.5	153.6	328.8	82.6	95.5	164.5	206.0	698.3	198.8	164.8	207.8	47.9	358.0	142.9	574.7	972.4	270.1	246.9	165.2	132.4	155.6	267.1	162.0	10.6	341.5	246.0	146.8	170.2	133.5	104.7	163.1	153.8	526.3	413.9	65.6	11.3	468.0	236.0	224.6	167.8	308.1	154.7	162.9	218.7	12.2	239.8	208.5	178.2	9.5	20.1	296.2	447.5	157.2	178.7	186.2	615.8	868.5	158.8	166.9	164.3	147.0	188.1	288.0	159.1	227.7	167.5	245.2	124.7	200.4	480.7	219.2
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 665.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Proximal tubular cells: 774.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (7.36e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	52.9	51.3	78.2	31.2	96.8	33.8	33.8	116.0	120.6	32.1	86.6	50.0	104.2	31.2	5.2	62.2	28.8	17.6	170.7	72.6	92.3	67.9	68.2	30.2	36.7	103.6	85.5	31.7	89.6	43.9	50.2	19.9	108.2	34.1	9.8	5.7	75.6	26.3	665.9	37.9	73.8	10.5	95.6	41.8	53.0	58.9	88.5	19.3	32.1	159.4	11.4	36.7	37.7	120.2	127.0	109.3	17.5	77.6	16.0	20.3	68.8	52.0	19.3	39.4	39.0	155.3	52.8	146.2	71.4	13.0	9.7	85.4	17.3	44.1	1.0	157.6	143.2	47.0	113.1	125.7	53.4	76.5	90.1	27.2	47.4	17.7	0.0	13.2	40.2	110.5	103.1	196.6	13.6	130.0	138.6	77.0	67.5	40.8	141.0	144.6	36.3	254.9	23.6	86.9	105.7	89.5	48.5	117.8	158.6	2.1	84.0	118.1	72.3	67.3	49.5	85.5	100.0	326.9	218.4	121.5	110.9	159.0	70.4	176.5	299.0	143.8	166.6	342.4	147.5	249.4	161.6	159.7	354.9	235.6	151.8	146.9	75.6	160.6	308.0	276.8	241.8	193.2	78.2	96.8	116.0	120.6	72.6	92.3	103.6	85.5	108.2	95.6	88.5	120.2	98.5	80.1	92.5	14.0	117.7	89.9	98.4	275.0	100.2	74.3	116.7	146.0	77.1	158.7	167.0	145.3	50.1	225.2	75.0	482.1	812.0	161.8	443.2	69.2	74.2	88.4	175.4	94.9	13.8	163.3	197.1	92.2	162.1	66.2	111.7	99.4	72.5	243.9	333.4	52.2	15.1	332.9	248.2	188.4	129.7	414.5	83.9	154.6	261.5	7.5	182.1	111.2	111.2	14.6	57.0	121.1	346.7	74.1	155.2	81.0	616.5	774.9	122.4	81.9	72.3	105.0	120.2	268.8	134.9	266.2	106.0	186.8	100.9	128.8	410.8	138.7
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 146.9;tongue: 60.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 93.8;Early spermatids: 128.7;Intestinal goblet cells: 105.4;Late spermatids: 461.2;Paneth cells: 183.4;Syncytiotrophoblasts: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"intermediate monocyte: 45.1;non-classical monocyte: 112.0"	"Lineage enriched"	"Detected in many"	19	"monocytes: 112.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.7;HeLa: 8.6;HMC-1: 6.9;JURKAT: 7.4;SCLC-21H: 17.1;SiHa: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	0.5	4.6	25.5	3.8	29.6	2.2	0.4	20.8	37.4	14.1	0.0	15.2	10.9	25.8	15.1	4.3	2.6	1.9	0.5	32.2	7.2	2.4	1.2	0.9	0.8	1.7	4.1	1.9	18.8	8.3	15.9	4.6	1.3	1.4	10.3	39.5	2.9	1.3	146.9	1.8	17.2	5.2	0.0	1.9	5.2	13.0	5.0	1.1	0.5	60.5	0.5	18.7	2.6	17.2	0.9	0.2	1.3	0.0	0.2	0.1	13.7	0.5	0.9	0.2	0.1	0.3	0.2	0.4	0.7	0.1	0.9	0.6	0.4	0.2	0.1	0.4	0.8	0.2	8.6	0.3	0.0	0.3	6.9	0.2	0.5	0.1	0.7	0.2	0.0	7.4	2.3	0.5	0.2	1.2	1.4	0.9	0.0	0.5	4.2	0.2	0.7	1.5	0.0	0.5	17.1	5.9	8.8	0.0	0.4	2.5	0.7	1.7	0.0	0.1	0.9	0.3	0.2	1.0	0.2	0.3	0.5	0.0	0.4	0.8	2.8	0.5	0.7	45.1	1.1	1.1	1.0	1.1	5.8	0.7	1.2	0.8	2.3	0.6	112.0	4.7	0.4	4.1	25.5	29.6	20.8	37.4	32.2	7.2	1.7	4.1	1.3	0.0	5.0	17.2	0.3	0.0	0.6	1.3	1.5	0.5	1.5	0.2	0.0	53.2	2.0	2.7	1.6	0.0	0.2	0.0	93.8	4.6	3.1	7.9	0.0	12.0	128.7	0.0	0.8	2.2	78.3	4.6	47.9	0.7	12.9	2.2	13.3	0.1	0.0	1.2	0.0	0.2	4.5	3.3	32.9	105.4	32.6	4.6	2.4	461.2	5.6	4.8	0.0	0.0	5.5	9.0	2.1	1.0	4.2	0.5	183.4	5.3	0.6	1.3	7.2	0.0	0.2	88.0	6.6	2.4	1.0	56.6	33.6	0.0	1.8	113.4	1.7	8.4	9.4	0.7
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995475-13098796	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA007533: AB_2667855"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.66e-4)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	76.4	14.9	30.4	19.7	80.2	14.9	48.0	99.8	97.7	67.2	4.0	60.4	20.9	88.5	10.9	72.4	69.5	53.9	60.9	54.0	15.0	8.9	20.3	50.0	6.2	50.9	45.1	73.8	23.8	13.2	18.9	11.8	39.4	85.0	19.7	11.7	150.4	60.0	410.3	99.2	24.3	67.8	45.6	11.3	37.3	16.0	46.9	11.6	31.0	138.2	6.2	45.0	52.7	105.2	39.2	16.2	1.0	119.9	111.7	149.5	1.3	48.1	68.6	45.7	31.8	1.3	3.3	0.6	13.4	211.3	31.4	17.5	12.8	37.4	20.1	25.8	19.7	20.2	7.6	17.2	53.8	8.5	10.3	99.0	10.9	44.1	24.6	80.3	12.4	8.6	6.7	6.2	29.3	12.1	14.9	5.7	0.5	8.6	132.3	43.5	22.2	23.1	0.4	8.5	17.9	47.6	34.5	0.3	43.0	0.0	22.7	17.3	12.2	191.5	23.5	185.1	68.5	4.5	1.7	0.3	49.9	12.1	62.0	0.1	0.1	0.0	0.5	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	30.4	80.2	99.8	97.7	54.0	15.0	50.9	45.1	39.4	45.6	46.9	105.2	19.5	12.8	59.3	62.7	6.8	58.8	45.5	22.4	134.9	13.3	57.9	74.2	33.2	27.1	15.9	14.7	4.2	0.2	3.7	16.5	1.9	24.3	64.0	12.1	40.1	20.0	12.1	145.2	69.0	12.7	0.3	89.7	32.6	3.0	3.8	4.3	17.9	33.9	1.0	0.0	38.1	25.8	2.0	4.1	15.2	43.1	112.2	5.8	26.6	17.8	1.9	93.7	0.0	52.3	140.9	15.2	12.0	126.0	2.5	60.3	8.4	10.0	19.0	3.0	6.6	174.7	38.3	15.6	13.2	99.4	51.4	0.3	3.8	56.0	29.5	31.8
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117086-104138241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Syncytiotrophoblasts: 433.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004211, HPA065646"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004211: AB_628018, HPA065646: "	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	32.9	40.8	34.0	15.2	34.3	14.7	27.2	30.5	50.8	28.6	26.8	60.4	15.0	30.5	33.1	16.1	30.1	18.5	37.4	31.0	31.2	24.0	30.6	29.0	24.7	32.9	34.0	23.2	21.3	21.7	17.4	23.6	32.0	39.0	18.4	21.2	20.6	67.9	36.2	18.4	21.7	21.1	34.7	19.4	26.3	22.6	32.1	26.3	22.7	36.3	22.8	38.1	23.9	36.2	30.1	25.3	55.3	35.7	34.2	35.6	48.6	31.5	27.2	37.2	25.6	21.2	14.0	44.4	15.1	30.3	22.9	22.0	46.5	20.9	37.4	28.9	14.7	27.4	31.0	19.7	31.0	35.0	17.6	49.3	25.6	14.5	25.5	62.0	24.0	40.1	27.1	16.2	31.6	29.6	53.2	40.5	52.8	22.1	26.0	43.5	30.9	18.8	27.3	25.3	31.3	26.2	58.0	132.5	19.3	36.8	53.1	42.9	15.2	21.3	13.1	17.5	24.0	28.5	29.5	42.0	12.5	23.7	22.8	18.0	5.7	18.5	12.1	7.8	16.6	12.3	12.1	12.5	5.7	8.5	13.0	13.7	7.2	13.5	9.0	5.0	16.9	9.1	34.0	34.3	30.5	50.8	31.0	31.2	32.9	34.0	32.0	34.7	32.1	36.2	42.5	54.5	26.7	8.8	21.1	37.3	106.8	42.9	15.9	22.7	24.3	31.8	39.5	12.8	30.3	18.4	4.2	58.8	24.5	13.3	37.2	24.2	6.2	20.4	36.4	36.5	12.0	39.4	13.1	18.3	86.3	43.0	11.2	17.5	21.5	30.8	77.1	31.2	23.1	15.2	13.7	15.4	30.5	14.4	29.8	5.4	34.2	19.2	28.4	8.4	20.2	43.3	22.6	11.1	25.3	27.3	16.9	30.5	17.1	54.5	12.6	42.5	26.7	27.2	19.7	35.4	40.0	90.0	32.4	18.0	37.1	433.2	25.6	18.8	18.3	55.7
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 23.0;skeletal muscle: 36.9;tongue: 57.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 10.0;Hepatic stellate cells: 18.2;Inhibitory neurons: 32.1;Oligodendrocyte precursor cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.6;RH-30: 9.4;RPTEC TERT1: 5.8;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.1	0.1	12.7	0.4	12.4	0.2	0.1	5.7	7.0	0.3	0.0	2.2	0.1	0.1	0.2	0.8	0.3	0.0	0.0	4.0	16.2	1.3	0.0	0.8	0.1	12.1	11.0	0.0	1.4	0.0	0.9	0.0	12.2	0.9	0.4	0.3	3.4	0.1	36.9	1.9	0.4	0.3	2.3	0.0	0.2	0.5	23.0	0.0	0.1	57.2	0.1	0.0	0.7	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	9.4	0.0	5.8	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.7	12.4	5.7	7.0	4.0	16.2	12.1	11.0	12.2	2.3	23.0	3.3	0.0	0.0	0.0	1.3	0.0	3.8	10.0	2.4	4.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	3.0	5.1	0.4	3.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	8.4	0.0	0.0	18.2	0.0	0.0	0.0	32.1	0.2	0.0	0.3	0.7	0.6	0.3	0.2	1.8	1.9	0.0	0.0	0.0	48.2	5.7	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.1	1.8	0.1	0.6	0.0	0.2	0.0	0.0	1.0
NPHP1	"JBTS4, NPH1, SLSN1"	ENSG00000144061	"Nephrocystin 1"	O15259	2	110122311-110205066	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"		"Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.5;Endometrial ciliated cells: 136.3;Respiratory ciliated cells: 167.4;Spermatocytes: 146.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046093, HPA074071"	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA046093: AB_2679535, HPA074071: "	"unprognostic (2.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.66e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.64e-2)"	3.1	3.7	4.5	1.0	4.7	0.1	4.0	4.0	8.6	4.7	11.1	5.3	1.0	5.4	9.0	1.3	17.1	3.3	4.8	4.6	5.2	8.0	0.8	4.3	0.9	5.4	5.8	4.5	3.2	17.0	11.7	1.3	5.0	4.4	1.7	10.8	2.5	4.7	36.2	1.7	1.9	4.6	4.6	1.9	3.6	24.9	5.5	1.1	7.4	10.8	0.6	4.1	2.7	4.6	9.8	3.1	5.9	4.3	3.3	7.9	1.3	2.4	7.9	8.5	8.4	3.1	7.1	0.5	6.0	5.8	7.8	4.7	2.8	7.5	10.0	1.7	3.9	0.2	1.9	2.1	4.5	1.4	0.0	5.2	4.4	12.7	3.6	12.0	4.7	1.9	0.1	0.8	4.9	2.0	1.0	2.1	2.8	0.2	4.9	0.2	6.5	0.3	14.5	0.8	3.0	3.1	3.2	4.2	9.2	2.8	5.1	1.0	3.2	4.9	4.2	5.0	7.7	2.4	2.9	0.7	13.9	0.2	3.3	0.3	0.0	0.0	0.3	0.1	0.5	0.8	0.2	0.1	0.3	1.5	0.5	0.3	0.2	1.1	0.0	0.0	0.0	0.1	4.5	4.7	4.0	8.6	4.6	5.2	5.4	5.8	5.0	4.6	5.5	4.6	8.3	6.4	8.9	31.6	1.6	5.2	8.7	18.1	2.8	11.8	5.3	6.6	14.3	8.6	23.3	9.2	47.9	1.9	0.3	0.8	19.6	15.6	148.5	136.3	15.8	7.0	0.0	0.0	29.1	4.9	0.5	8.1	0.0	17.0	0.0	13.4	9.3	2.7	1.4	21.9	15.0	0.9	18.3	0.8	3.1	65.2	7.5	1.4	7.2	4.7	0.0	12.3	0.0	12.1	11.5	6.4	1.3	9.8	0.1	3.1	0.2	35.9	167.4	69.1	13.1	14.3	10.3	146.3	24.9	1.0	4.0	0.3	1.3	9.6	1.7	5.8
NPHP3-ACAD11		ENSG00000274810	"NPHP3-ACAD11 readthrough (NMD candidate)"		3	132558142-132722459	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 2.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.9"	"Low region specificity"	"Detected in many"													NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.50e-1)"	"unprognostic (1.82e-1)"			"unprognostic (1.04e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.63e-5)"	"unprognostic (4.17e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.59e-2)"	2.7	1.0	2.3	0.3	2.9	1.1	2.2	2.4	5.2	1.7	2.3	1.6	0.7	3.0	0.0	0.8	1.6	1.3	0.8	2.2	2.3	0.7	0.7	2.2	0.9	2.7	2.5	5.7	1.2	1.0	0.3	0.8	3.1	0.6	0.7	2.7	1.6	1.1	3.8	0.3	0.8	1.1	2.6	1.6	0.9	1.3	2.6	0.8	0.6	0.0	0.8	0.6	0.4	3.2	1.5	0.2	3.8	0.3	1.5	7.9	2.0	4.0	3.9	1.0	1.7	0.0	0.8	0.4	1.5	4.1	3.0	0.8	0.2	0.7	1.5	0.5	0.5	0.3	0.0	2.1	2.0	0.0	2.7	5.0	1.5	2.1	2.2	5.1	0.0	1.0	0.3	0.7	2.0	0.0	0.0	1.4	1.1	1.9	0.3	0.0	2.6	0.4	1.8	0.0	0.2	2.8	1.6	0.3	3.6	3.0	0.4	1.1	5.5	3.1	2.4	3.3	0.0	1.1	0.1	0.4	4.3	0.1	1.8	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	2.9	2.4	5.2	2.2	2.3	2.7	2.5	3.1	2.6	2.6	3.2	0.0	3.2	1.1	2.3	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	1.9	0.0	0.8	0.4	0.0	0.0	1.3	0.0	0.0	0.4	0.5	0.0	1.8	0.0	0.0	0.3	0.0	0.7	0.0	0.5	0.0	3.7	0.0	0.6	0.0	4.5	3.7	0.0	0.1	0.0	0.5	0.6	0.4	0.0	0.0	1.1	0.0	0.6	0.3	0.5	0.4	0.7	0.0	0.4	0.6	0.0	0.1	0.6
NREP	"C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17"	ENSG00000134986	"Neuronal regeneration related protein"	Q16612	5	111662621-111997464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 118.3;Excitatory neurons: 116.1;Theca cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 24.6;NK-cell: 6.9;plasmacytoid DC: 25.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 425.3;SH-SY5Y: 461.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 1766.0"	"Region enhanced"	"Detected in all"		"cerebellum: 219.5"	HPA000545	Approved		Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA000545: AB_1845721"	"unprognostic (2.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.76e-3)"	18.9	56.5	50.1	19.4	52.6	36.7	29.3	141.8	71.6	32.3	56.9	28.6	16.9	84.8	17.9	23.0	18.2	65.4	70.9	52.5	44.0	49.5	50.7	27.7	17.3	47.8	52.1	41.8	9.8	8.4	13.3	119.8	50.8	52.7	25.2	107.4	36.1	72.2	179.9	22.1	16.7	54.6	44.6	36.9	25.7	12.7	46.4	168.1	18.6	118.2	18.4	27.5	16.8	54.7	0.6	7.1	425.3	91.5	20.2	46.6	20.3	140.9	83.9	135.7	221.0	0.8	2.8	73.1	44.6	71.3	18.9	0.3	91.0	5.2	69.4	29.5	13.0	57.5	35.2	77.6	28.1	77.0	0.8	45.6	22.5	129.5	44.5	318.6	154.2	81.4	0.6	7.4	143.4	1.6	308.3	53.7	244.1	0.2	33.3	326.3	173.4	19.9	52.2	1.6	96.9	461.8	31.6	2.2	2.9	224.2	17.7	210.6	31.1	163.7	54.1	80.8	15.8	34.6	29.3	92.3	35.6	159.8	32.8	0.0	4.0	0.0	0.0	2.2	0.0	1.6	0.1	0.2	24.6	1.1	1.2	1.6	0.1	6.9	1.0	25.1	0.0	2.2	50.1	52.6	141.8	71.6	52.5	44.0	47.8	52.1	50.8	44.6	46.4	54.7	20.8	6.4	30.8	43.1	3.6	18.1	1.6	4.5	14.2	66.9	12.4	22.6	33.4	8.6	5.7	12.9	87.6	118.3	12.9	2.5	33.2	14.4	2.5	5.4	69.1	38.9	21.6	52.2	116.1	5.5	18.6	31.7	31.1	7.4	5.1	69.9	27.5	10.1	35.5	20.2	51.4	9.3	42.7	10.0	19.0	1.0	8.4	14.9	14.2	17.8	11.5	14.9	5.2	37.2	4.6	8.2	2.0	23.3	0.9	0.7	1.2	61.0	0.5	29.0	13.1	25.4	51.8	0.8	12.6	11.9	12.6	31.5	3.2	150.8	11.3	0.2
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NTPCR	"C1orf57, HCR-NTPase, MGC13186, THEP1"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	3.0	4.0	8.9	2.0	9.3	0.8	3.6	8.3	9.6	5.0	10.9	4.5	2.0	4.2	3.8	3.2	4.7	3.2	4.5	9.0	10.3	3.6	2.8	3.4	2.9	11.4	9.3	5.3	5.9	5.3	4.2	2.5	12.0	4.1	4.3	8.0	3.3	4.0	13.5	4.3	3.9	4.1	9.8	3.4	3.0	2.2	10.0	3.6	4.4	11.8	2.7	3.8	4.2	9.1	2.0	4.9	5.4	2.7	4.0	5.2	0.1	1.3	4.3	4.0	5.5	3.5	2.3	3.1	2.9	2.7	2.2	2.6	3.7	5.0	4.4	2.3	6.9	0.9	3.4	4.5	4.1	1.7	1.8	6.9	9.4	3.9	3.9	4.0	3.3	5.8	2.8	4.6	4.8	1.5	4.4	4.4	5.4	4.0	5.7	2.9	3.5	4.6	5.9	2.4	4.7	7.8	1.9	1.6	1.9	4.0	4.0	3.8	2.5	3.3	2.7	3.6	3.7	5.2	4.6	3.5	3.9	4.1	4.9	0.3	0.5	0.2	0.6	0.6	0.7	0.5	0.9	0.3	0.4	0.6	1.2	1.0	0.9	0.5	0.5	0.1	1.1	0.4	8.9	9.3	8.3	9.6	9.0	10.3	11.4	9.3	12.0	9.8	10.0	9.1	45.5	19.2	21.1	24.8	16.9	19.4	37.3	85.3	24.5	15.8	31.5	34.8	63.9	38.6	36.3	25.8	27.1	68.9	16.1	37.3	93.9	62.2	47.7	27.3	29.4	29.1	25.8	15.8	16.1	64.5	59.1	33.1	16.3	27.7	16.5	44.9	23.9	34.3	42.3	10.1	16.1	50.0	75.3	22.8	17.3	27.3	20.2	21.2	23.2	15.0	30.1	41.0	47.4	16.1	20.8	46.5	31.2	30.5	12.2	40.1	66.0	82.0	27.2	21.8	13.1	21.3	27.7	86.5	40.4	40.1	23.9	28.0	16.5	67.9	66.5	41.6
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	13.9	11.8	11.1	13.2	13.2	11.7	11.2	13.2	14.0	8.1	10.2	11.2	14.5	10.2	6.4	12.8	9.7	5.7	8.3	11.0	11.4	11.7	15.3	8.7	15.1	12.8	12.6	8.9	15.4	6.8	9.3	10.3	13.7	8.9	6.1	7.3	14.0	3.6	20.9	10.7	13.3	6.3	12.8	12.8	11.8	10.4	12.5	8.1	9.4	5.0	9.8	9.2	10.3	17.7	62.3	32.3	23.5	37.1	14.1	10.4	31.3	24.6	7.0	8.7	13.9	28.6	46.3	35.5	57.5	4.0	39.8	30.6	12.6	13.9	10.7	70.6	36.6	32.4	42.0	26.4	15.3	37.3	35.3	3.8	7.7	8.4	12.1	12.3	9.8	39.1	35.1	42.6	8.9	25.2	55.1	80.9	25.8	18.4	35.2	45.7	39.2	63.0	8.0	14.3	59.6	33.6	38.7	24.7	66.3	13.8	47.2	37.8	21.9	29.4	43.8	32.6	56.7	35.0	63.8	61.5	34.2	63.2	31.4	49.9	48.3	32.5	60.2	59.8	76.5	91.7	84.0	71.8	68.0	68.0	88.7	79.0	6.2	83.8	51.5	81.1	83.5	69.1	11.1	13.2	13.2	14.0	11.0	11.4	12.8	12.6	13.7	12.8	12.5	17.7	58.0	28.9	23.8	9.1	47.5	59.4	54.9	92.6	42.7	30.7	70.4	88.6	43.1	35.8	53.1	38.6	22.9	118.7	43.8	25.4	148.7	63.6	95.1	57.6	44.1	47.4	43.8	78.4	18.8	64.0	55.8	48.6	32.1	38.3	31.6	35.7	36.0	55.1	69.8	10.1	14.0	45.3	87.5	41.8	42.7	24.5	51.6	35.7	49.8	11.2	46.4	51.4	52.5	11.1	36.0	59.9	33.6	51.1	55.5	95.2	31.5	112.5	65.1	38.2	39.5	51.3	46.5	87.6	44.2	56.0	67.6	56.8	48.3	64.8	68.6	59.3
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392669	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		87000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	12.8	12.9	72.7	11.4	65.3	12.0	14.7	41.2	73.1	17.2	33.8	10.4	9.0	13.2	30.1	12.3	17.3	9.2	20.7	64.9	55.9	18.0	12.1	13.3	13.7	60.8	59.6	19.7	10.5	29.9	5.7	10.4	59.0	12.8	10.9	43.1	11.4	17.5	70.8	13.4	9.4	13.0	64.5	16.5	9.8	7.6	73.7	11.4	25.3	51.8	14.9	9.4	7.4	59.5	11.0	8.0	20.9	41.2	13.7	22.9	8.7	7.9	13.2	8.0	5.7	9.7	7.2	37.3	10.5	14.3	5.1	9.2	11.0	21.3	14.7	14.5	15.2	42.9	10.4	20.7	13.0	41.5	21.7	20.8	18.8	9.0	16.8	9.9	23.2	20.1	42.5	14.0	12.6	11.4	28.7	48.1	13.4	32.5	7.3	24.7	17.4	39.2	18.2	22.7	29.3	32.4	17.5	24.4	32.1	6.0	23.6	28.2	25.7	15.6	5.7	14.1	17.4	11.7	28.7	27.9	9.7	40.1	25.4	1.4	3.9	9.2	2.1	4.1	2.4	2.2	2.1	1.9	4.4	3.0	1.9	2.2	2.8	1.4	4.2	2.1	1.6	1.8	72.7	65.3	41.2	73.1	64.9	55.9	60.8	59.6	59.0	64.5	73.7	59.5	36.6	16.0	26.7	0.0	41.4	59.9	72.2	32.4	51.8	117.0	30.5	27.9	47.5	62.9	25.0	42.3	118.9	34.7	28.2	16.1	13.7	19.2	4.1	25.0	38.6	67.0	49.1	40.8	0.0	28.5	32.0	36.4	19.4	37.2	13.9	30.3	109.6	56.1	76.0	169.9	0.0	29.0	22.4	107.1	79.2	8.1	37.6	65.2	53.4	0.0	90.1	137.4	42.2	0.0	0.0	27.9	16.0	63.2	22.8	90.1	25.3	24.4	46.4	126.6	59.2	68.1	35.0	45.6	83.9	58.4	60.2	19.6	26.5	32.8	31.8	64.7
NUTF2	"NTF2, PP15"	ENSG00000102898	"Nuclear transport factor 2"	P61970	16	67846923-67872567	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 336.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040915, HPA040956"	Supported					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA040915: AB_10794073, HPA040956: AB_10796233"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.17e-3)"	"unprognostic (9.80e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	57.1	53.7	86.4	36.5	86.6	42.0	49.8	88.8	93.4	47.4	75.3	57.9	27.4	60.7	49.4	53.7	47.9	26.6	74.7	88.4	96.6	50.8	51.5	49.9	47.8	96.2	99.6	42.4	56.9	41.6	43.0	49.8	99.2	44.6	42.6	17.2	40.5	32.5	93.4	58.7	42.8	58.0	90.7	41.4	45.9	56.6	88.3	57.4	39.3	79.2	53.3	57.9	45.2	91.7	149.0	174.8	186.9	212.2	92.8	94.1	249.9	118.8	102.8	165.4	134.1	222.3	152.5	169.2	107.7	161.3	95.9	130.3	235.4	176.2	179.3	65.9	225.5	114.2	73.6	357.5	124.0	161.6	83.1	123.4	114.1	152.9	190.7	91.0	175.5	127.7	164.2	59.1	173.6	301.8	257.3	311.1	318.9	152.4	117.6	228.2	121.5	254.2	218.9	128.5	169.6	164.4	266.4	109.5	93.6	174.5	161.0	137.3	147.4	140.3	168.3	104.2	144.0	94.8	131.0	367.5	92.9	113.0	147.8	47.8	64.0	27.4	61.0	95.7	70.1	52.7	64.9	60.3	81.5	51.8	48.8	55.9	17.9	71.9	88.3	78.7	72.8	101.8	86.4	86.6	88.8	93.4	88.4	96.6	96.2	99.6	99.2	90.7	88.3	91.7	67.6	57.7	20.2	4.9	58.6	68.2	79.5	136.5	64.9	15.9	62.8	53.7	38.7	27.1	58.5	49.7	2.1	208.2	62.4	66.2	137.0	196.5	9.9	71.4	66.1	71.9	98.3	126.4	6.9	105.1	336.1	57.6	60.6	52.7	39.3	65.1	28.2	22.5	149.4	20.2	7.4	69.1	89.5	32.4	83.6	20.8	33.2	75.2	58.7	4.7	130.2	26.5	69.0	4.0	8.3	198.8	93.3	42.9	86.2	166.0	96.5	124.1	53.7	7.6	13.1	48.5	187.5	54.6	82.0	88.7	87.7	183.5	62.9	62.1	95.6	114.5
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101828231	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.2;tongue: 50.5"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 177.7;Plasma cells: 59.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		12000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	7.8	6.4	13.6	11.7	23.2	12.5	6.0	20.1	18.7	7.6	1.3	5.3	3.5	8.1	3.3	6.1	7.4	6.5	18.4	12.4	21.0	3.3	3.5	9.4	16.7	21.6	21.3	7.1	2.5	20.7	6.8	6.7	24.2	8.3	4.6	11.3	3.5	9.8	73.2	2.0	5.0	10.6	16.5	12.5	5.0	7.4	23.7	13.1	5.9	50.5	14.2	7.2	4.5	34.8	19.8	29.9	25.1	9.2	26.6	26.9	5.7	21.7	27.2	25.4	36.6	7.0	2.0	29.3	62.6	24.4	30.4	4.1	28.3	23.2	31.2	36.7	8.9	22.7	19.0	19.3	35.0	19.4	19.9	15.6	3.9	21.1	7.8	33.1	27.8	27.3	4.7	92.0	42.5	10.6	26.2	4.6	14.6	1.0	18.6	11.5	30.7	12.7	18.8	5.1	19.6	23.4	9.3	2.2	16.7	14.9	4.3	27.2	24.5	28.0	33.7	3.3	23.0	43.0	47.5	34.0	23.9	83.7	5.4	8.0	16.5	20.1	14.6	13.0	10.0	10.8	16.0	15.2	14.2	6.4	21.6	17.6	8.6	8.9	12.7	8.8	20.8	14.1	13.6	23.2	20.1	18.7	12.4	21.0	21.6	21.3	24.2	16.5	23.7	34.8	24.1	25.6	5.1	11.4	19.2	3.7	2.2	2.3	6.2	26.1	9.8	9.0	49.4	4.3	2.3	0.0	8.4	0.7	12.8	1.0	0.0	2.6	1.4	2.9	11.8	17.2	7.2	0.0	34.1	2.6	1.6	10.0	1.5	1.9	13.3	46.0	40.4	1.8	6.8	48.8	35.2	0.6	4.1	19.1	10.0	1.8	9.3	11.0	7.2	9.4	26.3	22.7	23.7	44.2	177.7	2.9	0.1	7.5	59.6	1.0	0.8	0.8	3.1	17.1	19.7	14.9	8.3	11.8	15.1	3.8	3.0	0.7	16.2	20.0	0.9	1.1
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162045-24397880	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 214.3;Oligodendrocytes: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	22	"basophil: 93.4"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favorable (4.98e-13)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	72.0	27.8	77.1	9.4	105.6	15.4	47.9	99.6	136.0	52.4	114.0	34.9	20.7	48.0	17.2	30.8	29.6	21.1	52.0	77.3	90.6	43.5	13.3	24.2	10.4	89.7	95.0	27.3	16.5	62.8	18.7	8.3	94.5	23.0	22.7	82.2	51.5	26.2	170.9	17.5	20.2	41.1	79.2	9.9	21.3	14.3	91.3	9.6	29.0	123.1	7.9	25.4	20.0	136.8	38.2	11.4	26.3	49.1	60.0	48.7	24.5	14.0	40.4	12.4	10.2	7.1	38.9	0.1	16.0	25.1	19.7	37.9	10.4	24.4	11.4	0.2	19.6	12.1	7.8	0.2	29.9	30.4	6.0	63.4	34.4	9.5	38.4	54.0	15.9	10.4	0.0	0.3	15.5	16.1	7.0	9.1	21.7	19.5	36.8	0.0	21.0	3.2	3.3	27.7	16.9	16.6	32.6	37.5	46.1	24.5	13.7	21.7	3.4	45.9	9.4	14.9	13.6	0.4	5.3	1.0	22.3	8.7	26.8	93.4	4.2	1.1	0.2	2.2	0.1	0.0	0.8	0.6	4.1	0.4	0.6	0.5	1.6	0.2	0.7	4.1	0.8	1.5	77.1	105.6	99.6	136.0	77.3	90.6	89.7	95.0	94.5	79.2	91.3	136.8	214.3	16.0	21.6	142.0	5.4	20.1	43.4	16.6	29.6	66.6	73.6	64.3	78.0	41.5	20.0	20.2	22.9	12.1	11.1	23.6	64.6	13.3	67.7	27.6	55.3	89.9	4.8	18.7	180.3	7.4	8.1	59.9	16.3	17.0	17.2	137.9	37.5	12.4	26.6	25.2	166.4	40.0	40.7	27.4	17.9	76.4	42.9	34.3	58.7	67.5	11.0	124.8	0.0	75.9	433.0	10.7	19.1	54.9	2.5	27.1	29.8	71.7	21.7	112.3	32.9	44.7	65.8	6.7	9.9	27.2	10.2	6.4	3.8	103.7	16.2	26.4
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402893	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.8;tongue: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2"	"Cancer enhanced"	"Detected in many"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.8;hTERT-HME1: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	1.3	1.5	4.1	1.0	6.1	0.2	1.7	3.7	16.3	1.1	0.0	1.0	0.7	0.8	0.7	2.4	1.0	1.1	3.8	6.1	8.0	2.7	5.6	4.0	1.1	5.7	6.9	1.4	1.2	0.8	6.7	0.6	5.3	3.1	1.0	8.4	2.2	1.5	33.8	8.7	3.5	1.4	1.7	1.0	0.8	1.3	7.5	1.6	2.3	20.3	0.8	1.0	1.5	8.3	0.0	1.1	8.3	16.9	6.8	7.5	6.3	13.9	7.2	12.0	14.6	1.4	0.2	0.0	0.5	12.9	6.6	0.3	19.6	11.4	20.2	0.2	10.2	48.8	2.9	0.0	4.4	8.0	0.3	5.0	17.6	26.4	50.8	4.3	5.8	6.2	0.9	5.8	15.9	7.0	0.1	0.0	10.0	0.0	10.2	0.0	16.9	3.2	0.9	0.0	6.3	3.8	6.2	1.8	13.7	9.2	2.4	0.1	11.4	13.7	8.5	9.3	16.3	31.8	13.4	0.0	16.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.1	6.1	3.7	16.3	6.1	8.0	5.7	6.9	5.3	1.7	7.5	8.3	0.7	0.0	7.2	281.4	0.0	13.3	2.1	1.3	7.4	59.4	2.1	1.7	15.2	4.3	6.5	0.0	25.0	0.2	0.0	0.1	1.9	0.6	1.0	4.4	1.0	1.7	1.8	0.0	314.2	0.8	4.9	4.3	0.0	0.4	7.0	2.0	0.0	6.2	3.9	1.7	404.2	6.0	4.1	3.5	1.0	1.1	0.0	0.7	5.4	62.8	0.0	10.6	0.0	134.2	10.3	0.2	0.0	1.5	1.5	2.2	9.5	6.2	78.2	6.9	0.0	25.4	5.8	0.1	2.1	6.4	20.9	0.1	0.9	14.5	1.4	0.5
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU deubiquitinase 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	6.6	6.2	5.7	6.3	6.1	5.9	7.2	5.9	8.6	5.2	5.0	5.3	4.2	6.0	4.6	6.4	4.2	3.9	6.5	5.4	6.1	5.4	5.4	4.7	7.4	6.2	6.2	5.3	4.6	4.0	3.5	8.0	6.3	5.8	5.4	3.1	4.3	4.7	10.2	6.4	4.4	5.5	6.3	5.0	4.3	6.4	5.9	5.7	6.0	9.2	6.1	6.3	5.4	7.5	27.6	11.1	12.8	10.4	6.4	5.6	14.5	19.1	7.4	19.1	12.6	8.6	16.6	25.6	9.0	10.2	7.6	9.1	26.4	16.1	31.6	21.6	16.9	34.5	11.7	8.3	13.3	18.7	21.0	7.2	9.8	14.0	35.5	11.6	17.5	19.4	36.5	19.1	18.9	9.6	31.7	17.5	8.1	20.3	27.3	19.4	11.2	28.9	18.9	15.1	3.5	14.6	2.6	55.9	22.7	16.3	25.5	11.8	15.8	12.3	17.2	20.6	20.5	17.1	29.5	37.2	16.8	26.2	23.1	1.7	1.9	1.1	1.5	2.7	2.0	2.0	1.4	1.7	2.6	1.8	2.1	1.9	0.2	3.4	2.1	4.0	0.8	1.0	5.7	6.1	5.9	8.6	5.4	6.1	6.2	6.2	6.3	6.3	5.9	7.5	11.9	9.6	11.3	9.8	13.7	23.2	6.5	4.0	10.8	13.0	6.5	5.2	14.3	8.6	9.2	1.8	33.3	10.8	16.5	5.1	9.8	4.8	0.9	10.6	9.9	10.9	10.8	8.2	18.0	4.9	10.0	9.0	7.7	8.6	18.4	10.7	8.9	11.7	8.1	11.8	15.5	4.9	4.1	8.7	12.5	2.2	9.6	8.3	3.6	12.2	10.2	12.2	11.3	18.6	21.6	6.6	3.7	4.1	12.0	8.9	2.8	8.2	8.8	15.3	0.0	8.2	9.6	3.2	7.0	12.5	18.2	6.7	10.7	9.9	6.4	5.9
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.4;skeletal muscle: 12.4;tongue: 7.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.6;Excitatory neurons: 8.9;Inhibitory neurons: 7.9;Ionocytes: 8.2;Skeletal myocytes: 20.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;LHCN-M2: 6.7;RH-30: 4.2;U-87 MG: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.3	1.1	0.0	0.3	0.2	0.0	0.1	1.0	2.6	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.3	0.8	1.3	1.0	1.5	0.2	0.1	0.3	0.2	3.4	0.4	0.3	0.1	0.0	1.3	0.8	3.4	0.3	0.0	0.3	0.2	0.7	12.4	0.1	0.1	0.1	0.1	1.6	0.2	1.1	0.6	0.0	0.0	7.7	0.0	0.2	0.1	1.2	0.0	0.4	0.7	0.2	0.1	0.0	0.8	0.1	1.7	0.7	1.2	0.0	0.0	0.0	1.1	0.4	2.9	1.3	0.0	0.1	0.1	0.2	0.0	1.9	0.9	0.0	2.8	0.0	2.4	0.3	0.0	1.2	0.0	9.7	0.0	0.0	2.1	0.6	6.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.2	3.1	1.2	0.1	0.5	0.1	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.2	0.0	0.0	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	2.6	1.0	1.5	3.4	0.4	3.4	0.1	0.6	1.2	0.2	0.0	0.6	0.3	0.1	0.1	0.8	0.8	0.6	7.6	0.0	0.4	2.4	0.0	0.2	1.8	0.0	0.5	0.0	0.1	0.0	0.0	2.2	1.8	0.5	0.2	3.5	2.7	8.9	0.0	0.4	1.4	0.0	0.7	2.5	0.1	1.8	0.1	0.1	1.7	7.9	0.7	8.2	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	5.0	3.3	0.0	0.0	0.4	0.1	0.2	0.0	0.3	3.2	1.1	0.0	20.8	0.4	1.6	0.4	0.3	0.1	0.4	0.5	0.1	0.1	0.2
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119451	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 240.6;skeletal muscle: 311.8;tongue: 492.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3"	"Cancer enhanced"	"Detected in many"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 43.3;neutrophil: 100.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 100.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	0.9	85.9	9.3	161.5	23.7	41.1	164.3	103.9	3.3	33.5	89.8	1.4	0.8	0.6	6.1	2.7	1.6	0.6	82.2	165.1	12.7	0.7	4.4	1.0	205.8	167.0	0.2	1.5	2.1	3.7	1.4	212.0	2.6	92.3	50.5	44.4	1.6	311.8	9.6	8.4	5.8	189.3	13.4	2.2	0.8	144.3	2.1	0.6	492.3	1.3	2.5	1.0	240.6	0.0	11.6	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	4.9	0.2	1.5	0.5	0.1	1.6	0.4	0.1	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	3.8	0.6	1.4	1.6	3.9	0.0	0.0	0.0	0.4	33.1	0.0	2.1	0.2	0.0	50.7	0.0	2.7	13.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	1.3	16.2	43.3	0.0	0.9	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	100.6	0.0	0.2	0.4	0.0	6.4	85.9	161.5	164.3	103.9	82.2	165.1	205.8	167.0	212.0	189.3	144.3	240.6	0.2	0.0	1.3	28.4	1.0	0.3	0.4	0.6	0.0	2.2	31.2	32.5	0.4	0.0	3.3	1.8	95.9	0.2	0.7	178.7	11.7	0.6	6.1	0.0	0.0	8.2	3.6	0.0	1.5	0.0	0.5	0.6	0.0	0.1	17.1	0.5	0.7	0.0	7.2	0.0	1.4	77.3	2.0	4.8	25.8	10.3	0.3	9.2	28.4	15.9	33.8	33.6	0.0	13.6	117.1	0.0	72.3	0.7	0.4	0.5	15.0	0.3	0.2	29.6	0.0	5.6	1.3	0.2	0.4	0.0	0.4	0.1	0.4	0.0	51.8	0.2
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764523	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	1.3	2.9	2.5	1.9	3.0	0.2	2.7	2.8	3.1	2.7	3.0	4.0	2.7	2.5	3.2	2.7	4.4	1.6	3.0	2.6	2.6	4.2	3.4	1.4	2.0	2.5	2.7	4.8	2.3	4.7	2.1	2.5	2.7	2.3	3.6	2.0	3.3	2.8	4.4	2.9	2.1	2.0	2.7	1.8	2.5	4.8	2.7	2.6	2.9	5.5	2.4	2.1	2.0	3.0	4.4	7.2	4.6	6.0	5.5	4.6	10.3	3.7	4.5	6.4	4.6	8.3	2.8	7.7	5.6	3.3	9.3	6.9	8.3	5.8	4.7	5.0	7.5	7.4	4.0	6.2	8.5	4.3	2.5	5.0	8.8	8.3	7.4	5.5	4.8	8.4	13.2	1.0	4.9	4.6	6.1	5.7	10.6	8.3	9.1	4.6	9.0	9.0	5.4	3.2	4.7	4.8	5.3	6.9	9.7	8.7	3.9	5.5	2.6	4.8	4.9	6.8	4.7	7.3	6.6	3.0	3.6	5.1	2.8	1.2	5.3	4.5	4.8	7.7	5.9	4.9	5.3	5.3	7.3	5.5	7.8	5.3	0.5	7.4	10.7	5.9	8.2	5.0	2.5	3.0	2.8	3.1	2.6	2.6	2.5	2.7	2.7	2.7	2.7	3.0	0.6	0.0	1.1	0.3	1.0	0.6	0.9	2.0	1.8	2.6	1.3	1.9	1.5	2.8	1.8	0.0	0.0	7.0	0.2	2.4	9.8	4.5	11.0	1.1	1.4	0.8	0.0	0.0	0.9	2.8	3.9	1.3	1.5	0.6	0.0	2.9	0.0	2.3	3.1	5.0	1.1	2.8	0.0	1.2	0.3	6.8	3.7	0.8	0.0	2.8	1.1	3.2	0.0	0.5	1.6	1.9	1.5	3.0	0.3	1.8	1.5	6.5	1.0	1.9	0.0	1.3	1.1	10.5	11.5	2.0	1.0	3.3	0.7	5.1	3.5	0.8
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18630846-18748866	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 4.2;skeletal muscle: 5.7;tongue: 4.4"	"Cell type enriched"	"Detected in some"	284	"Skeletal myocytes: 341.4"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.4;CAPAN-2: 1.4;U-2 OS: 3.0"	"Region enriched"	"Detected in single"	17	"midbrain: 4.6"	"Region enhanced"	"Detected in some"		"thalamus: 4.3"							NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	3.1	4.2	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	1.3	0.3	0.1	3.1	4.2	2.2	2.4	0.4	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	341.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051374-141059346	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cardiomyocytes: 2.7;Respiratory ciliated cells: 2.2;Skeletal myocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA053921	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.2	0.4	0.1	0.4	0.4	0.0	0.9	0.5	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.1	0.4	0.2	0.3	0.1	0.1	0.2	0.4	0.3	0.1	0.4	0.3	0.5	0.1	0.4	0.1	0.0	0.5	0.2	0.0	1.4	0.3	0.2	0.0	0.1	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.9	0.5	0.4	0.2	0.4	0.3	0.4	0.1	0.3	0.4	0.0	0.0	1.1	0.0	0.4	0.0	0.9	0.0	0.0	0.3	0.1	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.2	0.4	0.0	1.2	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408597	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		410000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	25.7	29.6	35.8	22.6	36.2	23.2	24.4	36.5	39.3	26.2	34.1	32.4	17.9	26.9	17.5	37.2	22.6	11.9	40.2	34.4	36.1	28.5	31.3	24.0	18.9	37.3	37.9	25.7	26.6	22.5	21.9	19.2	37.4	26.0	18.0	22.9	26.2	20.9	105.0	27.9	23.3	21.1	37.6	23.8	26.3	19.7	37.0	25.5	24.3	59.7	22.4	29.3	26.4	36.6	96.9	82.4	54.6	71.0	41.5	43.2	34.7	76.7	44.9	61.6	51.8	83.9	47.4	41.3	67.2	74.7	78.4	50.2	66.3	78.4	60.5	59.8	74.4	43.6	80.8	74.1	60.8	80.1	40.5	45.6	58.5	68.1	110.3	56.3	62.7	67.5	103.0	75.6	61.4	200.3	110.4	111.2	68.7	98.1	88.3	50.5	54.3	73.6	63.6	73.0	54.8	110.6	58.0	92.4	43.4	61.3	41.1	42.5	57.6	83.6	91.4	100.8	123.6	71.4	87.5	91.0	67.7	72.2	89.1	13.4	12.1	12.5	15.4	16.6	13.9	15.7	14.2	11.2	10.2	14.9	9.8	13.2	31.6	28.0	15.6	21.1	20.9	6.6	35.8	36.2	36.5	39.3	34.4	36.1	37.3	37.9	37.4	37.6	37.0	36.6	82.9	86.6	94.7	6.2	73.6	62.2	110.6	104.6	57.5	97.4	84.3	76.6	63.6	72.9	86.7	42.3	33.3	213.1	84.7	101.6	168.3	176.1	60.3	91.3	118.6	99.1	117.9	151.7	10.1	171.0	223.0	87.4	59.7	88.3	72.2	83.4	61.8	80.8	114.9	77.4	11.6	116.5	75.3	38.3	63.3	78.3	83.6	66.1	103.2	5.6	102.1	166.4	119.4	8.0	17.4	177.4	92.2	92.2	102.5	184.3	100.0	134.5	96.8	101.0	52.6	85.6	127.2	132.5	123.0	131.9	65.6	184.4	79.5	115.2	114.0	122.5
PDCD2L	MGC13096	ENSG00000126249	"Programmed cell death 2 like"	Q9BRP1	19	34404399-34426168	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 24.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 35.7;Spermatogonia: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052181	Approved		Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA052181: AB_2681751"	"unprognostic (5.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.98e-2)"	4.2	5.6	5.0	2.7	5.3	3.1	4.1	4.8	5.8	4.3	4.2	5.3	2.6	5.0	2.9	5.3	5.0	2.1	7.5	5.0	5.6	3.5	5.5	2.9	4.7	4.5	4.7	4.4	8.3	2.2	5.8	2.5	4.9	3.4	3.4	1.1	5.5	3.8	24.7	4.7	4.0	3.1	4.7	4.8	6.5	14.4	5.4	2.9	3.1	9.1	4.8	4.8	3.9	5.7	21.6	35.9	4.4	8.7	2.0	4.2	13.8	6.8	4.9	11.1	11.1	33.6	15.1	17.7	28.8	3.9	11.6	7.4	17.4	14.9	11.7	26.1	36.6	17.4	5.7	26.8	14.5	34.0	9.8	5.1	12.9	6.5	21.2	4.6	11.3	28.0	35.1	9.0	9.6	27.3	13.4	12.4	16.0	47.3	34.4	19.2	8.2	25.1	14.1	12.1	25.8	9.2	0.7	21.4	12.5	7.3	9.3	13.9	6.0	7.3	9.0	8.6	23.4	20.1	32.8	31.4	9.1	29.8	6.3	0.0	3.3	0.0	9.1	5.3	12.9	12.7	8.9	9.0	6.8	10.1	13.1	9.9	0.7	12.5	3.4	23.6	11.7	5.7	5.0	5.3	4.8	5.8	5.0	5.6	4.5	4.7	4.9	4.7	5.4	5.7	5.5	3.2	4.8	3.6	7.6	8.2	15.0	7.6	10.2	4.3	4.8	7.4	5.1	5.7	4.8	3.7	2.1	8.1	12.0	1.7	7.9	13.3	27.4	6.3	4.3	4.9	12.1	4.6	4.2	15.3	7.0	5.1	9.2	2.7	4.5	5.6	5.0	5.1	7.5	1.7	4.3	5.0	2.0	3.3	3.7	3.9	5.3	4.1	3.6	2.8	7.1	4.8	9.2	4.0	3.4	13.1	5.0	6.8	8.2	27.6	1.1	10.2	6.1	2.4	0.0	6.1	12.6	35.7	42.9	7.5	10.7	1.8	5.4	8.2	7.7	9.6
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851701-136195574	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 346.4;Excitatory neurons: 136.7;Inhibitory neurons: 166.0;Oligodendrocyte precursor cells: 343.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;ASC TERT1: 10.2;EFO-21: 16.2;HeLa: 9.6;HSkMC: 22.4;HUVEC TERT2: 10.8;U-2197: 11.4"	"Region enriched"	"Detected in all"	5	"basal ganglia: 125.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.2	2.3	6.5	2.2	22.1	0.1	2.6	3.6	8.1	3.9	2.8	2.5	1.9	7.8	2.2	1.3	2.8	3.4	6.6	2.6	8.7	5.5	3.7	1.7	1.5	6.2	11.6	13.0	0.8	6.2	4.8	1.0	6.0	4.3	2.7	2.4	2.9	10.3	4.7	0.8	2.2	7.6	4.6	1.1	3.6	1.5	15.8	3.8	4.7	8.9	0.8	6.0	3.6	2.8	0.0	5.7	0.2	0.0	8.7	10.2	0.1	0.5	2.9	2.1	1.1	0.0	0.1	0.1	16.2	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	9.6	0.0	3.7	0.1	0.0	22.4	0.0	4.2	0.0	0.9	10.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.8	0.7	3.9	3.7	0.1	0.2	0.0	0.0	1.8	0.0	2.3	0.0	11.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.8	1.3	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.1	6.5	22.1	3.6	8.1	2.6	8.7	6.2	11.6	6.0	4.6	15.8	2.8	8.3	0.0	0.5	346.4	11.9	0.4	0.3	0.5	0.0	4.4	0.9	0.4	8.4	2.8	0.2	22.0	0.0	0.1	0.7	0.1	0.0	0.2	0.5	3.1	1.4	23.1	7.3	0.8	136.7	1.6	0.0	9.8	4.6	2.1	10.2	31.1	35.3	3.8	0.3	6.7	166.0	0.0	0.0	1.9	4.8	0.9	12.2	3.2	0.0	70.3	0.7	11.5	0.0	343.8	10.4	0.1	0.0	7.9	0.2	0.4	0.0	1.6	1.6	0.9	13.1	30.6	9.1	0.3	0.1	0.2	1.4	0.0	2.9	4.4	0.0	0.3
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		580000	"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	15.4	8.5	29.3	7.9	36.8	1.7	17.0	36.6	32.4	18.1	20.5	29.2	20.2	26.1	11.2	9.6	21.2	11.4	21.1	27.0	27.5	22.2	8.5	24.9	3.5	46.4	37.5	7.7	71.6	6.6	10.2	26.8	40.7	23.3	14.8	5.2	20.3	11.2	95.2	12.5	25.9	10.2	35.8	16.3	32.1	4.5	36.5	6.6	10.0	15.1	2.4	17.8	15.9	58.8	22.9	15.3	1.5	21.6	4.1	0.7	50.7	5.0	2.9	6.4	4.4	23.8	25.3	0.6	8.7	4.3	2.9	56.6	1.5	69.0	3.4	12.9	2.3	0.3	13.3	8.7	26.9	2.4	2.2	3.0	26.8	3.3	21.3	8.5	12.5	1.3	2.3	3.1	15.8	28.7	3.5	5.0	40.1	8.9	3.3	11.6	1.5	2.5	9.0	5.3	2.1	1.8	76.5	4.2	13.3	47.5	10.7	2.6	37.3	13.6	37.8	8.0	31.0	0.9	1.4	0.8	12.3	7.1	311.4	11.3	1.6	2.4	1.6	1.9	2.2	1.9	1.6	1.5	1.5	1.8	1.9	2.0	4.9	3.4	3.3	2.1	1.8	2.1	29.3	36.8	36.6	32.4	27.0	27.5	46.4	37.5	40.7	35.8	36.5	58.8	15.2	89.8	11.9	11.1	1.5	28.0	20.2	12.1	59.7	15.7	12.7	154.9	29.9	15.7	11.0	14.7	8.4	8.8	1.7	76.9	5.9	15.8	0.3	49.0	4.2	19.4	13.1	0.0	7.7	53.3	5.4	12.3	41.8	35.7	10.8	18.1	21.0	1.0	2.0	32.0	5.9	40.5	2.0	1.3	10.4	0.1	2.1	14.8	14.2	6.5	1.5	0.7	1.0	5.0	27.5	72.6	97.0	6.4	4.4	29.4	47.2	8.5	4.5	2.1	39.5	48.9	110.3	0.5	1.8	9.4	9.8	2.9	3.9	0.2	32.1	18.2
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.2;tongue: 285.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 123.0;Proximal tubular cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	40.8	63.8	49.9	8.7	51.2	5.0	26.4	65.7	58.2	30.5	37.1	42.7	28.1	29.4	124.4	21.8	24.3	18.0	116.6	50.6	41.8	62.7	50.8	15.3	10.1	40.8	44.0	48.2	44.3	40.7	17.0	14.7	41.8	23.5	21.5	14.7	25.7	27.4	216.2	26.0	32.5	25.7	40.8	18.4	33.7	13.7	44.6	12.6	27.3	285.0	9.2	30.9	22.2	44.6	12.4	17.5	20.6	18.5	21.2	16.5	2.2	13.2	19.3	19.3	18.5	1.7	13.2	15.5	21.7	37.0	13.0	6.4	13.7	5.3	18.8	30.6	19.3	14.0	17.1	13.2	11.3	0.0	15.0	33.6	19.6	12.5	0.9	33.7	17.2	20.0	5.7	15.0	11.0	15.8	11.8	0.0	4.5	37.2	17.1	17.5	45.8	21.1	10.4	10.4	13.8	20.7	18.7	5.9	9.0	25.0	35.0	13.7	8.8	22.5	18.4	16.0	10.1	29.4	29.9	8.2	33.3	4.9	15.4	14.3	16.2	8.9	16.2	12.9	12.8	12.9	14.8	18.0	18.4	13.8	17.2	18.0	2.6	22.9	14.1	25.8	22.4	17.4	49.9	51.2	65.7	58.2	50.6	41.8	40.8	44.0	41.8	40.8	44.6	44.6	17.9	9.6	10.3	18.3	12.1	15.2	12.3	12.4	17.6	19.0	16.0	26.8	5.4	12.8	11.7	20.2	6.2	19.6	16.7	38.6	58.7	11.7	8.8	6.5	12.1	11.8	13.8	10.8	18.6	9.1	3.6	17.7	13.7	7.8	1.3	19.0	18.2	52.0	19.9	43.7	15.6	50.2	16.2	13.6	9.1	18.9	24.2	12.0	24.9	8.4	14.5	37.3	7.2	6.0	11.3	6.2	55.2	52.6	25.9	6.7	123.0	131.9	6.5	11.0	19.7	15.0	20.5	3.3	11.7	14.6	18.8	7.9	12.9	29.0	36.9	11.3
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 382.5;skeletal muscle: 670.8;tongue: 581.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 177.3;Cardiomyocytes: 144.7;Muller glia cells: 198.7"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-266/70: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA025064	Uncertain				"Secreted in other tissues"	NA	NA		190000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	1.1	3.4	12.3	0.3	16.7	0.0	3.3	21.2	9.2	0.6	19.2	0.6	0.0	0.5	382.5	6.8	2.2	1.1	200.7	8.5	15.8	2.6	0.9	115.1	0.7	15.6	20.3	1.7	34.5	82.6	13.2	0.3	20.2	45.8	0.2	12.9	21.1	2.8	670.8	1.4	0.6	0.4	8.7	0.8	9.2	6.6	28.7	1.2	56.7	581.4	1.6	0.3	0.5	15.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	12.3	16.7	21.2	9.2	8.5	15.8	15.6	20.3	20.2	8.7	28.7	15.5	1.5	109.0	177.3	15.3	2.2	1.9	1.0	0.1	0.0	10.2	5.7	4.7	144.7	0.0	7.4	1.8	2.1	0.8	1.4	0.3	3.9	0.0	34.8	1.7	2.0	2.4	0.0	0.0	10.0	9.3	0.2	10.1	2.0	7.0	7.6	0.4	3.9	0.7	1.2	10.1	9.6	0.3	2.0	0.0	0.8	28.4	3.4	1.4	1.8	6.5	0.1	198.7	5.2	6.6	0.9	0.3	0.1	10.9	1.5	23.8	0.5	5.9	2.9	8.6	0.0	25.2	2.1	14.8	1.2	0.0	0.9	0.0	1.6	1.1	0.3	1.0
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.2	17.8	34.9	13.4	34.1	10.9	14.9	29.9	33.1	19.9	21.2	18.3	11.8	21.5	6.2	19.5	19.8	8.8	23.1	33.4	30.7	16.8	17.7	13.1	16.3	34.2	33.3	21.9	17.5	15.5	23.5	11.4	33.8	20.5	7.5	8.7	15.3	12.2	46.8	18.7	17.4	10.8	31.8	20.5	17.5	32.8	33.6	12.5	17.2	18.1	12.0	19.5	17.0	33.9	41.8	89.8	34.8	55.3	26.5	19.5	77.9	29.6	20.5	40.1	42.7	88.1	30.0	100.0	44.4	23.4	28.5	62.6	65.1	46.3	22.6	52.1	93.2	44.6	45.1	72.0	34.2	36.4	57.5	23.9	28.2	49.5	41.3	20.7	30.2	52.9	54.7	42.6	22.4	57.2	68.9	42.7	57.3	40.2	29.7	71.7	30.8	49.3	28.2	31.2	34.8	46.5	50.8	36.9	39.4	33.1	44.6	24.3	30.7	30.9	43.5	47.3	57.9	22.7	42.5	41.6	34.9	37.1	40.6	0.2	0.7	2.0	0.9	1.0	0.9	0.8	0.9	0.7	0.8	1.3	0.9	1.3	0.2	1.3	1.2	1.1	0.6	0.7	34.9	34.1	29.9	33.1	33.4	30.7	34.2	33.3	33.8	31.8	33.6	33.9	10.4	22.4	30.1	11.1	18.5	14.8	14.8	15.7	21.1	24.0	13.5	12.4	22.6	8.6	20.9	9.2	16.7	30.9	15.3	11.8	1.9	15.9	64.7	16.6	17.3	13.7	12.6	14.1	10.6	14.6	28.3	16.6	16.8	17.6	30.9	21.1	5.0	10.6	16.9	35.3	13.0	18.6	12.2	6.0	20.4	27.0	9.3	10.4	10.6	5.6	65.1	10.7	5.2	5.0	11.5	11.4	11.7	19.2	23.6	19.3	8.3	4.7	22.3	17.8	6.6	16.8	14.8	31.3	67.5	20.0	16.3	21.2	17.4	16.6	21.9	13.0
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245035-140303113	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavorable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	74.1	50.9	73.9	37.7	75.6	60.2	50.0	82.2	88.4	41.4	70.8	59.2	40.2	50.8	54.3	52.3	41.9	35.7	93.3	77.2	79.7	61.6	38.5	46.9	46.1	82.9	77.2	37.2	34.7	52.8	39.4	50.8	80.5	44.8	42.9	35.1	45.4	43.7	149.0	46.2	39.8	61.4	79.1	36.6	40.7	29.9	79.3	51.5	42.4	86.4	51.6	45.9	40.9	81.2	172.4	79.6	137.7	80.9	89.7	91.8	133.8	229.6	114.9	174.6	192.6	172.1	107.9	114.9	224.1	124.3	180.0	62.6	102.0	228.7	204.2	122.6	102.9	102.4	76.5	113.0	105.1	213.5	76.4	98.2	119.8	148.5	156.3	112.6	196.0	132.8	93.7	73.1	149.8	78.5	146.0	147.6	92.0	70.3	119.2	101.3	195.9	86.3	197.1	77.9	78.2	81.8	172.1	148.6	136.8	128.5	102.1	122.3	249.1	121.8	119.6	71.9	208.0	70.3	198.6	299.2	122.5	138.5	144.1	149.5	84.7	130.3	86.2	131.1	91.8	106.0	98.6	100.4	100.5	97.9	97.3	88.4	14.0	114.7	130.3	93.0	129.3	115.5	73.9	75.6	82.2	88.4	77.2	79.7	82.9	77.2	80.5	79.1	79.3	81.2	87.9	67.3	33.0	16.3	57.4	38.0	65.9	96.2	30.7	42.5	50.1	57.3	81.3	52.9	62.1	66.2	45.9	116.1	53.1	56.6	123.3	121.9	3.9	58.0	56.6	73.8	46.6	62.9	31.2	101.7	86.6	55.4	35.2	70.9	54.4	53.6	72.1	56.9	85.4	25.2	29.3	43.6	48.8	61.1	37.7	12.9	52.2	63.4	74.7	37.5	90.4	84.9	71.1	24.1	39.3	128.9	55.1	52.3	35.5	45.4	80.9	147.3	45.3	42.9	65.7	39.6	63.7	23.7	61.8	40.8	34.9	85.6	45.2	42.9	47.3	63.6
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 334.6;skeletal muscle: 621.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	334.6	22.7	66.1	72.2	81.2	246.0	153.8	75.4	66.6	30.2	22.1	22.2	19.4	24.0	11.1	51.3	37.7	59.9	21.9	62.8	105.8	243.9	32.8	67.7	24.5	145.7	100.9	24.2	21.0	10.1	39.6	20.0	100.9	20.2	8.9	31.5	40.4	49.5	621.3	53.6	22.9	16.9	90.1	50.2	26.1	13.9	91.8	15.1	10.9	30.4	28.2	63.9	40.3	105.6	22.0	296.2	23.1	18.8	85.2	10.5	12.2	31.6	22.5	22.9	35.5	14.1	78.0	37.2	20.2	13.8	18.0	69.0	24.9	50.2	26.3	44.6	17.3	22.1	16.2	5.2	7.2	21.6	32.2	7.6	16.4	39.5	9.5	58.3	44.9	25.6	16.6	13.6	18.6	35.7	15.3	20.3	22.5	31.1	20.5	34.3	11.3	14.7	181.8	11.1	21.9	8.9	22.9	24.7	45.8	39.5	192.0	25.2	57.0	23.9	22.0	3.1	38.7	27.8	10.4	33.7	65.8	25.0	37.4	2.9	7.5	7.7	2.2	9.2	5.7	1.8	4.2	2.9	4.7	1.6	3.0	3.0	26.4	1.2	5.5	2.9	4.3	4.3	66.1	81.2	75.4	66.6	62.8	105.8	145.7	100.9	100.9	90.1	91.8	105.6	37.1	76.9	55.1	153.8	27.2	102.6	16.7	21.5	37.5	6.4	37.1	36.8	19.5	22.8	32.1	195.0	52.1	0.4	37.0	14.9	0.0	54.7	5.0	41.1	18.9	32.9	8.5	1.3	42.8	25.7	6.9	30.8	33.1	64.3	44.2	72.5	8.9	15.8	20.6	6.7	19.4	6.6	18.3	88.0	132.3	9.5	2.8	122.2	46.2	41.2	19.6	0.3	4.1	14.1	31.9	59.6	5.2	7.2	25.3	4.2	5.4	2.4	19.2	1.9	0.0	58.5	24.4	0.6	2.5	20.9	63.9	1.0	61.7	12.4	8.1	14.7
PFN2		ENSG00000070087	"Profilin 2"	P35080	3	149964904-150050788	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 461.8;Ionocytes: 231.9;Muller glia cells: 289.3;Proximal tubular cells: 198.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035611, CAB037073"	Enhanced					NA	NA		19000	"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB037073: AB_1079600, HPA035611: AB_10672870"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.42e-4)"	"prognostic unfavorable (2.19e-7)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.99e-1)"	27.3	39.1	188.0	19.8	205.1	3.1	35.9	147.7	261.5	42.4	165.3	44.3	25.2	60.9	151.8	25.0	97.1	35.8	45.7	268.1	182.4	116.0	25.0	20.2	7.2	162.1	154.4	60.5	37.8	79.3	61.7	21.4	164.3	66.2	27.4	154.9	49.0	64.7	255.3	14.1	34.4	58.8	165.3	16.3	38.4	27.4	166.3	28.4	99.5	89.9	10.2	52.1	32.5	192.3	556.7	189.8	446.3	184.0	97.5	330.3	119.1	174.0	262.9	268.3	310.1	71.2	435.7	0.1	357.8	383.1	457.2	5.7	187.0	247.5	386.7	17.8	111.3	6.5	94.7	206.0	130.1	31.3	8.8	209.1	205.4	263.9	341.5	285.9	159.3	87.9	1.6	21.3	282.9	206.0	27.3	1.5	195.0	3.7	248.1	31.1	321.7	2.6	200.8	278.6	241.6	248.8	86.4	41.1	239.6	306.6	65.3	4.5	116.1	127.2	177.3	214.1	228.4	28.5	2.3	14.7	275.3	1.8	159.2	1.7	0.2	0.4	2.2	0.1	4.7	2.0	4.8	4.1	0.1	1.0	7.3	4.4	1.2	1.4	0.0	0.2	1.4	2.1	188.0	205.1	147.7	261.5	268.1	182.4	162.1	154.4	164.3	165.3	166.3	192.3	16.2	6.4	6.9	26.4	4.5	9.8	52.4	106.0	100.2	52.1	54.3	37.0	48.3	32.9	47.3	136.1	18.8	11.9	1.9	12.8	461.8	42.1	57.6	75.5	28.3	22.6	121.2	0.0	65.0	27.3	11.5	54.7	7.7	10.6	8.2	39.5	25.4	12.3	3.2	26.9	33.8	27.9	231.9	1.2	9.3	27.2	74.0	2.9	35.6	15.9	4.8	289.3	1.0	21.6	30.3	14.9	19.4	96.7	3.4	57.9	103.2	198.2	116.4	42.2	13.1	52.7	71.8	28.5	19.2	51.5	7.5	10.3	5.0	55.8	30.5	37.7
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600925-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA059630: AB_2684088, HPA070326: AB_2686253"	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	8.2	8.9	9.5	7.1	9.5	4.4	8.1	11.8	10.3	6.9	7.9	6.3	5.0	9.1	7.5	9.0	7.9	7.1	9.7	9.8	8.9	7.6	8.2	6.4	10.9	8.8	9.0	11.4	7.1	8.8	5.1	7.3	9.1	8.4	6.2	8.4	7.3	6.2	12.1	10.6	5.4	8.3	9.0	7.1	6.3	5.6	9.8	7.2	8.7	10.0	10.4	7.7	5.5	10.9	15.5	15.9	13.5	25.6	19.0	18.3	14.9	21.4	16.0	17.6	16.4	21.8	15.1	15.2	19.0	27.7	21.2	12.2	19.1	29.7	25.7	24.7	20.4	13.0	18.5	8.8	11.3	10.8	13.5	18.6	16.4	17.2	15.6	16.5	15.0	8.7	10.4	17.2	27.4	13.3	15.2	13.4	16.9	10.3	12.4	12.1	19.1	12.4	16.4	18.1	17.3	19.9	19.3	16.4	22.7	13.0	22.0	14.7	23.2	29.0	16.1	16.3	32.7	13.3	13.6	17.0	20.8	17.4	21.3	8.7	4.8	6.6	7.1	5.7	8.1	8.2	7.1	7.4	4.8	7.1	7.9	8.3	3.8	10.7	6.1	6.4	6.5	5.5	9.5	9.5	11.8	10.3	9.8	8.9	8.8	9.0	9.1	9.0	9.8	10.9	34.6	25.6	40.2	10.7	36.1	28.6	31.6	72.1	26.7	60.0	27.7	42.2	56.6	20.0	47.3	35.0	39.6	51.5	42.4	29.5	74.3	53.6	37.2	32.8	44.6	36.8	27.5	26.9	14.2	33.3	50.3	41.8	16.3	28.3	46.9	35.0	28.2	28.5	30.1	75.7	14.8	26.9	65.1	17.2	17.6	9.7	42.0	21.9	21.4	5.6	43.4	86.9	37.0	8.0	11.8	40.3	23.1	41.3	29.7	31.9	16.5	56.1	63.3	72.3	46.0	50.3	51.7	64.5	86.4	32.3	25.9	51.4	34.2	43.2	27.7	27.8
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703902-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055649: AB_2682875"	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	41.9	78.5	49.1	39.0	55.4	53.4	40.9	52.2	53.9	43.1	46.3	49.2	32.3	40.0	39.2	46.7	39.7	34.6	46.5	43.0	54.2	38.4	52.4	40.4	61.7	52.5	56.2	80.7	41.0	47.7	36.3	43.7	54.8	48.4	34.6	59.1	44.5	44.7	81.3	50.9	40.7	33.4	56.6	49.8	42.7	41.7	55.0	53.2	48.6	63.7	61.3	42.3	41.9	57.4	31.2	30.7	119.2	125.5	40.7	24.5	49.0	41.2	37.3	49.8	54.3	88.9	31.4	91.1	24.4	29.2	31.7	38.4	92.5	45.3	72.0	73.3	82.1	91.1	54.8	116.9	41.5	134.2	5.4	18.5	46.7	32.1	29.4	82.3	80.2	64.4	102.7	57.5	36.0	53.4	25.6	115.0	37.6	68.3	18.9	121.0	84.4	73.7	62.1	32.5	56.7	75.9	56.4	18.4	41.5	49.7	36.3	158.6	54.0	28.1	46.6	36.3	53.2	50.7	46.1	112.3	36.7	88.6	45.6	1.6	1.4	3.2	1.5	1.5	1.4	2.6	2.7	2.1	1.4	1.7	2.6	2.8	0.2	1.2	1.6	1.2	1.8	0.8	49.1	55.4	52.2	53.9	43.0	54.2	52.5	56.2	54.8	56.6	55.0	57.4	42.5	25.6	30.1	17.9	24.5	29.8	22.7	13.3	13.1	12.1	38.1	31.8	59.3	35.8	23.7	11.0	41.7	14.8	25.9	11.0	13.7	12.5	15.3	32.1	27.4	28.2	25.9	7.4	14.9	12.6	8.9	27.6	12.8	42.1	6.3	38.1	29.3	27.5	11.6	11.8	19.0	22.8	18.3	13.9	28.7	9.7	22.4	21.5	19.6	28.1	11.8	33.4	10.3	17.6	33.6	17.1	19.4	21.1	16.4	27.6	18.6	12.4	22.7	26.8	19.7	27.9	53.1	18.9	22.0	21.2	23.4	17.4	21.2	33.2	20.0	27.4
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"parathyroid gland: 32.0;skeletal muscle: 102.6;tongue: 89.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	3.2	17.7	6.9	1.0	11.4	0.7	4.8	8.9	5.7	2.6	17.0	4.0	1.1	3.3	6.5	5.6	3.8	3.2	7.5	6.0	8.7	2.7	2.3	2.1	1.1	8.8	11.9	8.3	7.6	32.0	9.8	1.8	9.1	6.0	3.3	3.9	7.1	6.4	102.6	3.4	2.1	3.4	7.9	3.4	6.9	2.1	10.4	4.0	6.9	89.2	1.4	4.8	3.5	6.7	15.3	21.2	1.2	12.4	7.2	6.8	12.9	2.8	2.6	0.5	0.1	6.2	13.3	0.0	8.2	0.3	15.1	5.9	24.9	10.3	0.8	39.2	25.1	7.0	17.4	5.7	7.5	0.0	0.0	9.1	10.0	2.4	16.7	12.5	14.5	12.7	11.0	0.0	13.6	11.0	11.1	0.7	16.5	25.2	28.0	0.0	0.0	0.0	3.7	7.2	12.9	15.3	13.4	17.3	0.2	15.4	6.2	0.6	7.5	0.0	6.2	2.7	7.3	17.1	17.1	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	11.4	8.9	5.7	6.0	8.7	8.8	11.9	9.1	7.9	10.4	6.7	5.8	0.0	3.7	85.2	0.5	2.4	6.5	2.3	4.0	2.4	5.2	3.7	6.6	1.5	3.5	11.0	8.4	1.0	0.1	0.8	0.0	1.6	0.4	4.8	1.4	3.5	2.4	4.0	5.3	2.7	1.1	2.5	3.6	2.9	6.3	3.4	5.7	1.9	1.6	3.3	16.0	1.8	4.1	10.4	0.7	0.1	3.1	0.6	1.8	6.5	0.0	1.5	0.0	18.6	0.5	5.4	0.4	8.6	1.3	9.0	0.4	1.6	6.6	3.3	0.0	7.1	1.9	0.4	1.0	5.6	3.4	0.5	0.3	1.9	2.6	8.9
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 264.6;tongue: 172.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Hepatocytes: 46.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	4.0	4.1	11.4	0.7	15.0	1.7	2.8	14.8	11.6	1.8	8.8	8.5	1.1	1.3	0.7	5.2	1.9	1.6	18.7	11.8	15.6	1.1	1.6	1.7	0.8	17.6	17.5	1.8	1.2	0.9	2.4	0.3	15.3	2.3	0.7	0.9	5.2	0.5	264.6	3.3	2.5	1.1	16.6	1.5	1.6	1.0	16.9	0.7	2.0	172.3	0.9	4.1	1.2	15.4	1.1	0.8	0.2	0.7	1.1	2.0	0.6	0.1	0.2	0.4	0.3	0.3	0.5	0.3	0.2	0.3	0.5	0.6	0.5	0.1	0.3	0.3	0.9	0.3	1.5	0.3	0.2	0.6	1.2	1.2	0.8	0.5	0.2	0.3	0.0	0.8	0.9	1.5	0.0	0.5	0.9	2.4	0.3	0.3	0.5	0.5	0.0	0.3	0.2	0.8	0.6	0.6	0.1	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.6	1.7	0.5	0.6	0.3	0.9	0.4	0.6	0.4	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.0	11.4	15.0	14.8	11.6	11.8	15.6	17.6	17.5	15.3	16.6	16.9	15.4	12.6	12.8	4.2	16.0	10.4	1.3	7.7	0.2	0.6	3.9	25.6	6.7	1.7	48.6	3.7	27.6	0.0	7.5	17.7	9.0	1.9	14.6	2.7	20.8	11.3	8.2	16.7	6.6	3.1	12.3	14.5	10.4	2.6	16.4	8.2	4.6	23.6	46.5	12.1	11.8	3.8	12.6	0.0	36.8	1.2	5.9	18.0	8.9	1.8	3.7	10.7	5.0	8.2	3.5	5.2	11.0	10.1	16.1	5.2	11.6	17.8	16.8	2.2	5.4	13.1	34.0	7.2	11.1	9.1	1.2	1.0	7.3	8.2	3.7	24.1	8.4
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA041706: AB_2677627, HPA046766: AB_2679794"	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	11.0	14.8	20.8	9.7	25.3	10.6	13.5	23.4	25.3	13.6	18.0	20.0	12.2	16.3	19.8	18.6	25.1	11.4	16.2	21.2	22.0	16.0	13.8	10.3	11.8	24.5	22.5	20.9	11.5	28.9	14.3	15.9	24.7	12.3	22.3	16.5	12.3	13.5	16.2	12.9	13.3	17.6	23.3	9.6	10.9	19.1	22.7	14.7	13.2	20.5	15.8	14.2	13.8	31.7	30.2	37.2	47.0	34.4	30.0	36.1	46.8	30.0	35.8	50.3	43.9	69.3	61.9	38.4	48.0	30.0	65.1	54.5	43.1	57.0	50.6	16.5	23.2	87.3	22.6	78.9	27.9	53.4	20.0	32.1	36.2	28.9	32.8	23.2	36.7	37.9	44.4	33.4	43.0	33.5	45.6	54.0	23.7	68.8	55.9	32.7	58.5	61.8	44.5	27.4	30.0	28.2	56.6	101.0	38.0	26.0	55.8	37.1	21.7	82.0	29.1	44.8	30.8	22.2	33.3	25.4	49.9	54.8	36.0	14.0	5.6	2.4	16.2	8.4	14.4	10.7	14.5	17.8	13.6	12.6	14.4	14.5	1.0	16.7	6.8	13.2	14.1	8.8	20.8	25.3	23.4	25.3	21.2	22.0	24.5	22.5	24.7	23.3	22.7	31.7	5.2	9.6	4.8	26.8	6.4	4.5	11.8	32.7	7.4	8.9	4.9	4.7	6.6	8.6	21.6	11.0	16.7	40.1	5.7	15.4	1.9	19.2	17.8	14.4	7.2	9.1	10.2	9.1	30.4	17.6	29.3	10.1	4.6	11.5	8.2	19.5	7.1	8.5	15.8	1.7	39.0	15.3	22.4	6.5	2.2	16.7	5.6	4.7	1.8	16.9	5.7	8.5	5.2	46.3	78.5	10.4	19.0	7.9	7.6	10.6	9.0	9.2	28.5	9.5	19.7	8.3	13.7	34.6	12.8	9.5	5.8	21.2	6.8	9.8	24.3	8.7
PINK1	"BRPK, PARK6"	ENSG00000158828	"PTEN induced kinase 1"	Q9BXM7	1	20633458-20651511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 384.4;tongue: 392.3"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	50.7	127.2	119.3	13.7	103.4	13.0	41.9	104.6	110.9	37.9	73.0	62.3	32.3	43.9	18.8	48.8	34.4	23.5	153.4	106.6	107.0	56.8	76.8	30.1	10.8	118.5	127.8	30.1	52.7	66.5	33.4	21.3	118.3	37.1	15.0	29.4	55.0	29.7	384.4	55.3	35.2	20.0	124.9	27.9	46.7	94.8	132.1	12.3	41.6	392.3	8.3	47.4	42.7	95.0	49.9	22.2	10.3	29.6	34.6	32.8	10.7	68.2	67.9	32.4	56.1	7.7	39.3	11.7	52.6	69.9	75.4	22.5	15.0	36.2	16.0	14.0	56.8	5.9	60.3	12.1	26.8	6.3	17.7	30.8	38.5	40.6	13.9	36.2	21.3	10.7	14.5	14.5	23.6	21.2	9.2	14.1	4.6	12.9	72.2	7.9	18.0	9.4	20.1	11.5	37.8	14.8	74.4	24.2	20.8	12.3	8.0	21.6	32.6	29.1	14.9	49.2	9.7	16.7	3.6	5.4	63.1	17.9	14.0	3.6	1.6	3.7	0.8	1.1	1.0	0.2	0.7	1.1	0.5	1.4	0.5	0.8	8.1	0.6	3.9	1.0	1.5	0.6	119.3	103.4	104.6	110.9	106.6	107.0	118.5	127.8	118.3	124.9	132.1	95.0	38.7	22.4	19.2	16.3	9.1	15.7	36.0	7.9	10.8	50.1	31.5	24.4	1.1	37.1	9.2	44.1	37.5	26.3	9.2	107.4	80.3	24.0	77.7	22.3	16.1	48.5	20.0	56.0	27.2	28.0	31.8	27.4	12.2	26.4	0.0	36.7	84.3	110.5	23.7	28.6	24.4	30.2	12.2	27.1	16.3	151.4	35.4	22.7	21.4	25.3	10.1	69.7	12.3	8.5	14.3	56.6	67.9	56.8	27.0	67.5	66.9	109.2	7.6	69.0	85.5	30.9	32.2	120.8	24.6	19.3	24.0	34.2	10.6	34.2	24.4	47.9
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765691-38800126	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062220			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.48e-1)"	19.9	27.0	82.5	15.5	85.6	7.3	20.8	62.3	93.9	30.1	43.3	24.2	10.3	28.8	23.3	15.4	29.1	16.3	30.2	90.7	75.2	20.1	14.4	21.4	20.5	65.9	65.7	49.8	16.4	16.6	25.2	22.8	67.1	22.2	14.0	36.0	16.9	25.3	99.0	24.6	17.3	29.5	63.2	23.2	16.4	13.0	80.4	23.4	20.3	75.6	20.4	22.9	20.9	81.4	18.1	40.2	66.0	69.9	56.7	45.5	12.2	31.6	38.2	43.1	35.0	28.2	18.4	44.8	17.2	59.8	36.3	35.9	44.9	28.7	41.4	27.8	17.2	38.4	27.3	40.7	26.2	43.7	23.5	40.0	34.2	33.7	24.2	59.2	36.3	48.6	34.2	22.3	46.8	14.2	44.0	34.0	32.0	20.7	15.8	44.6	63.7	25.6	31.3	22.3	34.0	46.1	30.9	13.9	34.5	68.5	43.6	44.5	33.4	35.8	21.6	29.4	28.9	27.4	36.5	19.7	42.0	36.8	32.9	1.3	1.9	0.6	3.4	1.6	3.5	2.3	2.9	3.3	2.4	2.3	3.2	2.9	1.8	2.8	1.4	2.2	3.0	3.3	82.5	85.6	62.3	93.9	90.7	75.2	65.9	65.7	67.1	63.2	80.4	81.4	15.8	19.2	11.4	21.5	6.7	6.1	3.5	4.6	7.4	31.6	11.5	13.3	23.4	4.3	7.5	5.5	10.4	7.0	14.8	3.7	1.9	5.3	9.2	10.8	17.7	17.3	11.5	9.0	33.5	4.9	5.0	13.8	5.6	9.0	1.3	22.6	18.2	12.7	8.8	43.7	29.1	7.4	2.0	11.3	4.9	21.1	15.2	8.6	1.8	18.7	6.9	14.8	10.3	22.1	24.0	6.0	4.1	16.6	6.2	4.9	5.4	7.7	6.4	14.0	6.6	13.8	13.2	4.6	7.4	9.9	4.4	2.5	8.1	17.3	7.2	2.7
PITX3	ASMD	ENSG00000107859	"Paired like homeodomain 3"	O75364	10	102230186-102241512	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.5;skeletal muscle: 16.5;tongue: 6.0"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 22.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"midbrain: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"RH-30: 30.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 9.1"							NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (8.13e-2)"	"unprognostic (4.07e-1)"		"unprognostic (5.15e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"		"unprognostic (6.04e-5)"	"unprognostic (6.30e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.36e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.13e-2)"	1.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.1	0.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.5	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	5.5	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	22.1	0.3	1.4	1.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 4207.6;tongue: 2900.8"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 2065.2;Late spermatids: 1763.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		310000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	190.5	600.9	539.0	341.4	552.3	439.0	190.5	586.8	629.9	406.8	755.0	225.0	170.8	202.8	205.7	658.3	240.0	212.0	779.6	549.1	561.6	549.5	32.2	236.9	284.1	640.0	559.1	169.4	112.6	269.6	224.1	168.6	636.2	252.6	206.2	1266.7	389.8	291.6	4207.6	350.5	218.0	298.9	522.3	239.2	228.6	235.1	677.1	203.5	174.6	2900.8	429.2	578.5	374.9	530.6	1584.6	3937.1	788.9	938.8	914.3	1009.4	638.7	1684.6	3878.2	2619.1	2623.6	1094.4	1931.2	1184.5	1627.3	3157.6	1937.8	2253.9	2480.9	3383.2	2051.7	2134.0	1126.5	727.7	1809.1	929.7	637.1	955.2	1525.1	926.4	1559.2	2025.1	810.9	3403.0	1558.6	587.3	182.8	933.3	4267.0	965.1	359.4	419.6	966.2	2438.6	1433.3	1046.5	2560.0	2301.7	3557.2	1973.8	804.4	871.5	2226.3	1344.7	1755.4	1291.4	932.0	675.7	1247.3	3003.7	1622.0	2928.7	3110.3	1170.0	1762.1	1037.2	3720.5	1534.4	3002.3	131.9	836.3	138.6	192.6	466.7	187.9	205.2	254.1	190.4	685.6	142.9	215.8	162.5	100.7	108.4	380.1	140.5	334.0	1261.7	539.0	552.3	586.8	629.9	549.1	561.6	640.0	559.1	636.2	522.3	677.1	530.6	95.9	118.6	88.1	107.7	169.6	565.5	708.9	2065.2	307.9	480.7	157.8	174.7	313.2	87.2	759.4	829.4	369.1	566.1	100.2	358.9	802.2	1395.6	315.0	169.2	77.3	207.7	282.2	44.8	90.2	597.0	1416.7	220.1	138.1	188.0	206.7	144.0	73.2	4.3	750.0	1065.0	97.6	166.8	925.7	297.7	532.9	1763.1	157.2	558.8	355.8	38.4	1255.0	784.1	78.2	53.3	33.4	1213.2	264.5	268.1	209.9	431.4	389.1	208.7	396.9	708.6	124.9	160.9	398.2	43.4	98.6	341.6	389.0	575.7	192.7	157.4	380.7	860.7
PKNOX1	PREP1	ENSG00000160199	"PBX/knotted 1 homeobox 1"	P55347	21	42974510-43033931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 106.8;Early spermatids: 121.1;Spermatocytes: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004285, HPA057215, HPA065017"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (4.54e-8)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (9.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.31e-3)"	4.8	4.2	6.6	4.0	6.6	2.5	3.9	9.6	6.9	8.1	5.5	6.5	2.8	8.3	5.4	4.1	6.5	4.7	3.5	6.7	6.7	6.7	4.4	4.5	5.0	6.9	6.6	8.6	3.9	3.4	4.6	5.3	6.6	5.0	3.8	4.7	4.2	6.6	7.6	5.4	4.3	6.0	7.5	4.7	4.4	8.2	7.3	5.2	11.5	5.9	4.5	7.0	4.6	7.6	8.8	3.0	3.9	3.8	7.3	11.0	4.8	11.0	7.6	6.5	5.6	5.2	6.6	12.2	8.9	9.7	5.1	4.6	9.1	7.0	8.6	8.4	7.3	7.2	5.7	4.9	7.5	6.6	5.4	8.3	11.3	8.1	6.6	6.8	6.3	4.1	5.8	8.8	15.1	5.2	6.2	7.3	6.1	12.4	6.5	9.8	17.7	6.7	13.0	6.9	12.6	7.5	7.8	5.6	7.6	4.5	4.7	8.4	7.5	10.2	5.0	5.7	7.1	5.1	6.1	6.2	12.9	11.6	5.5	0.3	2.1	1.7	3.9	2.9	4.1	2.8	2.8	3.2	1.9	2.2	3.3	3.0	5.7	2.3	1.9	1.7	3.3	2.4	6.6	6.6	9.6	6.9	6.7	6.7	6.9	6.6	6.6	7.5	7.3	7.6	18.4	6.4	15.7	28.1	12.5	17.5	106.8	13.7	17.1	23.7	12.4	11.7	7.4	12.8	18.2	16.5	4.2	14.9	11.1	12.3	9.8	17.1	121.1	15.1	37.7	16.0	14.9	11.0	30.3	12.6	28.8	22.3	3.6	23.8	6.3	17.3	10.0	8.4	12.6	13.5	27.2	11.8	14.2	8.4	22.5	40.8	18.6	15.3	14.2	16.9	20.8	9.5	11.3	27.6	40.8	14.5	7.0	29.3	8.6	32.2	8.5	7.5	16.3	11.5	32.9	27.3	20.8	99.7	26.4	17.1	13.8	29.0	17.1	24.2	10.8	45.2
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108959-45133354	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	13.5	34.3	42.2	5.1	49.7	2.0	11.7	50.5	36.0	12.4	27.9	34.2	2.5	13.2	1.5	14.7	10.1	6.4	34.1	33.8	42.5	9.6	1.4	7.7	1.0	69.8	50.5	18.9	2.7	1.3	7.6	5.8	46.4	13.0	15.3	14.4	10.8	5.4	85.7	20.6	6.5	5.1	62.8	2.0	21.0	10.8	59.4	0.9	5.3	56.5	1.5	30.4	11.9	54.0	23.1	56.2	4.1	8.1	5.9	12.8	28.0	12.3	27.3	11.2	10.5	13.7	40.9	0.8	43.5	29.0	9.2	51.9	6.3	53.1	4.4	11.6	21.0	0.9	62.6	18.1	30.3	1.3	3.2	13.7	21.0	10.4	13.7	28.5	7.0	2.5	5.0	1.7	12.1	36.2	3.7	5.4	4.9	109.9	55.0	8.1	9.2	1.5	35.8	45.1	1.1	7.2	13.3	22.1	12.5	8.5	47.0	2.5	14.3	6.9	37.9	9.3	14.8	2.1	2.6	1.8	11.4	1.5	5.7	0.7	0.3	0.5	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.1	42.2	49.7	50.5	36.0	33.8	42.5	69.8	50.5	46.4	62.8	59.4	54.0	8.7	12.8	1.3	22.9	1.0	7.6	16.3	12.2	21.1	29.8	6.8	9.3	26.9	14.3	4.9	7.3	25.0	3.9	0.9	195.8	1.9	6.7	15.8	3.3	12.7	9.0	4.9	0.0	1.3	3.5	13.1	10.6	29.6	9.6	1.3	6.5	10.4	0.7	1.6	6.7	3.7	15.1	4.1	1.4	1.9	5.5	19.9	1.6	3.6	1.0	1.2	8.9	0.0	0.0	0.1	30.0	104.7	33.1	1.1	28.7	4.2	2.0	2.7	40.0	6.6	16.8	4.9	2.3	7.6	3.8	5.7	7.3	1.1	7.0	46.2	88.6
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 91.2;skeletal muscle: 210.1;tongue: 74.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	4.8	9.7	10.0	1.1	11.5	0.4	4.9	16.4	13.9	6.3	1.4	9.6	0.7	6.4	0.6	2.5	5.1	2.1	91.2	10.6	9.1	4.2	0.3	2.1	0.5	11.0	10.7	8.7	2.3	1.2	4.7	0.5	11.1	4.9	0.5	4.0	3.4	2.5	210.1	1.4	3.1	2.7	8.8	2.4	3.1	5.0	11.7	0.4	1.8	74.4	0.3	6.7	4.0	11.0	0.0	0.0	2.2	11.1	11.4	8.6	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.5	2.4	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.6	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.8	0.1	0.1	0.7	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.8	0.0	2.6	0.0	0.0	1.7	0.0	0.4	0.0	0.0	2.3	0.5	0.2	0.2	0.0	1.3	1.5	1.0	0.0	0.9	10.0	11.5	16.4	13.9	10.6	9.1	11.0	10.7	11.1	8.8	11.7	11.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	1.8	2.1	0.1	0.1	0.0	1.9	0.0	1.4	0.1	1.7	1.4	0.0	1.3	0.0	0.6	0.7	4.1	0.0	0.1	0.0	0.8	1.1	0.0	0.5	8.4	0.0	0.0	0.0	0.3	0.0	1.7	5.0	2.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	2.3	0.0	3.7	0.0	7.0	3.0	0.0	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634061-55693863	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease variant, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	6.7	5.9	5.4	4.0	7.0	7.4	5.7	6.4	7.7	5.2	6.4	5.7	3.3	6.4	4.5	4.6	5.7	3.0	6.6	4.8	6.5	5.6	5.2	5.0	4.3	6.9	6.0	4.8	7.8	4.9	5.0	2.9	7.1	4.4	5.2	5.5	5.0	3.2	11.5	5.9	5.3	4.2	5.7	6.2	5.8	3.2	6.3	3.4	5.2	5.9	3.3	5.6	4.5	9.0	9.0	4.3	6.5	2.9	4.7	7.8	8.4	12.2	7.7	19.8	13.1	13.5	4.2	17.9	5.4	5.8	6.2	7.1	8.3	10.1	9.5	6.3	16.3	10.2	5.9	7.0	11.8	25.0	6.4	8.6	6.9	8.4	7.0	4.7	6.4	7.3	11.5	4.2	8.0	4.4	15.4	17.9	15.5	9.3	8.1	15.2	10.9	16.6	8.6	5.2	15.2	9.6	4.4	14.3	17.0	5.6	3.8	11.4	6.4	4.6	3.9	4.2	13.5	18.9	1.3	3.8	9.2	21.1	8.3	3.3	3.4	4.0	4.2	2.8	2.4	3.1	1.7	4.1	1.3	5.6	3.4	3.9	3.4	2.2	2.7	4.1	1.4	2.9	5.4	7.0	6.4	7.7	4.8	6.5	6.9	6.0	7.1	5.7	6.3	9.0	25.1	48.1	57.0	23.8	21.6	24.2	23.1	17.5	29.0	41.3	12.6	11.2	25.6	15.7	46.8	20.2	58.4	19.9	14.2	7.7	9.8	18.6	25.6	27.9	28.9	24.4	10.2	17.4	48.4	16.0	23.3	25.3	14.8	14.3	58.7	21.8	11.7	14.7	15.4	30.3	48.1	12.8	26.4	12.2	17.7	4.8	17.4	26.7	16.0	17.8	16.5	23.9	13.4	34.2	97.7	15.8	11.4	18.4	23.1	26.0	7.6	19.8	38.5	58.6	26.3	31.7	22.3	43.4	20.7	25.7	20.2	12.3	24.7	58.2	18.6	17.6
POLR1G	"A34.5, ASE-1, CAST, CD3EAP, PAF49, RPA34"	ENSG00000117877	"RNA polymerase I subunit G"	O15446	19	45406644-45410737	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.8;Extravillous trophoblasts: 26.3;Hofbauer cells: 11.5;Syncytiotrophoblasts: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 14.5"	"Cell line enhanced"	"Detected in all"		"U-251 MG: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	3.2	2.4	2.9	3.3	3.0	2.1	3.1	4.1	4.3	2.4	1.1	2.5	2.4	2.7	1.4	4.3	3.0	2.8	3.5	2.9	2.4	2.7	2.6	2.0	3.5	3.4	2.6	3.5	3.8	2.9	1.9	2.2	3.6	2.2	2.1	2.7	2.8	1.9	6.7	4.4	1.9	3.0	1.1	2.1	1.8	1.8	3.4	2.1	2.3	4.5	4.0	4.1	2.4	3.8	31.4	29.0	5.3	20.6	7.5	6.5	20.3	15.3	5.2	26.2	15.1	32.5	21.5	48.3	14.8	11.3	20.6	29.5	46.4	43.0	18.4	22.1	28.7	24.3	11.0	23.9	12.8	25.3	8.9	9.4	27.3	38.2	20.7	7.0	19.2	16.0	63.0	8.9	25.6	37.0	18.7	9.3	37.0	34.6	27.3	25.1	19.5	32.2	10.5	22.7	30.8	9.6	30.9	40.6	6.4	10.6	19.9	15.4	18.2	36.5	36.7	20.4	200.5	16.1	74.0	51.6	16.8	37.6	25.9	1.5	2.7	0.3	1.4	3.5	3.1	2.7	2.0	2.2	4.2	3.0	2.9	3.5	1.3	3.3	2.8	14.5	1.3	2.0	2.9	3.0	4.1	4.3	2.9	2.4	3.4	2.6	3.6	1.1	3.4	3.8	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	15.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	26.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0
POLR2I	"hRPB14.5, RPB9"	ENSG00000105258	"RNA polymerase II subunit I"	P36954	19	36113709-36115213	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1145.8;Late spermatids: 2796.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035632, HPA045156"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035632: AB_2674711, HPA045156: AB_10964748"	"unprognostic (1.95e-2)"	"unprognostic (7.88e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	32.6	41.0	97.6	23.3	104.3	44.4	34.8	104.2	118.6	30.6	85.8	35.0	28.9	28.4	39.7	40.2	55.7	27.2	78.9	94.6	100.8	32.9	40.2	25.5	31.5	98.5	98.6	50.0	83.9	61.3	26.1	21.8	101.0	30.2	20.2	25.9	66.9	35.9	195.2	41.5	29.9	21.7	98.5	29.7	31.5	66.8	97.4	30.4	37.2	119.7	24.2	28.3	15.7	120.6	96.7	364.7	61.9	103.8	38.5	44.6	67.7	35.5	47.5	80.5	67.5	179.0	62.0	61.6	80.4	38.2	46.8	49.6	60.4	82.5	42.1	107.8	115.5	59.1	88.8	180.9	70.0	88.7	53.1	47.5	71.4	51.7	75.1	51.1	52.8	112.2	66.6	117.1	48.5	292.1	124.6	111.0	74.5	201.6	151.7	130.4	51.6	114.0	94.0	121.3	145.0	74.0	60.1	172.5	59.5	53.7	81.3	92.7	35.7	88.6	91.6	60.3	128.2	83.2	88.4	99.6	102.3	88.0	94.7	130.7	109.5	128.4	113.9	115.2	130.6	168.7	148.3	134.1	90.2	134.8	150.4	117.2	72.5	111.0	113.0	223.8	176.5	114.0	97.6	104.3	104.2	118.6	94.6	100.8	98.5	98.6	101.0	98.5	97.4	120.6	108.2	83.3	66.3	2.9	62.9	79.0	94.9	156.4	75.1	63.1	203.5	279.4	253.5	133.0	124.7	163.7	25.0	144.5	76.3	141.5	352.1	178.2	1145.8	380.4	114.9	101.6	106.2	199.9	2.9	240.5	166.2	96.9	71.4	126.0	82.4	150.0	111.0	282.5	124.3	33.7	3.2	163.3	126.1	72.9	63.8	2796.6	139.1	68.7	168.9	0.0	122.5	183.2	77.2	1.5	7.9	196.8	196.8	154.2	88.5	127.9	221.4	528.2	386.6	73.6	111.7	111.1	125.1	378.2	183.1	155.9	109.0	103.8	68.1	133.7	167.7	90.1
POLR2M	"GCOM1, Gdown, Gdown1, GRINL1A"	ENSG00000255529	"RNA polymerase II subunit M"	"P0CAP2, Q6EEV4"	15	57706695-57782762	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068141			Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA068141: AB_2685962"	"unprognostic (3.07e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.07e-1)"	19.4	20.0	24.6	10.6	34.0	17.0	18.4	28.6	27.0	21.8	13.6	15.5	12.3	34.7	19.6	15.3	19.5	16.1	29.2	22.1	30.0	20.1	15.4	14.3	19.2	30.7	37.6	31.3	16.2	25.5	9.1	18.1	28.0	26.1	15.0	12.7	16.1	24.1	36.0	15.3	13.1	27.0	31.1	21.3	15.0	10.4	31.6	21.4	24.1	38.9	17.3	15.2	13.3	39.0	18.4	21.8	20.9	52.2	38.6	38.4	15.8	29.4	49.0	33.3	30.4	19.5	14.8	27.7	25.9	22.3	25.2	33.1	26.2	24.3	44.5	24.3	27.9	37.9	21.5	15.6	42.1	33.4	31.0	36.3	38.3	19.0	54.2	37.5	26.1	29.5	34.6	20.7	28.5	8.8	38.2	22.7	31.9	27.7	19.0	37.8	49.1	22.0	25.2	19.5	14.6	26.6	21.2	25.1	35.9	29.2	28.4	49.0	24.7	47.0	47.2	68.4	30.7	26.5	27.1	36.1	28.4	52.4	32.2	26.6	14.7	12.1	17.4	13.3	16.2	16.1	15.1	16.4	13.9	17.1	19.6	14.6	1.5	24.4	11.6	12.4	19.0	15.6	24.6	34.0	28.6	27.0	22.1	30.0	30.7	37.6	28.0	31.1	31.6	39.0	19.5	22.4	11.5	0.0	25.7	16.8	20.2	12.4	26.7	14.9	16.9	12.6	27.7	10.0	14.5	25.8	4.2	12.8	25.3	11.8	25.4	13.3	48.5	13.9	22.7	23.2	23.4	24.0	0.0	15.3	19.1	24.3	16.8	32.4	12.6	11.0	25.0	15.4	18.2	11.8	0.0	16.6	18.3	27.4	15.8	14.6	22.1	17.9	24.9	0.0	18.9	24.9	29.9	0.0	0.0	19.5	15.8	28.2	13.3	30.3	13.6	17.2	13.3	9.8	19.7	17.2	20.8	21.2	24.2	22.7	14.3	12.0	22.9	16.9	20.0	23.7
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105157900-105180014	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;skeletal muscle: 96.3;tongue: 29.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.8;Early spermatids: 88.0;Excitatory neurons: 16.6;Late spermatids: 18.2;Oligodendrocytes: 15.0;Skeletal myocytes: 32.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.9;RH-30: 15.8;SH-SY5Y: 15.4;U-87 MG: 14.2;WM-115: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012514			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.5	0.3	5.1	0.3	6.8	0.0	0.2	5.8	10.0	0.5	4.8	2.5	0.1	0.9	1.5	1.8	0.4	0.7	23.0	6.2	6.2	0.2	0.0	0.1	0.1	6.3	6.4	0.2	0.1	0.1	4.4	0.7	6.2	0.8	0.0	0.5	1.3	0.3	96.3	0.2	0.5	0.0	6.3	0.0	3.2	3.9	6.0	0.0	0.2	29.6	0.0	1.3	0.4	9.7	1.3	1.6	0.5	0.2	2.7	6.8	0.6	2.9	2.5	4.5	5.2	0.0	1.6	0.1	1.1	5.5	25.9	0.0	1.7	1.5	3.6	0.0	4.1	0.0	1.1	0.0	0.1	0.0	0.0	2.3	0.3	7.5	1.0	1.4	0.3	0.1	3.4	7.0	12.8	0.0	0.0	1.5	3.0	0.0	6.3	0.5	15.8	0.0	0.0	0.0	7.5	15.4	0.0	0.1	11.5	1.4	0.0	6.2	6.5	3.4	0.0	2.1	10.7	0.0	0.0	0.0	14.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.8	5.8	10.0	6.2	6.2	6.3	6.4	6.2	6.3	6.0	9.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	42.8	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	88.0	1.5	1.0	0.4	0.0	0.0	16.6	0.0	1.2	2.0	0.0	5.6	0.0	0.1	0.0	0.0	0.3	0.0	4.9	0.0	2.0	0.0	0.0	18.2	0.6	0.7	0.0	2.8	2.0	0.0	0.0	0.5	15.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	32.0	3.5	2.9	5.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270690-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 261.2;SK-MEL-30: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: AB_2677923"	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	26.6	14.6	17.5	16.1	18.2	20.6	17.6	16.0	19.2	13.1	22.1	18.2	14.0	17.9	13.7	16.4	12.1	22.1	14.5	15.6	15.8	16.4	15.0	19.8	15.7	25.9	21.0	15.1	15.9	18.0	13.2	24.1	20.6	12.4	15.8	14.9	13.4	14.0	31.6	18.0	16.2	17.4	17.6	15.3	13.5	26.3	20.1	15.7	23.3	26.8	14.0	17.0	12.1	25.1	261.2	30.4	31.8	22.5	33.1	20.3	34.9	30.0	24.4	40.8	26.0	66.8	22.8	25.8	39.6	27.3	39.4	38.3	30.7	28.3	35.9	15.5	21.5	19.7	34.3	24.7	33.4	26.2	22.1	24.9	46.8	53.1	44.6	31.4	27.9	21.3	33.1	19.9	37.3	30.8	19.3	17.7	19.7	59.5	34.3	20.6	80.2	22.2	20.6	32.9	31.9	21.5	45.2	59.1	156.6	36.0	37.5	31.2	30.0	38.0	29.8	54.3	32.4	24.7	15.8	37.3	28.2	20.1	43.0	0.0	1.6	1.1	0.8	1.2	1.2	1.5	1.2	1.1	1.3	1.0	0.9	0.6	5.0	0.4	3.5	1.7	1.2	0.6	17.5	18.2	16.0	19.2	15.6	15.8	25.9	21.0	20.6	17.6	20.1	25.1	33.0	25.6	53.5	114.6	19.3	27.4	26.4	14.2	30.1	39.1	32.8	24.1	27.2	20.0	25.1	18.4	31.3	44.2	14.2	39.3	11.7	21.8	190.4	28.7	44.4	31.4	26.9	24.8	57.8	20.3	13.7	33.3	25.5	45.4	8.8	94.3	20.7	25.2	25.2	33.7	52.8	19.8	16.2	35.5	28.8	97.7	27.7	40.4	21.4	38.4	28.8	71.8	17.5	47.7	56.4	36.2	24.7	25.6	23.6	36.7	19.2	22.7	27.1	45.8	19.7	45.4	30.0	60.7	61.9	36.1	33.1	74.3	22.2	42.2	25.1	37.2
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 218.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA		75000	"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	40.2	20.4	41.2	19.5	48.0	44.0	23.9	45.1	61.8	23.0	43.1	28.6	20.3	23.9	30.0	22.5	21.2	21.8	33.3	38.6	42.1	29.0	44.0	21.9	28.7	41.4	44.1	22.9	32.4	35.8	18.9	18.8	42.1	30.6	28.7	49.9	27.0	23.3	129.4	20.5	21.7	22.8	40.2	26.4	23.1	21.4	42.7	36.0	22.8	86.5	27.0	24.7	21.4	50.9	37.1	32.8	41.8	31.2	51.3	23.8	47.6	27.9	32.0	28.2	24.8	43.8	23.3	40.7	42.4	32.4	23.0	19.6	47.6	18.2	41.6	41.7	18.4	42.9	19.9	30.8	41.4	38.6	34.1	23.0	31.5	22.5	37.9	22.2	23.5	18.4	31.7	41.5	25.7	30.6	38.6	61.5	52.4	33.4	11.0	40.5	46.6	27.1	66.3	36.9	33.7	42.5	25.3	37.4	33.5	62.3	20.2	26.7	21.6	24.7	35.5	20.6	27.8	36.2	25.5	37.7	13.4	63.2	18.3	6.9	2.2	8.1	4.6	3.0	3.9	4.2	4.3	3.9	3.7	4.5	5.8	4.0	6.1	3.2	3.6	3.6	4.3	1.1	41.2	48.0	45.1	61.8	38.6	42.1	41.4	44.1	42.1	40.2	42.7	50.9	17.4	19.2	20.8	78.4	49.3	60.5	40.3	14.4	35.3	51.9	31.8	19.9	55.4	38.6	24.0	40.5	64.6	31.5	68.6	64.5	46.9	42.5	68.5	44.1	33.3	22.0	40.2	32.8	95.9	46.4	29.7	33.7	35.2	62.4	26.6	27.4	20.3	55.0	26.8	107.7	91.8	31.5	30.5	55.2	63.0	43.0	35.8	45.0	56.9	38.4	46.7	57.5	51.5	112.6	218.0	44.7	46.6	33.8	51.9	71.2	26.8	41.0	16.9	147.5	26.3	33.5	32.4	48.5	27.7	36.6	62.4	64.6	63.8	29.5	37.3	88.7
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078902	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.7;Excitatory neurons: 344.6;Inhibitory neurons: 175.7;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 4.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 79.8;U-266/70: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	6.0	5.9	7.6	2.2	8.5	2.4	3.2	11.0	13.4	7.3	0.0	5.9	1.9	4.2	1.9	6.2	4.1	5.9	6.6	9.2	5.6	5.8	3.2	3.0	1.0	11.3	7.6	2.2	3.7	15.5	10.1	8.6	13.1	4.0	3.9	11.3	15.2	2.2	21.8	6.0	2.5	4.1	0.0	2.2	6.1	1.7	12.7	3.5	10.7	17.8	2.2	10.8	4.0	0.8	2.6	1.7	8.7	4.6	5.1	0.1	5.4	0.3	0.2	0.9	0.3	0.5	0.6	0.5	0.8	0.4	2.0	8.1	7.4	0.5	0.3	79.8	7.9	7.7	7.0	0.9	0.2	4.7	8.6	0.9	3.5	0.2	0.5	0.6	0.5	3.8	0.3	12.0	0.1	4.2	1.8	0.5	5.1	14.2	1.7	9.5	1.5	1.8	0.4	8.4	10.5	9.0	4.5	5.2	0.3	3.0	5.7	4.7	0.4	0.9	0.9	0.7	2.9	75.6	0.3	4.3	1.1	3.9	1.9	0.4	1.6	3.2	1.5	3.5	0.1	0.1	0.3	1.0	0.8	0.6	0.5	1.0	0.1	0.6	4.9	0.4	0.0	1.6	7.6	8.5	11.0	13.4	9.2	5.6	11.3	7.6	13.1	0.0	12.7	0.8	2.6	6.4	2.7	126.7	1.5	8.7	5.7	3.0	8.6	59.4	4.7	3.0	33.9	8.6	10.9	1.8	35.5	3.8	11.6	12.5	0.0	2.1	1.2	3.2	17.5	5.3	13.8	3.4	344.6	4.3	3.4	6.5	11.7	6.8	0.0	2.2	2.5	18.1	7.1	6.7	175.7	8.0	14.2	15.4	7.2	1.2	5.0	14.0	3.6	53.4	6.6	10.2	26.8	111.6	77.4	2.2	8.3	5.3	2.9	5.9	2.2	3.7	9.5	10.4	0.0	42.5	21.4	2.6	3.4	13.1	8.7	2.6	3.8	2.6	5.6	21.2
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 213.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.1;Rod photoreceptor cells: 74.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"non-classical monocyte: 142.4"	"Lineage enriched"	"Detected in all"	11	"monocytes: 142.4"	"Cell line enhanced"	"Detected in many"		"OE19: 24.1;RT4: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043577			Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	2.0	0.8	15.5	2.0	14.7	2.6	3.3	14.5	19.9	2.0	14.5	2.6	0.6	0.7	1.3	2.6	0.9	1.4	1.3	15.1	15.0	1.4	2.6	2.5	3.0	14.7	14.7	0.6	0.5	2.1	1.1	4.7	15.1	1.2	1.3	25.8	0.9	2.0	213.3	3.1	1.6	1.2	13.7	9.2	2.8	5.3	14.3	2.3	1.1	0.2	3.4	2.4	1.6	16.2	2.6	7.1	1.2	5.1	5.9	7.8	14.7	1.9	3.0	0.6	2.3	1.7	15.8	11.1	3.2	1.8	4.1	7.6	3.0	2.2	0.9	10.9	4.5	9.0	2.7	1.9	1.4	0.8	18.1	3.2	3.6	3.1	1.9	4.0	1.0	4.4	10.3	9.6	1.0	1.9	3.1	4.6	4.0	24.1	1.4	2.0	1.5	3.0	3.4	29.9	5.8	6.8	1.0	11.1	9.2	8.8	3.8	2.7	1.5	8.2	4.7	4.3	1.4	1.7	4.5	2.3	6.1	2.3	7.2	6.7	4.4	3.2	6.4	22.5	5.5	6.3	3.9	6.2	12.8	3.6	4.3	7.9	6.5	3.1	142.4	2.4	4.5	5.7	15.5	14.7	14.5	19.9	15.1	15.0	14.7	14.7	15.1	13.7	14.3	16.2	6.4	0.0	2.7	1.0	7.5	3.4	14.7	6.2	17.6	14.1	5.9	32.5	2.3	17.2	2.5	3.7	31.3	3.2	6.0	5.5	0.0	2.9	12.5	2.0	3.9	3.5	3.0	0.8	1.1	1.8	123.1	6.5	3.1	7.4	7.0	1.0	5.3	1.3	20.1	1.7	1.4	4.2	0.0	15.5	15.7	4.9	0.9	15.2	1.8	1.0	6.1	7.3	20.6	0.0	0.3	3.1	4.7	0.7	1.7	6.7	6.9	0.6	0.8	74.3	0.0	25.6	5.5	2.9	9.1	3.4	4.1	8.5	7.5	0.3	3.1	8.4
PPP1R3F	Hb2E	ENSG00000049769	"Protein phosphatase 1 regulatory subunit 3F"	Q6ZSY5	X	49269793-49301461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 38.6;Horizontal cells: 48.8;Oligodendrocytes: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 9.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 13.6;HDLM-2: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000244, HPA000918"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles"		"HPA000244: AB_2665949, HPA000918: AB_2268692"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.83e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (5.99e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.55e-1)"	3.1	4.0	13.9	2.4	14.9	1.5	3.2	14.0	18.3	5.7	8.1	7.4	1.3	5.8	5.8	4.2	7.1	1.5	18.1	15.2	14.1	4.1	3.4	3.3	2.7	14.7	13.5	8.2	2.6	1.1	15.5	1.0	17.2	5.6	0.6	9.7	3.1	1.4	27.5	3.3	3.5	1.3	12.5	4.0	3.4	4.2	14.1	1.3	5.3	12.8	1.4	6.7	4.6	19.1	2.1	4.7	2.9	3.6	2.4	1.8	2.3	2.8	1.8	1.3	2.2	3.0	1.8	2.2	0.6	0.6	13.6	3.6	0.9	0.5	0.9	13.2	4.4	0.2	4.0	0.3	1.5	0.6	1.5	1.4	1.4	1.5	0.5	2.2	0.1	2.8	0.6	0.9	0.9	6.2	1.2	2.5	9.8	0.1	5.8	6.1	3.2	1.1	1.4	1.1	3.8	3.7	0.9	0.1	6.2	4.5	3.3	2.3	2.5	4.1	1.0	3.0	2.0	3.6	4.4	1.5	1.6	5.2	4.8	0.0	0.2	0.0	0.2	0.3	0.6	0.3	1.8	0.6	0.2	0.0	1.5	0.6	0.0	0.3	0.7	0.2	9.4	0.3	13.9	14.9	14.0	18.3	15.2	14.1	14.7	13.5	17.2	12.5	14.1	19.1	2.1	0.0	0.5	14.0	2.8	1.9	2.4	1.0	4.0	38.6	2.5	3.4	16.8	0.0	0.7	3.7	8.4	1.1	1.7	0.3	7.9	0.3	0.1	3.6	2.8	2.2	3.0	0.8	9.6	0.2	0.1	3.8	0.0	2.0	0.0	4.3	3.3	1.1	0.7	48.8	10.7	0.1	0.0	0.6	1.8	0.7	4.7	1.5	0.0	3.7	0.2	11.9	0.0	12.5	34.3	0.4	0.1	3.0	2.0	2.2	0.0	7.6	2.6	17.8	0.0	4.0	3.9	2.0	8.5	7.3	1.3	1.2	5.6	2.4	0.2	2.3
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
PRCC	RCCP1	ENSG00000143294	"Proline rich mitotic checkpoint control factor"	Q92733	1	156750610-156800815	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.9	31.8	43.4	29.7	45.2	41.9	31.4	44.5	50.4	32.4	42.3	36.6	27.0	34.5	23.1	39.7	29.7	23.0	37.6	45.7	42.0	36.7	34.2	29.6	36.3	43.3	42.8	30.9	29.0	34.7	28.1	29.0	43.7	33.5	22.5	26.6	30.4	24.1	63.4	43.2	30.9	27.3	41.3	37.4	31.8	27.0	43.3	37.5	31.0	34.4	30.7	32.6	32.2	46.9	79.1	67.3	51.6	59.5	42.5	33.8	89.8	53.8	52.8	59.3	50.8	106.2	65.0	80.6	90.4	43.1	34.1	80.3	74.7	57.0	45.3	101.6	97.4	59.1	47.4	68.4	52.5	81.9	66.6	48.1	64.7	51.5	46.6	45.7	55.2	52.5	99.7	72.1	41.8	140.2	94.1	94.6	124.9	108.9	82.0	81.6	45.7	108.7	62.5	74.0	91.6	163.4	57.0	140.6	92.4	84.4	102.7	129.8	51.1	59.3	61.9	66.0	89.6	184.6	298.5	124.1	58.7	52.2	56.1	46.9	28.6	57.4	27.5	29.9	26.5	24.0	24.7	30.0	32.5	27.6	24.0	25.2	27.7	30.2	37.1	38.9	27.1	26.0	43.4	45.2	44.5	50.4	45.7	42.0	43.3	42.8	43.7	41.3	43.3	46.9	22.2	9.6	16.4	12.7	32.0	52.4	38.2	52.1	46.1	19.8	31.1	24.4	13.0	18.6	29.4	20.2	22.9	63.1	36.0	27.2	21.5	39.4	13.5	21.4	21.9	30.2	34.3	16.6	15.9	32.2	63.4	28.7	24.5	23.2	17.1	28.9	25.4	16.0	44.0	28.6	14.4	26.9	40.7	22.6	27.4	10.4	30.4	28.4	21.4	9.4	44.9	16.9	30.9	18.1	25.4	35.5	34.2	28.6	48.8	43.8	29.8	29.9	21.5	19.8	32.9	32.2	29.2	43.3	46.2	39.6	51.3	101.1	30.3	32.4	29.4	39.2
PRKG1	"PGK, PKG, PKG1, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase cGMP-dependent 1"	Q13976	10	50990888-52298423	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	7.0	8.3	6.4	2.7	7.2	0.6	3.1	1.4	6.9	10.3	12.4	5.5	2.4	10.3	3.5	5.2	5.2	7.0	14.1	6.6	10.7	3.8	1.7	6.8	1.2	5.1	4.6	4.2	1.7	9.6	1.3	10.1	3.2	6.4	5.3	3.6	4.0	8.1	25.8	1.0	3.4	14.6	5.3	2.5	3.3	1.8	12.2	1.5	7.0	36.1	0.9	5.4	4.2	2.7	0.1	0.2	1.7	14.3	6.5	6.0	0.1	5.4	19.2	2.1	2.6	0.1	0.9	0.3	0.0	16.1	2.0	0.1	0.0	0.1	1.7	0.0	5.0	1.0	0.3	0.0	5.5	0.0	0.1	8.1	0.1	4.8	0.1	0.6	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.0	4.1	0.0	2.5	0.0	3.9	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	2.0	0.1	0.0	0.0	11.2	1.9	5.9	3.7	1.5	0.8	0.0	10.0	0.0	2.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.4	7.2	1.4	6.9	6.6	10.7	5.1	4.6	3.2	5.3	12.2	2.7	10.5	16.0	10.8	778.3	0.3	0.9	1.7	0.0	7.4	5.9	2.8	9.4	31.4	0.0	0.0	3.7	0.0	1.0	0.3	2.9	0.0	2.4	56.0	0.4	14.7	7.1	0.0	3.4	244.9	3.6	1.2	24.2	0.5	0.5	4.5	0.1	5.0	0.0	0.4	0.0	473.0	4.2	0.0	0.0	2.2	53.0	32.6	5.3	3.6	188.3	0.0	23.6	0.0	24.6	8.0	4.8	14.1	39.5	0.1	0.5	3.2	0.2	0.9	1.3	39.5	3.9	69.9	0.9	0.9	1.6	0.6	2.2	0.2	7.9	3.6	1.0
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358584	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	9.7	11.9	8.1	6.2	8.3	4.7	10.5	8.4	10.2	9.8	12.0	10.8	3.2	9.4	3.3	7.5	10.7	4.3	13.2	8.3	8.3	8.6	10.2	5.9	9.4	8.9	8.4	12.1	9.7	4.8	11.1	6.3	8.8	10.5	3.0	4.6	10.0	7.0	21.8	9.8	8.8	4.5	8.3	9.7	8.8	9.8	8.4	14.4	8.6	13.5	5.8	9.7	8.3	8.4	18.1	24.7	13.2	36.1	7.1	7.0	50.8	13.8	6.8	19.5	15.6	79.4	16.1	42.4	29.8	14.0	8.4	22.6	20.4	13.8	12.6	12.7	24.5	8.6	30.8	36.8	7.8	24.3	15.8	11.3	4.9	15.2	14.0	9.3	11.8	18.7	28.1	0.8	10.3	28.2	25.8	36.3	25.3	16.5	18.8	43.7	19.3	25.7	10.7	17.7	19.8	13.2	53.5	16.2	15.7	11.9	25.2	22.2	16.0	14.7	12.9	19.9	17.6	9.6	22.5	41.6	17.1	23.4	16.8	12.3	8.2	7.1	17.4	10.6	20.2	10.9	11.6	14.9	11.8	12.8	16.7	15.4	0.8	21.4	9.5	32.9	14.7	14.3	8.1	8.3	8.4	10.2	8.3	8.3	8.9	8.4	8.8	8.3	8.4	8.4	7.1	19.2	10.6	16.6	12.1	6.9	8.9	12.8	9.1	21.2	10.8	8.8	13.3	8.6	10.0	9.2	54.2	25.4	12.6	28.3	5.9	12.3	4.4	12.9	8.7	7.6	13.2	7.8	25.0	16.1	8.4	10.5	23.4	5.9	7.0	24.9	6.8	8.4	12.2	30.3	25.9	32.4	10.2	7.7	20.6	4.3	11.8	6.2	8.8	12.2	9.1	9.7	13.4	18.6	20.4	23.6	29.8	13.2	6.9	6.7	24.7	7.7	14.5	18.2	13.1	9.9	8.6	6.9	19.3	6.1	6.0	11.6	16.5	10.0	24.1	12.7
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.3;skeletal muscle: 81.0"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 104.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053354, HPA060103"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA053354: , HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	1.4	4.8	4.2	0.9	3.3	0.4	1.5	3.5	2.5	1.4	2.2	1.9	1.2	1.7	0.4	1.0	2.1	0.4	23.3	3.3	4.5	1.7	0.6	0.9	1.0	6.4	7.8	0.6	0.4	2.3	2.9	0.6	4.9	3.3	0.1	0.3	2.4	1.3	81.0	0.7	1.6	0.5	6.1	1.6	1.2	0.8	5.0	0.7	1.0	18.4	0.6	1.6	1.0	2.9	1.5	0.6	0.3	0.3	0.1	0.3	0.5	1.2	0.3	1.3	1.1	4.3	2.6	5.7	1.1	3.9	0.1	0.7	0.5	0.1	0.3	104.7	1.4	1.4	2.7	0.5	3.0	0.0	3.2	0.9	0.7	2.8	0.6	0.7	0.1	3.7	0.5	5.7	4.1	1.2	4.9	2.6	1.4	0.6	2.7	15.4	0.4	12.5	0.2	0.1	1.3	0.7	6.0	4.5	0.2	1.3	2.1	3.0	0.4	0.1	0.4	0.2	0.4	1.0	1.8	9.2	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	3.3	3.5	2.5	3.3	4.5	6.4	7.8	4.9	6.1	5.0	2.9	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.2	0.0	0.4	0.1	29.7	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.2	2.4	1.5	2.5	0.0	0.4	0.0	0.0	0.3	1.2	1.1	0.9	0.0	0.7	2.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.1	1.2	3.0	0.3	0.0	2.4	0.0	0.2	6.6	5.6	2.9	0.4	0.8	0.3	0.0	2.6	0.4	2.4	0.6	0.3
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1146.8"	"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		6200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	84.0	116.0	129.1	58.7	134.2	32.0	81.0	141.4	134.3	71.3	141.1	80.8	61.1	71.0	129.5	102.3	93.3	61.0	136.8	136.4	141.1	98.5	119.1	64.7	49.0	137.9	138.4	61.6	80.9	143.5	80.1	90.1	145.2	76.8	88.7	59.7	73.5	78.6	332.4	76.0	53.0	103.4	141.3	50.3	81.0	57.8	136.5	79.5	72.3	274.1	68.6	92.1	68.4	146.5	181.0	398.9	250.6	245.5	360.4	318.9	261.8	252.0	307.3	446.1	376.1	329.2	282.2	228.0	228.1	352.1	298.4	239.7	428.4	320.2	401.9	139.9	311.4	146.9	260.3	1146.8	287.3	170.2	162.1	354.2	292.0	331.8	264.1	289.7	475.5	190.5	218.6	121.5	376.0	557.2	97.6	218.4	285.7	341.6	631.4	133.8	197.7	150.7	349.9	256.6	336.0	251.0	179.9	354.8	245.4	322.2	175.0	217.7	254.1	212.4	210.1	197.3	247.8	99.7	218.4	158.8	164.9	140.8	274.6	97.8	127.6	58.0	89.4	125.6	103.5	103.8	101.1	85.1	137.6	99.7	135.0	102.5	48.1	67.4	92.7	172.4	91.3	147.8	129.1	134.2	141.4	134.3	136.4	141.1	137.9	138.4	145.2	141.3	136.5	146.5	94.2	76.9	69.2	16.0	47.3	140.2	174.1	461.5	100.7	61.0	130.4	135.5	157.6	112.9	240.4	95.6	29.2	400.1	40.2	75.0	275.9	277.7	93.0	149.0	109.5	150.0	154.6	82.5	17.6	231.3	435.2	139.9	73.9	88.0	31.0	162.6	89.6	171.6	221.6	70.7	18.0	109.2	329.6	57.5	80.9	106.4	118.7	64.0	115.6	15.9	138.2	170.8	25.7	11.6	29.4	285.7	88.0	122.2	78.2	185.1	81.2	437.8	268.9	71.8	98.6	87.1	355.1	174.4	81.6	144.7	157.1	430.2	43.4	215.7	148.9	215.3
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
PTPN20	"bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B"	ENSG00000204179	"Protein tyrosine phosphatase non-receptor type 20"	Q4JDL3	10	46911396-47002488	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 16.3;Distal tubular cells: 21.5;Early spermatids: 44.2;Late spermatids: 34.9;Proximal tubular cells: 17.7;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 50.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043337, HPA046896, HPA048310, HPA069148"	Enhanced		Supported	"Centriolar satellite"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Centriolar satellite"		"HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: "	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.34e-2)"	1.6	9.1	3.4	0.2	4.4	0.2	3.5	9.2	5.1	0.8	8.9	0.9	1.3	0.9	0.3	3.4	1.4	0.7	9.1	3.9	5.2	4.4	0.8	0.8	0.4	18.5	9.0	1.9	4.1	0.0	3.1	0.2	19.6	1.2	1.6	2.9	2.4	1.4	12.3	5.7	0.6	0.8	4.6	1.2	1.1	14.0	5.3	0.3	2.0	14.7	0.6	0.9	1.1	4.8	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.9	0.0	3.7	0.0	0.0	0.0	50.2	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.2	1.3	9.0	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.3	0.1	0.6	0.9	0.0	0.8	0.0	0.7	0.4	0.2	3.4	4.4	9.2	5.1	3.9	5.2	18.5	9.0	19.6	4.6	5.3	4.8	0.5	0.0	1.5	0.0	0.7	0.0	2.0	0.0	5.7	6.0	5.9	3.7	16.3	0.0	2.5	9.2	6.2	0.1	0.3	0.7	21.5	1.8	44.2	5.0	0.1	0.5	1.2	1.7	0.0	0.9	0.2	1.9	3.1	0.2	0.0	4.9	1.4	0.9	0.4	11.8	0.0	0.4	0.0	0.0	0.0	34.9	0.0	0.4	0.0	0.0	0.7	7.3	0.0	0.0	0.0	2.2	0.2	7.2	1.5	0.9	0.2	17.7	3.6	3.1	0.0	2.7	0.8	24.8	12.2	5.2	0.0	0.1	0.4	8.4	0.8	0.9
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2 small subunit processome component"	Q15269	21	44107373-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	4.0	3.2	3.3	3.2	4.4	0.9	3.3	3.6	4.4	4.2	2.4	3.6	1.5	3.3	2.6	3.5	5.7	0.5	3.7	3.5	3.2	2.6	3.0	3.2	3.0	3.5	3.5	2.9	4.1	1.9	2.2	2.5	4.2	3.0	0.3	1.2	3.4	1.4	5.0	4.9	3.7	0.5	3.2	4.5	4.6	3.1	3.4	5.6	2.9	7.2	6.9	4.1	3.2	5.7	4.7	0.5	1.5	3.6	10.4	11.4	28.5	39.2	16.9	44.3	29.5	82.9	1.4	84.3	1.4	0.0	4.5	4.2	1.5	26.4	24.7	24.4	59.5	10.8	15.6	19.2	6.2	6.8	2.9	0.7	0.0	27.1	0.0	10.1	1.7	39.2	32.5	33.8	17.1	1.1	0.2	2.1	1.5	4.1	3.3	4.8	0.2	44.1	0.0	1.2	26.8	5.4	2.2	3.0	24.2	14.6	0.9	3.2	20.9	19.6	3.1	42.4	4.3	47.6	66.6	3.7	1.8	10.6	28.4	0.5	2.2	2.5	4.7	2.7	5.8	5.1	4.0	5.1	1.8	3.4	3.7	4.6	1.1	2.7	3.7	2.2	3.3	3.0	3.3	4.4	3.6	4.4	3.5	3.2	3.5	3.5	4.2	3.2	3.4	5.7	0.4	0.0	2.0	0.3	3.2	10.7	0.1	9.6	3.4	0.7	1.1	0.3	4.5	0.0	5.4	0.0	0.0	0.1	2.3	4.6	1.9	0.0	0.1	0.2	0.2	2.0	2.4	4.8	0.0	0.0	2.0	1.8	1.1	0.4	0.0	0.3	2.2	0.3	1.9	0.0	0.0	3.8	6.1	5.4	4.9	0.0	1.2	0.4	1.8	0.0	0.6	0.5	3.1	0.0	0.0	0.0	2.4	0.0	1.5	1.2	1.8	0.3	4.6	0.3	0.0	1.4	3.7	1.4	1.7	0.8	8.5	0.7	2.6	0.5	4.6	0.3
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538884-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Endometrial stromal cells: 18.2;Inhibitory neurons: 30.4;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-698: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	1.8	2.3	2.6	0.9	3.0	0.2	1.7	7.3	2.3	3.7	2.9	3.2	0.4	5.6	2.0	1.8	2.5	2.3	1.3	2.6	4.6	0.9	0.1	1.9	0.5	3.3	4.5	6.1	1.4	13.2	3.0	2.0	3.1	4.5	1.0	4.5	0.9	4.8	11.7	0.7	0.9	4.7	3.3	0.3	1.4	3.2	4.9	0.4	6.8	9.1	0.4	2.2	1.7	2.4	3.7	6.3	12.2	6.2	4.4	10.0	4.6	7.8	8.9	6.2	7.1	4.5	0.0	0.0	2.4	5.3	8.9	0.0	12.4	0.1	8.3	0.0	3.9	1.8	1.8	0.4	5.9	6.6	0.0	5.5	6.2	5.5	0.9	6.9	3.2	1.0	0.1	0.0	10.3	0.1	0.3	0.0	3.3	0.9	3.4	0.0	14.8	0.0	2.1	2.7	6.5	7.3	7.6	0.0	5.6	1.7	2.3	2.1	0.0	15.8	6.9	0.3	9.5	0.2	0.2	33.6	4.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	7.3	2.3	2.6	4.6	3.3	4.5	3.1	3.3	4.9	2.4	0.6	9.6	6.3	23.5	0.0	1.7	5.9	0.1	4.6	5.6	2.4	3.6	6.1	0.0	1.9	9.2	0.0	1.5	0.1	0.0	0.0	0.5	2.9	1.6	18.2	1.1	0.0	0.0	1.8	0.0	0.2	9.3	0.0	1.9	0.0	7.1	1.1	0.0	0.5	0.0	30.4	0.0	0.0	0.6	1.4	2.6	9.9	0.3	7.2	4.7	0.0	7.0	0.0	59.8	1.9	0.5	0.0	12.0	0.0	5.7	0.0	0.2	1.8	4.5	0.0	12.7	6.1	11.6	2.8	1.4	0.9	0.3	0.6	2.0	0.0	0.7
RAB5B		ENSG00000111540	"RAB5B, member RAS oncogene family"	P61020	12	55973913-55996683	"Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010224, HPA068337"	Approved		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB010224: AB_2175453, HPA068337: AB_2685974"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.09e-1)"	"unprognostic (8.42e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.31e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.49e-1)"	50.9	54.4	95.4	39.4	102.3	35.0	68.2	106.2	96.8	76.8	76.5	72.2	52.4	73.8	92.4	99.8	75.7	55.8	87.2	93.1	99.5	70.1	68.8	72.9	44.5	103.5	105.6	85.4	47.9	112.1	31.4	63.4	106.0	74.6	80.6	72.9	61.7	94.6	100.6	92.4	50.4	79.9	103.6	48.1	67.0	57.1	99.9	64.0	64.6	127.6	76.0	65.6	69.6	112.9	62.3	39.1	80.2	59.4	128.5	115.9	72.1	56.1	102.3	68.3	57.5	67.5	76.7	34.7	65.5	107.6	50.3	44.8	51.4	77.8	63.3	44.1	39.5	39.3	53.1	38.6	94.5	33.2	61.6	94.9	142.7	64.2	54.2	153.0	87.0	42.2	36.2	99.3	87.3	42.3	42.6	51.9	35.8	51.5	35.2	36.5	49.9	45.1	128.2	100.7	40.0	35.6	73.1	72.4	89.0	88.3	104.6	102.5	72.3	44.5	32.5	32.8	22.2	56.4	46.9	21.8	71.5	30.7	38.4	18.5	10.1	32.6	11.1	9.3	10.3	8.9	9.0	9.9	8.0	6.9	10.2	8.0	27.4	7.6	10.6	8.0	7.6	8.9	95.4	102.3	106.2	96.8	93.1	99.5	103.5	105.6	106.0	103.6	99.9	112.9	24.4	57.7	37.1	13.1	26.7	51.7	26.5	34.0	35.3	33.3	54.4	38.2	53.2	55.8	34.0	42.3	52.1	44.0	29.1	88.1	35.2	49.4	11.1	24.1	22.8	30.8	38.9	29.8	21.4	37.1	42.8	33.1	37.2	33.9	19.7	34.1	42.1	86.0	31.1	16.8	23.4	51.1	16.2	46.4	52.3	27.7	53.4	25.4	35.6	11.2	64.7	41.6	32.0	11.1	26.3	71.3	44.4	59.5	27.1	57.0	44.7	35.9	23.9	31.6	59.2	31.9	33.2	36.8	25.6	64.7	89.2	88.0	25.0	23.4	42.7	65.8
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 179.1;Oligodendrocytes: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA064860: AB_2685372, HPA072273: AB_2686504"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	22.5	15.5	27.3	16.9	28.8	7.3	21.6	23.8	31.6	21.9	19.4	39.7	12.2	28.8	25.4	31.7	21.9	19.0	26.3	28.0	27.8	19.9	11.7	19.3	19.5	27.3	29.8	23.8	16.3	31.3	16.8	21.4	28.0	29.4	22.7	24.9	24.3	30.2	34.5	23.6	17.2	31.7	26.1	18.4	21.6	21.8	27.1	19.6	39.2	30.7	19.4	26.0	21.8	30.2	19.5	25.7	39.6	33.0	44.8	36.2	24.5	20.0	35.8	30.3	28.2	29.9	18.6	26.6	15.6	31.3	40.4	64.7	25.6	25.0	32.4	25.1	15.4	20.8	40.4	22.9	38.3	17.2	17.5	35.2	37.6	26.1	29.3	43.5	34.8	26.2	18.3	19.9	36.9	43.3	22.5	13.5	14.6	55.7	19.6	36.7	72.3	23.0	25.2	21.3	22.3	17.2	35.7	31.9	18.6	29.5	60.7	9.4	26.9	25.6	15.1	28.3	20.3	19.3	33.9	27.7	24.0	8.7	22.9	3.4	1.3	1.8	0.9	2.1	0.7	1.1	0.9	0.9	1.1	1.4	1.6	1.1	2.1	0.8	1.0	1.5	1.2	0.5	27.3	28.8	23.8	31.6	28.0	27.8	27.3	29.8	28.0	26.1	27.1	30.2	47.2	25.6	50.8	115.2	26.6	18.0	23.0	20.8	40.5	44.9	26.7	26.4	46.9	11.5	31.9	11.0	50.1	25.5	26.0	24.9	3.9	11.8	15.4	31.5	30.3	33.1	16.9	17.0	179.1	14.5	8.7	22.9	18.3	47.7	14.0	34.2	27.1	15.4	15.9	57.2	129.7	16.7	24.4	28.6	14.4	17.5	40.7	25.1	14.2	78.7	35.9	33.6	33.0	101.0	147.7	13.0	18.6	51.6	11.9	39.7	11.7	10.1	30.6	34.6	85.5	31.0	51.4	73.8	37.4	27.6	17.3	41.6	16.4	22.5	21.6	27.8
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	37.5	45.5	49.9	29.8	67.2	51.9	35.9	43.7	69.2	33.5	30.2	59.9	39.8	38.5	10.7	57.4	36.4	15.3	86.3	47.6	35.6	55.3	24.3	41.7	26.9	47.8	41.0	39.5	101.5	22.7	69.9	21.0	41.8	67.4	21.2	15.3	42.8	20.1	154.5	45.7	51.6	16.2	35.6	50.3	61.7	50.0	47.2	28.2	42.1	60.9	18.2	43.7	35.0	45.9	75.2	97.9	68.4	80.3	27.5	30.7	178.5	65.8	42.2	63.1	45.9	109.7	77.2	104.7	40.5	52.0	66.4	159.9	76.8	58.6	21.5	110.1	97.5	64.5	127.2	129.9	49.4	120.6	79.4	34.2	59.6	39.0	42.8	38.3	66.4	88.8	142.0	50.0	43.9	149.5	130.2	82.9	128.0	91.3	82.4	167.4	81.6	103.1	41.5	65.7	223.5	92.5	117.2	135.6	83.5	36.1	116.8	120.1	81.1	80.9	69.8	86.5	109.1	42.3	51.8	85.5	68.2	57.8	77.5	0.5	1.8	1.2	1.4	2.4	1.5	2.2	1.5	1.4	1.3	2.0	1.2	1.5	0.9	2.3	0.8	1.7	2.3	0.6	49.9	67.2	43.7	69.2	47.6	35.6	47.8	41.0	41.8	35.6	47.2	45.9	36.2	28.9	41.2	24.5	25.5	18.0	17.7	12.6	38.7	39.5	38.7	33.4	35.3	0.0	13.8	25.8	20.9	25.2	35.3	172.7	31.3	34.9	13.4	42.6	40.6	25.7	52.0	25.6	37.7	58.2	33.2	28.1	43.3	43.8	15.2	85.2	0.0	0.0	31.0	38.7	34.3	78.5	20.3	0.0	26.5	18.5	19.6	37.0	40.9	8.4	27.5	22.2	24.7	18.1	26.9	62.5	80.9	26.7	67.7	36.6	59.4	55.8	18.3	38.3	0.0	19.0	33.3	18.1	28.0	55.3	19.5	28.3	29.6	41.0	94.9	26.5
RAD52		ENSG00000002016	"RAD52 homolog, DNA repair protein"	P43351	12	911736-990053	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 34.9;Excitatory neurons: 38.0;Inhibitory neurons: 48.8;Microglial cells: 23.4;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028957			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	"Plasma membrane"	"HPA028957: AB_2672842"	"unprognostic (4.53e-1)"	"unprognostic (8.08e-3)"	"unprognostic (4.68e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-1)"	"prognostic unfavorable (2.22e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.74e-2)"	4.9	4.7	5.9	5.0	8.2	3.6	6.0	7.8	8.4	8.8	5.1	7.2	5.8	7.3	8.4	4.7	6.6	4.2	4.7	7.1	7.0	7.6	6.4	4.0	6.3	7.2	7.3	10.8	6.6	4.9	5.2	5.4	7.6	6.2	7.0	6.8	4.4	6.0	12.3	9.8	6.6	6.1	5.3	6.0	5.5	4.4	7.8	7.0	8.3	6.8	5.9	6.1	5.8	13.7	4.0	15.2	11.6	13.8	12.1	9.7	12.7	7.9	7.5	9.0	8.7	14.8	14.3	12.8	2.4	8.2	7.4	12.0	9.4	5.4	7.7	17.7	8.2	14.6	16.2	10.0	7.0	15.6	4.2	5.5	9.4	9.1	28.3	17.6	7.4	12.4	9.8	7.5	8.6	8.7	10.8	15.7	15.4	10.0	9.9	10.8	11.6	4.8	9.4	7.1	4.3	5.0	10.3	10.8	6.0	16.8	10.2	7.5	7.4	12.3	14.6	9.8	8.6	2.7	4.6	13.5	6.3	6.9	4.5	7.0	2.1	1.5	2.9	1.9	3.5	2.9	3.0	2.5	2.7	4.0	3.3	3.2	2.0	2.6	2.5	6.0	2.9	1.0	5.9	8.2	7.8	8.4	7.1	7.0	7.2	7.3	7.6	5.3	7.8	13.7	2.5	3.2	5.9	34.9	3.4	1.8	1.4	1.7	4.0	4.2	2.7	2.7	3.6	2.8	3.2	3.7	2.1	4.8	4.5	5.9	1.9	2.3	4.0	2.3	4.5	3.4	1.8	4.2	38.0	1.6	2.8	3.3	5.1	2.6	5.7	4.5	0.7	2.6	2.5	3.3	48.8	2.0	0.0	1.0	2.9	7.5	0.6	2.6	0.0	23.4	2.8	1.4	1.0	30.2	54.5	0.9	3.4	0.7	2.3	1.6	3.9	1.8	1.7	2.6	6.6	4.2	3.9	4.0	4.7	1.9	1.0	2.1	2.6	2.2	3.3	0.8
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92540481	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	8.3	8.6	8.2	5.6	9.4	14.1	8.2	10.1	12.1	9.0	6.5	8.0	5.3	8.2	4.8	7.6	8.4	3.8	10.0	8.5	7.5	7.4	9.0	6.4	8.4	9.0	7.7	9.8	8.5	4.6	7.5	4.6	9.1	8.2	4.6	6.5	8.3	3.3	13.5	8.0	9.0	3.7	7.3	11.3	8.0	8.9	8.5	6.5	8.4	7.0	6.4	7.3	8.3	12.1	5.5	4.0	6.8	11.1	6.5	7.3	5.4	6.5	5.2	6.4	6.1	4.9	6.9	8.0	11.8	4.4	9.9	6.2	6.6	4.6	7.9	7.8	9.4	5.3	12.0	5.8	5.2	10.2	7.1	5.2	8.5	7.2	6.5	8.9	6.9	10.1	11.5	13.1	6.9	5.6	12.1	10.1	6.1	6.9	5.8	6.5	6.1	9.8	5.9	5.9	7.6	9.9	5.7	11.6	8.6	8.3	3.7	8.5	4.4	11.7	6.3	9.1	8.9	8.6	11.1	13.3	5.3	8.6	11.0	67.8	12.4	30.3	23.2	16.3	25.7	28.5	25.1	23.7	12.3	28.7	32.1	27.3	19.2	26.2	13.3	14.3	25.7	16.0	8.2	9.4	10.1	12.1	8.5	7.5	9.0	7.7	9.1	7.3	8.5	12.1	13.5	12.8	7.5	8.1	23.5	8.5	13.2	11.9	12.5	12.7	8.7	7.7	16.7	5.7	10.9	3.7	0.0	10.9	18.8	6.9	7.9	9.2	9.4	9.5	12.3	13.8	0.0	8.6	20.5	6.0	5.8	11.7	6.6	12.9	30.4	11.9	7.9	3.7	6.2	11.8	15.8	4.0	14.2	6.8	6.4	5.9	5.9	8.1	5.4	5.6	9.8	11.5	26.8	11.1	34.3	5.5	6.2	6.4	16.6	10.5	7.0	9.6	7.8	13.2	13.1	15.0	13.7	24.0	15.5	9.9	11.4	15.3	18.9	8.4	5.7	11.8
RGMA	RGM	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3;skeletal muscle: 199.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		2000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	30.2	3.2	62.1	22.5	73.8	0.4	30.3	72.5	59.1	55.9	7.7	79.4	9.9	50.9	2.9	57.4	39.9	7.7	29.4	60.4	68.0	3.6	0.6	4.6	2.4	126.3	113.9	38.5	11.4	0.8	6.9	1.3	70.4	12.8	6.2	1.0	24.2	6.4	199.1	17.1	42.9	60.6	91.5	1.3	73.6	33.5	120.6	2.6	10.0	45.0	3.4	10.0	29.2	62.8	2.1	0.3	50.0	0.8	10.3	5.7	14.6	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.4	0.0	3.4	8.4	0.2	0.0	0.0	9.2	0.1	0.3	0.0	0.0	0.1	0.2	6.1	0.2	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	1.0	15.5	0.2	22.2	0.1	0.0	13.1	11.4	0.1	0.0	0.5	5.1	3.0	0.5	0.2	0.0	2.6	4.0	2.7	0.0	0.1	10.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	73.8	72.5	59.1	60.4	68.0	126.3	113.9	70.4	91.5	120.6	62.8	4.2	0.0	1.5	143.3	0.5	5.5	20.4	10.2	40.5	1.9	7.5	4.4	4.4	0.0	3.9	0.0	2.1	4.4	0.5	0.3	0.0	6.5	1.2	0.6	10.9	2.7	0.0	0.4	16.8	0.7	1.2	40.5	1.5	2.3	0.0	0.6	1.8	0.3	2.1	0.0	2.8	0.0	12.2	2.5	2.3	6.4	119.0	1.6	3.6	9.4	0.6	4.5	0.0	11.1	1.6	0.4	0.0	116.9	0.1	61.3	0.0	0.1	1.3	1.2	13.1	69.3	20.3	0.9	43.8	58.3	2.8	2.5	1.4	0.1	0.1	29.2
RHEB	RHEB2	ENSG00000106615	"Ras homolog, mTORC1 binding"	Q15382	7	151466012-151520120	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 724.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019436	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB019436: AB_2178777"	"unprognostic (2.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.08e-5)"	"unprognostic (9.37e-2)"	"unprognostic (4.76e-3)"	"unprognostic (9.76e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.15e-1)"	118.6	136.8	124.2	62.0	127.4	108.1	100.9	124.3	173.8	77.1	108.4	130.2	52.9	116.2	160.1	73.0	90.2	56.3	134.4	136.9	133.0	103.7	98.4	93.1	44.3	124.5	129.1	87.0	86.5	81.6	84.3	104.9	130.2	83.0	60.5	106.8	72.4	97.0	193.5	66.9	62.6	114.5	121.5	63.6	85.2	47.3	130.2	71.8	98.9	160.8	47.6	117.2	76.8	125.3	335.9	100.3	173.3	165.7	211.5	172.3	131.3	241.7	211.1	198.0	240.4	145.0	354.0	86.4	370.3	215.2	517.4	111.6	126.3	116.8	255.5	91.7	96.9	73.7	113.2	109.5	329.6	137.7	115.2	132.7	183.1	158.1	211.1	207.7	155.2	128.6	231.7	387.1	276.5	216.7	196.0	195.7	285.7	241.5	145.0	94.1	152.6	173.9	233.1	118.4	166.3	208.6	245.4	235.0	283.0	167.7	88.0	169.9	171.0	156.1	65.5	271.9	395.5	145.2	212.2	123.8	376.9	252.7	432.0	39.5	34.1	47.0	24.8	30.5	41.0	23.6	34.2	31.5	26.7	23.9	24.5	30.5	33.9	36.5	34.4	47.0	37.3	39.6	124.2	127.4	124.3	173.8	136.9	133.0	124.5	129.1	130.2	121.5	130.2	125.3	230.5	60.9	45.8	72.5	87.3	398.2	611.3	272.9	114.4	72.8	187.7	179.2	102.0	81.5	169.0	108.5	18.8	207.0	111.9	126.2	416.7	211.7	53.4	107.7	102.6	168.8	98.2	122.9	64.7	213.3	384.1	179.0	40.8	160.8	106.1	95.0	103.9	137.6	233.9	121.1	49.6	76.3	290.9	111.1	384.6	33.2	112.2	174.5	318.4	29.0	114.3	473.6	65.9	30.2	30.6	271.5	109.2	151.6	119.9	620.3	87.8	296.6	85.0	68.7	124.9	149.4	312.2	355.1	173.4	144.7	405.6	421.1	110.4	86.9	79.7	724.9
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3541430-3558333	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	10.6	8.7	9.7	9.5	10.6	11.4	9.7	8.2	12.3	8.5	6.8	7.8	7.2	11.7	11.3	9.6	7.8	7.5	13.0	11.1	11.2	7.1	8.1	7.9	10.2	10.1	9.1	8.2	8.7	9.1	3.3	7.9	10.1	9.3	9.5	8.7	7.7	11.8	15.3	9.9	7.8	13.3	9.2	9.0	6.9	7.0	11.7	10.3	9.5	15.0	10.9	8.5	4.7	10.5	11.9	21.4	22.1	22.5	24.9	23.2	17.2	29.0	30.6	24.8	16.5	19.4	13.0	33.6	13.7	31.5	18.8	14.7	32.6	23.2	30.9	12.4	17.5	33.1	18.9	27.5	35.5	42.0	23.3	23.5	24.9	24.2	29.3	18.5	21.5	54.8	33.0	19.4	31.1	9.3	32.7	27.3	34.7	20.6	17.0	26.9	32.0	34.3	21.0	19.7	33.3	48.9	17.8	15.9	27.5	16.7	10.3	22.9	24.8	24.1	11.5	24.7	40.7	36.1	37.5	43.9	43.2	35.1	37.5	0.1	0.6	1.3	1.3	1.2	2.2	1.1	1.0	1.7	0.7	0.6	1.0	2.1	0.5	0.4	1.2	1.5	0.4	0.7	9.7	10.6	8.2	12.3	11.1	11.2	10.1	9.1	10.1	9.2	11.7	10.5	15.6	22.4	6.9	9.1	30.7	7.5	26.1	21.0	13.6	25.7	14.9	12.6	25.9	11.5	14.7	3.7	20.9	32.7	25.4	14.4	37.2	44.3	5.1	9.6	20.8	20.1	15.0	13.5	11.8	48.7	44.3	20.2	17.9	11.0	27.3	17.9	16.8	18.0	30.8	35.3	10.7	16.4	14.2	18.8	8.9	3.4	13.7	16.2	10.6	10.3	32.3	17.5	30.9	7.5	9.8	48.3	9.9	26.4	41.7	50.2	16.6	28.6	14.1	18.8	19.7	23.6	23.4	21.0	27.5	17.8	12.1	36.5	18.9	27.7	15.9	37.9
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266682-127288567	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	52.9	37.0	49.5	32.4	56.0	10.6	42.7	79.4	61.2	48.1	36.2	40.5	21.9	57.4	60.8	25.3	42.4	38.6	46.9	50.7	51.6	37.1	31.8	38.7	35.1	53.2	52.1	49.5	23.3	40.0	33.3	51.8	56.8	31.7	30.9	48.1	31.2	34.5	114.9	29.5	31.1	45.9	55.2	47.1	29.9	31.3	52.5	24.3	47.1	91.5	33.3	36.9	34.3	61.5	13.2	16.2	60.3	53.6	54.7	54.3	22.2	43.5	69.0	22.8	32.4	21.3	19.3	23.6	30.3	35.7	36.2	16.4	18.1	20.4	32.9	27.6	16.0	30.3	21.8	30.0	54.0	18.0	20.6	47.6	42.1	26.1	51.1	52.5	40.6	23.2	33.0	22.5	50.7	25.2	17.9	32.0	22.1	8.1	17.1	22.6	15.7	12.1	32.4	14.3	36.0	36.6	17.1	23.6	27.7	35.5	16.1	60.8	48.3	39.7	13.1	41.8	31.7	32.3	22.0	15.6	30.5	31.0	38.5	27.5	30.0	26.6	14.3	32.4	14.7	17.4	12.2	16.3	22.8	17.9	11.0	15.5	37.0	19.8	40.1	11.7	15.0	16.1	49.5	56.0	79.4	61.2	50.7	51.6	53.2	52.1	56.8	55.2	52.5	61.5	24.6	35.3	29.3	35.6	23.7	17.7	14.3	15.1	18.8	34.7	16.9	14.7	38.9	31.5	16.7	9.2	4.2	29.0	14.7	13.5	41.1	28.0	52.5	15.7	29.5	30.5	20.4	12.8	53.5	15.8	27.2	50.6	7.1	11.5	22.2	28.1	31.4	30.5	26.3	30.3	54.5	12.1	38.7	68.4	24.6	45.4	69.6	29.9	46.2	42.2	31.1	41.1	28.8	56.3	76.5	18.0	17.0	66.5	9.3	26.3	15.7	51.7	23.9	20.9	32.9	36.2	31.9	41.7	24.9	15.0	20.0	38.4	20.8	36.0	10.9	25.9
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663892-218672002	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	10.9	11.4	18.5	8.9	18.6	7.3	10.9	18.3	21.0	12.2	17.1	12.0	6.2	12.7	15.8	11.7	12.4	10.8	13.9	18.6	19.7	10.4	11.1	10.4	14.5	18.4	18.4	14.5	11.5	15.1	11.4	11.4	19.0	11.8	8.2	7.0	11.0	13.9	15.0	14.5	7.9	13.6	18.5	10.3	9.4	14.3	19.2	15.1	14.1	17.1	11.9	14.0	9.7	19.0	18.8	20.4	22.1	24.6	27.6	17.5	20.4	27.3	43.5	58.0	53.6	32.4	13.2	11.6	17.6	42.3	35.2	19.5	22.1	33.9	31.0	16.4	27.3	22.7	21.3	34.6	33.6	19.3	20.6	33.9	30.9	55.5	44.7	21.4	31.0	40.9	27.4	24.3	41.1	45.3	20.6	20.4	32.9	16.2	23.4	23.2	15.5	15.9	36.3	21.8	19.5	23.8	18.1	17.2	28.4	21.9	20.6	25.6	26.6	40.2	20.5	19.2	31.1	23.7	13.7	23.5	33.4	19.1	25.7	58.6	21.5	32.6	26.0	21.3	24.8	25.7	25.7	27.2	17.1	30.4	29.0	23.2	17.1	30.5	25.2	15.0	25.9	24.8	18.5	18.6	18.3	21.0	18.6	19.7	18.4	18.4	19.0	18.5	19.2	19.0	4.2	0.0	0.5	5.2	7.8	6.2	4.8	16.3	6.8	7.7	3.4	3.7	4.0	10.0	8.9	1.8	8.4	12.3	4.5	7.4	15.6	12.3	16.8	6.3	8.1	7.6	1.2	2.1	6.2	12.9	9.7	7.5	9.7	4.8	7.0	5.9	8.9	7.1	13.2	5.0	5.8	5.5	8.2	5.0	4.0	5.3	7.2	5.5	8.8	2.8	8.9	7.9	9.2	3.5	4.9	12.7	9.6	12.8	8.5	3.8	7.2	14.8	8.2	5.0	26.3	5.6	9.2	19.3	12.8	5.9	6.8	10.0	8.0	8.5	6.1	3.6
RNF34	"FLJ21786, RIF, RIFF"	ENSG00000170633	"Ring finger protein 34"	Q969K3	12	121400041-121430623	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074151			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA074151: AB_2686668"	"unprognostic (3.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (3.39e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.55e-3)"	"prognostic favorable (3.02e-4)"	13.7	10.8	25.5	23.6	29.7	13.4	13.4	31.6	32.2	11.6	21.8	19.2	19.5	13.7	13.5	14.9	12.5	17.3	18.4	26.8	28.6	11.3	13.0	12.9	34.3	26.0	26.6	14.7	13.8	13.3	13.7	11.5	26.7	10.5	15.6	19.0	13.9	13.5	59.5	15.7	18.3	16.7	24.7	23.3	18.4	24.6	26.6	26.8	13.9	36.8	26.4	19.0	11.9	32.7	45.4	53.8	34.7	36.3	26.8	24.5	43.2	47.5	42.2	46.3	35.3	67.3	16.9	64.9	35.3	51.3	24.6	31.8	52.6	29.8	41.0	95.3	30.8	75.4	37.7	62.5	32.1	65.7	50.4	21.9	39.6	40.2	34.7	26.4	49.3	37.9	58.0	29.3	46.0	35.7	57.5	95.7	44.5	26.6	48.4	54.0	45.1	38.1	32.0	53.2	50.7	33.0	59.4	21.8	36.6	31.6	38.0	49.1	39.5	39.5	28.4	34.6	37.8	51.2	92.8	70.5	28.2	45.4	40.6	83.7	42.1	91.2	72.4	48.4	74.1	77.1	83.2	76.8	40.4	65.0	71.1	71.1	65.2	76.2	53.3	34.3	106.3	68.3	25.5	29.7	31.6	32.2	26.8	28.6	26.0	26.6	26.7	24.7	26.6	32.7	14.5	16.0	16.2	15.3	22.9	17.5	18.7	23.4	13.6	13.9	16.5	13.2	22.0	27.1	18.9	9.2	4.2	26.1	30.9	19.0	37.2	32.7	23.5	13.7	15.3	17.3	40.8	24.8	34.3	27.3	38.8	16.1	15.8	13.9	17.7	19.0	17.2	11.2	21.2	13.5	32.7	15.8	30.5	18.0	14.9	10.7	17.1	14.0	17.8	13.1	35.0	23.6	46.4	9.5	45.5	26.2	17.2	18.0	27.9	17.0	20.5	19.9	18.7	21.4	19.7	11.1	25.0	134.0	73.9	15.3	16.1	24.2	34.3	18.5	21.2	25.7
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229302	"Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 82.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009861, HPA074448"	Approved		Supported	Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"CAB009861: AB_2180141, HPA074448: "	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.2	38.0	19.9	6.2	11.7	17.5	13.6	51.1	13.1	10.5	10.2	6.9	2.6	6.0	4.7	17.3	6.8	9.1	7.2	3.7	12.6	12.6	28.7	11.2	6.2	7.8	36.0	9.9	14.0	10.1	7.6	2.9	5.9	5.7	3.5	37.8	8.5	5.5	41.4	82.8	6.3	5.4	4.5	9.3	6.2	13.9	49.6	4.3	12.8	20.3	7.5	5.2	9.2	4.2	0.1	0.8	2.7	0.0	3.4	1.7	0.9	1.3	1.5	1.2	1.4	1.8	0.5	0.0	0.6	3.4	3.6	0.5	6.1	2.6	2.2	2.9	5.2	0.0	0.4	2.9	1.3	0.0	0.3	7.8	0.6	3.3	0.0	1.1	11.6	11.2	0.2	73.2	5.1	0.2	0.6	0.0	2.1	1.9	1.1	0.1	2.4	1.1	2.4	0.5	1.9	4.4	0.3	0.6	0.1	7.3	0.0	0.0	0.3	10.1	4.5	4.2	0.1	41.7	62.1	0.2	17.0	0.0	1.2	0.2	0.1	0.0	23.2	0.0	26.7	1.4	17.4	16.0	0.0	0.1	5.4	11.5	0.5	6.5	0.1	0.7	16.3	4.7	19.9	11.7	51.1	13.1	3.7	12.6	7.8	36.0	5.9	4.5	49.6	4.2	32.5	41.7	31.7	2125.3	23.4	185.2	30.1	17.0	55.2	167.5	24.7	16.1	26.3	30.0	23.4	58.8	454.5	0.7	185.3	1.4	13.7	21.4	148.8	26.9	52.9	40.8	18.5	42.5	627.1	12.3	1.9	69.4	11.7	36.1	2.5	7.9	34.2	97.2	0.8	126.2	1056.8	3.3	10.2	9.1	35.8	97.1	46.6	8.3	60.5	757.0	4.7	50.4	250.3	1524.0	114.9	8.2	0.5	87.3	88.7	24.0	0.7	44.6	16.0	160.0	39.5	57.9	32.2	1.9	3.8	73.2	423.4	4.7	237.6	11.5	2.1	61.9
RPL37A	L37A	ENSG00000197756	"Ribosomal protein L37a"	P61513	2	216498825-216579180	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA065327	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		87000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA065327: AB_2685469"	"unprognostic (9.94e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.84e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	2894.2	2485.3	3571.1	1229.7	3641.9	2540.7	3450.6	3500.1	5561.8	3540.4	3427.6	2751.2	1111.0	2511.3	1607.3	3586.9	2970.5	473.7	2704.2	3470.4	3604.5	2072.8	2064.6	1905.6	1484.2	3596.9	3545.7	5492.1	4241.2	2106.3	2029.8	971.3	3587.7	2527.0	1539.4	1236.7	2385.3	1378.1	5240.2	4441.1	2070.2	1297.7	3658.7	2374.5	2568.6	1257.5	3665.2	3015.1	1910.2	4156.0	2246.3	2758.2	3080.7	3688.7	2117.5	1757.0	3750.8	2542.5	3820.2	6666.2	2783.2	2804.7	3711.8	2778.8	2362.0	4478.9	2000.9	2310.8	3821.8	3450.3	3000.1	2165.8	3570.4	4118.4	2861.6	2653.7	3779.3	3786.9	3130.5	6449.1	6532.0	4206.8	2285.8	7292.0	8500.4	2410.8	6755.9	7614.5	3897.7	4509.9	3008.0	3296.4	3653.4	4222.0	4025.0	8611.8	4350.4	4680.8	1985.4	2874.3	2818.9	2846.9	3975.2	3650.5	2425.5	2719.7	1032.7	3199.3	6926.2	5291.2	2027.5	7146.0	2649.0	2006.9	2201.6	1991.6	3119.4	3471.7	5348.9	4515.3	2242.4	2876.4	2081.6	1025.7	2303.5	546.8	2463.3	1720.1	3379.1	4446.9	3801.3	3078.0	3061.9	4258.4	4343.3	4006.9	281.8	2725.4	1469.9	4230.5	3011.4	6099.2	3571.1	3641.9	3500.1	5561.8	3470.4	3604.5	3596.9	3545.7	3587.7	3658.7	3665.2	3688.7	1310.3	1198.7	1865.0	20.2	3813.1	4936.9	3370.7	3086.2	2318.0	513.1	5676.7	3353.1	1482.9	2713.7	2139.1	1265.3	185.6	3021.4	2978.5	1879.2	3155.8	2994.2	3958.3	1634.1	3979.9	2334.0	2623.6	2835.7	16.8	8453.9	5257.7	1903.5	1194.2	2334.1	2170.9	3057.7	3945.8	4967.1	3060.4	200.2	18.2	4863.9	935.8	4892.5	4112.7	7778.0	5740.1	2453.8	2853.1	15.9	3968.7	2304.7	3980.5	11.1	24.2	6102.8	5240.6	2969.2	2205.6	3694.1	3198.7	3898.4	964.1	755.8	2005.0	4215.6	2775.8	2230.8	1623.5	4320.7	7355.8	3208.5	2814.6	1760.7	5273.7	3405.9
RPL38	L38	ENSG00000172809	"Ribosomal protein L38"	P63173	17	74203582-74210655	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052543	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA052543: AB_2681864"	"unprognostic (1.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.71e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.17e-8)"	"unprognostic (1.89e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-2)"	1529.9	1174.4	1493.3	822.1	1517.9	1450.0	1568.3	1474.2	1847.8	1873.4	1400.3	1523.8	648.5	1256.8	845.0	1496.0	1435.2	271.4	1470.8	1447.8	1522.6	1124.6	1109.4	1065.7	1010.8	1521.8	1487.5	3163.1	1992.1	754.3	941.5	546.1	1528.1	1267.5	660.1	379.7	1190.0	533.6	2848.0	1967.6	1244.9	535.6	1533.5	1419.7	1231.8	784.8	1535.7	1452.5	1083.8	1900.3	1197.5	1373.2	1569.6	1604.3	1720.7	1654.5	1568.1	1609.4	2096.5	2459.6	1552.1	1818.4	1160.9	1622.8	1130.0	1870.1	1274.6	3002.4	1237.3	1565.8	1504.9	1512.7	1888.2	2361.4	1266.0	844.7	3028.3	1724.1	1374.6	2467.9	2443.9	3251.8	1474.0	4777.2	3230.5	1527.0	2469.4	2179.8	2416.1	2387.7	2155.9	1622.2	1375.7	1793.0	3170.7	3903.4	1837.0	3823.2	2488.8	2259.2	3321.0	2695.8	1971.0	1317.5	1415.6	2630.5	757.0	3129.9	4282.5	1942.0	2389.2	3316.1	1592.2	1347.1	2210.4	1254.4	2416.6	2187.4	3677.2	3159.9	1104.9	2101.7	1314.4	1192.1	1841.8	676.2	1819.2	1524.9	2176.5	2904.1	3073.8	2304.5	2001.8	2772.2	3429.7	3037.1	575.3	1491.2	1383.9	2455.1	2101.1	4458.5	1493.3	1517.9	1474.2	1847.8	1447.8	1522.6	1521.8	1487.5	1528.1	1533.5	1535.7	1604.3	863.9	451.9	901.6	12.7	2204.9	2331.7	1278.1	1084.7	961.2	186.6	2059.8	1364.6	753.8	1509.9	820.1	614.3	73.0	1330.3	1639.9	1230.1	1441.9	1518.1	1413.7	1051.3	1657.7	1158.2	1469.3	1411.7	9.9	2875.9	2467.6	981.1	490.8	1223.8	1223.7	933.3	2189.2	2371.8	1800.6	87.5	9.1	3044.0	413.0	2925.5	2553.8	3689.8	3016.5	1394.9	1213.1	7.5	2817.4	751.3	2063.9	7.1	15.2	2380.8	2171.4	1509.4	769.1	1476.4	2127.6	2377.0	565.8	266.1	959.8	1959.8	1054.6	956.0	1132.1	1084.0	2690.5	1450.3	1884.0	684.7	2643.7	1293.5
RRAGA	"FIP-1, RAGA"	ENSG00000155876	"Ras related GTP binding A"	Q7L523	9	19049427-19051025	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (6.30e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (6.74e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.05e-1)"	79.3	73.7	73.6	39.6	75.1	30.2	72.8	77.5	82.5	67.3	74.6	74.0	38.6	94.8	77.4	62.1	74.7	49.7	87.1	76.7	83.5	67.7	68.3	51.9	46.4	73.5	74.2	83.0	46.7	47.6	68.7	71.0	77.5	58.1	45.6	39.7	53.3	73.8	128.9	72.5	57.1	82.7	80.2	52.9	57.1	40.2	78.1	53.2	57.1	104.5	47.9	70.7	58.0	84.5	115.2	92.7	74.9	78.4	263.8	167.0	51.5	112.7	134.4	96.2	117.7	35.8	34.7	22.6	61.1	190.8	86.7	42.8	64.8	106.6	101.2	97.7	72.8	145.3	122.6	139.0	172.8	20.3	52.7	148.8	101.3	82.2	55.7	132.4	116.1	36.9	33.4	32.1	202.5	72.5	56.2	118.8	41.9	59.5	70.6	43.0	48.8	32.6	147.9	98.8	61.4	76.6	61.9	55.5	60.4	67.5	71.3	54.0	91.0	116.2	44.6	83.6	85.3	22.5	39.4	51.6	127.9	30.8	43.1	155.3	85.6	147.8	74.5	98.0	72.7	49.4	77.1	74.6	81.0	50.4	70.1	69.8	58.9	81.9	109.3	58.2	100.0	107.8	73.6	75.1	77.5	82.5	76.7	83.5	73.5	74.2	77.5	80.2	78.1	84.5	84.3	25.6	27.7	16.0	35.0	61.1	123.7	138.8	50.7	47.8	43.2	57.9	51.8	41.5	63.8	53.3	18.8	130.9	28.1	32.9	105.7	95.9	92.5	74.0	70.6	86.5	17.5	38.1	17.5	61.4	98.6	80.3	28.1	47.2	33.6	38.0	71.4	61.9	64.6	48.8	20.0	29.8	81.4	37.1	33.2	28.3	93.8	39.2	56.9	20.6	51.0	95.4	49.4	21.1	29.6	52.3	44.3	103.0	24.0	50.8	51.4	130.1	75.4	37.0	32.9	65.3	79.1	113.8	22.9	47.7	59.2	121.4	37.3	61.6	34.8	74.8
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364616-89412273	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 129.1;Distal tubular cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	9.8	9.1	14.0	2.3	18.9	11.6	8.2	31.8	16.1	9.4	17.9	4.0	1.7	1.5	6.9	13.8	13.7	3.6	38.4	15.9	13.9	26.5	4.4	7.0	2.8	16.4	12.2	1.6	6.4	22.7	11.4	3.2	17.2	6.1	1.8	21.8	52.2	2.8	84.5	6.7	2.0	2.1	21.5	4.8	1.7	6.9	14.8	5.5	28.1	60.3	2.5	5.8	6.2	23.8	0.1	1.7	4.4	3.3	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.1	0.1	0.0	1.5	0.0	22.6	0.1	24.5	0.1	0.0	0.0	12.1	5.8	0.1	0.1	1.8	16.9	19.0	0.4	1.5	0.0	0.1	0.0	0.0	16.9	0.5	63.9	0.1	1.8	8.2	8.4	3.6	0.0	1.8	16.8	23.1	0.2	5.8	0.6	33.1	1.8	0.6	2.2	28.8	1.3	0.7	13.2	0.0	1.8	2.8	11.5	3.0	80.0	39.8	0.0	6.1	12.5	1.9	2.6	0.6	1.4	0.0	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	3.3	0.1	2.4	0.3	0.0	0.1	14.0	18.9	31.8	16.1	15.9	13.9	16.4	12.2	17.2	21.5	14.8	23.8	1.4	9.6	16.7	5.2	3.7	16.2	17.0	5.8	4.0	21.7	17.4	9.7	129.1	17.2	13.9	14.7	31.3	0.6	4.7	0.1	117.4	20.2	25.6	10.4	2.5	4.8	1.2	5.0	17.6	16.9	1.5	10.0	1.1	15.0	4.5	2.9	2.5	9.7	51.9	47.1	20.6	0.5	42.7	25.8	9.2	15.5	3.1	23.2	39.2	3.7	10.4	29.6	0.0	13.0	17.2	8.1	0.0	4.1	8.0	28.4	0.0	18.6	19.4	16.3	0.0	11.8	7.0	21.7	30.3	32.4	22.6	0.7	3.9	0.2	0.2	30.2
RTL6	"dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3"	ENSG00000188636	"Retrotransposon Gag like 6"	Q6ICC9	22	44492583-44498233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 11.1;Collecting duct cells: 12.9;Ductal cells: 8.4;Endometrial stromal cells: 12.9;Granulosa cells: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005697	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA005697: AB_1079244"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	10.6	12.1	21.3	7.2	19.2	3.2	8.9	15.1	18.9	11.2	8.3	12.5	8.8	15.7	12.1	8.2	16.6	11.0	15.3	20.1	17.4	9.3	3.2	9.4	6.3	18.8	20.0	19.2	11.0	17.8	8.7	5.1	17.1	9.8	9.1	9.6	7.2	13.6	15.5	3.4	8.4	16.9	18.8	7.5	9.7	11.2	21.9	14.2	10.2	18.0	4.8	10.4	5.4	17.2	13.8	18.9	23.9	31.9	18.3	14.8	6.3	17.9	21.1	24.6	19.2	6.3	8.0	0.0	10.9	33.5	18.5	11.8	16.3	17.7	15.1	6.5	31.8	0.0	35.8	0.0	22.6	1.8	8.7	16.2	16.8	22.5	17.3	33.4	22.3	21.6	7.8	0.1	16.9	24.3	44.4	4.1	14.7	15.1	20.0	12.1	12.7	0.0	21.1	15.8	25.6	30.0	29.2	14.0	18.1	11.5	14.0	19.3	23.1	19.2	25.7	25.7	14.5	8.3	3.5	0.0	28.5	4.5	29.2	0.0	0.7	0.0	1.8	0.3	1.9	0.0	1.0	1.5	0.5	0.0	0.4	1.0	0.0	0.4	0.4	0.0	0.2	1.1	21.3	19.2	15.1	18.9	20.1	17.4	18.8	20.0	17.1	18.8	21.9	17.2	5.8	0.0	5.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.1	6.5	0.0	0.0	2.5	12.9	0.0	2.9	4.8	0.0	0.0	8.4	0.0	7.4	12.9	4.0	0.0	0.0	0.0	6.5	2.7	3.5	0.0	8.1	0.0	13.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.7	0.0	0.0	5.7	7.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.2	1.8	5.2	0.0	0.0
RTN2	"NSP2, NSPL1, SPG12"	ENSG00000125744	"Reticulon 2"	O75298	19	45485294-45497055	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 509.8;tongue: 207.7"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.3;Extravillous trophoblasts: 145.7;Skeletal myocytes: 73.2;Syncytiotrophoblasts: 120.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.2;eosinophil: 2.6;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.6;granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.3;RT4: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034941, HPA034948"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"		"HPA034941: AB_10671358, HPA034948: AB_2674375"	"unprognostic (3.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (4.34e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.03e-1)"	9.9	13.6	21.4	3.4	25.7	1.7	12.0	15.9	43.6	5.9	7.8	21.8	2.8	15.2	2.5	12.1	4.6	7.9	21.9	24.7	22.0	7.1	3.9	8.2	4.7	27.3	19.3	1.9	4.8	10.1	7.6	19.2	27.0	17.0	2.2	5.7	22.3	10.6	509.8	9.1	8.7	7.3	14.1	11.2	7.9	1.6	25.1	1.1	4.9	207.7	2.0	12.4	7.8	29.0	3.8	5.2	8.6	6.7	14.4	17.6	16.9	8.5	20.0	5.2	9.9	10.4	3.2	3.3	11.4	9.3	4.2	7.2	5.6	4.1	1.7	7.9	8.2	23.0	3.9	7.8	6.2	1.4	25.0	19.5	2.2	2.3	4.2	9.2	9.6	0.9	12.9	6.2	15.6	2.9	0.0	4.3	6.3	17.0	6.8	3.6	44.3	18.8	3.0	45.0	24.1	23.1	1.7	40.7	13.2	8.0	32.3	9.1	8.6	14.7	4.4	0.4	1.9	3.5	8.7	7.7	3.9	5.2	7.7	6.2	0.1	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.3	1.6	0.0	0.2	21.4	25.7	15.9	43.6	24.7	22.0	27.3	19.3	27.0	14.1	25.1	29.0	9.8	3.2	8.1	2.6	0.8	6.4	27.7	8.9	6.8	10.4	18.4	21.1	4.6	4.3	4.6	3.7	6.2	134.3	2.9	0.9	0.0	21.3	0.3	2.1	7.0	15.3	11.4	1.7	21.0	6.8	145.7	14.0	3.1	3.4	16.5	4.2	18.9	3.1	27.3	23.5	13.3	2.2	12.2	12.9	12.0	0.4	5.6	10.7	23.2	1.9	6.5	9.1	1.0	4.5	2.1	13.1	0.3	6.8	2.5	13.0	0.3	0.3	1.3	13.6	13.1	73.2	12.3	0.5	3.9	2.3	3.4	120.1	1.0	16.4	0.7	23.2
RUNDC1	DKFZp761H0421	ENSG00000198863	"RUN domain containing 1"	Q96C34	17	42980565-42993690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023726	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"HPA023726: AB_2184078"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.39e-2)"	"prognostic favorable (6.93e-5)"	"unprognostic (9.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.77e-3)"	5.5	8.0	8.7	6.6	11.0	6.8	10.0	6.5	11.0	8.6	9.7	9.4	6.5	8.7	12.1	6.6	14.5	6.1	7.3	9.6	8.8	8.4	5.0	6.9	7.2	6.3	6.8	5.0	7.9	12.0	9.4	4.8	6.2	12.1	7.6	8.5	7.5	8.5	11.6	7.1	7.8	8.6	5.8	8.1	10.1	6.8	7.9	6.7	10.2	9.0	7.7	8.4	6.2	8.2	12.9	22.1	8.8	11.9	14.7	8.8	9.3	12.2	12.6	17.1	12.7	14.0	7.2	8.6	10.7	12.1	11.6	15.8	11.3	12.3	18.9	9.7	17.7	5.8	12.8	13.5	9.4	12.6	11.9	6.6	14.7	15.1	10.0	13.6	9.2	9.3	11.2	5.3	9.9	9.3	15.6	8.9	9.9	18.3	13.8	11.2	12.3	8.6	14.3	17.0	12.8	11.8	9.6	9.0	10.2	12.9	17.5	13.9	7.6	15.4	9.6	9.2	14.7	12.6	13.1	7.5	11.0	6.6	9.8	4.7	2.3	7.9	1.3	3.8	1.7	3.7	1.6	1.1	1.8	3.7	1.6	1.7	5.4	1.1	2.8	5.6	2.0	1.0	8.7	11.0	6.5	11.0	9.6	8.8	6.3	6.8	6.2	5.8	7.9	8.2	5.3	44.8	38.4	6.5	18.7	15.0	11.0	5.8	9.1	18.9	19.2	9.8	13.7	22.8	17.2	5.5	22.9	9.8	19.1	28.7	21.5	11.8	8.1	26.4	9.6	10.3	19.2	5.7	13.8	9.8	7.3	8.6	20.4	19.5	11.4	8.4	10.4	6.1	8.4	38.7	11.0	16.9	6.1	10.5	14.7	4.5	9.9	9.5	3.6	7.5	14.3	14.3	12.3	5.0	6.2	10.1	16.4	14.3	11.7	16.6	15.1	12.8	24.7	33.2	19.7	8.5	9.6	22.9	14.9	7.2	14.6	5.5	13.9	10.4	17.8	17.0
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 218.9;Kupffer cells: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 19.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.5;monocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	40.5	22.7	33.5	14.5	36.4	18.9	11.2	25.5	29.4	12.2	16.9	16.6	25.8	13.5	8.7	28.5	16.5	13.6	19.4	27.1	30.2	16.0	32.9	18.8	8.2	32.9	31.3	21.7	25.4	45.1	3.5	14.5	30.8	15.6	10.0	5.4	21.7	17.1	106.5	88.1	28.0	11.1	30.4	25.1	14.7	7.9	42.7	6.0	17.6	51.9	7.6	16.2	8.2	22.6	19.6	36.4	14.7	21.9	42.8	19.1	66.7	14.1	16.1	9.6	6.5	20.7	28.0	0.0	25.8	22.5	15.1	105.5	7.7	32.8	2.9	26.3	7.2	0.1	47.5	30.0	20.4	18.8	4.8	29.0	52.1	11.5	10.6	12.9	12.8	1.6	26.0	1.1	8.7	61.8	1.1	59.5	17.5	63.4	16.9	7.4	30.3	36.7	12.2	64.3	17.2	10.5	37.3	46.9	10.6	7.1	44.9	78.8	16.5	16.2	23.4	17.4	9.7	1.7	0.2	0.4	11.6	33.9	12.7	1.3	8.1	6.6	1.4	12.9	0.2	0.3	0.9	1.0	3.2	0.1	0.2	1.2	19.5	2.2	11.2	0.7	1.2	3.2	33.5	36.4	25.5	29.4	27.1	30.2	32.9	31.3	30.8	30.4	42.7	22.6	32.1	32.1	22.9	36.2	4.6	34.5	16.5	21.1	12.5	6.0	16.7	14.4	38.8	72.9	26.2	9.2	25.0	30.1	11.0	72.3	1.9	13.9	4.3	19.8	16.6	28.9	9.6	30.9	9.1	14.1	29.5	23.7	17.9	17.4	1.3	21.3	71.0	218.9	31.9	33.7	17.6	21.2	10.2	134.2	30.0	18.8	32.3	50.4	12.4	10.3	80.4	36.5	14.4	29.1	6.0	15.9	32.4	21.1	7.4	17.7	55.6	19.9	34.4	19.9	19.7	34.6	30.6	0.9	9.4	34.4	46.9	23.9	12.6	15.5	27.5	32.8
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;pituitary gland: 29.9;retina: 24.3;skeletal muscle: 49.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 39.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	2.4	3.2	14.6	0.4	16.6	0.0	1.0	11.7	17.4	3.0	11.7	4.1	0.7	1.1	0.7	1.0	2.8	0.6	5.3	12.4	21.5	0.2	0.3	2.8	0.3	25.6	14.8	1.0	2.1	0.1	29.9	0.7	22.2	1.1	2.0	24.3	1.2	1.4	49.7	2.3	1.6	1.2	13.6	0.4	1.4	1.0	32.1	0.1	0.7	7.6	0.0	1.6	2.1	15.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	16.6	11.7	17.4	12.4	21.5	25.6	14.8	22.2	13.6	32.1	15.6	0.9	0.0	0.0	13.4	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	2.8	5.0	0.0	28.4	0.0	0.0	16.8	0.0	1.0	1.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.5	13.1	35.9	3.4	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
SAP30L	"FLJ11526, NS4ATP2"	ENSG00000164576	"SAP30 like"	Q9HAJ7	5	154445997-154461053	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048665, HPA078308"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048665: AB_2680486, HPA078308: "	"unprognostic (3.79e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.69e-4)"	10.0	8.4	12.2	5.3	13.7	1.6	11.3	13.0	13.2	14.0	10.2	14.9	10.5	13.4	9.0	7.1	12.9	6.7	9.8	11.1	12.9	13.1	8.0	9.3	6.8	13.2	13.4	19.7	6.4	13.8	5.0	7.7	12.7	10.6	8.7	6.1	7.3	12.4	14.1	11.4	11.0	11.6	13.7	8.9	8.9	7.7	13.1	9.9	9.3	15.3	8.3	10.9	10.0	13.8	9.0	7.3	13.3	8.8	28.4	22.5	6.5	9.2	19.9	10.4	11.2	4.9	5.0	9.7	7.2	14.0	12.1	7.1	10.1	7.5	11.6	4.9	9.9	7.9	6.8	3.6	8.5	10.5	5.7	8.2	13.4	4.6	11.3	16.0	8.5	9.1	3.3	6.0	8.8	4.5	9.9	6.7	3.3	8.2	5.0	9.4	13.3	4.8	6.0	4.4	8.0	10.5	7.3	15.6	17.6	12.4	5.6	12.8	12.1	7.2	5.3	9.6	6.6	5.6	8.6	5.0	10.6	8.1	4.2	0.0	0.3	0.3	0.5	0.4	0.6	0.2	0.6	0.6	0.3	0.5	0.6	0.4	0.2	1.4	1.2	0.4	0.6	0.3	12.2	13.7	13.0	13.2	11.1	12.9	13.2	13.4	12.7	13.7	13.1	13.8	25.7	19.2	6.9	7.8	7.1	17.3	8.7	4.2	8.0	4.5	17.0	14.1	19.8	17.2	6.3	3.7	6.2	7.7	15.5	26.5	3.9	4.8	22.4	15.6	18.4	17.6	7.2	11.0	6.6	8.2	12.3	18.1	4.6	9.8	1.3	16.4	15.7	16.3	8.5	10.1	6.5	11.4	0.0	9.7	12.4	18.0	20.5	11.3	10.6	9.4	10.7	21.4	14.4	6.0	12.1	10.6	13.9	18.0	7.8	16.9	32.7	10.5	9.5	5.8	0.0	14.9	16.0	16.1	17.2	5.5	18.2	6.3	8.9	10.5	12.1	13.3
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS ribosome maturation factor"	Q9Y3A5	7	66987680-66995587	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	139.1	107.5	136.1	57.9	152.1	157.2	113.7	151.2	168.3	97.3	115.8	143.6	127.8	117.2	83.3	128.6	99.2	84.9	238.0	133.1	148.4	117.8	126.8	113.8	43.8	156.2	142.3	90.1	89.3	145.0	87.4	106.2	155.0	107.9	111.6	90.3	80.7	122.6	374.0	92.0	114.2	128.2	152.6	57.3	104.6	60.9	143.4	38.8	107.0	263.3	52.5	113.9	90.7	169.7	168.3	68.9	59.9	54.6	212.7	157.9	67.0	281.4	225.4	206.1	157.1	143.1	83.0	62.2	209.7	253.5	136.3	80.1	101.7	164.3	219.4	59.8	136.4	31.1	125.9	86.6	188.9	78.1	40.8	144.0	215.1	157.0	269.8	105.9	129.2	39.7	227.2	65.0	324.2	100.0	41.8	112.4	67.2	227.3	165.9	31.3	132.6	129.3	218.1	73.6	91.7	63.7	142.3	235.5	194.3	131.0	176.2	64.8	176.4	276.5	96.7	142.5	205.4	40.6	51.4	141.0	95.7	125.5	157.4	75.5	33.2	61.4	64.7	37.7	81.7	62.8	82.7	75.2	33.4	59.9	104.4	85.7	13.0	51.8	35.1	45.4	80.2	62.2	136.1	152.1	151.2	168.3	133.1	148.4	156.2	142.3	155.0	152.6	143.4	169.7	169.9	304.5	128.0	10.7	101.6	464.2	466.2	213.2	145.7	73.7	118.5	154.0	286.6	108.7	160.3	92.0	12.5	130.5	98.0	270.9	262.2	177.4	583.0	93.0	131.2	153.2	101.9	51.3	12.5	165.7	232.1	197.7	96.8	128.2	150.0	29.7	138.5	102.1	107.0	58.9	15.3	221.9	142.4	47.2	238.1	2042.9	127.1	74.8	256.1	11.2	66.5	161.9	30.9	7.5	36.0	300.0	242.2	168.5	117.5	267.2	359.3	264.6	75.6	56.8	164.3	512.9	266.2	86.3	47.9	129.9	430.0	398.5	144.5	132.2	165.4	318.5
SBK1	Sbk	ENSG00000188322	"SH3 domain binding kinase 1"	Q52WX2	16	28259246-28323849	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.8;skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Excitatory neurons: 38.2;Granulosa cells: 26.3;NK-cells: 36.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 28.8;AN3-CA: 20.9;NTERA-2: 29.6;REH: 32.6;SCLC-21H: 45.5;SH-SY5Y: 42.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 275.9"	"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (5.15e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (2.08e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.87e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.03e-3)"	0.1	2.4	8.0	0.9	7.0	1.3	0.8	26.8	15.0	0.7	0.0	0.3	0.3	0.9	0.4	0.6	0.7	0.2	2.1	11.6	6.7	1.8	0.2	0.8	1.7	6.6	7.6	0.5	1.9	2.9	5.6	0.0	6.7	1.5	0.3	5.0	2.7	0.2	44.1	1.1	0.6	0.1	3.2	1.9	0.8	2.5	12.8	10.0	2.5	9.1	0.8	0.3	0.3	7.9	0.3	0.4	28.8	20.9	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.2	1.4	0.7	0.2	0.0	0.4	0.5	8.8	0.2	0.1	3.0	1.2	0.1	0.3	0.9	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.2	0.2	11.2	0.0	1.8	0.0	3.6	14.0	0.3	29.6	1.9	0.2	32.6	1.6	0.6	0.1	1.8	45.5	42.6	0.8	2.7	0.4	3.5	3.3	0.1	0.8	0.1	4.3	0.4	0.2	0.3	0.0	0.5	0.1	0.5	1.6	0.3	0.0	0.0	1.5	0.0	0.5	0.0	0.4	0.8	0.0	0.1	0.4	1.0	0.0	0.7	0.0	0.0	0.5	0.1	8.0	7.0	26.8	15.0	11.6	6.7	6.6	7.6	6.7	3.2	12.8	7.9	0.2	3.2	0.5	1.0	0.6	0.6	0.7	1.4	3.4	13.0	6.3	2.9	3.6	2.8	2.5	0.0	81.3	0.0	11.1	0.1	1.9	8.2	1.2	2.4	0.3	0.3	6.0	0.4	38.2	5.6	0.0	0.4	0.0	1.8	0.0	26.3	0.0	0.2	0.1	0.0	13.8	0.8	4.1	0.0	0.8	3.9	0.6	0.4	0.0	0.0	0.7	4.1	36.0	5.0	1.7	3.6	0.0	0.0	2.3	1.5	0.1	0.7	1.7	2.7	0.0	2.5	2.7	2.4	2.1	1.0	0.1	0.1	5.6	0.2	1.2	0.4
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	46	"dendritic cells: 6.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	2.9	46.5	0.2	56.3	0.8	1.2	52.6	55.0	2.5	28.9	11.1	1.0	3.9	0.7	3.4	2.3	1.9	80.4	50.0	48.7	2.5	0.7	2.9	0.5	51.0	48.2	0.5	0.4	0.2	11.8	10.9	52.6	5.6	1.1	3.6	1.9	1.4	101.3	0.4	3.6	5.4	55.6	4.8	4.6	1.9	46.9	0.8	0.8	92.8	0.2	0.7	1.2	81.0	0.1	0.0	27.0	49.2	0.0	0.2	0.0	0.2	0.1	0.1	1.1	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	2.4	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.7	1.1	0.3	11.2	0.4	58.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	29.8	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	167.0	0.0	0.0	0.2	7.0	0.0	3.1	10.9	0.6	1.5	0.4	2.5	2.1	0.0	0.0	0.7	2.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	46.5	56.3	52.6	55.0	50.0	48.7	51.0	48.2	52.6	55.6	46.9	81.0	4.5	6.4	1.7	0.0	0.1	0.4	4.8	2.5	1.2	5.4	0.6	0.8	14.2	0.0	2.2	3.7	2.1	1.5	2.7	0.1	0.0	0.3	0.0	4.4	0.4	6.0	0.0	2.1	0.0	0.2	0.5	1.6	0.0	3.1	0.0	0.1	2.2	0.5	0.2	15.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	3.6	0.0	0.0	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.6	0.0	1.4	3.7	0.6	0.0	7.0	2.9	0.0	0.4	0.4	0.6	0.8	0.2	0.2	0.0	1.4
SCN1B		ENSG00000105711	"Sodium voltage-gated channel beta subunit 1"	Q07699	19	35030470-35040449	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 256.5;skeletal muscle: 572.0;tongue: 227.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.9;Excitatory neurons: 50.4;Hofbauer cells: 31.3;Inhibitory neurons: 48.3;Kupffer cells: 35.1;Macrophages: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.5;EFO-21: 12.7;TIME: 26.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 349.1"						"Secreted in other tissues"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (8.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.72e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.78e-2)"	20.2	13.6	48.2	3.3	53.0	2.3	16.3	95.8	256.5	15.5	7.7	9.7	1.9	9.4	2.2	8.6	21.7	4.8	95.4	45.0	97.2	8.3	8.5	11.1	3.0	120.4	67.0	7.8	12.3	18.2	17.4	5.3	115.7	8.7	2.7	10.7	15.4	3.6	572.0	6.3	8.0	4.5	52.2	19.8	8.4	2.8	153.5	1.3	11.1	227.8	0.8	13.4	10.5	113.6	0.4	17.5	0.2	1.0	5.2	7.8	0.1	7.1	6.1	3.4	0.9	0.7	0.2	0.2	12.7	7.1	3.0	0.3	1.1	0.7	1.6	0.2	0.8	0.2	2.5	4.5	6.9	0.1	0.1	2.5	0.1	0.4	0.2	6.8	11.6	0.2	0.4	0.1	2.2	1.7	0.2	0.2	0.8	1.6	5.1	0.9	1.8	0.2	0.5	0.1	8.1	4.3	0.9	0.1	1.4	0.6	1.6	0.4	26.1	6.7	6.6	0.3	4.6	0.3	0.5	1.0	4.0	0.8	4.8	0.7	0.2	0.1	0.3	0.1	0.6	0.1	0.1	0.1	0.6	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.3	0.7	48.2	53.0	95.8	256.5	45.0	97.2	120.4	67.0	115.7	52.2	153.5	113.6	12.8	0.0	3.3	11.8	1.1	1.8	0.8	1.6	0.0	67.9	1.6	7.7	20.3	0.0	0.6	0.0	2.1	0.4	2.9	0.0	9.8	0.3	0.3	2.0	2.0	9.7	0.0	0.4	50.4	2.6	0.6	9.9	2.0	1.8	2.5	0.1	20.7	1.2	31.3	8.4	48.3	1.6	0.0	35.1	3.7	0.0	7.5	29.5	3.6	15.9	3.0	13.3	0.0	6.0	18.5	0.7	0.1	2.2	2.7	1.1	0.1	2.5	1.0	22.8	0.0	25.3	3.6	0.2	0.7	0.1	1.1	1.0	2.0	0.1	0.8	0.3
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77088749-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 430.3;Hepatic stellate cells: 286.3;Late spermatids: 740.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 355.0"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 355.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 398.1;TIME: 251.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	66.7	54.2	42.6	44.6	63.3	65.5	57.6	75.4	60.7	39.5	36.3	19.5	21.8	24.6	28.2	31.5	27.3	34.3	50.2	49.5	57.5	42.0	25.3	66.9	49.7	64.0	63.0	20.7	30.8	25.1	27.9	76.7	54.6	18.3	19.8	19.0	35.0	16.8	94.1	20.5	21.7	27.1	46.2	49.9	31.7	51.9	63.6	24.1	41.6	54.7	46.2	26.0	20.6	50.9	55.0	45.4	65.6	105.0	27.4	36.3	24.1	47.4	42.0	57.8	49.5	55.7	39.6	143.1	93.3	65.0	71.1	26.3	36.0	47.8	72.6	27.3	50.1	81.1	42.4	75.9	44.4	26.8	39.8	46.6	20.7	47.8	47.8	69.1	398.1	24.3	55.8	136.0	79.2	36.2	28.5	22.4	25.0	25.7	43.7	20.3	104.2	112.2	91.2	26.2	59.5	44.8	51.1	31.3	32.1	58.3	27.9	20.7	251.1	65.4	60.6	35.0	37.7	71.1	64.8	79.9	27.9	22.1	21.6	33.8	19.4	48.9	7.1	28.3	8.9	14.6	6.9	5.3	12.7	10.8	10.9	5.9	355.0	10.0	33.3	18.9	12.5	11.5	42.6	63.3	75.4	60.7	49.5	57.5	64.0	63.0	54.6	46.2	63.6	50.9	430.3	41.7	18.6	55.8	69.4	29.3	23.5	22.5	37.0	31.5	86.5	37.8	17.6	15.7	28.9	27.6	18.8	10.8	77.5	20.3	99.7	18.0	242.6	114.8	46.7	205.9	19.7	86.5	33.0	20.7	10.8	34.0	35.2	240.5	34.7	104.3	286.3	11.1	51.6	37.0	54.6	14.0	61.1	127.2	48.1	740.3	26.4	115.1	35.6	62.8	76.1	31.4	34.0	23.1	44.4	41.8	15.2	17.3	269.1	39.5	9.6	24.8	69.5	17.2	39.5	36.4	36.3	45.1	42.5	25.1	30.4	13.3	51.6	64.3	11.5	39.1
SELENOW	"SELW, SEPW1"	ENSG00000178980	"Selenoprotein W"	P63302	19	47778585-47784686	"Predicted intracellular proteins"		Antioxidant		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1609.8;skeletal muscle: 1723.7;tongue: 1969.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 855.4;Breast myoepithelial cells: 490.5;Distal tubular cells: 633.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 541.5;HUVEC TERT2: 624.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.46e-3)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	188.5	103.4	1283.6	107.6	1308.6	44.7	204.0	1297.0	1609.8	270.1	1374.7	535.1	127.4	218.5	258.8	266.6	306.9	240.5	988.8	1351.6	1261.2	146.6	109.6	199.7	112.1	1273.2	1296.9	170.9	132.6	168.7	138.6	153.5	1251.5	233.2	224.7	128.1	195.8	291.5	1723.7	312.3	177.5	467.0	1278.9	146.1	207.8	55.3	1333.8	113.7	156.7	1969.8	87.8	323.5	173.3	1321.9	74.4	119.6	174.0	141.4	124.7	268.1	43.7	76.7	59.6	71.4	53.8	49.6	57.1	0.0	64.3	163.1	70.1	57.8	293.6	389.6	124.1	216.4	72.9	34.9	61.7	63.2	138.0	9.1	131.8	285.1	541.5	119.4	113.0	158.7	624.7	109.1	46.4	28.6	317.7	179.0	156.6	115.4	68.0	186.0	91.4	26.9	18.3	23.5	208.0	130.8	72.4	51.5	77.6	203.0	77.9	299.2	114.2	43.7	213.9	71.0	151.2	50.7	141.3	46.3	153.1	16.1	75.3	93.2	165.0	309.3	187.8	448.3	303.8	226.2	265.1	182.4	333.6	311.7	147.8	159.2	331.0	288.3	19.9	216.1	293.5	166.8	436.6	414.1	1283.6	1308.6	1297.0	1609.8	1351.6	1261.2	1273.2	1296.9	1251.5	1278.9	1333.8	1321.9	855.4	333.3	282.3	0.0	20.4	0.0	0.0	0.0	0.0	0.0	347.1	490.5	0.0	0.0	219.7	154.5	0.0	157.0	127.3	0.0	633.9	278.3	0.0	350.2	221.5	220.8	0.0	0.0	0.0	244.5	327.9	145.5	0.0	188.4	119.8	153.8	0.0	0.0	251.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.3	0.0	0.0	156.6	0.0	0.0	0.0	0.0	243.7	0.0	0.0	21.3	0.0	0.0	380.8	303.9	0.0	0.0	0.0	210.7	0.0	0.0	0.0	0.0	182.4	66.9	341.7	0.0	0.0
SETD3	"C14orf154, FLJ23027"	ENSG00000183576	"SET domain containing 3, actin histidine methyltransferase"	Q86TU7	14	99397748-99480889	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 206.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003591, HPA003639"	Approved		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA003591: AB_1079930, HPA003639: AB_1079931"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-1)"	"prognostic favorable (1.89e-15)"	"unprognostic (6.81e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-3)"	38.8	26.6	49.6	25.2	50.6	23.5	30.1	46.9	59.2	29.2	45.1	49.5	36.3	26.2	83.5	36.6	46.6	29.4	79.0	48.1	47.8	96.1	47.2	37.4	24.1	46.4	45.5	22.0	37.6	40.1	21.6	42.6	45.9	35.9	37.9	64.5	57.8	41.6	174.0	31.6	37.4	39.4	46.2	28.4	29.1	85.0	52.2	24.5	53.4	118.2	24.8	36.3	24.4	52.1	39.9	44.6	33.1	31.7	37.6	42.0	117.1	49.4	37.4	50.3	51.1	43.5	65.7	38.8	39.5	55.6	39.5	50.4	40.8	55.2	79.6	38.5	22.0	35.3	27.8	40.2	46.9	53.6	51.2	29.6	71.3	44.7	64.8	37.9	63.4	57.2	28.3	56.9	56.3	74.7	56.6	57.9	19.9	98.5	50.7	34.1	67.8	32.0	72.6	48.4	58.9	27.4	44.3	45.4	38.4	59.7	61.6	46.2	56.6	22.6	31.5	153.8	38.2	40.6	49.3	42.1	42.6	52.5	35.3	7.6	18.1	24.9	17.7	21.5	20.6	11.4	15.0	16.6	22.4	8.9	12.3	15.4	10.8	20.6	19.2	14.1	12.2	14.8	49.6	50.6	46.9	59.2	48.1	47.8	46.4	45.5	45.9	46.2	52.2	52.1	31.1	25.6	44.5	43.1	16.9	24.3	18.6	14.4	21.6	26.0	22.8	17.1	83.0	18.6	24.8	25.8	27.1	61.9	37.3	37.2	33.2	24.7	206.6	29.9	24.9	29.1	21.7	11.3	47.7	28.0	45.4	22.2	17.3	30.7	32.9	7.5	22.9	27.5	35.8	18.5	43.6	28.2	14.2	29.7	23.2	121.0	19.0	35.9	10.6	52.5	27.9	47.6	60.8	38.2	36.8	25.7	20.3	21.1	23.6	26.1	30.1	101.5	28.1	39.5	6.6	25.3	23.0	130.4	73.0	25.0	32.4	30.0	27.9	9.2	30.5	20.8
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.4;Extravillous trophoblasts: 67.0;Plasma cells: 30.0;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.4;granulocytes: 1.8;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 64.2;Karpas-707: 60.7;RPMI-8226: 46.7;U-266/70: 56.1;U-266/84: 106.7;U-698: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051131: AB_2681354"	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"	5.4	1.8	6.3	5.8	4.9	3.6	3.6	4.3	5.3	4.6	1.3	2.6	2.2	4.5	0.3	1.9	4.6	1.5	2.2	3.9	9.3	6.0	1.8	5.7	10.7	10.6	11.2	1.9	1.9	1.0	3.0	1.8	7.0	4.4	0.5	0.8	2.8	0.7	37.3	3.6	5.5	0.9	7.1	14.5	2.4	3.4	10.4	0.8	4.5	13.8	5.5	4.0	3.4	3.5	3.7	2.8	3.0	6.6	0.7	0.3	27.6	1.3	0.5	0.8	0.6	0.8	0.6	64.2	6.4	0.5	2.8	3.7	0.7	0.9	0.3	8.1	2.8	0.0	1.7	0.6	0.6	0.5	2.2	0.6	0.9	0.5	0.2	1.1	0.2	1.6	0.4	60.7	1.3	6.9	0.3	11.5	7.0	2.3	11.5	8.1	3.3	46.7	2.1	1.0	3.2	11.4	2.3	5.6	1.6	2.3	1.0	8.4	0.2	1.0	6.2	11.0	1.3	56.1	106.7	88.3	3.9	2.3	1.5	0.0	0.3	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.3	3.4	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	6.3	4.9	4.3	5.3	3.9	9.3	10.6	11.2	7.0	7.1	10.4	3.5	5.6	0.0	0.0	6.2	31.4	2.5	2.5	0.0	1.8	6.8	3.4	2.9	1.1	1.5	0.0	0.0	0.0	9.3	2.9	0.8	0.0	0.2	0.4	3.8	2.4	7.3	1.8	0.4	2.2	0.0	67.0	2.0	1.1	5.4	0.0	1.0	2.2	0.8	7.8	5.0	4.8	0.6	0.0	14.1	17.6	2.0	0.6	15.1	7.2	2.8	6.0	9.2	1.0	1.0	0.5	0.1	0.5	0.4	30.0	5.7	0.1	13.0	0.0	1.4	0.0	6.6	2.0	1.1	15.8	0.6	1.6	58.1	1.3	0.4	1.3	2.2
SH3BP5L	KIAA1720	ENSG00000175137	"SH3 binding domain protein 5 like"	Q7L8J4	1	248810446-248825915	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.7;eosinophil: 4.1;neutrophil: 4.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038067, HPA038068"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA038067: AB_2675814, HPA038068: AB_10670651"	"unprognostic (2.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.99e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.66e-2)"	9.6	10.5	18.0	10.1	18.7	9.0	7.7	17.3	21.0	8.8	13.9	12.2	13.5	10.5	7.8	15.8	10.0	8.0	14.1	19.4	15.8	9.5	10.5	9.2	11.3	17.0	16.7	8.6	10.0	12.0	5.9	11.4	16.9	9.1	7.3	5.3	11.9	11.6	30.6	18.4	12.4	9.9	15.8	12.3	9.9	9.5	17.1	13.8	8.1	17.8	10.2	9.0	9.1	18.3	23.2	14.7	18.5	21.2	25.7	17.1	24.6	51.1	17.4	29.2	21.8	14.3	20.0	11.6	29.7	44.1	7.3	24.6	17.9	22.1	15.0	25.4	6.3	18.6	16.4	11.9	15.8	20.4	21.9	14.4	23.4	33.0	12.9	20.7	19.6	21.4	33.0	12.0	20.2	7.9	19.7	16.5	32.4	25.5	36.9	21.9	13.0	23.5	20.5	10.6	21.1	29.2	15.6	19.3	17.9	14.0	21.0	42.4	27.5	36.9	15.7	14.7	80.2	30.5	34.3	10.5	26.8	23.5	15.4	7.7	1.2	4.1	0.7	0.8	0.7	0.6	1.0	0.6	1.1	0.6	0.3	0.3	4.6	0.3	0.3	0.4	0.2	0.8	18.0	18.7	17.3	21.0	19.4	15.8	17.0	16.7	16.9	15.8	17.1	18.3	5.2	0.0	2.0	5.9	4.3	4.6	2.1	2.9	4.0	8.3	6.1	5.0	9.4	1.5	2.3	11.0	0.0	9.6	4.7	15.1	1.9	8.8	1.3	10.5	5.4	6.0	7.7	6.9	6.5	6.0	5.2	4.9	7.7	6.1	0.0	9.0	6.1	10.0	6.0	8.4	5.7	8.4	2.0	5.3	4.5	1.0	4.4	5.6	3.6	3.7	7.1	4.7	6.2	6.0	6.4	10.6	8.1	5.7	5.4	3.0	13.8	9.2	5.1	3.5	0.0	3.7	5.8	8.8	7.0	7.0	4.7	11.4	6.3	5.4	7.3	3.3
SHISA4	"C1orf40, hShisa4, TMEM58"	ENSG00000198892	"Shisa family member 4"	Q96DD7	1	201888680-201892587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.6;skeletal muscle: 219.7"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 37.5"	"Cancer enhanced"	"Detected in all"		"glioma: 49.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 24.6;intermediate monocyte: 8.1;neutrophil: 9.1;non-classical monocyte: 10.2"	"Group enriched"	"Detected in many"	10	"granulocytes: 24.6;monocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061273, HPA067885"	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"			"HPA061273: AB_2684460, HPA067885: "	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.48e-3)"	"unprognostic (2.12e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.06e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"	6.7	26.9	64.6	2.0	71.6	0.5	5.9	61.5	59.4	9.2	27.3	7.7	0.4	10.9	3.5	2.7	6.9	3.6	48.6	55.5	53.3	6.4	3.2	5.2	0.8	63.9	64.9	10.7	5.1	3.9	9.2	2.3	58.0	8.5	0.9	4.7	15.7	4.0	219.7	3.6	3.5	3.7	59.1	2.8	6.7	5.7	68.4	0.3	11.4	58.3	0.6	8.6	6.4	57.1	1.3	10.5	1.6	7.8	12.7	7.7	1.3	9.1	19.3	5.2	6.5	2.0	4.1	0.0	10.6	12.6	17.2	3.4	0.1	1.4	3.0	1.3	0.6	0.1	2.8	1.3	8.2	0.1	6.7	7.6	4.3	6.5	3.0	23.2	8.0	0.1	0.2	0.7	8.1	1.3	0.0	0.0	0.8	0.9	11.3	0.4	0.0	2.1	5.0	4.1	0.5	6.6	3.3	1.6	10.9	7.6	4.4	1.0	7.5	6.3	5.5	3.9	4.4	2.4	2.9	0.1	9.2	0.0	11.2	0.0	1.7	24.6	1.7	8.1	0.8	0.0	0.3	0.4	0.9	0.0	0.0	0.3	9.1	0.0	10.2	0.0	0.0	0.7	64.6	71.6	61.5	59.4	55.5	53.3	63.9	64.9	58.0	59.1	68.4	57.1	12.8	0.0	1.7	14.4	0.3	14.1	4.5	7.4	6.8	11.7	8.2	14.4	20.9	8.6	3.7	11.0	4.2	2.0	0.9	0.1	33.2	24.9	0.7	2.4	10.0	11.1	1.8	0.0	8.4	15.4	27.2	19.2	3.6	2.7	1.3	10.4	12.5	12.1	3.2	5.0	6.5	0.1	6.1	6.9	25.1	2.3	15.8	3.7	23.2	1.0	4.6	37.5	0.0	17.6	19.2	9.5	0.0	29.3	0.2	7.4	0.0	6.3	1.3	3.8	19.7	9.2	18.0	1.4	0.8	0.9	6.8	2.7	1.5	2.3	0.1	2.1
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 302.1;tongue: 218.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	43.2	44.0	101.6	11.5	137.5	17.4	39.7	141.1	123.0	41.5	79.4	49.2	12.6	37.2	10.4	42.5	37.2	15.0	76.9	100.7	111.2	35.9	51.5	38.2	13.7	151.0	129.6	49.0	33.4	18.2	31.2	10.5	144.7	32.7	10.2	11.9	41.5	14.9	302.1	48.8	32.4	18.3	121.3	40.1	41.4	43.5	127.6	13.1	34.5	218.2	13.0	41.3	37.8	173.5	16.1	9.8	8.4	20.6	46.7	31.8	5.8	11.3	20.2	17.8	22.7	17.1	10.2	5.4	23.7	21.3	13.2	8.3	14.6	25.1	10.9	25.2	15.6	10.1	10.9	10.9	33.0	7.0	22.4	33.5	29.7	14.4	16.9	21.4	31.9	17.7	10.1	42.0	28.2	8.9	15.4	6.2	1.2	27.6	13.6	19.9	22.8	15.3	14.8	14.9	20.7	9.0	12.9	17.8	13.0	7.0	8.0	19.2	28.9	24.0	5.1	37.2	17.0	16.9	8.8	12.6	18.1	19.0	22.0	48.9	54.7	59.8	44.9	69.1	28.5	24.9	21.9	31.0	42.9	28.9	14.3	23.6	42.7	36.5	56.7	44.0	33.1	51.9	101.6	137.5	141.1	123.0	100.7	111.2	151.0	129.6	144.7	121.3	127.6	173.5	39.5	16.0	19.4	26.1	21.0	51.6	30.3	35.1	35.3	29.7	28.8	29.7	42.1	14.3	27.2	12.9	35.5	36.5	90.8	28.4	37.2	29.0	173.0	24.7	15.4	31.1	17.5	27.1	31.2	17.6	15.2	30.3	44.9	26.5	25.4	29.5	28.5	19.7	66.3	30.3	27.2	24.1	97.6	38.3	51.7	74.8	31.1	37.1	46.2	11.2	20.0	22.6	85.5	76.4	110.8	26.5	23.9	41.0	39.7	14.9	54.0	38.8	30.1	28.2	19.7	113.5	27.9	15.3	7.2	30.1	60.1	42.3	45.8	31.3	18.2	21.5
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 130.6;skeletal muscle: 131.2"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 250.2;Oligodendrocytes: 151.7;Urothelial cells: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 132.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	11.9	8.0	33.4	9.8	45.3	3.0	12.1	55.4	37.1	15.8	130.6	22.8	46.7	18.5	9.9	32.7	24.5	15.1	63.2	30.1	48.7	17.5	39.7	15.1	6.5	46.5	56.5	8.1	51.6	15.0	10.5	13.5	47.5	13.6	19.0	7.5	87.9	17.6	131.2	23.3	18.8	17.9	42.7	7.4	15.1	15.9	67.8	11.9	82.8	57.6	9.1	22.0	21.7	52.8	52.7	14.3	19.0	16.0	10.4	8.8	41.1	46.9	80.8	23.9	58.7	38.9	132.9	17.4	53.6	42.1	13.5	81.1	11.4	45.2	41.6	4.3	8.7	27.8	4.8	22.0	14.9	9.9	12.3	9.5	40.2	24.7	22.7	16.7	12.0	13.7	27.2	14.0	47.3	14.4	18.1	16.1	19.2	50.5	8.8	14.9	20.9	18.5	21.4	47.5	5.1	19.2	12.8	21.8	12.8	15.0	17.5	17.3	34.9	50.0	17.4	12.3	25.7	9.0	22.2	12.6	15.8	19.5	28.3	3.2	2.2	0.2	3.6	1.6	4.3	2.1	4.0	3.5	3.7	2.1	4.8	3.7	0.8	6.8	1.3	2.0	4.1	3.1	33.4	45.3	55.4	37.1	30.1	48.7	46.5	56.5	47.5	42.7	67.8	52.8	11.1	28.9	18.6	51.6	9.1	98.9	250.2	22.7	96.2	13.4	21.7	14.9	60.2	14.3	21.7	16.5	16.7	23.9	14.3	76.2	13.7	29.6	10.4	79.9	15.8	18.9	12.0	6.9	88.9	31.4	23.7	15.8	15.8	61.2	3.8	17.1	6.4	30.7	10.2	6.7	88.4	11.5	18.3	7.7	12.2	10.0	7.2	10.2	10.6	78.7	7.3	14.4	14.4	63.3	151.7	47.4	35.8	11.7	8.6	76.6	20.0	7.3	57.6	10.2	6.6	22.9	28.3	5.2	7.2	73.9	74.3	25.4	14.2	23.7	12.5	170.3
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006357-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA045847: AB_2679472"	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	29.5	47.2	53.3	13.3	55.6	11.3	29.5	55.0	56.1	42.4	53.0	24.8	18.1	44.4	55.1	22.2	40.2	28.6	34.3	57.7	54.9	27.7	14.3	21.4	18.1	56.8	54.0	54.5	32.7	34.9	40.0	19.7	59.6	23.1	19.2	25.7	31.1	23.7	61.8	24.6	23.8	29.4	49.8	19.6	27.8	44.7	54.7	34.4	32.0	47.9	19.3	28.9	29.6	48.4	43.7	17.4	28.5	24.1	78.7	45.3	42.4	24.4	42.1	32.9	39.0	23.3	38.7	31.4	44.8	48.9	35.7	33.3	10.8	42.1	29.0	31.1	32.0	17.2	32.1	34.2	65.3	31.4	18.4	44.0	50.8	20.0	41.1	48.7	46.5	38.2	14.7	26.2	44.0	22.2	35.1	25.7	21.7	57.4	26.3	18.6	29.3	43.5	39.6	31.6	22.1	23.8	37.8	12.3	104.0	26.6	12.2	41.9	32.2	30.8	23.2	47.1	28.0	19.4	17.2	15.8	27.7	14.0	28.9	13.0	6.3	4.6	12.0	9.4	9.6	9.4	11.1	12.2	9.8	9.0	9.6	9.1	1.2	14.9	6.1	9.6	21.8	6.1	53.3	55.6	55.0	56.1	57.7	54.9	56.8	54.0	59.6	49.8	54.7	48.4	25.6	16.0	10.9	9.8	13.5	13.8	22.3	24.9	20.5	15.4	22.9	23.5	14.4	32.9	20.5	22.0	4.2	34.6	14.6	7.5	3.9	35.8	36.7	34.1	15.3	28.5	21.1	5.0	17.0	24.7	36.1	19.7	11.7	17.9	5.7	21.2	35.0	7.2	16.1	28.6	20.7	12.1	30.5	12.8	10.3	14.7	37.6	8.6	14.2	15.0	13.5	25.9	7.2	11.6	8.0	24.3	6.8	54.9	10.3	15.3	14.7	12.6	14.8	12.1	26.3	23.1	20.7	16.7	45.4	18.2	15.3	25.3	17.7	42.4	15.6	19.0
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644557	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 171.1;Extravillous trophoblasts: 257.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 333.2;SK-BR-3: 306.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	74.7	33.2	69.6	43.9	85.0	65.0	72.7	78.4	67.4	64.6	33.4	58.3	26.7	43.0	36.2	81.6	59.0	55.8	71.4	62.7	69.7	68.7	17.8	98.5	75.3	99.6	76.5	32.3	41.2	48.7	20.5	157.5	87.0	43.8	49.5	29.1	55.5	65.8	141.2	78.3	50.8	43.6	84.3	115.5	112.9	82.5	79.1	48.8	64.9	92.4	77.7	56.3	69.2	97.6	333.2	8.3	70.0	42.1	103.9	63.5	201.1	69.6	169.5	112.3	131.6	75.6	154.9	65.6	91.1	193.9	13.6	254.1	10.7	53.2	71.6	1.7	9.3	42.0	39.3	3.1	115.0	0.6	33.9	69.2	69.8	42.3	37.2	91.0	86.8	30.2	20.2	10.8	172.6	243.6	35.1	32.1	24.9	96.9	29.3	74.1	102.7	2.9	37.1	171.8	6.9	42.0	56.7	306.1	7.7	73.8	123.0	3.2	79.8	50.1	18.4	60.5	18.0	4.0	7.9	64.8	12.5	29.1	57.3	146.3	39.4	227.9	114.1	113.0	90.4	92.1	78.5	87.4	20.7	94.8	83.3	87.1	482.8	79.2	278.3	100.4	95.7	147.4	69.6	85.0	78.4	67.4	62.7	69.7	99.6	76.5	87.0	84.3	79.1	97.6	84.0	54.5	29.1	32.3	53.4	9.7	17.3	17.2	13.1	12.3	45.8	29.1	38.6	28.6	47.7	92.0	14.6	137.8	51.9	49.9	1.9	44.1	171.1	15.8	31.4	52.7	9.6	45.0	14.3	44.3	257.0	22.6	84.6	38.6	20.3	7.1	75.7	1.9	37.0	3.3	15.5	17.7	14.2	38.7	3.9	35.1	38.8	22.8	5.4	15.9	10.2	36.4	88.6	18.6	18.4	41.1	31.9	56.4	18.9	9.8	20.1	3.7	19.0	3.0	59.2	26.3	29.4	3.2	2.9	33.5	8.5	93.4	41.2	6.8	23.4	20.6
SLC49A4	"DIRC2, FLJ14784, RCC4"	ENSG00000138463	"Solute carrier family 49 member 4"	Q96SL1	3	122795069-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 44.0;Extravillous trophoblasts: 61.2;Syncytiotrophoblasts: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	4.4	5.0	4.9	2.7	5.1	5.9	3.1	4.9	5.3	3.0	6.2	4.1	1.9	2.6	3.8	5.6	3.1	3.7	6.4	5.7	5.9	4.6	3.5	5.2	2.0	4.8	5.6	2.2	6.5	12.7	2.4	7.6	5.6	4.9	4.5	5.7	3.7	3.6	15.9	6.6	2.6	2.7	5.2	2.8	3.1	2.5	5.6	1.9	5.2	14.0	2.5	4.0	2.6	5.9	7.4	6.1	5.9	3.3	7.5	6.1	19.6	3.1	6.7	4.9	5.0	14.4	8.0	1.0	3.9	3.5	10.9	10.5	4.3	5.6	4.7	1.6	3.2	1.2	3.3	6.2	5.5	0.7	0.7	5.0	15.0	3.5	5.9	7.6	5.6	2.0	0.7	1.3	6.3	3.3	0.9	0.8	5.3	2.5	9.8	2.0	13.3	1.5	7.0	8.4	6.1	4.6	9.1	4.1	8.4	3.7	4.8	1.6	8.0	7.6	2.8	4.6	2.6	1.3	1.2	0.4	3.8	1.3	4.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	4.9	5.1	4.9	5.3	5.7	5.9	4.8	5.6	5.6	5.2	5.6	5.9	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	44.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	61.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	226.6	0.4	0.0	0.0	0.0
SLC8A3	NCX3	ENSG00000100678	"Solute carrier family 8 member A3"	P57103	14	70044215-70189070	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 10.8;retina: 9.6;skeletal muscle: 20.6;tongue: 9.4"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 32.8;Excitatory neurons: 80.5;Inhibitory neurons: 129.4;Oligodendrocyte precursor cells: 107.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.2;LHCN-M2: 7.9;SH-SY5Y: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.65e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	0.3	1.2	7.1	0.3	6.0	0.3	0.2	1.7	6.6	0.4	0.0	0.3	0.3	0.2	0.2	0.3	0.1	0.4	0.6	5.3	7.7	0.1	0.1	0.6	0.2	6.1	7.6	0.0	0.2	0.7	0.9	0.1	7.1	0.3	0.2	9.6	0.3	0.1	20.6	0.3	0.4	0.3	5.4	0.1	0.3	0.1	10.8	0.2	0.0	9.4	0.2	1.2	0.2	4.7	0.0	0.0	4.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	24.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	6.0	1.7	6.6	5.3	7.7	6.1	7.6	7.1	5.4	10.8	4.7	0.0	0.0	0.6	2.9	0.0	0.1	0.0	0.0	0.0	32.8	0.0	0.0	1.4	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	80.5	0.0	0.4	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.1	8.4	129.4	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	4.7	0.0	0.8	0.0	107.1	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	12.2	13.9	21.6	6.1	22.2	17.6	19.5	25.7	27.7	14.6	21.2	14.7	10.3	12.3	19.5	12.6	15.2	7.4	20.0	22.1	22.0	18.2	15.1	9.7	16.1	21.6	21.4	22.5	21.5	18.0	14.9	7.3	22.2	16.1	11.2	16.0	22.7	13.4	35.6	14.8	13.5	8.4	21.3	12.6	17.7	6.9	21.3	12.4	18.6	37.9	12.2	12.4	11.9	22.4	5.7	3.7	7.4	8.9	13.1	9.5	5.8	2.0	10.0	12.1	10.5	7.1	5.3	7.8	2.4	10.3	3.4	6.1	9.8	10.4	7.7	3.8	15.7	4.7	8.1	10.3	16.5	8.6	5.9	7.4	17.3	4.8	9.9	6.9	12.2	5.1	7.9	12.3	8.4	11.2	12.1	13.0	2.8	14.1	2.7	10.8	6.5	20.8	15.5	6.4	9.2	6.0	5.0	11.1	12.8	3.7	9.3	9.3	4.8	5.1	5.3	4.5	3.9	8.2	9.8	16.9	7.9	8.5	4.1	4.0	5.8	2.9	3.1	3.1	5.9	5.9	8.6	4.5	8.4	7.2	9.3	6.0	0.5	5.5	4.5	6.4	5.4	5.4	21.6	22.2	25.7	27.7	22.1	22.0	21.6	21.4	22.2	21.3	21.3	22.4	161.1	83.3	109.3	11.8	295.0	166.7	202.2	157.3	191.2	71.6	400.9	477.3	350.9	237.4	160.3	204.1	20.9	308.7	127.8	285.6	573.2	160.0	114.0	156.8	81.1	138.2	345.2	135.7	10.5	199.6	190.6	127.8	150.3	127.2	91.4	55.4	161.3	380.1	256.1	55.5	12.8	356.5	262.4	164.5	200.6	131.9	189.2	187.7	211.7	5.6	125.8	196.4	124.6	7.5	13.8	193.7	314.0	149.0	275.8	238.2	486.7	623.4	223.7	109.5	124.9	133.6	202.7	256.0	55.5	271.5	274.1	308.8	186.3	151.7	308.8	272.2
SNRNP35	U1SNRNPBP	ENSG00000184209	"Small nuclear ribonucleoprotein U11/U12 subunit 35"	Q16560	12	123458088-123473154	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059145, HPA067031"	Supported		Supported	Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli		"HPA059145: AB_2683926, HPA067031: AB_2685766"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.56e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-3)"	19.0	20.0	33.1	16.0	34.8	17.6	18.7	36.2	46.3	24.2	33.4	20.8	15.4	22.2	15.1	26.2	19.0	10.3	41.2	32.7	35.3	29.2	26.4	19.1	20.1	34.6	34.0	17.1	19.2	20.5	24.5	16.8	34.1	24.9	17.8	18.3	23.7	12.7	79.5	26.5	23.3	16.2	32.0	30.8	22.9	16.4	34.8	18.7	23.3	43.3	19.3	18.4	21.4	37.2	22.8	23.7	28.1	14.4	20.0	18.6	24.6	19.5	28.4	20.1	14.6	14.9	15.3	45.0	14.0	28.4	14.5	23.0	24.3	34.9	17.2	33.0	19.7	21.1	22.0	34.6	14.0	21.8	32.5	22.7	24.0	18.0	17.1	36.3	27.8	14.0	27.5	8.9	28.4	48.0	23.6	49.1	19.6	30.5	22.4	18.0	12.3	24.0	46.8	45.2	23.9	35.3	17.3	36.1	28.2	27.8	43.6	29.1	32.4	13.3	24.3	16.9	17.7	22.0	23.8	26.6	21.7	21.1	18.6	81.0	45.6	74.3	43.3	48.5	43.0	71.5	54.3	49.2	47.0	66.2	41.9	45.2	70.2	47.9	47.0	47.8	79.3	36.8	33.1	34.8	36.2	46.3	32.7	35.3	34.6	34.0	34.1	32.0	34.8	37.2	21.4	51.3	20.1	14.0	25.0	14.0	19.1	57.3	13.1	30.9	16.3	19.3	29.5	18.6	36.7	33.1	12.5	51.6	31.3	26.9	50.9	35.2	38.3	26.1	21.2	22.5	14.9	29.2	8.4	33.6	34.8	19.3	27.0	22.9	13.3	19.9	23.9	27.1	33.1	15.2	12.1	22.4	44.7	17.0	10.2	10.9	24.2	19.3	16.0	11.2	35.9	37.1	39.1	12.1	27.1	35.0	33.4	25.9	15.9	20.6	37.4	48.9	32.5	28.6	32.9	19.0	24.1	25.3	24.2	18.9	14.5	42.0	24.4	18.3	18.1	25.4
SNTA1	"LQT12, SNT1, TACIP1"	ENSG00000101400	"Syntrophin alpha 1"	Q13424	20	33407957-33443763	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.3;skeletal muscle: 307.9;tongue: 327.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 117.2;Cardiomyocytes: 175.1;Muller glia cells: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 10.4"	"Group enriched"	"Detected in many"	4	"B-cells: 5.7;dendritic cells: 10.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 66.5"	"Low region specificity"	"Detected in all"							"CAB037059, HPA067154"	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB037059: AB_261497, HPA067154: "	"unprognostic (2.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (5.68e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	39.2	18.7	162.7	4.5	179.8	2.0	25.5	158.2	198.3	24.9	127.9	23.7	6.6	16.9	8.0	22.6	20.4	7.6	195.9	158.1	149.3	23.0	16.6	8.0	5.9	167.9	166.0	20.6	13.5	20.9	12.4	3.1	144.5	19.6	3.0	15.0	31.3	18.1	307.9	15.0	13.7	9.3	147.4	5.0	23.8	19.3	178.7	3.4	77.8	327.9	5.2	38.6	17.0	144.5	13.0	6.5	2.9	28.2	66.5	13.0	2.8	9.8	13.6	18.3	15.2	16.9	4.3	9.3	11.6	16.8	33.4	16.9	8.4	5.4	3.2	1.9	10.8	0.5	15.7	23.9	18.8	0.9	1.6	12.0	6.7	8.0	3.0	10.1	2.8	8.8	22.8	3.5	9.3	1.6	17.7	2.2	1.6	1.9	37.2	11.1	20.8	10.3	3.8	11.6	12.3	10.6	38.5	11.5	19.4	2.2	17.8	1.6	4.6	9.0	17.5	36.1	9.2	21.2	11.7	5.6	19.5	1.7	1.4	0.0	0.0	0.0	0.9	0.0	1.9	5.7	0.9	0.9	0.0	2.8	0.3	0.7	0.0	0.0	0.0	10.4	1.1	0.3	162.7	179.8	158.2	198.3	158.1	149.3	167.9	166.0	144.5	147.4	178.7	144.5	4.6	3.2	2.0	117.2	5.1	3.2	4.7	1.3	1.2	5.7	6.2	8.0	175.1	8.6	1.9	1.8	4.2	1.2	4.9	1.3	39.2	2.0	1.0	1.2	3.7	4.4	4.2	5.7	12.7	2.6	1.9	13.4	5.1	4.1	0.0	10.1	3.9	9.1	1.9	0.0	8.3	1.6	8.2	1.9	2.3	2.3	25.1	1.6	5.4	10.3	0.0	83.7	3.1	5.0	6.3	3.3	1.6	28.2	2.3	5.7	5.4	33.5	0.8	36.5	26.3	12.7	36.7	1.8	4.9	3.5	2.8	0.8	9.3	3.2	1.6	5.6
SNUPN	"RNUT1, SNURPORTIN-1, Snurportin1"	ENSG00000169371	"Snurportin 1"	O95149	15	75598083-75626469	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 137.1;Spermatocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005004	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB005004: AB_425829"	"unprognostic (2.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-3)"	"unprognostic (9.07e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.14e-2)"	18.2	16.0	21.0	15.5	21.6	13.8	23.5	20.5	26.3	20.4	21.9	18.1	14.9	18.9	20.3	14.3	23.7	13.5	16.4	22.1	20.9	20.1	22.1	14.9	20.1	19.5	20.1	26.3	12.7	21.0	12.1	15.2	20.1	16.5	17.4	13.2	19.8	17.6	34.7	16.7	15.4	24.5	18.7	17.2	15.8	34.3	20.5	22.1	20.9	30.5	21.1	18.0	15.5	21.2	26.1	34.1	30.4	21.6	42.1	46.8	23.2	26.1	38.5	44.2	47.8	25.4	62.6	47.4	35.7	34.0	36.6	29.9	60.3	38.3	34.5	27.3	56.1	56.4	29.3	16.4	40.6	39.4	37.3	44.6	37.3	32.8	41.0	40.1	42.4	36.8	36.8	30.9	45.4	9.0	38.5	38.7	40.6	42.7	19.5	48.7	23.7	46.7	39.7	13.6	28.5	19.9	11.4	38.7	68.9	37.5	33.0	73.8	27.9	35.3	32.8	19.4	23.3	21.9	43.7	69.8	38.7	59.6	47.0	10.3	39.5	12.2	47.4	37.7	57.3	34.7	48.9	45.8	47.7	41.1	63.2	53.0	6.7	36.9	40.1	47.0	42.1	41.0	21.0	21.6	20.5	26.3	22.1	20.9	19.5	20.1	20.1	18.7	20.5	21.2	19.1	12.8	14.5	7.8	13.1	13.3	10.4	30.5	18.2	19.0	18.7	21.5	11.7	14.3	16.8	9.2	12.5	28.7	19.2	10.3	54.8	23.1	137.1	14.9	23.6	14.4	16.2	14.1	9.0	19.3	38.5	25.2	10.7	12.8	12.7	20.4	17.2	18.5	24.7	13.5	8.2	12.4	14.2	17.7	17.3	60.3	31.4	19.1	19.6	7.5	24.2	18.3	25.7	3.0	7.6	14.7	10.5	29.3	9.9	11.5	17.6	34.1	15.1	20.4	19.7	16.6	14.5	93.2	14.6	15.0	10.9	11.9	16.2	27.3	18.1	5.7
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027439-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.6;Enteroendocrine cells: 7.8;granulocytes: 8.2;monocytes: 7.9;Paneth cells: 8.0;Proximal enterocytes: 6.5;Undifferentiated cells: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.1	13.3	17.3	10.2	18.5	10.5	15.3	19.4	19.2	16.6	9.0	22.5	15.3	15.8	6.4	14.9	12.9	7.4	15.0	18.4	17.1	17.0	10.1	11.9	9.3	19.3	18.2	14.8	12.7	10.7	9.4	7.3	16.1	12.9	8.8	5.8	12.3	10.9	25.7	17.5	16.8	8.9	16.1	10.8	16.4	5.3	17.8	9.4	10.6	15.5	7.4	18.0	14.9	18.5	31.1	22.3	14.7	14.2	17.3	12.4	7.9	10.0	13.6	23.3	21.3	17.6	23.7	30.7	16.7	17.4	29.3	16.8	16.8	15.2	9.8	47.0	14.0	15.8	18.2	30.2	18.3	10.7	24.5	10.6	22.2	24.7	14.5	13.0	14.1	22.6	27.0	19.6	12.5	18.8	29.2	36.8	15.5	12.0	21.9	23.7	8.4	34.0	17.6	6.7	25.6	19.2	25.3	23.0	23.2	9.7	23.4	18.6	27.5	23.5	22.9	24.1	14.7	20.9	38.3	30.3	23.2	14.5	8.4	9.2	13.6	13.6	7.6	16.2	6.2	8.9	7.8	6.8	9.4	8.7	5.6	5.1	2.1	4.3	23.6	6.4	8.3	7.3	17.3	18.5	19.4	19.2	18.4	17.1	19.3	18.2	16.1	16.1	17.8	18.5	0.3	0.0	3.3	0.0	0.8	1.0	0.1	0.4	4.0	0.0	0.5	0.3	0.4	0.0	0.2	0.0	0.0	0.4	0.1	5.6	0.0	4.8	0.0	0.1	0.2	0.9	7.8	1.3	0.0	3.1	0.6	0.4	1.1	0.1	8.2	0.4	0.7	0.1	1.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	7.9	0.2	0.0	0.0	0.0	3.9	8.0	0.4	1.1	0.0	6.5	0.6	0.7	0.4	0.0	0.7	1.0	0.0	0.0	1.5	0.4	0.4	1.1	0.2	5.6	0.1
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120868	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.2;neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 12.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: AB_2684528"	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (8.10e-4)"	32.2	22.6	50.9	19.0	64.6	26.7	22.4	60.7	58.4	21.5	38.2	23.1	20.4	27.6	12.3	29.1	18.7	26.7	22.6	44.2	55.1	33.0	32.9	30.4	13.6	64.0	56.0	30.1	30.6	27.4	17.5	32.0	65.1	17.9	19.7	36.6	14.3	19.3	66.3	22.6	21.0	27.0	58.7	18.4	15.9	51.0	60.1	19.3	40.1	40.6	15.7	29.6	20.0	99.1	53.3	58.5	73.3	36.0	68.0	59.9	64.7	42.6	41.5	46.8	57.9	53.0	35.7	28.6	29.1	70.3	94.1	44.7	48.5	35.8	86.4	43.5	57.7	23.9	46.4	39.5	51.1	34.9	26.8	43.4	40.7	63.3	112.4	44.9	38.9	14.2	53.6	30.9	66.9	26.6	22.0	14.5	19.5	35.5	74.8	24.7	81.8	25.3	42.8	99.4	56.6	78.8	37.6	34.5	38.8	44.0	28.5	40.9	54.6	129.6	30.3	101.0	63.4	43.5	67.4	46.2	44.3	20.4	46.0	9.2	1.2	0.7	1.2	0.8	0.9	1.0	1.0	1.2	1.3	0.9	0.6	0.8	12.1	0.4	0.5	1.0	1.7	0.5	50.9	64.6	60.7	58.4	44.2	55.1	64.0	56.0	65.1	58.7	60.1	99.1	162.5	131.4	121.3	190.3	53.1	165.1	149.7	37.5	107.6	96.0	45.7	38.7	62.6	41.5	41.1	25.8	125.1	43.2	60.2	189.0	27.4	56.7	243.0	151.6	142.1	122.9	69.8	20.4	110.2	57.6	28.4	106.5	81.6	337.1	43.1	52.8	74.3	48.7	36.7	67.3	130.5	56.0	24.4	43.3	246.6	137.8	76.1	123.1	71.2	104.9	49.8	32.7	25.7	192.5	304.7	89.6	123.5	67.0	59.7	156.9	69.6	86.9	39.0	85.5	65.7	109.0	86.4	215.1	54.8	93.8	172.3	138.9	59.4	56.3	56.3	182.5
SPSB3	"C16orf31, SSB-3"	ENSG00000162032	"SplA/ryanodine receptor domain and SOCS box containing 3"	Q6PJ21	16	1776712-1793700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046602	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA046602: AB_2679717"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.25e-7)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.72e-4)"	27.1	44.7	27.9	7.7	28.5	21.2	25.8	37.0	40.2	27.1	24.0	28.9	14.7	21.3	3.3	36.1	23.7	10.0	28.6	26.4	27.2	24.3	41.8	20.6	12.4	29.7	28.3	37.1	44.0	11.4	15.3	10.3	27.4	23.3	5.1	9.6	26.4	15.5	88.5	48.4	18.8	5.6	28.3	23.3	27.8	17.3	29.2	26.1	19.7	31.0	7.8	23.2	28.7	31.8	7.3	9.1	9.7	13.4	13.6	12.5	19.8	10.6	11.0	11.5	12.6	8.4	20.0	3.2	17.4	6.0	4.5	13.9	4.8	10.9	1.8	14.7	15.0	5.2	13.9	10.4	20.2	4.5	12.0	11.3	26.8	7.2	8.4	17.1	17.5	22.1	7.8	15.4	5.4	24.0	16.3	16.0	8.1	10.8	7.1	29.7	5.9	26.7	10.6	1.3	12.9	16.6	12.6	27.8	29.4	6.9	16.1	18.0	16.1	5.6	10.6	10.5	5.5	26.1	28.2	8.9	5.4	8.9	5.9	112.3	44.8	83.4	67.9	41.8	81.2	46.8	63.1	61.7	42.3	44.2	43.6	46.6	91.5	45.7	37.2	42.8	100.7	48.4	27.9	28.5	37.0	40.2	26.4	27.2	29.7	28.3	27.4	28.3	29.2	31.8	74.2	38.5	32.1	29.7	56.1	98.4	53.3	72.7	60.3	74.1	64.1	83.7	0.2	40.0	54.9	55.2	39.6	63.0	104.2	68.6	52.8	50.8	46.7	29.4	32.3	46.1	48.7	50.5	18.2	47.6	74.8	42.8	65.2	37.8	35.4	76.2	57.1	62.5	31.8	90.9	19.4	57.8	38.7	42.7	72.2	91.6	77.0	44.8	76.5	24.4	61.6	76.0	99.9	24.6	30.7	45.3	83.2	74.9	61.2	50.5	96.3	50.6	37.2	89.8	39.5	34.0	45.3	23.8	39.7	37.0	128.3	64.4	87.8	33.2	52.7	54.3
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.5;skeletal muscle: 123.9;tongue: 69.8"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 39.2;K-562: 47.8;U-937: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		7800000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	2.2	1.5	5.3	0.2	11.2	62.5	0.3	28.3	11.4	0.3	27.7	0.2	0.1	0.2	5.2	2.0	0.5	0.4	22.7	10.8	4.0	1.0	0.1	0.4	0.0	28.5	5.3	0.2	2.6	11.1	5.3	6.7	28.2	1.5	0.1	1.6	2.2	1.1	123.9	0.2	0.2	0.8	8.5	0.8	0.2	0.7	9.3	0.4	0.1	69.8	0.0	0.2	0.2	4.4	0.3	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.3	2.3	6.3	0.2	0.0	0.4	3.7	39.2	0.3	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	47.8	0.0	0.0	0.3	0.0	0.3	0.0	0.5	2.1	0.0	0.0	0.2	0.0	0.2	6.1	2.6	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	6.7	0.0	0.6	1.5	7.7	0.0	0.1	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.3	11.2	28.3	11.4	10.8	4.0	28.5	5.3	28.2	8.5	9.3	4.4	0.1	0.0	0.0	0.7	0.0	0.8	0.7	0.6	0.0	10.3	0.5	0.1	6.3	1.5	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.4	0.9	0.4	3.0	81.0	16.0	0.2	0.3	0.8	0.0	0.9	2.5	0.2	0.0	0.0	0.2	16.8	32.1	0.3	0.0	0.0	0.4	0.4	0.3	0.3	1.8	1.9	0.0	5.0	1.0	11.1	2.1	0.3	0.0	1.2	0.1	0.7	0.0	0.2	0.0	2.6	6.6	11.6	3.8	0.1	1.1	0.5	0.4	0.1	0.6	0.4	0.1	0.6
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072517	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 314.6"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 162.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"medulla oblongata: 314.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	37.5	34.6	23.7	24.8	25.2	21.9	36.3	25.5	76.6	39.4	24.6	47.2	21.3	39.7	35.1	49.8	37.4	17.3	42.8	34.8	27.7	31.6	37.0	34.0	29.0	314.6	25.1	39.8	65.7	37.7	37.7	33.1	49.6	30.6	27.4	28.0	38.5	26.1	103.1	43.7	32.2	34.5	30.5	31.5	41.5	22.2	25.9	30.8	32.8	47.0	36.7	41.9	37.9	26.4	98.0	89.8	51.0	54.9	71.5	57.2	94.3	72.4	50.7	80.7	62.9	75.5	45.5	81.6	36.8	70.5	69.2	66.2	98.2	74.2	119.2	34.3	118.1	72.6	63.4	102.8	86.3	83.9	54.7	48.5	81.3	70.7	61.1	60.0	95.1	47.4	109.0	70.9	67.2	60.1	84.6	43.5	50.3	81.2	91.0	70.1	137.1	79.9	59.2	80.6	63.2	64.9	61.9	103.8	81.8	85.2	91.5	76.4	62.3	89.2	70.7	42.7	99.4	70.5	34.7	87.1	64.0	62.2	66.4	7.6	28.6	37.3	24.5	26.3	26.4	30.5	34.8	37.9	34.3	25.3	39.2	29.4	4.3	45.4	27.1	27.1	34.6	19.4	23.7	25.2	25.5	76.6	34.8	27.7	314.6	25.1	49.6	30.5	25.9	26.4	20.9	28.9	22.9	12.1	27.9	31.4	49.3	30.2	22.2	24.2	18.2	19.2	27.2	28.6	25.9	12.9	37.5	86.9	21.2	18.3	37.2	43.6	15.0	24.3	26.1	28.1	14.4	41.3	11.1	41.4	63.2	26.8	16.8	28.5	17.1	25.6	21.8	23.2	37.9	37.0	10.8	22.8	20.3	18.5	17.4	20.0	24.2	17.8	24.9	11.2	31.8	36.8	29.9	7.1	11.5	39.0	15.8	28.2	37.9	46.5	20.7	30.4	23.7	26.7	0.0	28.5	31.7	47.2	24.4	26.6	31.7	162.3	25.2	30.2	24.1	48.9
SRPK3	"MSSK1, STK23"	ENSG00000184343	"SRSF protein kinase 3"	Q9UPE1	X	153776412-153785732	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 211.4;tongue: 76.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 25.0;Cone photoreceptor cells: 8.4;Oligodendrocytes: 7.4;Skeletal myocytes: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 47.0;U-266/70: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (1.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.47e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.10e-4)"	"unprognostic (8.70e-2)"	"unprognostic (5.38e-7)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.07e-4)"	1.6	4.3	12.5	2.2	15.8	2.1	1.4	20.2	19.2	3.2	8.7	17.0	3.3	8.4	1.6	6.5	2.9	1.5	47.3	12.2	12.8	1.6	0.7	1.1	2.2	14.6	14.3	2.3	1.6	1.4	18.7	0.5	14.5	7.8	1.7	1.7	7.6	1.1	211.4	5.7	3.9	3.1	11.4	1.9	5.0	1.1	16.0	0.3	0.6	76.8	0.1	6.7	2.7	23.4	5.1	6.7	1.2	3.3	0.0	0.2	1.5	0.6	0.0	0.3	0.1	5.7	0.9	5.1	0.6	0.6	0.5	1.4	0.0	0.1	0.0	4.4	4.6	2.7	5.1	0.9	0.1	1.3	7.6	4.1	0.0	0.0	0.0	0.3	0.0	7.1	3.5	5.8	1.3	10.8	1.0	7.5	1.2	0.3	1.8	2.3	47.0	1.5	0.1	2.3	8.0	3.8	0.0	3.5	1.6	0.5	4.4	5.8	0.1	1.8	4.2	3.5	0.7	19.4	3.5	3.3	1.0	9.5	2.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	12.5	15.8	20.2	19.2	12.2	12.8	14.6	14.3	14.5	11.4	16.0	23.4	0.1	0.0	0.0	3.3	0.0	0.6	1.0	0.1	0.0	4.3	2.5	1.0	25.0	0.0	0.1	0.0	8.4	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.2	0.5	1.2	0.0	0.7	0.0	0.1	1.1	1.5	0.2	0.0	0.2	0.0	0.0	0.0	1.7	1.8	4.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.1	0.5	0.0	0.5	7.4	0.0	0.0	3.0	0.2	0.7	0.0	0.0	0.1	0.5	0.0	18.9	2.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.6	0.4
SRRD	"HC/HCC, SRR1L"	ENSG00000100104	"SRR1 domain containing"	Q9UH36	22	26483877-26494658	"Predicted intracellular proteins"	"Biological rhythms, Heme biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 49.0;Late spermatids: 54.9;Pancreatic endocrine cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002945	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA002945: AB_1079265"	"unprognostic (3.25e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (9.00e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.96e-1)"	5.0	3.5	8.4	4.1	8.8	6.2	6.2	10.4	9.7	5.5	6.2	6.0	3.6	6.3	6.1	5.3	5.5	3.7	7.6	8.7	8.0	6.4	6.9	5.3	5.6	8.2	8.2	7.1	5.5	6.7	5.1	5.3	7.7	6.8	5.2	5.8	4.9	7.2	19.6	6.0	3.9	7.0	8.1	5.4	4.9	4.8	8.6	5.7	10.5	17.1	7.3	5.5	4.2	8.6	10.7	6.3	10.6	10.9	10.8	6.5	6.1	7.4	10.4	14.7	13.5	6.2	4.6	23.6	5.1	9.7	7.4	9.5	16.6	15.6	14.3	12.2	16.5	10.4	5.5	10.1	7.6	23.1	7.8	6.2	13.4	10.5	16.4	9.7	12.9	13.8	17.2	14.5	9.7	9.2	10.4	7.3	6.6	11.7	7.9	23.3	13.2	17.0	9.7	7.6	11.2	7.6	8.5	7.6	19.7	8.8	9.1	9.0	9.9	11.3	37.2	6.4	13.1	9.5	8.3	19.4	7.7	9.4	15.0	0.3	0.5	0.2	0.7	0.4	1.0	1.1	0.8	1.0	0.5	0.6	1.1	1.2	0.4	0.9	0.4	0.4	0.2	0.3	8.4	8.8	10.4	9.7	8.7	8.0	8.2	8.2	7.7	8.1	8.6	8.6	12.1	0.0	6.4	3.6	10.6	29.7	16.2	7.5	3.4	13.0	10.0	10.5	3.0	12.8	5.9	1.8	2.1	13.3	5.9	3.7	9.8	24.9	22.4	5.8	10.6	11.2	4.8	46.9	3.1	49.0	22.9	8.9	7.7	8.9	11.4	15.1	11.0	15.4	14.1	13.5	3.0	4.5	2.0	3.8	8.6	54.9	7.2	8.6	8.8	1.0	6.1	9.8	10.3	3.5	1.9	48.9	2.4	9.1	10.4	12.1	3.4	19.9	3.2	9.3	6.6	12.6	10.3	17.8	12.9	7.7	31.8	16.7	9.1	21.7	5.9	14.7
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 79.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 140.8;Leydig cells: 185.8;Peritubular cells: 267.4;Skeletal myocytes: 139.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"memory B-cell: 57.4;naive B-cell: 16.9"	"Lineage enriched"	"Detected in many"	19	"B-cells: 57.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 24.4;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	21.3	10.7	18.0	6.4	26.5	0.1	20.1	26.2	15.4	39.5	8.6	21.2	4.4	23.9	17.8	18.3	25.2	21.9	46.0	16.1	30.1	6.1	1.4	8.9	7.0	26.5	29.1	33.8	8.0	3.2	3.8	4.6	27.9	22.4	12.7	2.9	9.4	34.4	60.7	4.4	7.7	24.3	31.5	8.7	7.7	8.3	21.5	8.7	17.1	79.0	12.1	19.2	15.4	38.4	0.8	1.6	4.0	0.0	24.4	14.5	0.2	6.9	10.8	1.1	3.1	0.1	9.5	0.0	1.8	11.0	6.0	3.0	0.0	0.5	2.1	0.1	0.0	0.0	0.1	0.0	2.9	0.1	0.0	9.3	1.0	3.5	0.8	91.6	0.4	0.0	0.0	0.1	8.4	1.9	0.6	1.9	7.9	0.6	2.7	0.3	10.7	3.2	2.4	8.3	0.4	6.3	2.7	0.6	7.0	4.0	0.9	0.3	3.0	2.5	1.8	3.4	1.8	0.3	1.2	0.2	5.3	0.0	8.6	0.0	0.0	2.7	0.0	0.0	0.5	57.4	0.0	0.0	0.1	16.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.7	18.0	26.5	26.2	15.4	16.1	30.1	26.5	29.1	27.9	31.5	21.5	38.4	10.8	3.2	3.2	39.2	30.7	13.6	23.1	21.6	30.1	2.1	21.8	89.2	95.4	10.0	14.8	18.4	0.0	74.0	1.4	36.0	5.9	11.4	4.0	12.4	52.1	10.2	4.9	1.3	3.5	7.1	7.5	140.8	3.6	6.0	0.0	10.7	9.7	0.2	15.3	6.7	5.8	10.1	0.0	0.6	11.1	5.8	185.8	6.6	19.6	18.7	18.6	41.2	0.0	41.7	18.4	2.8	7.3	267.4	41.2	19.4	0.6	3.1	7.9	2.7	39.5	139.9	56.3	0.7	3.8	7.7	7.1	27.8	2.1	30.7	7.7	24.7
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	105.4	77.3	101.9	64.1	107.4	61.0	94.8	101.9	119.7	82.1	112.6	95.9	75.1	80.4	88.3	123.3	80.6	52.7	131.5	106.2	113.3	105.5	122.4	87.9	74.3	106.6	106.6	81.9	115.0	63.4	99.9	52.0	109.0	86.8	62.7	52.1	100.6	53.6	246.7	100.2	90.8	53.8	103.4	105.9	96.1	58.9	113.2	65.1	107.8	136.3	67.7	83.6	87.2	103.9	204.6	127.6	90.2	140.3	152.1	145.4	92.2	172.8	134.1	147.6	152.5	120.8	229.7	205.4	92.1	137.0	143.7	155.0	147.4	142.5	142.8	172.8	173.9	129.3	110.7	193.8	171.5	165.6	108.4	130.7	117.8	158.4	149.8	123.2	140.1	122.6	227.9	154.1	118.6	181.4	190.8	264.5	158.5	198.9	191.5	149.5	145.5	289.8	163.7	61.8	166.1	114.0	117.1	296.3	535.3	152.0	154.6	142.0	107.8	140.8	89.2	160.9	150.7	186.5	241.2	258.1	148.0	260.1	69.9	143.4	93.0	188.6	80.0	98.9	99.3	120.7	105.9	95.9	100.2	117.7	127.6	105.1	204.1	75.3	91.7	62.9	161.5	101.0	101.9	107.4	101.9	119.7	106.2	113.3	106.6	106.6	109.0	103.4	113.2	103.9	107.5	28.9	72.7	14.7	130.6	186.2	138.9	100.0	108.1	95.9	169.6	173.7	92.4	151.5	69.2	101.2	20.9	208.6	129.9	171.2	291.6	76.3	283.0	107.8	77.6	91.5	142.0	78.8	23.3	106.6	239.4	84.4	89.7	101.0	61.5	90.6	98.6	132.7	141.1	112.7	23.8	165.8	83.4	178.4	130.0	700.2	104.7	123.3	167.2	15.9	144.8	152.3	193.6	25.6	20.1	91.9	206.7	85.7	132.5	199.6	242.8	325.8	59.0	73.4	59.2	77.6	136.6	97.1	157.4	155.9	220.4	245.3	128.1	86.2	172.1	153.2
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0;tongue: 82.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 59.7;Excitatory neurons: 94.4;Granulosa cells: 52.5;Inhibitory neurons: 120.1;Microglial cells: 57.1;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	12.9	14.7	28.5	5.0	27.3	11.0	11.0	30.8	32.5	14.6	22.8	19.4	2.6	16.7	9.8	8.3	12.8	6.9	26.1	27.2	29.4	9.9	13.5	8.7	6.1	27.9	29.0	14.9	8.0	6.7	17.8	6.5	29.2	13.2	4.4	24.5	8.3	13.3	88.0	7.0	6.6	13.1	23.2	7.6	9.6	22.6	30.8	4.9	8.4	82.9	3.7	16.7	10.1	28.1	4.3	2.7	23.4	11.0	17.4	21.9	3.0	15.5	30.8	14.1	13.7	2.6	6.6	7.0	8.6	19.0	7.7	3.8	2.8	10.2	15.7	8.7	5.8	15.0	10.6	7.5	14.7	6.6	7.1	12.1	7.4	9.7	21.3	26.1	12.1	18.4	8.8	13.1	25.3	2.7	7.0	11.7	9.2	1.0	8.1	11.4	3.3	6.1	11.0	2.4	9.3	13.8	5.5	2.5	14.1	9.6	3.5	30.3	10.4	8.3	3.9	13.3	15.4	10.4	6.1	6.9	11.7	15.7	15.3	1.7	2.1	1.2	3.3	1.1	2.9	2.2	2.1	2.5	1.5	2.8	3.5	2.6	2.4	2.2	1.9	3.3	2.9	3.3	28.5	27.3	30.8	32.5	27.2	29.4	27.9	29.0	29.2	23.2	30.8	28.1	6.7	6.4	19.3	59.7	6.6	3.3	3.0	4.1	5.7	9.4	4.6	3.3	34.5	1.5	3.8	3.7	0.0	3.1	2.7	2.2	5.9	2.6	19.4	2.4	6.6	7.6	2.4	8.4	94.4	2.4	1.6	9.0	1.5	2.8	24.1	52.5	4.6	8.6	3.1	18.5	120.1	1.4	4.1	2.2	3.1	14.5	3.7	4.5	3.6	57.1	3.6	6.1	5.2	66.9	66.2	2.7	0.2	11.7	4.2	2.2	0.1	6.3	4.9	17.8	19.7	5.8	9.8	8.5	5.1	2.7	1.3	1.0	6.0	15.7	1.7	10.0
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 1108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	15.6	11.6	21.7	14.6	30.6	13.3	20.2	29.7	23.8	19.3	19.3	21.5	20.7	20.6	15.5	25.4	18.3	16.9	22.3	20.6	24.5	21.9	19.0	15.7	19.3	31.3	28.0	17.7	12.2	24.3	9.3	17.3	30.4	22.1	23.2	14.6	21.5	15.6	37.4	16.7	20.4	21.3	27.9	14.9	18.2	15.8	27.1	23.2	22.6	42.8	21.6	16.8	16.0	38.6	39.0	44.0	34.0	31.6	31.1	37.2	39.1	23.3	31.7	42.1	40.3	73.7	35.9	32.2	35.8	19.8	55.7	30.0	36.6	81.7	47.6	56.6	41.3	43.3	29.1	58.1	43.4	35.8	50.0	30.1	57.6	49.6	70.7	53.5	25.1	43.7	47.9	47.8	1108.9	46.8	55.9	32.4	54.9	55.1	22.7	38.6	89.4	46.1	45.2	43.0	62.0	45.8	28.4	34.6	49.1	36.4	32.3	21.4	22.0	37.5	44.5	22.9	41.9	44.8	46.9	24.9	46.4	38.1	44.7	30.7	18.9	34.2	15.9	21.4	17.2	21.5	18.3	15.6	19.9	19.3	18.9	14.4	27.6	22.3	19.9	19.5	25.8	14.9	21.7	30.6	29.7	23.8	20.6	24.5	31.3	28.0	30.4	27.9	27.1	38.6	22.1	19.2	17.7	22.9	21.5	16.3	28.9	61.7	31.3	22.3	28.8	27.7	41.1	28.6	34.4	25.8	12.5	43.0	27.4	48.7	49.0	37.9	80.8	35.6	37.3	21.4	10.3	34.9	18.5	36.3	32.5	26.0	18.8	45.8	52.6	21.2	17.5	41.1	33.0	26.9	22.1	36.4	40.7	27.7	16.2	125.0	32.6	25.2	7.2	16.9	34.1	24.9	25.7	26.2	67.2	44.5	41.8	34.6	21.5	40.9	57.2	68.8	24.5	21.0	39.5	28.2	27.2	33.1	44.2	44.5	21.6	44.5	21.4	27.5	34.3	27.1
STX8	CARB	ENSG00000170310	"Syntaxin 8"	Q9UNK0	17	9250471-9576591	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 261.6;Late spermatids: 964.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001540	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA001540: AB_1080168"	"unprognostic (8.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.14e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	50.7	42.9	51.1	21.7	51.9	42.9	45.6	52.3	72.9	46.8	53.0	59.5	23.1	41.5	64.2	35.6	38.8	28.5	56.2	51.6	51.4	46.3	48.0	35.4	32.8	52.4	51.9	42.6	45.2	42.8	33.7	29.1	53.1	40.2	38.7	32.3	42.8	41.0	64.0	39.7	34.1	42.4	52.7	35.7	43.3	76.2	51.6	43.5	42.8	61.5	39.4	48.6	41.9	54.5	35.1	65.9	54.6	28.9	86.2	107.7	24.6	40.3	69.4	55.6	73.5	22.5	27.6	42.3	34.6	79.7	48.0	37.7	35.5	76.6	86.2	66.6	59.2	26.7	19.0	52.5	117.4	20.3	47.1	87.9	120.9	43.8	65.7	66.5	67.2	44.8	13.2	18.8	62.5	18.5	39.9	41.6	14.2	41.5	34.2	56.2	46.6	25.9	71.8	32.6	7.3	34.7	30.8	16.3	48.2	73.8	21.3	32.3	61.0	42.8	26.6	24.5	54.3	17.5	17.3	16.3	64.1	47.4	39.6	117.0	142.5	159.3	124.3	128.0	113.5	117.0	133.3	139.5	142.6	108.8	85.6	100.7	40.9	167.4	132.6	123.1	198.8	197.8	51.1	51.9	52.3	72.9	51.6	51.4	52.4	51.9	53.1	52.7	51.6	54.5	39.2	32.1	27.0	65.3	37.0	45.8	52.8	83.8	23.3	15.2	32.8	36.2	61.5	31.5	58.5	29.5	12.5	55.9	49.8	34.6	103.7	62.3	261.6	31.4	33.2	33.9	25.0	25.2	79.7	82.8	55.3	49.3	23.0	27.7	54.5	33.5	29.3	38.6	87.1	6.7	63.0	41.2	85.5	46.3	84.0	964.1	46.3	43.6	78.2	89.9	70.4	58.4	107.1	91.0	86.9	69.9	58.1	47.4	23.5	23.8	66.2	93.5	45.0	24.3	13.1	33.9	59.7	58.6	23.8	29.4	44.6	43.4	54.2	20.1	31.2	38.7
TARS3	"FLJ25005, TARSL2, ThrRS-L"	ENSG00000185418	"Threonyl-tRNA synthetase 3"	A2RTX5	15	101653596-101724473	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.8;skeletal muscle: 38.5;tongue: 36.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;B-cells: 9.5;Cardiomyocytes: 41.0;dendritic cells: 27.6;Plasma cells: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066697	Enhanced		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA066697: AB_2685705"	"unprognostic (9.33e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.76e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.79e-2)"	4.9	4.2	16.1	4.1	24.8	3.1	4.6	20.1	21.1	6.4	9.0	7.9	3.8	4.3	3.5	3.8	5.2	3.4	15.2	14.7	18.4	5.2	3.6	3.7	4.7	20.0	19.8	6.9	6.4	7.5	6.3	1.9	20.2	5.7	3.7	6.2	4.9	5.9	38.5	3.3	6.2	4.2	17.5	4.4	5.7	3.5	19.1	4.2	6.2	36.7	4.7	6.9	4.6	33.8	2.5	4.6	7.9	4.3	8.4	6.4	3.9	8.6	5.8	6.5	4.0	6.8	2.2	3.3	3.3	10.3	5.3	7.6	13.8	4.9	6.0	3.8	22.0	8.1	2.9	5.5	3.9	3.8	1.7	4.5	4.6	3.2	3.7	7.7	4.7	7.0	8.0	6.9	6.6	4.3	2.0	7.4	9.5	12.5	3.3	4.1	12.0	8.6	5.7	2.7	12.5	8.2	11.5	4.5	5.1	14.5	2.9	8.0	6.4	3.2	7.4	6.4	2.8	9.6	11.5	4.1	8.2	6.6	5.9	0.8	1.0	1.5	2.7	1.5	2.7	4.9	5.0	4.3	0.7	7.5	4.9	2.6	0.2	7.9	0.7	1.7	0.9	1.1	16.1	24.8	20.1	21.1	14.7	18.4	20.0	19.8	20.2	17.5	19.1	33.8	7.7	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	3.3	27.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.8	5.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	7.3	0.0	0.0	0.0
TBC1D17	FLJ12168	ENSG00000104946	"TBC1 domain family member 17"	Q9HA65	19	49877425-49888750	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068119	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA068119: AB_2685958"	"unprognostic (5.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.33e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.18e-4)"	"unprognostic (6.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.02e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.38e-1)"	"unprognostic (9.52e-2)"	29.8	26.4	31.7	9.6	34.9	6.5	26.6	32.8	41.1	22.7	17.6	32.2	14.1	30.2	12.5	17.7	24.3	10.6	35.9	31.2	28.5	20.4	28.3	15.8	10.3	38.8	32.6	30.6	27.6	18.1	21.1	13.2	34.6	20.6	5.8	13.2	28.0	17.7	124.2	38.2	19.0	12.3	29.3	15.4	27.8	10.3	32.4	12.3	20.6	39.4	7.1	30.9	20.1	41.2	12.4	25.3	7.9	11.5	36.0	24.5	18.2	14.2	48.0	15.5	25.0	13.8	18.0	7.3	13.8	26.6	26.5	13.7	7.0	19.3	8.4	22.3	18.3	8.7	20.6	15.3	30.4	4.5	12.8	29.0	19.7	14.7	11.5	27.9	14.6	11.5	9.9	41.9	13.7	14.3	5.9	9.4	13.4	13.5	20.4	8.9	11.1	20.1	21.3	22.9	14.5	16.0	18.6	20.0	12.3	10.2	18.5	6.9	17.8	34.2	11.5	12.8	7.3	26.4	37.0	5.3	35.6	5.1	13.2	13.8	3.9	8.5	7.9	3.9	7.1	8.1	7.2	8.3	3.7	10.9	7.1	6.0	5.1	10.8	3.7	4.9	4.4	6.0	31.7	34.9	32.8	41.1	31.2	28.5	38.8	32.6	34.6	29.3	32.4	41.2	18.1	12.8	12.2	19.2	14.9	14.5	16.3	27.1	17.6	32.0	22.4	23.2	7.8	25.8	15.9	20.2	39.6	49.5	15.3	21.3	25.4	16.1	2.8	16.9	12.3	14.4	48.7	12.2	6.9	18.9	17.6	17.7	23.4	23.7	4.5	12.7	21.8	27.7	13.6	48.8	8.9	28.7	28.5	13.1	26.5	5.0	27.4	12.9	14.2	5.6	22.0	23.9	15.5	11.6	16.0	12.2	19.1	31.2	16.2	15.1	31.7	22.5	7.5	52.6	13.1	18.1	17.7	10.5	13.1	10.8	12.9	66.4	17.2	16.1	16.2	10.5
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	8.8	8.2	14.2	6.8	18.7	5.8	12.0	18.2	16.4	10.6	12.7	9.9	9.5	10.8	9.9	10.4	9.8	9.2	10.7	11.8	16.0	11.4	9.4	12.5	9.1	17.1	15.5	14.0	14.1	10.9	7.7	6.0	16.6	8.0	11.1	10.9	9.3	7.4	16.7	11.3	8.7	9.2	16.0	8.7	11.2	12.3	17.9	11.9	12.0	18.5	9.2	8.1	7.7	21.2	6.7	7.3	15.3	36.7	5.9	13.3	9.5	7.6	8.4	8.7	5.6	4.9	10.9	16.0	3.0	11.1	7.4	8.9	12.6	11.0	9.4	12.5	10.1	30.4	13.7	9.4	12.0	21.3	15.4	8.9	15.4	5.1	15.1	17.9	12.0	13.3	6.7	9.7	9.5	7.4	19.5	11.4	11.7	24.4	5.5	10.1	7.5	11.0	12.0	8.8	13.8	16.4	10.9	13.2	27.9	10.9	6.8	9.3	10.2	5.4	5.6	6.1	8.5	18.8	17.7	13.7	5.0	11.0	16.7	0.3	1.4	1.6	3.2	2.2	2.3	2.2	3.7	3.7	2.1	1.4	3.0	3.8	0.1	2.1	1.7	4.6	4.5	1.3	14.2	18.7	18.2	16.4	11.8	16.0	17.1	15.5	16.6	16.0	17.9	21.2	24.5	22.4	30.0	169.1	13.8	7.9	9.6	9.3	14.8	30.9	10.8	10.2	44.4	11.5	18.2	11.0	54.2	8.8	18.7	11.5	21.5	13.4	20.9	18.8	24.4	15.9	17.4	7.2	101.1	17.8	10.6	18.5	18.3	15.7	152.3	26.1	11.7	8.8	6.9	20.2	128.9	12.8	12.2	9.5	7.8	24.4	19.0	22.2	19.6	69.3	12.2	12.7	20.6	142.7	168.7	10.6	19.2	18.4	14.6	7.1	12.4	12.3	22.8	30.6	6.6	32.9	12.9	38.9	21.6	14.1	6.7	6.7	20.9	30.6	14.0	8.0
TFEB	"bHLHe35, TCFEB"	ENSG00000112561	"Transcription factor EB"	P19484	6	41683978-41736259	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 97.4;Syncytiotrophoblasts: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 16.1;eosinophil: 16.9;intermediate monocyte: 16.3;memory B-cell: 34.2;myeloid DC: 14.7;naive B-cell: 22.6;neutrophil: 47.4;non-classical monocyte: 14.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 60.3;Daudi: 35.8;OE19: 53.1;U-698: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067082			Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA067082: "	"unprognostic (3.63e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"	14.3	10.7	18.3	16.7	29.9	8.3	15.0	24.0	23.5	13.4	9.6	25.7	5.8	11.1	1.5	14.8	12.8	7.7	37.1	18.1	19.7	26.7	11.6	18.2	26.1	30.9	27.7	6.5	12.9	17.8	31.3	14.5	25.8	23.4	4.3	2.2	21.2	7.0	89.9	17.9	34.6	5.7	22.5	57.2	14.4	2.6	25.4	5.0	22.9	41.5	17.2	19.6	15.6	39.9	3.5	3.2	0.6	12.3	3.8	2.5	60.3	5.3	6.9	3.4	2.7	6.9	2.7	35.8	6.8	3.5	2.9	8.7	2.4	4.9	1.0	28.3	4.1	0.1	8.8	12.8	6.8	1.0	4.3	0.7	9.8	4.9	2.6	6.9	4.1	3.3	4.1	7.4	1.0	1.8	2.3	1.2	0.1	53.1	1.6	24.3	0.1	5.0	7.5	2.6	12.8	4.3	4.7	10.5	1.0	3.4	2.3	19.5	7.1	1.5	3.1	0.1	3.0	15.7	2.3	42.1	2.6	15.3	0.9	0.3	16.1	16.9	3.8	16.3	0.9	34.2	1.5	1.8	14.7	22.6	0.4	1.5	47.4	1.7	14.1	2.9	0.6	8.7	18.3	29.9	24.0	23.5	18.1	19.7	30.9	27.7	25.8	22.5	25.4	39.9	14.5	9.6	9.3	10.1	36.7	14.1	8.2	14.8	5.2	6.1	5.7	5.6	19.2	10.0	6.0	12.9	12.5	50.7	13.8	16.3	21.5	3.7	1.1	11.4	2.6	12.2	13.2	3.2	6.3	6.9	8.3	6.9	6.1	8.0	1.3	0.5	6.4	4.2	26.8	26.9	7.9	10.2	26.4	22.8	13.3	4.2	3.4	19.6	0.0	17.8	20.0	18.4	22.6	11.1	97.4	10.6	18.0	10.9	16.0	7.1	14.1	3.7	7.4	5.2	6.6	13.1	7.8	0.9	1.0	6.4	14.5	120.4	9.1	0.8	8.8	6.3
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	13.6	17.6	29.3	10.4	41.7	8.2	11.0	27.5	33.0	9.4	28.5	11.5	14.2	12.1	15.1	8.5	14.9	9.7	14.8	30.1	27.0	14.4	11.3	9.5	10.6	28.4	27.5	12.6	11.4	19.8	11.1	6.7	27.7	16.0	10.6	13.2	17.3	14.0	23.6	6.9	9.8	11.8	27.9	10.7	10.7	20.1	27.9	11.0	11.5	20.7	10.2	10.2	7.3	29.3	3.9	24.1	11.4	12.4	26.3	14.6	6.3	11.2	9.7	10.7	10.5	4.9	15.9	7.2	9.5	13.1	12.1	11.8	12.1	13.8	7.8	15.9	13.7	10.2	16.9	13.3	13.0	9.1	8.7	20.6	10.2	16.4	12.0	22.9	13.0	11.6	7.7	15.9	15.7	11.6	14.6	3.7	4.1	20.9	20.1	9.9	7.9	13.4	18.9	7.6	22.1	10.6	10.8	22.0	6.6	6.6	14.9	4.4	10.9	7.0	7.4	14.5	6.5	18.9	12.2	4.4	7.3	4.2	10.9	13.7	16.0	8.7	9.8	12.0	9.8	10.2	7.2	7.6	14.7	15.3	11.7	10.2	1.7	8.3	16.1	18.7	6.4	10.9	29.3	41.7	27.5	33.0	30.1	27.0	28.4	27.5	27.7	27.9	27.9	29.3	8.1	6.4	7.5	16.6	14.5	0.0	7.8	0.0	6.8	27.4	12.0	10.7	0.1	8.6	3.7	7.3	8.4	11.0	9.2	7.2	54.8	14.5	21.9	6.7	9.2	6.2	6.1	3.4	11.8	12.4	5.1	9.9	9.2	6.7	23.5	7.7	7.1	10.8	18.4	8.4	23.1	7.5	0.0	7.9	0.0	23.0	11.5	9.8	0.0	4.7	9.9	33.4	14.4	15.1	37.0	8.2	9.6	7.5	11.3	9.3	15.2	38.9	2.9	11.6	13.1	13.2	7.7	57.5	8.3	9.5	0.0	6.7	9.3	14.2	7.7	5.9
TICAM2	"TICAM-2, TIRP, TRAM"	ENSG00000243414	"Toll like receptor adaptor molecule 2"	Q86XR7	5	115578496-115602479	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Basal squamous epithelial cells: 1.8;Endometrial stromal cells: 2.6;Macrophages: 2.0;monocytes: 1.7;Plasma cells: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.0;U-138 MG: 16.0;U-2197: 19.1"															NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (1.78e-1)"	"unprognostic (4.27e-4)"	"unprognostic (6.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.94e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.83e-1)"	3.2	3.3	2.3	3.4	2.3	0.8	2.3	2.1	2.8	3.2	2.1	2.8	0.8	2.6	3.2	1.4	2.3	1.7	2.3	2.0	2.4	2.2	2.9	2.8	3.7	2.6	2.5	2.6	3.3	0.6	2.1	1.4	2.5	2.4	1.3	0.6	2.9	1.9	6.9	1.2	2.2	2.1	2.6	4.3	2.5	0.6	2.9	0.7	2.0	1.9	2.0	2.6	2.6	2.7	4.5	0.2	0.1	0.3	2.5	11.2	0.1	11.6	6.3	5.5	4.2	0.0	1.3	0.0	0.8	9.9	1.2	0.3	0.6	1.4	6.3	29.0	0.7	0.6	2.2	0.0	1.1	0.3	0.2	4.5	0.6	4.9	0.2	2.6	1.2	0.0	0.7	1.1	9.4	0.0	0.1	1.0	0.0	0.5	1.9	1.0	0.2	0.5	3.8	0.1	0.1	0.4	0.7	0.0	0.3	0.4	0.0	1.3	5.3	16.0	0.9	19.1	10.2	0.4	0.3	0.0	10.8	0.6	2.4	0.0	7.4	2.2	0.1	8.3	0.0	2.7	0.1	0.3	6.3	1.6	0.6	0.1	2.1	0.5	6.4	3.7	0.1	2.4	2.3	2.3	2.1	2.8	2.0	2.4	2.6	2.5	2.5	2.6	2.9	2.7	0.5	3.2	0.5	0.0	1.1	0.0	0.0	0.0	1.8	0.6	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.6	0.2	0.0	0.4	0.0	0.2	0.1	1.2	0.5	0.2	1.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.3	2.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.5	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.9	0.0	0.3	0.3	0.0	0.0	0.1
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107572-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 47.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;granulocytes: 44.4;Hofbauer cells: 50.9;Kupffer cells: 37.8;Langerhans cells: 46.4;Macrophages: 45.9;Microglial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 76.6;eosinophil: 195.8;neutrophil: 118.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 195.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.2;HHSteC: 49.6;HUVEC TERT2: 27.7;JURKAT: 36.4;TIME: 68.3;U-698: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"			"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	6.5	3.9	5.4	5.2	6.0	5.3	4.6	7.7	8.8	3.3	6.3	2.6	2.0	2.8	2.1	3.1	2.8	3.7	9.6	5.2	5.6	1.9	2.3	10.7	5.7	6.8	6.0	1.7	1.2	1.8	0.9	7.8	6.6	2.1	2.6	2.8	2.9	1.3	47.3	1.8	2.6	3.9	6.9	6.2	2.1	3.6	5.4	2.2	10.4	21.8	3.0	3.8	1.5	7.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.3	5.6	0.0	0.2	0.0	0.3	0.1	1.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.3	23.2	0.0	0.0	49.6	1.6	0.1	0.2	0.0	0.0	0.1	0.3	27.7	36.4	0.9	0.0	0.4	0.0	0.0	3.0	0.6	0.0	0.0	0.0	4.2	0.0	0.1	0.4	1.2	0.3	0.2	0.0	1.9	0.5	0.0	14.9	68.3	0.6	0.9	0.1	0.3	2.1	0.0	17.0	0.1	3.4	0.1	76.6	31.7	195.8	5.0	13.4	0.0	0.3	0.5	0.8	18.9	0.9	0.1	0.8	118.1	5.0	6.4	2.6	0.0	11.8	5.4	6.0	7.7	8.8	5.2	5.6	6.8	6.0	6.6	6.9	5.4	7.6	30.5	0.0	6.0	2.9	0.9	2.4	0.1	0.4	0.6	1.6	0.5	1.8	1.2	1.5	0.8	0.0	0.0	0.3	7.5	0.0	0.0	0.2	13.1	0.6	0.2	16.7	0.0	4.4	18.7	2.0	0.4	1.5	0.0	0.3	44.4	0.0	7.9	0.1	50.9	0.0	22.4	0.0	0.0	37.8	46.4	7.4	0.9	45.9	3.6	46.9	19.4	0.5	16.5	2.0	1.9	0.4	0.0	0.0	0.7	0.1	0.0	0.0	1.4	1.3	0.0	1.4	0.6	13.1	7.5	0.1	1.7	0.3	4.2	0.1	0.0	0.1
TMEM11	"C17orf35, PM1, PMI"	ENSG00000178307	"Transmembrane protein 11"	P17152	17	21197954-21214176	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051795, HPA062854"	Uncertain		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA051795: AB_2681612, HPA062854: AB_2684882"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.61e-2)"	17.6	11.7	18.9	12.4	19.3	37.7	10.8	21.1	25.1	10.6	18.4	13.9	12.5	11.8	18.6	14.2	9.4	9.0	21.3	19.1	19.9	9.9	9.9	11.8	13.8	20.3	19.3	12.2	30.4	14.9	1.3	17.1	19.8	12.2	10.0	10.9	23.7	9.1	81.3	16.8	14.2	9.8	18.7	11.5	13.2	7.7	19.8	15.8	12.6	54.1	9.8	15.6	1.9	19.8	25.3	27.5	22.7	22.1	33.9	24.1	31.2	38.9	17.7	35.8	31.3	74.5	13.5	27.4	29.7	36.3	29.0	35.0	30.0	35.8	17.9	23.2	46.5	19.8	27.0	32.1	36.8	25.1	22.0	26.5	27.7	36.4	26.2	17.2	22.8	19.3	23.0	9.5	26.9	39.9	37.8	46.6	30.5	68.8	15.3	27.2	49.8	19.6	25.2	21.3	13.8	24.0	17.6	19.0	36.9	87.2	18.4	24.8	21.4	25.1	29.7	42.5	49.3	9.6	13.2	69.3	24.9	31.9	22.6	31.2	70.6	76.2	33.1	58.9	29.6	49.4	33.1	31.8	47.1	47.4	37.0	31.8	58.4	40.8	67.9	38.8	40.3	68.1	18.9	19.3	21.1	25.1	19.1	19.9	20.3	19.3	19.8	18.7	19.8	19.8	35.0	48.1	21.8	5.5	26.0	84.9	61.9	77.7	35.3	32.9	40.2	39.9	49.9	22.8	49.1	36.8	18.8	80.7	36.6	49.4	50.9	55.3	20.7	23.9	23.6	36.8	31.9	51.3	4.4	40.5	80.9	33.9	20.9	29.1	27.3	23.1	32.2	28.1	54.3	23.5	5.1	67.4	73.2	25.3	34.5	16.3	35.8	26.3	40.9	8.4	48.6	31.6	33.0	6.0	8.0	47.4	60.6	57.6	19.9	63.6	55.0	55.9	33.0	39.9	32.9	25.7	42.0	40.4	38.4	34.7	92.6	90.8	28.7	31.3	49.6	80.2
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588911-9614877	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	5.8	6.1	8.6	3.6	8.9	7.7	5.2	7.9	9.7	7.5	6.8	5.7	3.2	7.3	2.0	7.0	6.3	2.2	14.5	9.4	8.4	9.5	3.4	4.0	3.2	10.8	9.7	9.4	6.1	4.4	16.0	2.5	9.5	6.4	1.3	6.1	5.5	2.9	43.2	6.4	4.7	2.7	7.9	5.4	4.6	10.4	9.6	3.2	5.5	24.3	2.0	5.2	5.5	8.3	13.6	18.2	11.1	26.3	4.6	3.1	9.9	15.7	4.8	18.3	12.9	33.1	12.0	23.5	19.4	5.5	9.0	27.9	12.4	12.4	6.2	15.7	31.2	16.7	17.4	17.0	8.4	20.4	16.6	5.7	5.5	24.6	3.9	3.9	7.3	10.9	21.7	6.6	7.5	16.0	17.8	14.8	11.2	10.3	16.4	37.1	19.0	19.3	6.6	7.3	26.6	19.9	12.3	29.9	13.5	3.8	9.1	12.7	6.7	21.7	18.8	24.0	30.0	11.0	9.9	21.0	15.0	33.0	19.6	0.0	0.2	0.0	0.3	0.2	0.1	0.5	0.3	0.5	0.3	0.2	0.2	0.2	0.0	0.1	0.1	1.3	0.5	0.3	8.6	8.9	7.9	9.7	9.4	8.4	10.8	9.7	9.5	7.9	9.6	8.3	5.2	3.2	2.0	4.9	2.2	7.0	2.5	1.8	4.6	16.0	5.3	4.7	12.1	2.8	2.1	0.0	27.1	4.1	0.8	2.6	1.9	2.3	2.0	4.2	4.9	4.9	6.7	5.2	4.1	1.0	2.5	4.0	2.6	4.4	4.5	11.7	3.6	1.6	3.6	10.1	6.0	3.7	2.0	2.5	3.5	1.8	4.1	2.4	3.6	0.0	0.9	5.0	1.0	7.1	5.9	1.7	0.9	4.5	2.8	3.2	0.6	1.9	2.4	16.9	0.0	7.3	4.2	6.8	5.4	7.9	5.5	0.8	2.8	4.6	4.3	2.3
TMEM233	"DSPB2, IFITMD2"	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593774-119643075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 66.6;tongue: 21.2"	"Group enriched"	"Detected in some"	5	"granulocytes: 79.1;Skeletal myocytes: 77.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 22.2;hTERT-RPE1: 9.0;RH-30: 11.8;U-2197: 17.9;U-87 MG: 70.3"	"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA047506: AB_10963068, HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.7	0.6	4.6	0.1	6.6	0.0	0.4	1.1	9.0	0.4	1.3	0.2	0.2	0.3	0.2	0.3	0.2	0.5	1.2	4.4	2.5	1.3	0.6	0.9	0.2	1.8	1.4	0.9	0.2	1.3	0.8	0.1	1.8	0.6	0.2	0.2	0.5	0.3	66.6	0.1	0.3	0.4	1.4	0.2	0.3	0.2	3.4	0.9	14.3	21.2	0.2	1.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	1.7	0.0	22.2	0.0	9.0	0.1	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	6.6	1.1	9.0	4.4	2.5	1.8	1.4	1.8	1.4	3.4	4.4	12.0	3.2	1.1	0.7	0.0	0.0	0.4	0.0	0.0	2.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.9	9.5	0.3	0.1	13.3	0.0	0.0	5.4	8.5	0.0	3.6	0.0	0.4	79.1	5.5	15.4	0.1	0.1	8.4	3.7	0.0	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.5	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	77.8	2.2	3.1	1.0	0.2	0.1	0.1	0.9	9.2	0.0	0.2
TOMM7	Tom7	ENSG00000196683	"Translocase of outer mitochondrial membrane 7"	Q9P0U1	7	22812628-22822852	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 32: Non-specific - Translation"				"unprognostic (6.69e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.01e-2)"	573.8	563.3	949.6	275.4	981.1	502.7	881.7	958.2	1282.5	678.2	985.2	739.2	356.5	495.5	537.9	428.7	587.3	242.1	701.6	934.9	962.7	495.7	491.2	443.6	496.2	956.1	949.0	973.9	682.7	523.2	539.2	248.2	953.4	481.8	421.2	419.1	527.3	508.3	1753.2	585.5	466.8	408.5	979.2	484.0	554.7	223.6	972.7	428.0	390.2	1299.3	674.7	524.7	524.5	979.0	712.5	403.3	257.7	530.0	951.1	1090.9	303.8	501.7	813.4	382.9	337.6	295.1	454.1	556.3	592.0	704.4	1148.1	457.9	672.4	540.6	415.7	303.3	695.0	269.6	942.9	386.3	811.1	638.0	289.4	1368.6	1222.6	575.7	862.1	1434.9	637.3	418.4	951.4	470.7	696.7	572.4	335.1	899.0	900.4	1002.6	960.5	282.0	302.0	782.7	353.7	367.6	241.7	416.3	367.6	886.3	1339.5	1009.6	658.7	1079.9	405.1	292.7	469.8	533.7	578.4	969.8	1141.0	783.5	389.4	658.3	1061.3	264.1	588.8	556.9	665.4	489.8	831.8	1233.9	1126.6	806.9	566.8	1053.9	1488.5	1059.0	199.4	567.6	525.1	868.7	919.5	1759.4	949.6	981.1	958.2	1282.5	934.9	962.7	956.1	949.0	953.4	979.2	972.7	979.0	483.9	259.6	350.4	25.1	883.6	886.1	805.5	698.9	570.8	279.7	998.5	1129.9	1223.2	622.0	372.1	349.4	66.7	477.2	670.5	558.3	1328.5	434.1	385.9	473.8	382.6	503.8	531.4	351.7	13.3	935.5	735.0	535.1	270.1	386.9	504.1	461.8	745.0	1228.2	699.6	151.4	12.7	1021.7	280.8	934.6	818.0	344.0	993.2	536.6	788.0	12.2	781.9	1059.7	784.8	8.5	19.5	534.9	823.7	759.8	360.8	828.6	1052.8	1386.2	362.6	311.9	486.4	996.5	557.8	448.0	204.1	691.9	926.6	406.1	811.4	292.2	879.5	820.9
TRPT1	MGC11134	ENSG00000149743	"TRNA phosphotransferase 1"	Q86TN4	11	64223799-64226254	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 173.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038705, HPA038706"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria		"HPA038705: AB_2676161, HPA038706: AB_10671863"	"unprognostic (2.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.58e-3)"	27.6	38.8	33.1	14.1	34.9	8.4	27.5	36.3	36.2	26.3	33.8	35.2	22.2	23.1	21.4	35.2	26.3	15.4	88.3	31.7	34.6	52.0	46.5	20.3	16.3	35.0	34.0	26.0	51.3	19.2	35.2	10.9	33.7	36.0	18.4	12.7	38.9	28.4	173.8	27.4	30.3	12.0	34.1	30.8	41.9	51.1	36.7	21.1	33.5	116.1	17.6	30.0	25.8	34.3	25.1	24.5	26.5	43.0	32.0	23.5	32.2	16.4	31.6	28.7	24.0	16.1	37.1	24.7	63.6	27.4	22.2	34.1	11.8	35.7	10.1	23.8	14.2	12.7	23.8	28.0	46.4	16.2	21.4	17.7	20.7	31.6	28.1	52.7	20.4	49.0	22.3	27.1	24.2	59.4	30.3	33.7	16.8	33.3	26.1	39.3	19.5	71.4	74.4	29.1	23.0	33.4	13.2	32.1	47.5	18.0	37.1	25.8	23.9	19.4	14.9	37.9	16.4	53.0	14.3	16.3	46.7	8.3	32.1	11.0	16.9	28.5	18.8	31.2	15.0	38.0	18.5	19.9	24.4	39.9	20.1	23.3	15.8	26.1	27.4	59.0	25.2	12.0	33.1	34.9	36.3	36.2	31.7	34.6	35.0	34.0	33.7	34.1	36.7	34.3	17.1	9.6	23.1	9.8	31.4	13.3	18.7	32.7	28.5	8.9	40.4	45.3	42.5	32.9	25.5	27.6	0.0	44.4	17.0	66.3	95.9	41.4	147.5	41.3	20.1	17.5	26.9	14.9	2.8	58.4	46.7	19.8	41.8	27.5	24.6	10.0	21.0	30.0	25.5	10.1	4.9	111.3	30.5	18.9	12.8	82.1	19.9	15.0	37.4	2.8	27.2	32.1	15.5	7.5	6.8	46.6	60.5	17.0	47.1	24.0	92.0	82.9	48.2	11.6	6.6	22.4	29.3	59.6	13.4	42.8	18.5	36.0	21.8	20.2	40.3	22.6
TSC22D1	"MGC17597, TGFB1I4, TSC22"	ENSG00000102804	"TSC22 domain family member 1"	Q15714	13	44432143-44577147	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 17.9;granulocytes: 44.7;NK-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"HEL: 247.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077414			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear bodies"		"HPA077414: AB_2686839"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.78e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.08e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.14e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.48e-2)"	125.9	88.8	261.8	58.9	276.9	16.5	143.1	223.1	295.7	162.3	283.4	133.0	64.9	159.4	138.5	107.6	152.0	115.6	128.2	272.4	252.1	172.1	86.9	120.3	38.6	248.0	270.8	180.1	35.4	114.1	110.3	88.0	253.9	181.5	109.1	73.7	76.1	84.7	190.8	67.6	118.2	147.6	237.8	26.7	115.0	61.8	268.6	168.6	88.3	125.7	41.4	138.1	87.3	245.4	21.7	67.7	62.1	24.6	36.3	45.7	75.5	22.4	93.9	23.1	25.8	77.1	74.9	35.4	48.6	47.9	52.6	53.8	25.1	191.2	33.4	6.5	22.2	247.3	116.9	23.4	36.1	12.8	30.1	65.0	80.2	65.6	162.0	184.8	55.6	18.6	6.9	0.2	45.5	21.0	44.9	10.3	45.3	148.8	61.6	31.1	11.6	10.6	47.7	35.5	33.5	45.3	64.3	61.8	18.6	65.1	30.8	19.5	49.6	26.4	25.8	59.1	34.9	0.6	6.6	10.2	70.0	10.6	65.7	44.7	1.9	5.8	4.6	1.9	4.4	1.3	1.4	2.1	1.8	2.0	1.5	2.2	8.6	16.7	5.1	17.9	3.4	50.0	261.8	276.9	223.1	295.7	272.4	252.1	248.0	270.8	253.9	237.8	268.6	245.4	739.9	118.6	368.2	77.7	21.4	441.9	415.0	905.0	870.2	147.8	464.9	296.5	279.9	97.2	425.3	435.9	114.7	584.7	34.9	660.8	369.8	190.8	851.5	186.0	105.0	643.0	225.0	118.9	302.4	157.0	177.2	234.3	211.0	313.8	314.2	108.2	88.9	74.5	106.5	127.9	261.0	254.0	526.9	21.1	153.3	1231.0	91.6	218.4	402.0	148.0	16.2	246.2	26.8	207.1	103.8	229.5	339.6	136.5	17.2	550.9	212.0	155.1	265.8	149.9	447.0	268.2	500.9	80.9	34.6	178.2	610.0	1170.1	65.0	80.6	273.6	445.8
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	16.4	17.9	21.4	14.8	23.0	19.8	17.8	22.2	27.9	17.1	15.4	20.6	11.6	17.4	28.1	15.1	14.7	12.3	21.9	21.1	22.6	14.7	15.3	16.6	19.1	23.1	20.4	11.6	17.3	15.9	11.8	17.5	22.5	17.2	13.6	21.7	15.2	15.2	36.2	14.1	11.5	17.8	19.9	14.7	15.3	14.6	22.3	28.1	21.0	22.8	18.7	16.4	12.3	29.7	83.3	28.2	39.2	41.6	30.1	31.7	96.6	40.1	77.9	64.1	61.7	30.0	35.8	54.3	40.2	50.4	41.0	38.8	44.2	38.7	69.6	78.1	23.4	28.2	19.7	34.7	60.1	103.4	32.3	21.1	67.2	29.7	60.9	25.4	38.1	95.5	55.9	144.0	59.7	43.4	97.8	46.5	72.6	107.6	30.7	60.3	65.0	113.0	37.6	26.6	35.2	52.3	54.0	39.0	102.7	41.2	51.1	57.8	20.0	39.5	83.9	26.5	61.9	190.4	141.7	87.1	36.7	52.5	86.1	33.5	16.7	24.7	33.7	27.5	30.2	24.8	32.3	35.3	35.9	18.1	24.4	33.7	3.1	54.3	25.4	31.8	39.8	35.0	21.4	23.0	22.2	27.9	21.1	22.6	23.1	20.4	22.5	19.9	22.3	29.7	15.5	48.1	8.1	22.2	26.1	11.1	12.4	17.3	16.5	8.7	18.4	13.7	32.0	10.0	17.1	12.9	4.2	42.5	31.4	3.4	54.8	33.0	1.6	6.7	13.1	15.9	6.7	22.7	30.9	41.8	48.9	20.0	14.3	11.7	32.3	18.0	18.2	34.0	31.7	3.3	32.7	8.4	10.2	13.1	29.1	2.5	21.8	16.6	33.8	13.1	21.6	19.8	64.9	42.7	91.7	35.9	4.5	19.5	45.7	13.3	5.4	71.4	6.9	12.5	13.1	11.3	24.9	46.0	44.6	23.1	13.2	22.6	34.8	19.1	9.8	10.5
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 705.9;Muller glia cells: 508.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2"	"Group enriched"	"Detected in all"	5	"B-cells: 488.1;dendritic cells: 313.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	333.8	143.9	257.2	87.3	248.9	33.3	143.3	253.4	292.4	138.2	288.7	364.2	342.1	130.9	432.8	78.4	249.8	186.2	108.8	247.8	296.3	211.3	87.4	202.1	88.0	250.0	267.7	148.1	140.2	283.4	189.7	111.6	260.2	96.2	386.3	418.6	152.2	187.3	429.1	78.3	349.2	128.3	266.7	84.8	221.2	84.8	282.5	71.6	200.3	374.4	106.9	170.1	67.4	281.3	130.6	347.6	282.8	179.3	484.7	295.8	93.3	203.7	220.2	245.1	265.7	213.5	264.7	126.9	294.8	211.6	234.0	289.0	271.2	139.5	182.9	143.4	410.4	91.0	252.5	204.4	234.5	118.4	64.3	280.9	165.5	135.8	120.1	372.6	304.8	83.1	98.0	109.2	243.3	49.5	105.7	112.1	200.5	414.7	152.4	130.8	351.0	135.3	408.0	73.0	255.0	282.1	139.8	116.9	393.7	269.3	125.0	220.8	292.1	225.7	88.4	138.0	290.7	237.4	346.6	67.1	200.1	173.5	131.9	8.8	51.3	10.4	32.6	69.6	34.1	481.0	16.5	23.9	99.2	488.1	42.6	39.3	4.8	60.3	77.1	313.2	4.6	95.2	257.2	248.9	253.4	292.4	247.8	296.3	250.0	267.7	260.2	266.7	282.5	281.3	76.1	112.2	213.4	69.5	83.8	34.7	77.5	114.6	36.5	247.7	43.6	32.3	98.2	108.7	169.0	68.0	183.5	89.9	41.3	705.9	25.4	250.2	28.5	86.1	63.4	57.6	91.3	19.4	47.8	354.0	35.6	90.8	85.1	41.7	23.4	88.6	53.6	29.5	65.4	127.9	54.3	290.4	97.6	58.0	27.5	57.9	64.3	38.2	72.9	29.0	35.1	508.9	36.0	116.6	32.7	245.1	410.7	51.6	81.2	220.1	364.3	65.5	201.7	185.1	26.3	44.8	189.0	108.0	64.6	34.2	34.2	75.9	19.4	149.5	205.2	381.4
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715861-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	8.9	8.8	21.2	5.3	21.8	2.0	10.4	22.0	24.7	10.4	20.4	9.7	5.6	8.5	8.1	10.6	9.1	3.9	16.5	21.7	22.2	11.0	10.2	5.6	7.2	22.2	22.2	12.5	11.7	11.7	12.8	7.7	22.3	8.8	6.3	9.0	9.1	8.3	33.7	10.3	8.0	7.6	22.5	6.6	10.8	8.6	22.0	12.8	8.0	22.2	8.9	11.0	10.1	23.9	24.3	18.2	20.1	10.9	29.2	16.6	17.9	32.6	16.0	39.8	26.6	20.5	6.9	40.1	17.4	22.4	42.2	13.1	43.7	31.1	41.6	38.2	31.7	38.4	7.7	11.9	27.4	32.4	10.6	16.1	30.4	58.2	34.9	17.8	17.3	31.3	45.5	6.3	22.7	11.3	30.0	18.3	41.0	29.1	30.9	27.1	43.0	22.5	19.9	6.5	13.5	9.7	28.4	13.8	27.2	33.0	13.2	16.5	17.4	19.5	21.2	20.5	44.9	16.1	29.9	34.0	25.9	36.5	20.8	7.3	12.3	10.3	13.9	14.0	14.8	12.6	11.1	13.3	13.5	12.6	15.9	14.3	0.2	18.9	15.1	11.2	11.8	13.0	21.2	21.8	22.0	24.7	21.7	22.2	22.2	22.2	22.3	22.5	22.0	23.9	3.7	9.6	2.6	0.0	6.2	1.1	3.4	2.1	7.4	4.5	3.1	3.3	3.2	1.5	5.2	0.0	0.0	3.9	2.4	1.5	0.0	3.5	0.5	4.7	8.8	3.4	1.2	3.0	0.0	4.2	2.4	5.4	3.6	4.5	7.0	3.0	3.9	2.4	1.4	5.0	0.0	1.3	0.0	0.6	1.5	0.7	4.1	2.7	1.8	0.0	5.9	2.3	6.2	0.0	0.0	3.9	1.7	2.6	6.1	3.0	2.0	6.4	2.6	3.8	0.0	3.8	3.5	9.2	8.2	5.7	1.6	1.4	4.6	1.9	2.5	1.8
TTLL11	"bA244O19.1, C9orf20"	ENSG00000175764	"Tubulin tyrosine ligase like 11"	Q8NHH1	9	121821928-122093606	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 24.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 201.7;Inhibitory neurons: 157.5;Oligodendrocytes: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021828	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021828: AB_2670841"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.61e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.53e-2)"	3.8	5.5	7.7	2.7	11.4	1.3	3.6	7.7	18.0	4.2	0.0	10.3	2.6	5.2	3.0	7.0	4.9	3.4	5.1	3.3	7.6	2.8	5.4	3.8	2.4	9.2	8.8	4.3	4.9	4.3	2.9	4.4	9.1	4.4	4.0	6.0	4.7	5.2	24.3	4.2	3.2	9.3	8.4	3.2	4.2	12.1	8.1	2.7	3.5	8.7	2.6	5.7	4.2	19.0	2.4	1.2	3.9	5.3	5.4	6.5	1.6	4.5	5.5	7.7	4.4	3.6	1.4	5.4	1.4	9.3	2.5	5.8	6.8	5.4	4.7	3.7	5.6	2.6	5.2	3.7	6.2	4.7	2.9	4.7	7.6	3.1	4.9	2.9	2.8	4.6	8.1	5.3	2.7	3.8	3.3	3.8	2.1	8.2	8.3	3.4	6.8	8.4	4.0	1.9	8.2	3.4	2.7	5.0	3.6	2.1	4.0	4.0	3.2	3.6	0.7	6.5	6.1	5.8	7.9	2.3	3.3	5.2	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	7.7	11.4	7.7	18.0	3.3	7.6	9.2	8.8	9.1	8.4	8.1	19.0	2.1	0.0	1.5	18.3	1.6	2.5	0.9	0.8	6.2	3.0	2.2	2.4	1.4	1.5	0.4	1.8	10.4	1.7	1.2	1.1	1.9	1.9	22.3	2.8	2.7	1.5	1.2	3.4	201.7	1.8	0.7	2.2	1.1	1.3	1.3	1.0	0.7	1.8	1.6	6.7	157.5	1.6	0.0	0.9	1.2	23.1	3.7	0.9	3.6	22.5	0.9	2.4	2.1	58.8	412.6	1.9	0.1	3.0	2.2	0.8	0.5	2.0	1.8	2.6	0.0	5.5	2.6	13.3	2.5	4.2	4.1	1.0	1.8	2.7	1.0	0.9
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961373	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 301.3;tongue: 171.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 290.9;Late spermatids: 197.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 246.4;K-562: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		87000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favorable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	23.1	20.7	42.2	14.7	44.8	82.5	20.7	43.0	43.0	23.8	41.4	38.6	24.3	22.0	12.9	37.4	22.8	12.0	72.0	40.4	42.2	23.5	24.9	19.8	15.7	43.2	42.7	20.9	17.1	27.1	23.5	22.8	41.8	24.7	18.4	15.2	27.8	20.6	301.3	53.2	23.3	16.3	43.7	21.0	23.0	43.1	44.0	17.7	18.0	171.0	16.5	28.3	27.0	41.0	37.4	42.7	29.7	43.4	22.0	25.6	55.7	32.0	27.1	38.9	31.2	59.7	46.3	44.8	30.1	26.4	46.1	124.4	41.9	37.0	17.5	246.4	39.6	37.4	79.0	33.8	22.9	49.2	34.4	24.2	47.7	24.6	23.8	26.0	32.8	41.4	316.6	35.5	31.2	76.9	40.4	50.5	70.5	87.4	71.8	45.1	55.8	59.3	28.0	23.7	46.0	50.6	46.3	41.4	33.5	26.3	34.9	52.5	26.8	22.0	33.0	26.5	40.2	20.5	41.1	53.9	40.7	43.9	30.6	6.5	17.6	8.7	4.8	28.4	5.1	4.9	5.4	3.2	15.6	2.8	2.8	3.3	3.7	4.0	33.4	1.6	4.5	7.0	42.2	44.8	43.0	43.0	40.4	42.2	43.2	42.7	41.8	43.7	44.0	41.0	42.8	16.0	10.0	18.6	14.5	40.7	38.8	41.8	43.3	38.3	29.6	36.2	85.7	11.5	24.5	27.6	31.3	148.6	20.7	45.5	93.9	16.3	101.6	82.9	33.7	27.5	16.8	290.9	17.3	22.9	32.7	22.5	21.9	21.3	7.0	28.6	20.3	32.7	75.2	13.5	23.6	37.4	28.5	34.3	30.3	197.4	19.6	41.8	35.6	9.4	46.0	60.7	13.4	9.0	14.1	22.6	42.3	22.6	24.6	23.1	47.9	35.6	96.0	44.1	19.7	42.8	27.4	57.7	54.9	73.2	64.8	60.5	16.5	25.7	55.6	39.4
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926436-43956136	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 32.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 30.2"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	5.8	8.3	11.7	2.4	12.2	2.2	5.0	14.2	17.6	4.6	9.8	6.5	2.4	4.5	5.7	5.2	4.5	3.4	10.9	12.3	11.2	6.9	10.7	4.4	2.7	12.0	11.7	5.1	10.0	4.6	5.1	2.8	11.9	5.7	2.9	6.9	5.6	4.4	32.5	4.9	3.9	4.4	11.8	4.7	4.6	3.0	11.5	2.7	4.9	27.8	2.7	5.3	5.2	12.7	4.9	4.0	2.4	11.0	11.0	4.5	1.8	2.3	5.8	2.9	3.7	2.1	5.6	4.6	6.3	6.3	8.1	5.3	3.1	2.5	4.4	10.5	5.4	5.0	5.8	5.4	4.1	10.9	9.8	3.4	5.2	3.3	5.0	4.2	3.6	5.5	5.6	9.2	4.0	3.0	6.5	6.1	5.4	5.9	5.1	4.0	3.3	7.1	6.2	5.9	8.8	30.2	5.0	9.7	3.8	4.4	4.9	3.3	3.2	1.9	6.0	4.1	6.9	13.5	10.8	2.2	5.7	14.2	10.9	10.2	14.5	17.5	11.1	23.8	11.4	12.8	13.5	12.5	15.1	12.7	16.2	13.4	1.4	9.9	28.7	13.0	12.6	8.8	11.7	12.2	14.2	17.6	12.3	11.2	12.0	11.7	11.9	11.8	11.5	12.7	14.9	0.0	6.5	8.8	10.4	6.2	9.1	9.4	4.0	9.6	24.3	24.3	24.6	14.3	10.0	16.5	2.1	11.9	11.9	8.4	54.8	18.7	6.2	8.9	7.2	12.9	18.7	9.9	14.2	28.4	20.3	14.9	8.2	8.7	4.5	11.1	12.5	25.4	27.4	11.8	13.5	8.0	8.2	11.6	14.1	10.7	12.2	12.5	16.0	8.4	18.4	18.8	5.2	20.1	12.1	14.1	7.6	21.8	11.2	12.1	15.5	52.0	5.5	11.6	6.6	23.0	10.5	15.6	9.6	10.8	11.2	7.7	8.8	16.5	8.4	12.3
UBE2E3	UbcH9	ENSG00000170035	"Ubiquitin conjugating enzyme E2 E3"	Q969T4	2	180967248-181076585	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 654.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA030445"	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"			"HPA003303: AB_1858521, HPA030445: AB_10669599"	"unprognostic (8.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.08e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (8.75e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.40e-1)"	61.6	45.8	57.8	40.1	60.8	48.3	58.1	59.9	71.5	56.2	51.4	51.4	46.7	51.6	55.8	46.7	58.3	71.4	54.2	74.3	59.7	71.8	58.3	39.9	39.6	56.6	57.8	52.5	56.5	79.4	35.3	48.6	58.0	40.0	54.4	68.4	54.6	39.6	175.1	57.0	42.5	42.9	62.3	40.3	59.2	56.8	58.8	67.9	73.7	88.6	48.4	61.6	46.9	64.1	104.8	46.6	654.4	22.8	189.8	243.1	104.0	137.1	171.9	112.8	139.2	51.0	124.0	51.4	117.1	188.5	94.5	43.8	400.7	140.5	202.1	125.9	120.3	177.2	59.0	142.5	91.6	83.5	81.3	96.7	127.9	99.3	94.8	114.6	150.9	105.4	91.9	93.3	280.7	57.5	152.6	77.7	125.6	71.2	217.6	147.0	66.8	122.1	193.2	91.1	113.4	126.3	59.7	62.8	58.1	178.3	33.7	121.5	140.1	218.2	143.2	129.4	162.0	81.1	55.0	143.7	215.7	32.6	124.3	29.1	28.2	53.7	17.6	25.4	21.3	15.0	13.6	22.7	18.4	9.5	14.3	15.7	25.6	18.5	36.3	60.0	5.9	20.5	57.8	60.8	59.9	71.5	74.3	59.7	56.6	57.8	58.0	62.3	58.8	64.1	69.3	9.6	24.2	100.9	50.3	102.9	83.7	111.2	70.6	151.8	84.4	74.4	37.7	108.7	63.7	55.2	29.2	31.9	84.8	56.4	229.0	95.8	36.9	54.3	51.6	59.8	59.8	108.8	115.4	101.9	83.4	81.2	60.6	57.8	23.5	61.8	72.1	55.9	85.3	75.7	67.7	39.4	91.6	71.4	63.9	79.7	62.7	76.3	129.9	71.2	62.4	103.9	79.3	160.9	158.3	113.7	41.6	36.1	87.7	74.8	58.9	172.6	51.8	73.3	26.3	56.4	81.7	83.1	191.6	77.3	122.3	36.0	55.4	57.9	50.9	103.4
UBFD1	"FLJ38870, FLJ42145, UBPH"	ENSG00000103353	"Ubiquitin family domain containing 1"	O14562	16	23557721-23574389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051746			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA051746: AB_2681587"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.45e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.06e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.46e-1)"	12.8	20.7	18.8	11.9	18.3	10.8	12.7	16.6	19.0	13.7	25.0	13.6	7.4	17.1	18.3	13.1	17.3	12.0	20.7	18.4	24.3	15.5	17.0	9.9	12.4	20.1	21.2	17.4	13.5	25.2	19.6	18.0	26.2	15.4	11.7	10.7	12.4	15.2	81.2	10.6	9.6	18.8	16.5	11.1	10.7	26.0	21.9	21.0	17.7	39.0	15.7	13.4	11.1	16.7	17.1	40.0	55.0	40.0	62.3	76.9	48.8	45.8	44.2	42.3	39.1	29.9	30.1	39.3	68.5	66.9	28.5	23.6	88.4	36.1	53.9	57.1	47.3	20.8	34.0	66.3	33.2	21.9	34.7	55.1	26.5	41.3	38.4	64.9	41.4	31.1	47.6	20.7	47.1	37.4	30.9	39.5	118.0	29.2	17.2	53.6	33.7	33.0	39.5	14.9	53.5	47.6	17.6	34.3	31.8	52.7	47.1	31.6	43.1	23.3	26.1	25.7	27.2	25.0	29.8	23.6	43.0	25.3	36.6	0.0	0.5	0.5	1.4	0.7	0.7	0.6	0.9	1.3	1.1	1.3	0.5	0.8	0.0	1.2	0.3	1.5	0.8	0.4	18.8	18.3	16.6	19.0	18.4	24.3	20.1	21.2	26.2	16.5	21.9	16.7	10.0	6.4	2.6	10.1	6.8	8.8	10.2	10.3	13.1	11.6	16.5	13.8	35.1	8.6	6.6	20.2	22.9	19.2	14.9	8.1	15.6	13.0	49.3	20.7	29.4	11.6	7.2	10.3	14.6	11.5	27.2	17.2	7.1	20.6	0.0	26.4	5.3	19.0	13.4	6.7	12.3	10.2	2.0	6.6	5.1	76.1	18.6	6.6	10.6	7.5	10.7	11.0	6.2	5.0	9.8	8.8	8.9	9.8	9.8	20.4	4.8	18.3	8.8	14.9	26.3	17.1	19.2	21.3	21.7	14.0	14.2	36.0	8.3	22.2	9.3	14.8
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486615	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003617	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	18.3	29.6	31.2	11.3	32.5	11.2	17.1	28.8	38.3	21.2	25.8	27.1	17.7	19.0	18.0	29.1	17.9	11.4	47.8	32.4	30.0	20.0	28.1	17.7	16.1	31.0	29.7	15.8	36.9	20.9	16.0	13.5	31.7	20.9	12.4	6.4	27.8	20.2	97.9	24.8	19.5	11.9	30.4	18.9	23.1	4.5	32.0	17.3	15.8	72.1	17.0	25.8	21.5	34.0	84.8	50.9	15.3	42.1	31.3	31.3	51.0	35.0	26.3	37.2	39.5	50.3	32.6	64.1	107.8	33.7	31.5	31.5	76.9	40.4	20.2	42.6	46.5	46.3	46.6	29.6	38.9	55.8	48.1	24.0	45.9	24.8	42.8	36.1	27.0	46.5	51.9	31.4	30.1	66.2	49.9	52.3	17.8	74.4	82.0	44.5	44.5	68.4	31.0	34.2	29.3	44.2	19.4	66.7	59.0	18.2	30.8	40.3	27.3	37.6	42.5	61.1	77.9	60.8	67.8	115.8	39.6	92.4	44.5	94.7	22.0	22.1	33.2	18.9	46.4	20.4	31.2	35.5	21.7	16.3	26.5	30.0	7.1	34.1	16.7	12.7	34.0	41.9	31.2	32.5	28.8	38.3	32.4	30.0	31.0	29.7	31.7	30.4	32.0	34.0	17.6	3.2	6.7	3.9	12.3	9.6	11.7	13.2	4.0	19.4	16.7	24.5	32.5	15.7	9.2	16.5	4.2	32.5	25.2	21.8	43.0	25.3	0.3	5.7	11.9	14.2	8.5	29.0	8.7	32.2	47.4	14.5	9.2	7.7	9.5	16.8	13.2	18.9	24.2	18.5	6.3	17.2	14.2	13.8	10.2	1.0	12.5	31.7	28.4	1.9	20.3	17.2	38.1	5.5	4.9	30.2	11.4	18.8	19.5	16.7	24.6	25.1	4.7	11.4	0.0	13.2	24.9	0.1	5.7	21.9	12.1	13.0	16.2	7.2	17.4	7.8
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563627-56567868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.8	20.2	24.9	14.9	26.8	11.1	12.1	19.7	30.6	15.9	12.7	15.7	11.2	16.6	15.9	18.7	17.5	14.5	21.6	27.4	25.5	13.5	19.4	13.8	18.4	20.2	20.4	25.7	10.5	23.6	16.3	15.8	22.1	20.2	12.1	22.2	14.4	20.0	28.0	13.6	12.4	18.4	21.3	14.9	13.1	4.4	22.6	18.9	20.7	22.8	18.6	18.6	11.1	25.5	36.3	26.5	25.9	30.6	58.3	37.0	16.3	28.6	33.9	21.0	23.2	14.9	16.6	27.6	30.5	34.0	32.9	20.7	50.0	31.9	25.3	43.0	30.1	11.2	34.2	15.9	30.6	22.1	23.7	34.7	39.6	28.3	24.6	30.3	18.7	17.6	13.3	29.5	33.6	16.9	28.5	19.2	21.7	11.6	31.1	25.3	33.7	26.3	42.8	27.9	31.9	29.9	41.3	18.1	17.4	45.2	30.4	16.1	21.2	22.2	22.5	32.4	17.5	11.1	14.8	18.9	24.9	23.1	19.3	50.0	23.6	24.1	15.1	31.1	17.1	7.8	22.9	17.7	17.8	8.6	30.3	18.9	20.4	20.9	34.2	6.5	23.5	20.3	24.9	26.8	19.7	30.6	27.4	25.5	20.2	20.4	22.1	21.3	22.6	25.5	13.9	22.4	17.2	0.0	30.5	31.2	41.6	27.4	20.5	42.3	14.5	11.3	37.6	15.7	25.0	18.4	18.8	28.8	15.4	12.1	17.6	20.0	0.1	11.8	22.7	18.9	34.2	18.3	0.0	16.6	26.7	27.9	13.7	15.7	12.7	14.2	18.2	20.3	24.7	42.1	0.0	20.3	18.3	30.7	25.3	1.6	24.8	21.1	17.8	0.0	35.9	22.3	42.2	0.0	0.0	18.9	12.7	36.5	23.5	32.0	20.7	16.4	27.5	35.8	13.1	25.4	29.8	0.3	1.5	32.7	30.4	40.0	28.7	12.2	19.3	35.6
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	12.2	15.3	19.6	11.9	20.7	15.0	14.3	18.5	22.8	19.4	18.3	17.6	13.6	18.2	12.0	16.4	28.0	12.0	13.0	19.4	18.4	14.5	10.8	13.1	16.1	19.2	19.7	23.2	16.4	17.1	15.7	13.2	18.7	17.7	11.0	12.9	16.5	20.3	20.9	20.8	15.9	12.6	17.3	17.8	16.4	14.2	20.1	18.4	18.5	17.7	14.0	17.6	16.8	22.1	12.5	20.6	26.9	26.2	21.1	17.5	16.5	9.1	14.6	24.2	18.9	19.4	23.3	16.0	14.6	11.2	15.1	20.7	17.6	17.5	13.2	30.8	30.0	19.3	34.1	15.3	15.2	17.4	13.4	14.8	23.0	16.6	23.9	27.1	17.3	35.0	28.4	21.6	15.6	22.6	30.7	26.9	25.2	24.3	26.1	28.8	9.0	26.5	14.4	14.9	24.2	31.5	17.2	17.2	13.9	20.1	37.3	27.5	10.1	16.9	14.8	11.9	15.3	42.9	36.5	23.9	15.3	14.7	15.5	15.2	10.0	17.1	12.6	6.4	14.6	11.0	11.5	13.2	10.8	11.3	13.1	12.3	8.4	13.3	7.6	10.8	12.3	11.0	19.6	20.7	18.5	22.8	19.4	18.4	19.2	19.7	18.7	17.3	20.1	22.1	4.5	0.0	3.7	5.2	6.5	1.5	1.8	2.4	16.5	5.0	4.9	4.1	3.9	8.6	2.9	1.8	6.2	4.9	3.6	3.6	1.9	2.0	1.0	6.3	5.7	4.4	5.4	10.7	2.4	2.3	2.3	5.1	9.2	3.7	2.5	4.5	5.3	2.1	2.2	0.0	2.7	4.0	4.1	4.8	0.8	1.0	5.0	2.1	1.8	1.9	1.2	3.3	5.2	2.0	4.6	2.0	2.4	4.1	7.8	2.7	3.5	2.5	9.5	5.2	6.6	2.0	5.2	5.3	3.2	10.7	1.4	3.1	5.6	3.1	4.1	1.5
USP22	"KIAA1063, USP3L"	ENSG00000124422	"Ubiquitin specific peptidase 22"	Q9UPT9	17	20999596-21043760	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044980	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA044980: AB_10794503"	"unprognostic (7.24e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.17e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.07e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (8.95e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.79e-2)"	40.7	66.8	91.2	40.3	93.7	53.0	42.5	72.0	90.5	55.3	44.8	48.8	33.6	63.7	48.2	40.7	57.3	40.0	79.8	93.1	112.3	49.5	44.1	46.3	48.3	71.7	78.1	75.6	48.0	68.2	65.2	39.3	85.8	50.2	35.2	57.1	36.3	48.2	108.6	40.3	39.5	54.0	72.4	45.1	49.8	29.3	120.3	63.9	57.0	81.2	50.2	42.3	35.4	68.4	106.9	189.7	179.9	155.5	102.7	105.9	85.9	120.2	91.8	105.6	89.3	220.0	46.9	145.4	112.5	185.2	71.3	111.7	176.7	143.1	157.1	70.0	122.8	120.8	121.5	107.9	121.3	134.2	101.0	117.4	83.9	119.9	125.1	119.8	134.1	93.3	139.7	51.4	151.6	109.5	189.8	63.7	93.1	125.5	61.9	206.2	284.5	99.2	97.7	153.9	86.3	177.8	154.9	63.5	124.9	488.4	106.4	78.0	171.0	107.4	140.8	111.3	164.1	55.0	79.6	476.2	109.0	70.3	169.4	5.5	9.6	10.0	7.9	7.6	7.9	8.0	8.1	7.8	9.2	9.9	10.7	10.2	9.9	7.1	9.7	7.6	6.1	6.0	91.2	93.7	72.0	90.5	93.1	112.3	71.7	78.1	85.8	72.4	120.3	68.4	46.6	41.7	48.8	31.6	47.9	33.0	43.8	33.8	38.7	97.6	80.3	63.8	23.8	45.8	41.5	60.7	93.8	51.4	36.6	59.3	23.5	51.6	36.0	59.3	75.3	56.1	88.2	43.7	53.1	59.0	37.5	51.0	57.6	68.7	30.4	86.5	76.8	68.5	38.1	117.8	66.0	48.8	30.5	53.8	36.1	51.2	51.0	31.7	35.6	43.1	42.2	55.4	28.8	38.7	50.6	69.6	40.3	71.8	36.6	62.2	33.4	48.9	37.4	59.1	13.1	58.6	52.2	15.9	19.7	49.6	29.1	65.8	33.4	77.9	53.3	53.5
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584431-85593406	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 487.9;Endothelial cells: 337.8;Hepatic stellate cells: 486.2;Kupffer cells: 340.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 364.7;LHCN-M2: 428.9;TIME: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	134.0	117.4	71.0	59.9	74.1	41.2	118.4	72.9	89.1	78.6	66.8	76.4	23.3	79.4	33.2	45.3	84.3	58.0	114.7	69.4	76.1	90.0	79.3	134.6	92.7	79.1	71.4	52.8	29.0	14.7	31.9	74.1	74.2	72.8	20.5	2.9	36.9	36.7	217.3	44.5	54.1	77.2	73.8	97.5	54.0	11.4	78.0	50.9	63.8	199.6	41.2	87.1	69.7	71.7	0.8	0.2	2.4	0.0	89.3	155.8	2.4	98.5	155.9	95.5	104.5	39.5	15.1	0.3	2.3	172.2	50.7	1.1	0.0	2.4	42.2	142.9	2.8	1.9	2.5	56.1	187.2	4.5	0.9	108.4	9.6	40.1	1.1	138.9	364.7	61.7	0.4	0.3	428.9	14.5	63.1	13.8	0.1	27.2	0.6	92.4	0.4	2.7	2.7	3.6	0.2	3.4	0.6	27.4	0.5	2.2	3.2	5.1	250.0	2.3	6.7	7.5	0.2	0.1	3.1	2.4	110.5	5.4	65.9	59.1	222.6	176.5	180.5	503.8	171.7	60.7	136.1	135.2	79.0	54.5	102.4	125.1	70.2	94.4	424.9	86.4	248.7	283.0	71.0	74.1	72.9	89.1	69.4	76.1	79.1	71.4	74.2	73.8	78.0	71.7	487.9	19.2	21.2	3.6	43.9	60.8	39.8	104.1	39.3	0.8	14.9	27.3	84.4	71.4	70.1	44.1	0.0	22.9	64.5	38.8	29.4	29.9	1.8	7.7	64.7	337.8	12.6	35.6	0.1	49.1	7.2	148.0	9.7	7.9	44.4	22.2	486.2	198.6	80.3	3.3	0.2	20.5	36.7	340.8	91.5	10.2	192.6	147.8	275.7	4.7	136.0	17.5	112.3	0.5	1.6	44.2	51.9	165.1	68.4	64.7	126.5	91.2	50.6	1.0	59.2	152.2	83.9	5.5	6.6	19.8	45.3	21.6	88.5	19.2	7.8	49.4
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405937	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 385.2;skeletal muscle: 914.4;tongue: 942.7"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 403.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	67.5	76.2	117.3	59.1	119.4	92.1	70.3	116.8	150.6	53.7	115.4	106.9	79.8	63.5	68.6	99.9	85.8	56.0	385.2	121.1	130.8	108.8	92.9	51.9	66.3	122.7	119.3	61.6	64.6	92.4	58.9	63.9	139.2	69.5	106.4	123.1	61.6	81.3	914.4	54.1	73.0	92.8	114.1	67.3	72.1	114.5	118.6	80.1	83.3	942.7	79.3	78.9	59.8	113.8	226.3	225.7	174.5	185.9	146.3	126.6	84.8	180.0	151.1	225.4	205.2	173.4	190.4	235.8	165.0	153.7	196.3	142.5	238.4	194.1	244.7	117.2	196.6	352.9	138.4	250.2	105.2	172.0	190.1	98.6	143.3	171.6	80.9	149.6	279.8	201.3	284.4	158.6	235.7	126.4	373.3	197.1	205.2	285.6	144.5	193.6	322.1	165.3	245.7	198.8	156.8	133.3	112.1	132.8	116.1	126.4	279.9	129.9	149.8	86.6	150.0	217.7	174.0	145.2	264.1	266.9	117.5	238.0	150.9	142.8	165.3	183.4	145.8	167.2	148.7	126.5	155.6	146.5	222.7	96.6	152.7	147.7	82.8	125.8	155.6	163.0	202.5	360.5	117.3	119.4	116.8	150.6	121.1	130.8	122.7	119.3	139.2	114.1	118.6	113.8	78.1	44.8	24.4	50.6	59.8	64.5	81.1	197.8	58.1	85.9	53.0	73.9	321.2	55.8	82.8	66.2	35.5	145.5	91.9	65.7	307.2	116.3	151.1	112.8	56.7	70.5	47.8	186.4	63.2	90.0	112.1	81.5	41.3	47.1	55.2	100.6	68.2	60.4	139.7	138.0	78.9	86.1	177.0	58.5	77.8	146.4	69.3	107.7	72.9	26.2	130.1	72.9	83.4	38.2	34.7	84.9	86.7	97.4	75.9	48.9	125.3	177.5	142.1	94.5	65.7	146.4	123.8	403.7	156.3	82.3	70.8	58.3	79.7	94.2	124.8	70.4
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311350-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	13.2	15.3	15.7	8.9	16.9	8.8	12.8	16.1	17.1	10.4	11.0	13.5	13.5	11.7	8.1	16.0	10.3	9.4	20.6	15.5	14.9	18.0	11.6	9.9	11.8	16.4	16.8	12.2	27.8	20.6	7.6	10.0	16.7	10.4	7.6	10.2	19.9	8.4	54.0	15.3	12.8	8.4	15.4	9.2	17.6	6.8	16.7	6.2	16.7	33.6	7.3	11.4	11.3	18.2	21.1	34.9	23.2	30.7	21.2	18.8	20.5	27.9	25.2	36.4	24.3	33.4	19.0	35.0	27.3	28.0	17.5	30.3	23.9	28.2	21.8	14.8	30.8	22.0	20.7	26.3	32.6	27.5	19.6	21.7	36.3	31.6	28.7	21.4	27.4	27.3	37.0	10.3	27.2	46.8	36.4	20.5	26.7	20.6	24.5	47.8	19.0	41.3	18.5	16.8	39.1	24.7	59.3	18.1	21.4	15.4	31.4	20.6	32.8	33.2	20.8	30.4	22.1	36.9	31.3	62.6	30.4	18.2	37.1	8.8	9.9	13.3	11.2	8.7	10.0	8.5	9.3	13.9	9.4	7.4	10.5	9.9	7.5	8.0	11.5	5.5	11.8	13.8	15.7	16.9	16.1	17.1	15.5	14.9	16.4	16.8	16.7	15.4	16.7	18.2	39.8	25.6	19.0	14.7	33.8	30.7	37.3	22.2	22.8	51.4	30.2	28.2	31.0	22.8	16.7	23.9	22.9	59.8	48.4	48.9	74.3	51.7	11.2	14.9	27.0	34.9	31.3	43.6	14.5	82.5	66.5	32.9	29.0	25.6	29.2	36.3	31.8	21.6	45.1	74.0	14.9	34.2	20.3	33.7	24.6	11.9	29.5	30.2	44.4	5.6	40.9	66.0	38.1	4.5	16.8	67.4	42.2	30.5	31.9	67.6	76.4	57.7	6.4	41.8	52.6	36.0	38.9	28.7	38.3	27.1	31.3	70.1	35.6	26.0	41.4	41.2
VPS72	"Swc2, TCFL1, YL-1, YL1"	ENSG00000163159	"Vacuolar protein sorting 72 homolog"	Q15906	1	151176304-151195321	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065709			Approved	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA065709: AB_2685540"	"unprognostic (2.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-1)"	23.8	21.0	33.3	17.0	34.1	12.9	22.7	35.3	39.7	27.5	30.0	26.8	16.8	28.1	19.0	25.0	23.5	15.0	25.4	32.9	35.9	24.9	17.9	18.7	21.2	34.2	33.6	25.8	21.5	21.2	19.1	22.3	34.6	25.8	16.2	18.2	23.5	18.1	56.3	24.3	20.5	24.2	33.6	23.5	23.8	18.7	34.3	27.9	20.0	32.3	26.3	32.2	23.6	36.5	60.7	41.0	92.8	66.9	40.1	35.0	79.5	64.2	33.8	50.4	36.4	43.7	49.4	60.6	77.3	48.7	35.0	56.0	69.1	41.4	38.0	72.2	75.4	52.3	31.0	30.2	55.7	77.8	46.0	28.5	56.8	57.4	47.5	52.8	66.7	74.3	100.2	44.5	40.3	103.3	67.0	54.8	108.5	107.5	69.2	73.2	52.9	95.3	47.1	30.5	65.5	116.8	44.1	67.6	78.9	86.6	76.5	114.4	63.2	26.5	44.9	42.7	82.3	82.5	124.9	96.4	43.4	52.9	49.9	63.3	48.8	82.4	57.2	47.5	55.4	65.8	50.9	49.3	55.3	53.9	50.3	45.6	35.7	75.3	40.6	35.2	67.5	58.3	33.3	34.1	35.3	39.7	32.9	35.9	34.2	33.6	34.6	33.6	34.3	36.5	23.3	6.4	9.1	7.5	21.9	28.4	28.6	40.0	28.5	13.7	24.8	32.1	15.1	24.3	26.8	23.9	4.2	57.6	19.1	24.6	64.6	49.9	12.2	15.2	18.1	25.2	20.3	30.9	6.3	46.4	53.5	24.3	20.9	17.4	31.7	25.4	25.0	18.1	32.0	15.2	6.9	30.6	63.1	22.9	18.8	9.7	25.1	17.7	42.7	2.8	33.8	32.8	29.9	4.5	9.1	59.8	30.5	24.8	13.5	31.4	28.6	35.4	15.7	12.9	52.6	23.3	40.7	39.5	30.4	23.5	31.7	63.1	24.8	16.1	27.1	35.5
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061509-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: AB_2683803"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.52e-1)"	17.5	16.0	16.1	9.8	16.8	15.6	13.4	16.5	23.9	12.0	13.2	13.2	11.2	18.5	16.0	11.2	11.1	9.3	23.1	16.1	18.1	12.3	16.3	10.4	11.8	16.3	16.6	13.2	8.7	12.4	8.2	11.5	16.4	14.0	9.1	16.5	8.1	14.7	41.0	11.3	11.5	14.8	15.7	9.8	9.3	12.2	16.5	14.7	11.2	29.8	11.6	11.3	11.0	18.6	15.0	9.8	26.7	17.3	17.1	25.9	16.2	33.3	23.4	25.9	19.7	15.5	15.7	21.4	13.0	23.6	31.2	20.6	10.2	16.7	33.0	22.3	14.3	30.2	10.0	16.0	26.3	19.1	18.8	21.3	25.0	18.8	26.5	21.1	22.0	20.3	16.4	9.1	27.5	12.6	27.3	20.6	16.3	23.2	8.0	25.3	16.5	8.4	23.6	14.6	6.1	14.7	10.6	11.3	16.1	21.5	9.4	29.3	19.3	16.0	14.7	22.2	19.5	6.0	7.0	14.7	19.7	13.7	22.2	19.2	13.0	12.4	10.6	12.0	9.7	14.2	13.6	11.5	11.0	12.6	14.4	14.3	27.3	12.5	21.8	18.5	14.4	6.1	16.1	16.8	16.5	23.9	16.1	18.1	16.3	16.6	16.4	15.7	16.5	18.6	42.4	51.3	29.3	21.2	23.9	54.4	60.3	54.8	33.0	46.8	33.5	37.5	110.0	40.0	32.5	25.8	33.3	55.6	23.0	32.3	76.3	52.3	11.9	32.9	58.4	46.9	37.8	111.7	17.0	42.0	61.1	52.2	15.8	44.5	45.7	27.5	38.2	63.1	40.9	45.4	16.6	28.1	18.3	26.7	47.1	9.7	47.8	33.0	32.0	10.3	60.4	63.8	28.8	17.1	33.3	50.3	33.2	52.6	16.8	60.9	33.8	70.6	23.6	49.2	26.3	55.3	66.7	87.5	103.9	29.7	44.9	49.9	22.3	31.9	27.6	40.9
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234632-27308636	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	16.5	24.4	25.4	10.5	22.3	14.7	17.5	20.2	25.4	18.9	12.7	24.7	12.9	19.7	7.0	18.0	19.9	10.5	35.9	21.8	20.0	19.9	18.7	16.9	14.4	25.3	21.0	19.0	22.1	47.7	16.9	10.6	24.4	19.3	9.5	33.5	20.1	15.1	63.0	24.8	18.0	12.0	19.4	17.7	23.2	37.6	23.5	19.8	18.4	54.4	12.7	19.8	18.5	21.1	19.8	8.6	13.5	1.3	18.9	15.8	5.6	12.0	20.1	12.7	15.5	2.9	19.3	17.0	14.0	24.0	9.3	10.1	13.0	18.4	11.0	23.2	22.0	17.7	8.9	7.9	17.0	9.0	22.4	15.1	29.6	15.8	14.4	22.9	17.4	5.4	18.2	17.2	13.6	11.1	14.6	21.6	6.3	13.0	18.1	7.3	10.1	18.7	15.2	4.2	19.7	16.9	15.7	6.6	14.4	10.1	9.8	15.5	15.2	10.3	6.2	14.5	5.9	24.7	14.2	8.1	20.8	17.3	12.5	0.1	0.2	2.7	1.4	0.3	0.5	0.6	0.3	0.6	0.7	0.4	0.2	0.6	2.1	0.4	0.2	0.5	0.4	0.5	25.4	22.3	20.2	25.4	21.8	20.0	25.3	21.0	24.4	19.4	23.5	21.1	10.8	9.6	10.7	19.6	13.8	12.9	10.3	8.4	16.5	31.4	18.5	14.5	15.6	14.3	7.6	31.3	54.2	14.2	14.3	17.3	9.8	15.1	29.8	15.3	8.2	10.1	16.7	32.8	22.4	14.1	4.8	10.6	16.3	13.2	1.3	15.4	18.5	16.6	13.0	21.9	21.2	16.9	6.1	21.0	11.3	66.2	17.1	15.8	10.6	19.7	18.9	15.8	28.8	16.6	22.2	16.0	10.1	16.6	12.3	17.2	26.6	19.1	18.4	70.0	6.6	17.1	10.3	30.9	6.6	13.0	17.3	16.4	13.3	14.1	15.0	16.8
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344275-1400222	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008445, CAB016200, CAB021109, CAB047350"	Approved		Supported	Cytosol		NA	NA		83000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	221.9	198.9	251.8	122.8	264.2	121.3	198.7	266.3	272.8	168.8	195.7	161.1	136.8	155.6	192.7	239.1	188.1	103.7	242.3	260.7	275.4	229.3	211.7	176.9	113.7	271.1	246.8	170.8	154.9	236.9	178.8	198.2	267.1	150.0	168.1	220.8	184.8	121.6	656.7	193.3	129.3	137.3	279.2	101.5	136.9	165.4	262.2	211.0	208.5	441.8	164.5	186.9	179.7	302.7	615.3	565.8	700.2	563.4	376.9	454.7	589.8	382.1	481.5	724.5	571.3	907.5	305.5	524.7	411.9	621.9	439.7	463.1	859.2	745.6	798.7	294.2	930.9	334.1	366.2	409.4	483.4	277.1	311.1	421.6	458.6	619.3	897.0	520.6	729.2	458.5	402.8	337.9	719.7	368.5	445.8	264.1	566.6	596.9	332.7	477.3	255.9	380.4	547.7	365.7	354.2	497.2	531.1	240.3	364.3	439.9	442.3	290.9	467.4	411.9	293.8	453.7	731.4	190.5	329.9	346.6	478.4	387.5	585.4	78.6	137.2	41.2	47.3	153.6	57.8	78.1	67.3	55.1	180.3	59.1	55.7	51.2	49.9	64.1	144.8	133.8	99.7	151.0	251.8	264.2	266.3	272.8	260.7	275.4	271.1	246.8	267.1	279.2	262.2	302.7	363.6	298.1	194.4	83.2	161.1	573.9	457.5	468.4	281.7	153.6	313.6	219.1	473.4	265.9	310.9	371.5	50.1	463.2	128.7	300.7	745.4	460.8	258.0	573.6	414.3	352.6	352.6	244.7	73.4	421.4	709.5	319.4	194.7	502.7	211.5	328.1	262.3	309.0	384.9	111.0	72.4	346.3	376.4	260.9	434.9	434.3	280.8	227.5	425.2	60.0	320.5	357.8	55.6	56.8	112.1	464.8	289.8	294.9	279.5	487.9	272.1	707.8	504.6	173.3	243.3	361.2	524.6	508.7	573.3	333.8	586.6	519.5	130.7	287.2	361.1	474.4
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500976	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 91.0"					"Low region specificity"	"Detected in all"			HPA077591	Approved		Approved	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Centrosome"	"Nuclear membrane"	"HPA077591: AB_2686847"	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	20.4	35.8	16.4	11.8	17.7	7.2	16.8	20.0	16.1	16.9	11.3	16.4	18.9	18.0	5.3	12.2	13.0	12.9	32.5	14.4	17.1	13.9	32.5	12.2	12.5	25.1	21.7	13.1	21.4	11.3	10.4	9.9	22.8	15.4	11.5	8.1	16.8	10.5	70.9	22.3	20.4	9.3	21.3	15.5	14.7	7.8	20.9	11.3	12.1	37.4	9.3	13.1	12.9	16.2	11.6	28.3	20.2	22.4	12.6	13.3	91.0	16.1	17.5	9.3	10.7	36.4	10.0	22.8	18.1	21.5	25.5	5.4	19.5	16.7	6.9	27.0	26.0	17.0	23.4	31.3	16.5	10.6	34.1	19.7	12.8	9.8	7.3	13.8	22.1	15.2	21.9	7.3	18.2	8.2	17.7	8.5	49.9	7.4	16.6	14.0	20.0	10.8	15.6	22.2	24.0	23.6	13.7	36.2	25.6	22.6	10.0	22.3	30.7	19.9	10.5	11.0	17.7	8.7	0.1	37.4	8.1	14.8	11.5	2.2	11.8	10.3	10.6	11.7	9.3	8.4	6.1	5.9	13.3	11.2	5.7	4.9	12.5	5.5	9.8	9.7	6.4	11.7	16.4	17.7	20.0	16.1	14.4	17.1	25.1	21.7	22.8	21.3	20.9	16.2	12.9	12.8	11.7	0.0	20.7	15.2	17.6	14.1	29.6	55.5	12.9	12.4	27.8	40.0	9.2	25.8	14.6	15.9	18.7	23.3	11.7	22.8	0.4	23.0	18.2	17.5	15.5	7.6	0.0	23.4	18.0	22.6	8.2	28.5	14.7	37.1	18.5	37.3	18.0	10.1	0.0	19.4	10.2	22.2	24.9	1.3	19.9	19.5	8.8	0.0	23.0	20.5	34.0	0.0	0.0	22.7	17.3	23.0	8.8	19.7	25.5	18.1	15.8	23.5	6.6	23.7	19.2	0.7	2.6	15.8	11.2	38.0	14.4	29.5	23.2	12.9
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653697-42667580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.9;Inhibitory neurons: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5;fHDF/TERT166: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favorable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	23.2	13.7	74.4	9.3	69.3	2.7	17.9	52.6	65.3	21.5	32.9	29.3	3.9	23.0	4.5	11.5	15.2	11.4	70.3	61.0	54.0	9.4	6.2	14.0	2.7	70.5	63.8	15.3	13.4	9.9	12.3	6.2	58.2	23.5	3.3	6.5	17.4	14.5	112.5	16.4	11.2	14.8	59.9	7.2	18.7	9.1	70.8	2.0	19.4	63.1	1.8	23.7	15.9	81.2	6.7	5.9	3.6	2.4	55.5	20.7	1.2	15.1	12.7	6.5	4.7	1.3	2.7	0.1	6.4	30.9	2.5	1.6	0.9	5.9	1.2	0.0	7.2	3.7	18.9	1.6	17.5	0.1	5.3	23.5	10.4	8.5	7.1	17.0	7.3	0.0	3.9	4.8	12.9	1.7	0.2	0.5	2.1	0.2	3.5	5.0	6.7	1.9	3.4	1.3	4.0	6.7	7.3	1.2	6.0	1.5	8.3	8.6	17.3	14.1	8.2	13.9	6.4	0.2	0.0	0.0	13.1	4.8	4.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	74.4	69.3	52.6	65.3	61.0	54.0	70.5	63.8	58.2	59.9	70.8	81.2	1.8	0.0	1.1	21.9	0.0	4.0	1.5	3.6	3.4	6.4	0.8	0.9	10.5	0.0	1.8	1.8	0.0	0.1	1.6	0.1	0.0	0.7	10.0	0.5	4.5	2.1	0.0	0.0	7.8	1.3	0.2	6.4	4.6	1.2	4.5	2.9	2.2	0.7	1.4	0.0	11.8	0.3	2.0	1.9	4.1	2.5	3.4	2.0	8.8	8.4	0.8	7.7	0.0	9.0	11.5	0.6	1.2	3.0	1.9	2.0	0.0	0.6	1.1	1.9	0.0	7.8	4.4	0.0	0.2	1.3	3.1	0.1	0.4	5.9	0.0	1.1
ZC3H12C	"KIAA1726, MCPIP3"	ENSG00000149289	"Zinc finger CCCH-type containing 12C"	Q9C0D7	11	110093392-110171841	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"HSkMC: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038836, HPA038837"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane, Golgi apparatus"		"HPA038836: AB_2676229, HPA038837: AB_10675953"	"unprognostic (1.22e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (9.90e-6)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.11e-1)"	4.6	4.2	4.0	2.4	6.7	3.2	2.5	6.5	3.9	4.0	2.7	4.6	1.7	3.7	1.7	3.2	3.2	4.7	4.4	4.2	4.9	3.4	4.0	4.0	1.5	6.8	5.6	6.7	3.5	4.7	3.2	2.6	5.5	3.5	3.7	4.1	2.3	3.3	10.5	5.9	2.6	4.4	4.1	1.8	2.4	3.4	5.4	1.5	8.1	13.2	1.4	5.4	2.1	6.5	6.1	3.6	14.0	0.0	6.4	14.8	2.7	2.3	15.7	4.1	6.8	4.6	5.6	0.1	8.7	7.1	10.3	5.8	2.8	8.5	8.1	23.2	2.0	9.7	4.5	1.7	7.2	0.0	4.4	23.8	8.0	7.2	11.7	8.1	5.8	0.0	0.9	1.3	8.6	0.9	0.0	0.0	2.2	0.1	12.7	0.0	4.9	0.6	4.6	12.4	6.4	11.5	5.6	0.4	10.5	2.7	3.5	3.6	9.8	9.1	4.4	4.8	5.2	0.5	0.0	0.0	5.5	1.7	10.8	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	6.7	6.5	3.9	4.2	4.9	6.8	5.6	5.5	4.1	5.4	6.5	21.1	35.3	8.6	102.2	1.1	47.4	4.8	19.1	7.4	8.8	3.5	5.0	15.5	2.8	9.1	5.5	4.2	1.5	0.2	17.0	0.0	6.1	10.6	8.6	6.7	14.9	8.9	2.1	23.8	3.5	0.5	8.9	5.6	14.1	0.0	5.2	13.6	6.4	10.9	15.2	50.0	8.1	0.0	5.7	39.3	11.8	9.6	9.9	23.2	26.2	3.9	5.6	0.0	52.3	56.1	3.4	15.2	8.2	0.6	21.0	5.7	6.6	8.9	2.7	0.0	9.1	5.7	4.6	0.8	3.2	66.5	0.8	1.1	5.6	8.0	7.8
ZFYVE9	"MADHIP, PPP1R173, SARA, SMADIP"	ENSG00000157077	"Zinc finger FYVE-type containing 9"	O95405	1	52142089-52348671	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.0;Inhibitory neurons: 162.6;Oligodendrocyte precursor cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017702, HPA065852, HPA065862"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570"	"unprognostic (5.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.73e-2)"	9.3	8.2	13.7	3.3	14.5	1.1	11.2	20.5	16.6	12.4	31.1	8.3	5.7	12.0	7.3	9.1	10.0	6.9	7.2	15.5	13.2	12.9	9.2	9.8	2.2	13.0	13.2	16.3	15.0	25.7	8.9	6.3	14.2	11.1	8.2	13.7	9.2	11.1	25.7	10.7	5.5	11.2	10.9	3.6	7.4	13.8	13.5	5.3	16.9	20.2	3.4	8.9	8.6	13.5	17.9	8.3	11.7	15.1	27.5	25.0	19.2	14.2	18.8	16.5	18.8	9.6	1.4	0.0	8.7	20.0	22.7	6.5	20.8	22.5	25.1	0.1	14.6	5.1	9.3	11.4	18.0	4.5	2.9	16.7	24.9	14.2	31.9	20.1	24.0	11.8	8.0	3.2	22.2	3.9	6.5	3.3	15.4	4.7	14.8	5.7	20.1	1.7	9.4	38.5	9.9	10.2	15.9	13.4	18.4	23.2	6.2	5.9	22.3	16.6	6.7	12.8	8.6	4.5	2.9	2.2	11.8	5.4	6.8	1.3	0.0	0.1	0.2	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.1	13.7	14.5	20.5	16.6	15.5	13.2	13.0	13.2	14.2	10.9	13.5	13.5	11.5	9.6	5.9	61.7	0.7	5.1	10.0	4.0	10.8	19.9	6.6	5.7	13.6	7.2	9.4	1.8	4.2	5.5	1.1	8.8	7.9	6.4	12.6	6.3	19.1	9.3	17.5	0.0	131.0	7.4	5.3	11.0	23.4	7.9	1.3	16.0	5.0	8.5	0.5	23.5	162.6	8.1	2.0	0.6	1.3	17.3	15.2	0.5	7.2	45.9	0.2	10.0	1.0	80.9	37.5	4.1	7.9	16.6	3.5	7.8	8.2	10.2	2.5	14.3	13.1	20.9	8.3	45.5	46.8	11.7	7.4	2.9	3.8	15.0	6.3	6.4
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401215-3409364	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009656, HPA070692"	Approved		Supported	"Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nuclear bodies"	"HPA009656: AB_1080679, HPA070692: "	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	6.7	7.0	7.8	5.5	8.3	4.0	6.8	8.0	9.1	8.1	7.1	10.4	6.1	9.5	11.5	6.1	10.8	5.6	10.0	7.4	9.0	6.6	6.6	5.4	8.2	8.0	8.1	12.6	5.8	14.1	9.3	5.0	8.3	8.8	7.1	9.9	7.9	10.9	9.9	7.4	6.4	10.3	7.8	7.3	6.8	9.5	8.3	9.5	7.5	10.6	8.4	9.0	6.8	9.4	7.1	11.6	13.1	14.9	15.8	11.3	8.4	6.1	16.2	14.2	12.7	8.8	12.3	23.0	9.3	11.9	12.7	10.1	12.4	11.0	13.1	14.0	11.7	12.2	11.2	11.4	11.3	14.5	13.9	13.3	12.6	11.9	11.9	13.6	11.7	16.8	18.9	10.8	14.7	12.2	14.7	12.4	13.9	10.5	14.2	19.8	14.3	19.3	10.0	3.6	12.0	9.1	12.7	14.1	11.0	12.2	13.7	15.4	9.1	10.4	10.8	8.3	8.5	12.9	14.9	19.5	5.6	9.1	10.1	17.4	6.4	27.0	9.6	7.5	9.1	10.3	10.0	11.0	7.9	8.0	12.0	8.9	7.8	8.5	5.1	4.2	10.2	7.6	7.8	8.3	8.0	9.1	7.4	9.0	8.0	8.1	8.3	7.8	8.3	9.4	4.3	3.2	2.0	4.9	4.1	1.9	1.4	2.6	6.2	6.4	3.3	4.3	5.3	4.3	1.8	0.0	6.2	6.1	5.6	3.0	3.9	5.0	7.1	5.4	4.4	5.2	3.6	5.5	3.4	4.3	3.8	4.7	1.5	2.5	1.3	4.9	2.9	3.5	4.5	3.3	4.3	2.2	8.2	2.5	0.9	4.0	8.7	2.6	3.6	1.0	2.4	7.7	8.2	3.5	10.6	4.0	5.0	9.8	4.6	2.2	4.7	4.7	1.6	8.8	0.0	4.7	4.0	15.1	10.3	4.7	1.8	2.9	4.0	5.8	3.4	0.8
ZNF32	"KOX30, Zfp637, ZNF637"	ENSG00000169740	"Zinc finger protein 32"	P17041	10	43643860-43648881	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039148			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies"	Nucleoplasm	"HPA039148: AB_2676365"	"unprognostic (1.05e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.15e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.90e-3)"	"prognostic favorable (3.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (6.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	33.2	33.2	69.4	13.2	71.9	8.3	45.9	71.0	101.5	46.0	69.0	56.7	12.7	42.9	57.5	23.1	40.0	23.4	60.0	69.0	70.8	49.9	32.4	26.5	22.1	71.3	71.0	52.8	48.1	47.7	45.1	16.6	70.4	48.5	23.4	40.8	31.0	38.1	84.3	31.5	29.6	36.8	70.1	36.0	37.8	16.2	70.9	32.8	41.9	72.9	25.9	41.2	32.9	73.3	25.0	21.8	32.3	48.9	58.1	62.1	10.6	21.9	65.5	39.9	35.8	14.8	12.5	0.1	37.7	46.7	18.8	14.5	20.7	21.2	29.2	27.5	23.0	6.6	13.2	17.2	54.4	0.7	19.7	64.1	48.0	24.7	29.7	38.2	30.6	86.8	19.5	0.0	50.9	22.8	25.2	22.8	25.2	25.2	11.3	38.5	36.3	5.7	40.8	9.7	41.2	36.7	18.1	13.3	35.4	35.3	49.0	23.0	13.1	22.3	26.8	16.4	5.4	14.3	40.2	0.1	8.0	15.9	21.1	14.0	13.9	18.2	36.5	12.9	36.8	26.0	29.2	41.1	22.9	27.2	37.0	41.6	1.1	50.4	11.6	19.3	22.8	20.7	69.4	71.9	71.0	101.5	69.0	70.8	71.3	71.0	70.4	70.1	70.9	73.3	26.1	9.6	14.3	14.0	18.8	11.0	24.4	28.6	33.0	23.2	41.4	57.8	11.7	22.8	16.9	18.4	8.4	18.0	31.9	7.5	105.7	44.7	2.3	16.2	25.6	23.8	27.7	16.8	9.7	47.4	17.1	27.3	16.3	11.5	30.4	34.1	25.7	25.5	29.4	16.8	11.1	16.0	22.4	22.3	10.1	2.1	42.3	19.0	17.8	9.4	15.8	52.7	58.7	16.6	23.0	28.4	10.3	54.5	9.5	36.2	10.0	53.1	12.6	24.1	32.9	38.3	34.2	17.0	14.3	26.4	15.3	6.7	27.1	33.0	17.9	17.9
ZNF423	"Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015258: , HPA065820: AB_2685563"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	9.1	2.9	13.5	2.3	9.6	0.3	6.7	14.0	10.2	6.3	1.0	4.3	1.3	5.4	3.4	4.7	9.3	5.8	7.8	9.7	11.0	2.0	0.7	2.9	1.9	14.9	30.4	7.6	3.4	3.0	4.0	4.2	11.8	6.0	2.7	3.6	2.8	9.5	27.5	2.0	2.6	6.5	8.6	1.4	2.0	4.5	26.3	1.8	4.3	14.7	1.2	3.9	5.4	7.8	0.0	0.0	62.6	3.3	5.1	0.6	7.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.4	0.0	0.0	1.9	0.5	0.0	3.6	0.1	0.2	0.0	0.0	4.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	8.8	0.4	33.2	0.0	0.0	27.5	0.1	0.0	0.0	1.7	35.1	87.7	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	1.0	16.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.5	9.6	14.0	10.2	9.7	11.0	14.9	30.4	11.8	8.6	26.3	7.8	12.7	0.0	0.0	75.4	0.0	2.7	0.3	0.1	1.2	9.8	0.6	0.6	2.6	0.0	0.0	0.0	0.0	0.5	0.1	2.3	1.9	0.2	23.5	2.7	7.6	11.4	0.0	0.0	10.9	0.2	0.7	15.8	0.0	0.6	0.0	1.6	15.4	0.9	0.7	0.0	7.4	1.0	0.0	0.3	5.1	115.7	27.7	0.4	1.8	53.4	0.0	11.7	0.0	38.7	5.1	0.2	0.4	54.5	0.2	0.1	0.2	0.6	0.0	1.1	0.0	4.5	6.4	0.8	1.9	0.1	1.7	0.3	0.3	5.5	0.7	0.1
ZNF425		ENSG00000204947	"Zinc finger protein 425"	Q6IV72	7	149102784-149126324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 8.5;Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA020087	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA020087: AB_2670358"	"unprognostic (4.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-4)"	"unprognostic (9.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.21e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.25e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.58e-2)"	0.8	1.2	3.1	0.9	3.1	0.6	1.7	3.3	3.2	2.1	2.1	2.1	1.0	2.4	2.1	2.1	2.3	1.0	0.8	3.0	2.7	2.2	1.0	1.0	0.8	2.8	2.8	3.8	1.5	2.3	1.4	0.7	2.8	1.9	0.8	1.4	1.8	2.2	3.8	2.5	0.9	1.7	2.6	1.0	1.6	1.3	2.9	1.6	1.9	1.9	1.2	1.9	1.5	2.8	1.4	1.7	3.6	3.1	5.3	1.5	2.0	2.0	3.4	1.1	1.2	0.4	1.8	1.6	2.8	1.6	1.4	1.9	0.6	1.0	0.4	1.1	1.4	1.9	2.4	0.8	3.0	0.9	0.8	3.1	1.7	1.1	2.0	3.0	0.5	2.4	1.4	1.5	3.7	6.6	2.5	2.9	8.6	2.0	3.3	2.7	1.8	0.9	2.4	1.9	1.6	3.0	1.9	2.4	4.5	2.3	1.6	2.6	0.7	2.3	0.3	2.7	0.5	3.2	2.1	1.2	1.9	0.6	1.9	2.1	0.6	1.4	1.8	0.7	2.3	1.4	1.5	1.2	0.6	1.8	2.1	2.3	1.6	3.2	0.4	2.1	2.0	0.8	3.1	3.1	3.3	3.2	3.0	2.7	2.8	2.8	2.8	2.6	2.9	2.8	0.4	0.0	2.0	5.2	1.9	0.3	0.8	0.7	2.2	3.4	1.8	1.5	1.8	0.0	1.2	3.7	0.0	0.8	0.3	0.5	5.9	1.6	0.9	1.4	2.2	0.6	1.2	3.0	7.5	0.5	0.8	1.5	4.6	1.2	0.0	3.4	0.4	0.6	0.4	6.7	8.5	0.7	2.0	0.0	0.2	0.3	4.4	0.6	0.0	7.5	1.8	4.7	0.0	9.0	10.7	0.6	0.6	5.3	1.3	1.0	0.7	1.1	2.4	1.2	0.0	2.3	1.5	3.5	3.5	2.8	0.3	1.0	1.4	3.0	0.8	0.5
ZNF462	"DKFZP762N2316, KIAA1803, Zfp462"	ENSG00000148143	"Zinc finger protein 462"	Q96JM2	9	106863166-107013634	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.9;Oligodendrocyte precursor cells: 486.5;Oligodendrocytes: 152.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022283	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA022283: AB_2220602"	"unprognostic (4.22e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-2)"	3.4	8.4	10.6	1.9	16.6	0.1	3.8	13.9	14.2	8.0	6.2	4.9	1.0	4.2	1.8	7.8	5.2	2.9	5.8	8.6	16.4	3.9	1.6	3.0	0.8	14.7	16.0	7.4	1.1	6.1	4.1	3.1	17.6	6.8	3.8	8.2	7.7	4.1	13.2	6.7	2.2	6.7	10.0	2.9	1.7	5.9	16.0	2.0	7.2	5.8	1.3	3.9	6.2	15.9	4.8	12.6	22.5	14.0	6.9	4.9	3.2	3.2	4.0	2.8	3.0	14.8	5.7	0.1	8.3	2.9	13.8	7.6	14.9	12.4	3.5	0.1	2.1	0.0	5.3	0.1	2.6	3.4	0.4	4.6	6.0	6.8	18.0	7.4	1.3	6.0	0.0	6.7	7.3	8.2	2.7	0.1	16.0	0.0	10.0	0.0	15.4	0.3	7.8	4.4	10.6	12.3	6.3	0.1	4.7	13.7	11.2	0.1	1.3	3.8	13.2	8.1	9.8	0.0	0.1	0.1	5.8	0.3	13.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	10.6	16.6	13.9	14.2	8.6	16.4	14.7	16.0	17.6	10.0	16.0	15.9	25.6	22.4	29.1	114.9	0.9	33.6	10.8	10.6	44.9	60.7	21.6	18.7	27.7	25.8	10.3	7.3	31.3	14.4	0.2	14.7	5.9	7.9	63.1	7.6	25.5	23.3	16.8	2.1	18.4	2.6	7.3	14.1	4.1	10.1	17.1	18.7	40.4	0.0	1.8	18.5	91.6	15.5	12.2	0.8	4.2	16.8	14.6	1.3	12.4	15.9	2.0	19.8	0.0	486.5	152.2	7.7	5.3	27.1	0.0	15.1	6.3	17.4	15.2	39.4	26.3	21.5	22.1	1.3	24.7	24.0	11.5	3.1	1.1	22.0	17.5	6.6
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Approved	Mitochondria		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favorable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	2.9	5.1	7.1	3.4	7.3	2.0	3.2	7.9	8.2	4.5	3.9	8.0	3.7	7.2	2.5	2.8	5.7	2.5	4.4	7.5	6.6	4.2	4.2	3.5	4.5	5.7	6.0	3.2	5.6	6.4	5.1	2.0	5.8	4.6	2.4	3.8	4.2	4.4	5.3	4.2	4.1	4.5	5.3	4.2	4.9	2.4	6.7	8.1	3.5	3.7	3.0	5.5	2.8	7.1	7.7	13.4	32.0	25.2	4.3	3.0	9.8	5.7	9.7	12.1	11.2	6.7	10.0	16.2	10.7	5.3	3.4	6.6	15.7	8.9	6.8	12.0	20.2	7.2	6.9	10.2	5.9	9.6	9.1	2.6	11.0	10.0	6.6	11.4	10.9	14.3	12.6	7.2	5.3	28.1	20.8	11.9	26.4	6.0	5.4	47.7	7.4	20.0	7.4	6.6	25.1	31.6	2.5	16.7	2.5	8.4	11.2	8.9	5.1	7.0	8.1	6.3	6.5	8.6	10.9	14.8	4.0	5.8	1.7	0.0	0.0	0.4	0.9	0.0	0.6	0.3	0.4	0.5	0.1	0.3	0.5	0.6	0.0	0.9	0.0	0.4	0.5	0.1	7.1	7.3	7.9	8.2	7.5	6.6	5.7	6.0	5.8	5.3	6.7	7.1	4.0	3.2	2.2	4.6	6.1	3.1	2.5	1.7	4.0	11.7	4.8	5.1	5.4	14.3	3.9	3.7	8.4	3.7	6.7	4.8	1.9	10.4	0.2	3.7	2.8	5.4	9.6	5.2	4.9	7.4	2.2	2.8	1.5	3.7	17.2	7.5	4.2	3.1	2.7	16.8	5.5	4.0	2.0	1.6	2.6	0.3	2.8	1.7	1.8	2.8	6.9	6.6	3.1	1.0	4.0	7.2	5.4	6.8	2.0	4.3	3.5	4.1	1.0	7.3	0.0	3.0	5.5	3.5	3.3	1.8	5.3	0.3	5.0	3.7	6.1	1.7
ZNF511	"MGC30006, Zfp511"	ENSG00000198546	"Zinc finger protein 511"	Q8NB15	10	133308914-133313162	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035360	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931"	"unprognostic (3.35e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.52e-2)"	12.7	11.6	15.9	8.7	16.2	17.1	11.3	15.5	17.2	15.8	17.5	19.7	16.1	15.7	10.7	10.8	15.4	9.4	21.2	15.4	15.4	10.4	21.3	11.4	12.6	16.7	15.9	20.4	15.5	14.7	12.7	8.7	15.7	16.1	12.8	5.8	16.7	10.7	49.1	7.9	13.2	11.1	16.4	12.5	12.5	9.6	16.8	11.4	10.9	31.9	9.7	13.6	12.5	16.5	54.1	54.0	30.3	43.8	25.6	21.6	32.6	25.2	39.3	53.3	44.4	88.0	50.9	48.2	24.4	29.5	33.9	48.8	41.9	36.0	23.2	38.8	92.1	29.1	22.1	53.4	21.0	57.5	52.1	22.0	19.2	43.7	26.5	30.6	24.3	22.7	40.0	22.4	18.6	71.2	27.5	76.1	37.3	50.2	74.6	37.1	37.1	12.4	28.3	18.6	16.9	37.0	16.8	30.0	38.2	18.7	23.2	33.1	23.3	23.1	35.4	26.5	68.5	31.3	36.4	66.1	37.5	26.8	12.9	40.2	61.1	68.6	45.4	52.6	35.6	66.6	37.0	46.6	61.0	51.8	41.6	40.8	8.5	41.0	51.1	65.9	36.2	47.3	15.9	16.2	15.5	17.2	15.4	15.4	16.7	15.9	15.7	16.4	16.8	16.5	16.3	16.0	14.5	7.5	33.6	29.6	45.6	40.7	39.3	19.5	37.3	52.6	23.6	25.8	21.9	22.0	8.4	61.2	36.7	33.3	70.5	39.5	29.5	18.5	22.4	20.9	53.4	40.2	10.7	41.2	62.9	34.0	20.4	15.2	78.1	40.6	20.3	54.4	47.4	21.9	7.6	128.8	22.4	33.9	38.0	8.8	41.7	39.9	16.0	5.6	64.3	27.4	41.2	3.5	12.3	38.6	44.0	30.5	40.4	43.0	60.8	72.1	23.2	23.6	26.3	27.3	34.5	58.1	48.0	36.3	35.9	28.2	33.0	38.6	65.9	41.5
ZNF532	FLJ10697	ENSG00000074657	"Zinc finger protein 532"	Q9HCE3	18	58862600-58986480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.1;Excitatory neurons: 86.9;Inhibitory neurons: 90.9;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 178.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015322	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA015322: AB_2304947"	"unprognostic (3.43e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (4.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (5.76e-4)"	24.0	12.5	33.5	15.7	53.1	1.4	17.9	73.9	39.8	30.3	12.4	25.9	7.2	65.1	20.1	22.3	26.2	24.5	36.0	34.3	45.0	14.1	4.2	19.9	14.2	55.2	44.2	52.8	6.8	16.3	15.7	26.4	56.6	48.0	13.3	25.7	15.8	34.1	61.1	16.5	12.0	41.4	33.8	17.0	12.8	24.2	46.1	11.9	24.7	49.8	17.4	23.0	21.3	84.8	21.3	30.0	118.8	63.4	18.5	42.2	5.8	37.6	35.2	26.0	23.4	10.2	23.0	26.5	28.3	47.2	12.9	34.1	1.0	29.7	26.7	19.5	25.0	0.0	51.8	0.6	24.5	0.2	0.2	33.1	54.5	27.2	49.5	34.4	28.8	0.0	0.3	31.9	30.8	0.0	0.2	0.3	63.0	1.0	19.9	0.6	31.6	4.2	18.1	2.8	27.1	70.3	24.2	2.6	40.8	78.8	30.3	17.3	22.0	70.7	50.1	0.5	30.7	0.4	21.7	7.3	24.0	0.0	55.2	0.0	0.3	0.0	0.4	1.1	0.1	3.7	0.2	0.2	0.7	1.6	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.4	33.5	53.1	73.9	39.8	34.3	45.0	55.2	44.2	56.6	33.8	46.1	84.8	16.6	12.8	12.2	90.1	13.2	10.6	12.5	8.0	12.0	28.8	9.3	8.8	17.0	5.7	10.1	1.8	27.1	2.0	1.4	0.3	0.0	4.9	4.9	8.3	48.3	24.2	4.2	0.0	86.9	0.5	2.7	17.9	3.1	10.0	0.0	15.8	14.6	0.1	4.4	35.3	90.9	0.2	4.1	9.1	14.3	3.5	11.5	9.2	8.8	53.4	5.2	22.1	0.0	130.2	178.2	6.0	1.4	18.0	8.6	33.5	0.0	1.6	8.8	9.7	13.1	15.5	24.2	5.5	17.2	8.9	9.2	3.4	4.3	5.0	0.3	11.9
ZNF592	"CAMOS, KIAA0211, SCAR5"	ENSG00000166716	"Zinc finger protein 592"	Q92610	15	84748592-84806445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020332, HPA021600"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA020332: AB_1859365, HPA021600: AB_1859364"	"unprognostic (2.83e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.04e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.62e-1)"	9.7	8.7	9.4	6.7	10.0	11.1	9.6	10.4	9.4	9.7	7.4	9.4	7.9	9.1	7.9	7.4	9.8	4.9	9.6	9.8	9.0	8.7	10.9	9.0	9.5	11.5	10.1	11.8	10.9	9.1	7.9	5.9	10.2	8.7	7.1	7.5	7.5	6.5	18.2	10.1	10.7	6.8	9.3	11.2	8.1	8.0	10.2	11.4	8.8	14.5	9.4	8.5	8.3	10.6	7.7	12.8	11.6	6.5	12.7	8.5	12.8	5.3	7.5	8.6	6.8	12.2	8.9	11.1	6.7	11.9	7.4	13.9	18.0	7.6	6.0	9.0	10.8	12.9	12.9	11.0	7.8	10.6	9.9	9.4	10.6	6.7	11.0	10.2	7.6	7.7	13.0	6.8	9.1	12.0	7.2	13.0	10.6	7.3	5.0	10.3	10.4	9.8	9.2	15.4	10.5	11.4	12.1	10.7	9.0	16.1	6.0	22.3	10.8	12.7	7.4	7.1	10.2	7.8	9.0	11.8	8.0	15.5	7.5	0.0	1.2	0.9	1.2	1.4	0.4	1.5	0.7	1.2	1.3	1.4	1.0	0.9	2.6	1.0	1.3	1.0	0.8	0.8	9.4	10.0	10.4	9.4	9.8	9.0	11.5	10.1	10.2	9.3	10.2	10.6	9.2	9.6	10.5	23.8	15.2	8.4	4.2	8.2	6.2	9.0	14.3	8.8	5.3	8.6	7.5	3.7	8.4	5.6	9.6	18.8	0.0	8.4	7.8	24.7	10.8	9.8	7.8	12.0	21.7	8.1	8.9	8.7	13.7	40.3	3.8	10.2	10.4	16.7	11.3	3.3	20.7	10.8	4.1	21.1	9.8	11.8	4.7	14.6	7.2	28.1	14.9	3.7	11.3	10.1	29.9	9.8	11.1	9.8	16.9	5.6	16.2	6.3	8.4	8.5	6.6	13.1	9.2	13.2	12.4	8.9	7.1	4.8	11.6	8.1	11.4	5.1
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569672-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 180.3;Late spermatids: 576.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	8.7	8.4	17.6	9.8	17.5	11.4	5.1	20.5	19.1	6.7	16.4	9.7	14.6	7.8	5.6	5.6	10.4	4.2	7.0	16.5	15.8	8.2	8.3	7.5	9.5	17.5	16.9	9.1	12.3	9.7	8.4	3.3	17.2	7.5	6.4	5.6	10.1	6.9	25.6	9.0	11.6	5.8	16.2	12.0	10.1	13.6	18.1	8.2	5.1	9.7	5.4	6.6	5.7	20.2	10.4	9.5	7.3	8.1	13.3	5.2	3.1	6.7	8.2	5.0	4.0	2.5	15.1	6.2	12.8	6.9	6.0	8.6	2.2	3.6	4.7	16.7	6.4	3.8	3.7	2.7	6.3	4.3	17.9	8.7	8.2	5.3	6.0	7.7	4.7	7.7	3.9	12.0	5.3	13.5	14.9	9.9	3.3	8.6	4.9	13.3	3.8	9.2	8.2	3.2	12.1	13.2	2.4	14.1	15.3	2.0	15.6	7.8	5.4	5.5	4.0	5.2	4.7	20.5	13.2	5.7	12.2	4.3	9.7	12.0	4.6	11.0	6.2	4.2	5.4	6.5	6.6	6.8	4.2	7.6	5.7	5.0	5.3	20.4	6.5	7.4	11.2	3.3	17.6	17.5	20.5	19.1	16.5	15.8	17.5	16.9	17.2	16.2	18.1	20.2	16.3	6.4	3.1	5.9	22.8	6.4	10.5	12.6	16.5	19.8	20.3	22.7	11.2	22.8	10.2	16.5	18.8	7.5	26.0	38.6	49.0	24.8	180.3	25.4	9.5	14.0	20.4	11.2	5.1	31.2	9.6	15.6	17.9	9.0	5.1	12.1	20.7	22.6	24.4	21.9	5.1	27.7	12.2	33.1	12.0	576.6	19.9	17.4	17.8	1.9	28.3	31.2	30.9	9.0	10.3	21.8	37.2	19.9	16.7	10.1	59.2	54.1	38.4	27.4	6.6	17.2	20.2	34.5	8.5	11.2	7.1	4.7	23.2	15.1	23.6	8.5
ZNF710	"DKFZp547K1113, FLJ00306, FLJ37393"	ENSG00000140548	"Zinc finger protein 710"	Q8N1W2	15	90001324-90082206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 44.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.8;Microglial cells: 149.9;Oligodendrocytes: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.8"					"Low region specificity"	"Detected in all"			"HPA030226, HPA030227, HPA030228"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899"	"unprognostic (6.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.65e-2)"	3.6	4.3	12.0	14.7	13.0	8.7	5.4	6.4	11.2	6.3	3.1	8.3	9.1	5.3	5.0	17.1	5.2	7.0	10.0	6.9	8.8	5.7	5.3	9.8	10.0	12.2	13.6	4.8	44.2	3.3	4.5	5.7	12.9	7.5	6.9	1.2	9.6	4.3	33.4	12.6	8.0	3.4	10.4	14.2	10.2	1.7	12.4	5.6	6.2	1.5	6.5	7.7	9.2	11.5	9.2	10.7	20.1	7.6	2.7	4.0	10.5	9.4	8.8	6.8	8.6	7.7	8.3	9.3	4.3	9.1	6.4	6.2	5.1	13.5	3.8	6.0	9.4	17.1	4.6	13.1	5.5	5.0	25.6	6.6	7.2	14.6	7.9	3.2	11.8	10.0	5.8	6.2	2.6	23.7	11.1	13.9	15.8	11.3	6.9	13.5	4.5	10.2	2.7	11.4	18.3	12.3	12.5	44.8	6.4	5.2	9.6	17.2	17.1	13.9	6.8	4.2	7.4	5.0	2.7	9.0	10.6	14.6	7.4	0.0	1.6	1.2	0.2	3.5	0.2	0.1	0.1	0.2	1.2	0.1	0.4	0.4	1.9	0.2	5.7	1.4	0.5	0.7	12.0	13.0	6.4	11.2	6.9	8.8	12.2	13.6	12.9	10.4	12.4	11.5	1.7	3.2	8.2	38.8	2.7	5.4	4.7	2.8	1.8	1.4	7.1	3.6	12.1	4.3	6.3	11.0	2.1	2.3	6.8	7.7	0.0	3.6	0.8	4.0	4.1	4.3	4.8	2.5	10.2	6.1	3.0	3.1	7.1	6.2	1.3	2.1	5.7	1.6	11.6	3.3	12.0	8.1	0.0	15.8	33.5	5.5	2.5	15.7	1.8	149.9	13.3	1.4	2.1	22.1	36.4	10.1	11.5	3.0	3.8	8.5	2.3	0.8	3.6	0.9	6.6	1.6	3.0	0.3	2.5	4.3	7.5	2.3	2.5	2.0	6.5	13.7
ZNF768	FLJ23436	ENSG00000169957	"Zinc finger protein 768"	Q9H5H4	16	30524004-30526821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024630, HPA066512"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA024630: AB_1859446, HPA066512: AB_2685683"	"unprognostic (2.33e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (9.30e-6)"	"unprognostic (4.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-1)"	"prognostic favorable (6.46e-4)"	22.3	23.2	31.4	9.9	32.9	13.3	22.6	30.6	35.0	28.7	28.3	42.6	29.8	30.8	9.9	22.8	27.5	10.1	49.3	27.8	27.7	34.8	38.5	19.0	7.3	32.3	31.9	28.9	25.7	30.2	27.2	11.3	30.3	30.3	17.0	13.7	25.6	21.1	93.8	28.2	31.1	13.4	28.5	22.1	30.9	39.3	33.0	6.0	23.7	53.1	7.4	34.9	23.0	29.9	27.1	33.3	37.0	36.1	17.6	20.3	29.1	20.2	22.5	32.7	28.4	21.3	36.8	17.1	30.1	14.2	26.3	35.4	24.8	24.1	19.4	38.5	52.6	40.0	24.0	30.0	44.1	26.8	121.3	17.9	52.5	25.1	32.4	30.2	21.9	6.7	47.4	28.0	17.1	74.9	10.0	64.7	34.8	22.0	27.1	50.7	24.7	42.5	23.9	14.0	43.6	48.4	11.5	59.9	77.3	15.9	59.3	66.5	14.9	34.2	25.9	19.4	22.8	41.3	32.4	21.1	28.5	41.4	35.2	0.0	0.4	1.0	0.0	0.6	0.1	1.1	0.1	0.0	0.6	0.4	0.1	0.0	0.5	0.6	0.1	0.5	0.0	0.2	31.4	32.9	30.6	35.0	27.8	27.7	32.3	31.9	30.3	28.5	33.0	29.9	9.7	9.6	1.9	8.8	4.1	5.5	6.7	9.5	6.8	13.3	15.4	12.6	7.6	14.3	5.5	16.5	2.1	7.2	2.0	50.4	11.7	12.2	18.4	10.9	9.9	9.2	18.0	3.8	2.6	16.2	8.0	6.5	10.7	13.3	3.8	15.5	14.6	17.9	12.7	21.9	3.4	29.1	8.2	8.1	7.7	7.4	10.8	6.1	5.4	4.7	6.8	16.5	0.0	4.0	4.5	11.6	38.2	13.2	2.2	7.9	38.9	17.0	7.4	12.7	6.6	11.8	10.5	15.2	5.1	10.0	5.7	3.6	2.1	14.1	31.3	5.3
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615610-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.2;Granulosa cells: 15.1;Muller glia cells: 13.2;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.1;SH-SY5Y: 29.5;U-2 OS: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoli		"HPA067690: AB_2685888"	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	4.1	2.8	24.8	2.3	24.7	0.6	4.5	20.4	24.0	9.6	11.8	12.9	1.1	11.3	4.4	4.3	9.2	4.5	10.5	23.7	23.7	4.9	0.5	3.7	2.9	27.8	27.9	12.0	7.0	5.5	6.6	2.8	25.1	7.8	1.7	5.1	5.4	8.6	27.1	3.1	4.4	6.6	25.6	3.5	4.9	2.6	24.8	3.3	7.9	20.2	2.0	10.1	4.9	21.0	0.0	1.6	4.7	20.1	0.2	0.0	0.2	0.4	0.0	2.1	0.4	3.6	0.8	0.0	7.8	0.0	0.7	0.0	7.2	0.2	2.0	0.0	2.6	0.6	0.0	3.8	2.8	0.0	0.1	0.7	0.6	0.2	0.1	2.0	0.0	1.6	3.2	0.1	1.3	0.1	0.5	2.7	7.5	0.0	0.0	2.3	7.8	0.1	1.5	7.6	6.3	29.5	0.0	0.3	1.2	3.9	1.1	4.3	0.0	1.5	19.5	0.0	1.9	0.4	0.1	0.1	0.0	0.0	7.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	24.8	24.7	20.4	24.0	23.7	23.7	27.8	27.9	25.1	25.6	24.8	21.0	4.3	0.0	0.0	2.0	1.0	0.5	1.5	0.2	1.2	13.2	3.2	4.4	10.4	0.0	0.6	7.3	6.2	0.0	2.0	0.1	0.0	0.6	1.6	7.5	4.3	3.2	1.8	0.4	1.5	0.7	0.0	4.4	0.5	2.3	0.0	15.1	2.5	0.0	0.1	5.0	2.7	0.0	0.0	0.0	0.9	2.4	5.3	0.2	3.6	1.9	0.1	13.2	1.0	2.0	2.8	0.4	0.1	8.6	1.3	3.3	0.0	0.2	2.3	10.4	13.1	6.4	5.4	0.5	0.5	0.4	0.3	0.3	1.8	6.9	0.1	0.7
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726453-52827336	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.9;tongue: 62.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	9.4	8.4	13.5	5.5	14.5	7.6	7.2	15.9	14.0	9.1	3.5	9.9	4.3	10.8	5.9	9.5	6.8	6.6	17.1	13.7	16.0	12.9	18.6	7.6	5.1	8.5	9.7	10.8	5.1	10.0	4.6	7.1	11.1	9.4	7.5	13.4	6.3	8.6	78.9	6.3	4.6	12.5	8.0	5.6	5.0	8.6	16.3	6.9	12.8	62.0	5.4	7.7	5.7	10.3	10.8	9.9	12.1	15.1	21.7	18.5	10.0	11.7	15.3	9.4	8.7	8.4	3.5	10.2	11.1	23.6	12.6	5.5	14.1	10.6	14.9	7.9	8.6	13.1	10.4	5.3	11.5	9.9	7.7	13.5	11.2	13.4	9.4	13.1	16.6	2.3	12.0	2.1	17.2	4.4	3.9	6.4	12.3	5.4	10.0	6.7	22.4	9.3	9.6	17.2	5.5	10.9	20.6	12.8	10.6	15.2	7.7	7.8	19.1	14.4	8.2	14.3	7.4	8.6	10.8	7.4	9.8	6.6	9.5	0.3	0.7	0.9	0.5	0.3	0.6	0.6	0.7	0.4	0.7	0.5	1.1	0.8	1.7	0.6	0.6	0.4	1.0	0.3	13.5	14.5	15.9	14.0	13.7	16.0	8.5	9.7	11.1	8.0	16.3	10.3	26.8	25.6	28.8	29.0	13.4	11.3	10.5	12.1	10.2	49.5	13.6	11.9	88.3	20.0	14.0	14.7	20.9	24.6	6.9	37.2	7.9	12.2	5.7	13.2	40.9	22.1	10.2	9.0	72.4	11.1	12.0	26.3	12.2	18.6	8.2	32.0	32.5	107.7	20.6	97.6	82.6	11.4	14.2	37.5	11.8	7.9	24.5	21.5	21.4	36.5	21.9	21.6	4.1	46.3	52.0	16.3	17.9	30.9	11.6	26.0	14.0	30.0	11.1	24.4	26.3	35.7	25.9	11.4	23.7	17.3	14.6	34.8	9.7	19.5	15.5	19.0